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A b s t r a c t
Electrical stimulation of denervated muscle offers similar potential benefits as that for 
paralysed innervated muscle, such as enhanced tissue viability, cosmesis and retained 
contractile function. For acute nerve injuries, these benefits may enhance functional re­
innervation. Appropriate stimulation parameters are, however, essential in each case to 
optimise benefits and minimise tissue damage.
This pilot study has concentrated on the therapeutic benefits of charge balanced, long pulse, 
biphasic stimulation treatment of peripheral limb muscle, denervated for more than three 
years, with quantitative assessment of some clinically important tissue changes. The five 
study subjects include complete and partial limb denervation arising from T12 level spinal 
cord, peroneal nerve, and brachial plexus injuries. Treatment consisted of two sessions each 
day of up to 30 minutes, stimulating a single muscle group with surface electrodes with the 
contra-lateral limb as control. Non-invasive evaluation measurement of tissue thickness, 
resting limb segment blood flow, resting skin temperature and muscle excitability occurred 
before and at regular intervals throughout the 6 month treatment and 6 month follow-up 
periods. The custom designed portable stimulator unit issued to each subject, was 
programmed from the clinician’s personal computer, allowing on-line change of treatment 
parameters and Strength-Duration testing.
Pulse widths of 100ms or greater were required initially in all cases, eliciting only twitch 
contractions. Muscle responsiveness progressively increased, such that tetanic contractions 
were possible after approximately ten weeks and limited limb movement by the end of the 
treatment period, but no functional use. Trapezoidal, instead of rectangular, shaped pulses 
were used initially in cases of partial limb denervation to minimise co-contraction, but nerve 
accommodation was not possible at tetanic frequencies.
No significant changes in resting tissue property measurements occurred and those that did, 
were confused by high measurement variability including artefacts. However in the case, 
where treatment was most consistent, some positive changes were detectable in all 
measurements, suggesting that greater benefit may accrue from a more prolonged treatment 
period. Subjects remained enthusiastic about the treatment and of its perceived beneficial 
effects.
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1. I n t r o d u c t i o n
In the UK there are an estimated 1000 new spinal cord injuries (SCI) per year and 40,000 people 
are living with the condition; in the US numbers may be 10 times greater. [Hammell, 1995]. Of these 
10%* or more have T12/L1 level injury with possible lower motor neurone damage resulting in 
flaccid paralysis. In addition, there are an estimated 15,000 peripheral nerve injuries (PNI) in the 
US per year [Zanakis, 1990] and in the UK, 350 severe brachial plexus lesions [Wynn Parry, 1994]. 
Despite the sophistication of modem surgical techniques, there remain areas of concern to 
clinicians following lower motor neurone damage;
• During the period of nerve re-growth, the prospects of successful functional recovery may 
be limited by deterioration of the target muscle tissue.
• In cases where re-innervation is limited or absent, the limb undergoes severe atrophy and 
skin deterioration, leading to poor cosmesis with greater risk of ulceration and circulatory 
disorders.
• In cases of impaired function, especially mobility, disuse of the muscle or limb can further 
compound these effects.
For each of these, appropriate electrical stimulation of the denervated muscle has been shown to 
have positive benefits in at least some cases, however such treatment remains far from routine. For 
acute nerve injuries, this is largely due to the continued controversy over its effect on nerve growth 
and re-innervation. For long-term denervation cases, this is due to the ineffectiveness o f infrequent 
treatment with the traditional low frequency ‘galvanic’ stimulation (e.g. 100ms, IHz twitch 
contractions). In addition, there is a lack of awareness of and availability of home-use stimulators 
for the more recent, long pulse biphasic stimulation treatment (e.g.20ms, 20Hz tetanic 
contractions), for which beneficial effects have been demonstrated. Alternative treatment options 
for denervated muscle are limited and often not continued on a long term basis beyond the expected 
period for re-innervation due to the absence of significant functional benefit. The possibility of 
therapeutic value from improved tissue viability and cosmesis appears to be of lesser concern, but 
may ultimately result in greater health care cost savings and quality of life to the individual. 
Chronically denervated muscle is therefore typically allowed to atrophy and deteriorate, with 
consequent physiological and psychological impact on the person.
Cases of lower motor neurone damage may also become apparent from referrals for restoration of 
function by Functional Electrical Stimulation (FES) at centres like the Medical Physics and 
Biomedical Engineering (MPBE) department at Salisbury District Hospital (SDH)^. However the 
absence of a functioning lower motor neurone precludes these cases from such treatment.
1 Estimated from the proportion of intake at Duke of Cornwall Spinal Treatment; Salisbury District Hospital, 
 ^Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ, UK
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In view of this clinical situation and following the beneficial effects demonstrated in other studies 
of direct electrical stimulation of denervated muscle using long duration biphasic pulses, a small 
pilot study was conducted at Salisbury district hospital using this technique [Taylor and Ewins 1992]. 
This involved two typical long term post injury patients, one with flaccid paraplegia following SCI 
and the other 'flail arm' following brachial plexus Lesion (BPL) and also produced encouraging 
improvements in mean skin temperature and muscle thickness (§3.4.2).
Based on this experience, the aim of the present project was to investigate further the therapeutic 
value of electrical stimulation of chronically denervated muscle through research of existing studies 
and if necessary through clinical study. The hypothesis being that;
electrical stimulation treatment can produce clinically significant benefits to the tissue 
properties o f complete and partially denervated limbs. Also, that functional benefits may be 
evaluated as appropriate.
The outline of the project and following chapters of this thesis is
§2. Familiarisation with muscle denervation and reinnervation processes.
A review of peripheral nerve injuries, the recovery process and failures causing 
chronically denervated muscle with the resulting changes to tissue properties. Also some 
clinical means of assessing the state of innervation are discussed.
§3, Review of studies of stimulation of denervated muscle in animals and humans.
To identify any further clinical investigations necessary, the likely stimulation 
treatment pattern, suitable evaluation measures and the requirements for 
stimulation equipment
§4. Design of the experimental clinical study, treatment and evaluation protocols.
An outline of the clinical investigations conducted for this study into the 
therapeutic benefits of stimulating chronically denervated muscle
§5. Stimulation equipment specification, design and testing.
A technical description of the stimulator unit produced to perform the clinical study
§6, Analysis of study results and observations.
§ 7. Discussion of study results.
§8, Conclusions of the study with suggestions for improvements and further investigations.
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2. B a c k g r o u n d
2.1 The Neuromuscular System
The nervous system initiates and co-ordinates contractions of the muscles in the body to achieve 
movement and posture control (skeletal muscle), internal functions such as digestion and 
circulation (smooth muscle) and those of the heart (cardiac muscle). Skeletal muscle is controlled 
by the Central Nervous System (CNS) and the Peripheral Nervous System (PNS), which provide a 
form of feedback control system (Fig.2.1.1).
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Figure 2.1.1 Neuromuscular System Schematic for Knee Flexion Control
The brain normally acts as the central processing unit, generating the movement demand signal 
which is conducted via the efferent nerves cells (motor axons or neurones) to the muscle to produce 
a proportionate contraction. Feedback signals are relayed back to different levels of the CNS via 
afferent nerves providing, for example; the extent and rate of contraction from spindles within the 
muscle and golgi organs within the tendons, the limb position from proprioceptors in the joints, 
touch sensing organs in the skin as well as special sense organs (eyes, ears). Integration of these 
signals is distributed within the CNS forming a hierarchy of closed loop control. The inner most 
loop of the la  afferents and lower motor neurones (LMN) is completed at the corresponding level 
in the spinal column, forming the reflex arc, so that the rapid muscle contraction can be achieved 
autonomously, usually to withdraw the limb in response to a noxious stimulus. The brain therefore 
normally provides control signals to inhibit this and initiate contractions appropriate to the desired
Neuromuscular System 2-2
movement and feedback awareness. It can also adjust the 'feedback gain' and sensitivity of the 
system, such as muscle spindles by means of gamma motor-neurones. [Tortora and Grabowski 1993]. 
A wide range of neurological impairments can result from partial or complete failure of the various 
parts of the nervous system. Loss of voluntary control is referred to as paralysis, either central 
paralysis when it occurs in CNS (upper motor neurone) or peripheral paralysis when it occurs in the 
lower motor neurone. Terms also refer to the affected limbs; paraplegia when both lower limbs are 
affected, quadriplegia or tetraplegia when all upper and lower limbs are affected and hemiplegia 
when one side of the body is affected [Maynard, Bracken et al. 1997].
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Figure 2.1.2 Peripheral Neurone Cell and Fibre Structure [after Michael 1996 and Lundborg 1988] 
a] nerve fascicle (p perineurium, end endoneurium, epi epineurium) b] unmyelinated nerve (ax axon) 
c] myelinated nerve (nR node of Ranvier, my myelin sheath, Schw Schwann cell, cf collagen fibres)
Each nerve consists of many separate neurone cells, which form the basic unit of the nervous 
system (Fig.2.1.2). Signals are received directly from peripheral sensors or other neurones by the 
dendrites or cell body and the resultant is conducted down the axon to be relayed to other neurones. 
The method of conduction is by means of adjusting the electrical potential of the cell membrane 
(axolemma) which is determined by the relative concentrations of Sodium (Na+) and Potassium 
ions (K+) on either side. Normally the membrane is dynamically maintained at a negative resting 
potential (RP of approximately 75mV) by ionic pumps controlling the in and out flow of ions. 
Separate Na+ and K+ voltage gated channels allow the adjustment of concentrations to generate a 
momentary positive membrane action potential (AP) typically in less than 1ms, a process known as
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depolarisation. Once the RP is raised above a certain threshold, the AP is automatically generated 
and propagated along the axon to its termini. The absolute refractory period is the time taken for 
the RP to decrease to this threshold once more, during which period the cell cannot be excited and 
varies from 0.4 to 4ms depending on the axon diameter. Although still excitable thereafter, a 
further, relative refractory period is required to fully restore the resting RP. The speed of 
conduction is directly proportional to axon diameter; the largest A fibres are largely motor efferents 
to skeletal muscles and sense afferents with diameters between 5 and 20 pm and conduction speeds 
of 12 to 130m/s, B fibres (up to 3pm diameter and 15m/s speed) are predominantly autonomic 
efferent and somatic afferents, and C fibres (0.5-1.5pm diameter and 0.5-2m/s speed) are visceral 
efferent and somatic afferents. Conduction speed is increased for group A and B fibres by a 
discontinuous myelin sheath formed by successive Schwann cells along the length of the axon. 
This permits ionic current flow in the extra-cellular fluid, so that depolarisation need only occur at 
successive Nodes of Ranvier, a process known as saltatory propagation. Signals are transmitted 
between neurones at a synapse (Fig.2.1.2). On reaching the axon terminal, the action potential 
causes release of neurotransmitter. Acetylcholine (ACh) being the most common in peripheral 
nerves. When sufficient of these reach the receptors (e.g.AChR) on the receiving neurone, it 
becomes depolarised and propagates its own action potential. A synapse may involve axon 
terminals of neurones from various sources, relaying action potentials having different significance, 
and thus integrated processing is achieved in the nervous system. To prevent subsequent repeated 
depolarisation, neurotransmitters are removed from the synapse and returned to the termini by 
esterase enzymes (e.g.ActylcholineEsteraseAChE) [Tortora and Grabowski 1993].
All axons are surrounded by concentric layers of Schwann cell cytoplasm, myelin, and basal 
lamina, together with capillaries, endothelial cells, fibroblasts and collagen which form the 
supporting endoneurial tube or sheath. A number of such fibres are closely packed together in 
nerve fascicles or funicles and surrounded by a perineurium, a lamellated sheath that acts as a 
diffusion barrier to maintain the ionic environment of the endoneneurial space. Myelinated A and B 
nerve fibres are associated with only a single Schwann cell at any one level, whereas other 
Schwann cells surround a number of unmyelinated C fibres. The nerve fascicles, grouped into 
bundles, are embedded in the epineurium, a loose, soft connective tissue also containing the main 
vascular vessels and the outer layers of which are condensed into the nerve trunk sheath. The 
epineurium protects the fascicles against trauma and movement and is especially abundant around 
joints. The main metabolic processes of the neurone are concentrated in the cell body, which may 
be as much as 5000 cell diameters away from its most peripheral parts. In addition to the 
conduction of electrical signals, both fast and slow forms of axioplasmic flow transport nutrient 
and neurotransmitter supplies along the axon, to its distant synapse. There is evidence that the cell's 
anabolic processes are also regulated by neuronotrophic factors (NTF) synthesised by the muscle 
target tissue or components of the nerve trunk, such as Schwann cells [Lundborg 1988].
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The final synapse in the conduction path is that between the lower motor neurone and the muscle 
fibre cell, referred to as the neuromuscular junction (NMJ) or motor endplate. Here release of 
neurotransmitter initiates similar depolarisation of the muscle fibre membrane (sarcolemma) which 
propagates along its length, including the transverse tubules and resulting in contraction of the 
fibres' contractile elements (Fig.2.1.3). These consist of interleaved layers of particular proteins 
(Actin and Myosin) which have a characteristic banded structural appearance. Their contraction 
arises from a biochemical reaction initiated by release of calcium from the sarcoplasmic recticulum 
(SR) and re-circulating energy in the form of adenosine triphosphate (ATP). The ATP is derived 
anerobically from creatine phosphate and glucose reactions or aerobically from the blood by 
mitochondria. All these elements are contained within each muscle fibre cell (myofibre) which 
includes a number of myofibril contracting elements [Tortora and Grabowski 1993].
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Figure 2.1.3 Skeletal Muscle Structure [after Baker, McNeal et al. 1993]
In mature muscle, each fibre has only one endplate so is controlled by only one neurone, but each 
neurone may innervate several thousand muscle fibres, which form a motor unit. Motor units are 
smaller, where fine movement control is required, such as of the face and o f only 2 or 3 fibres in 
laryngeal or ocular muscles. However all the muscle fibres of a single motor unit are of the same 
type as they receive the same action potential stimulus or ‘firing’ pattern. Muscle fibres are 
classified according to their contraction speed, predominant energy metabolism and histological 
colour; type I are slow contracting oxidative 'red' fibres, type HA are fast contracting fibres with 
some oxidative metabolism and an intermediate colour, type IIB are fast glycolytic 'white' fibres 
usually located superficially. The type IIB fibres are faster acting both because of the greater 
conduction speed of their larger axons and their glycolytic energy metabolism, however they also
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fatigue faster. Muscles usually consist of a mixture of motor units of each type distributed 
throughout the muscle, which are recruited asynchronously in order to achieve a graded movement. 
The smaller, slower, fatigue resistant motor units are recruited first as these can sustain a 
contraction, followed by the larger, more powerful fast fatigable motor units to supply greater 
force. Each fibre has a finite refractory period during which it can remain contracted and then 
recover. To maintain sustained muscle contraction, motor units are fired asynchronously in rotation 
order according to their refractory intervals. The firing of muscle fibres can be monitored from 
their electrical signals, known as Electromyography (EMG) [Tortora and Grabowski 1993].
A single action potential results in a twitch contraction of the muscle fibre. A sufficiently small 
interval between consecutive action potentials results in a cumulative increase in muscle tension as 
the muscle fibre does not return to its resting tension or length in between. Above a certain 
frequency (typically 30Hz in skeletal muscle) individual twitch responses can no longer be 
identified and summate into a smooth continuous tetanic contraction. The generated muscle force 
increases with frequency as does fatigue, but also depends on the proportion of fibre types of the 
muscle [Solomonov, 1984 quoted by Rattay 1990].
2.2 Peripheral Nerve Injuries (PNI)
The peripheral nervous system may be subject to a wide range of both sensory and motor neurone 
damage as described in detail elsewhere [Schaumburg, Spencer et al. 1983; Ashbury and Gilliatt 1984]. 
This text is concerned specifically with the impairment of lower motor neurones and therefore 
muscular function, which may be partial or complete, sudden or progressive, temporary or 
permanent and primarily through trauma or degeneration of the lower motor neurone cell itself.
2.2.1 Causes of Peripheral Nerve Damage
Non traumatic peripheral nerve damage occurs from a range of causes and tends to be of a 
progressive nature, initially reducing conduction speed with resultant muscle weakness, and often 
accompanied by general fatigue. Eventually muscle fibre denervation may occur if  degeneration is 
persistent. Viral infection, such as Herpes in the facial nerve and subsequent inflammation can lead 
to complete paralysis of one side of the face. Bells Palsy [Wynn-Parry and Cowan 1994]. 
Poliomyelitis results in temporary denervation of some muscle fibres which may be reinnervated 
by colateral sprouting of remaining motor units (§2.2.3). Post polio syndrome (PPS), characterised 
by muscular weakness, pain and atrophy, occurring decades after an original attack of paralytic 
poliomyelitis, is thought to be due to NMJ transmission defects and ineffective lower motor 
neurone conduction following degeneration of these massively enlarged motor units [Trojan,
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Gendron et al. 1993]. Gillian Barre Syndrome (GBS) also thought to be of viral origin, causes 
widespread inflammation and PNS demyelination with very sudden but usually temporary, muscle 
weakness, often to the extent of loss of muscle function with the absence of EMG signals. This is 
largely due to reduced conduction velocity but fibrillation (§2.3.2) may also occur indicating 
denervated fibres. Metabolic neuropathies occur with diabetes mellitus, affecting sensory and 
motor nerve fibre conduction velocities with associated ischaemia become more susceptible to 
subsequent trauma. Hereditary neuropathies are often degenerative diseases and include Charcot 
Marie Tooth (MCT) and peroneal muscular atrophy (PMA) which result in progressive distal 
muscle weakness, severely reduced conduction velocities, increased depolarisation thresholds and 
loss of anterior horn (LMN) cells. Progressive degeneration of anterior horn cells also occurs with 
motor neurone diseases such as amyotrophic lateral sclerosis (ALS) and congenital spinal muscle 
atrophy (SMA). These are again characterised by reduced muscle bulk and strength and partial 
innervation of muscle fibres with some evidence of denervated fibres (§2.4). Neuropathies also 
occur from nutritional deficiencies, alcoholism, drugs and other toxic agents [Schaumburg,Spencer et 
al. 1983; Lenman and Ritchie 1987; Gilbert 1996].
Traumatic peripheral nerve damage usually results in more immediate loss of function and the 
causes of which are very varied; lacerations (e.g. knife or glass wounds), missile injuries (e.g. 
gunshot), traction or stretching (e.g. motor cycle accidents), fractures leading to traction or 
compression, compression ischaemia including from entrapment or inflammation oedema, injection 
injuries, electrical and bum injuries or radiation [Kaye 1991]. The axonal length of most lower 
motor neurones make them particularly vulnerable and common pathologies relate to the site of 
injury. The nerve roots may be affected by spinal cord injury especially at the level of the Cauda 
Equina (T12/L1) [Maynard,Bracken et al. 1997] and cervical levels [Mulcahey, Smith et al. 1999]. Nerve 
root avulsions, mptures and trauma are also common at cervical level resulting in a complexity of 
brachial plexus lesions [Wynn-Parry and Cowan 1994]. Individual peripheral nerves commonly 
affected are the medial nerve (most frequently at the wrist and forearm) ulnar (wrist, forearm and 
elbow), radial (midarm and shoulder), sciatic (hip) and peroneal (knee, head of fibula and gluteal 
region), tibial nerve (medial malleolus) [Lenman and Ritchie 1987]. The extent of the resulting 
impairment to upper or lower limbs depends largely on the level of nerve injury and the particular 
nerve fibres within the nerve bundle affected. For instance trauma of the peroneal nerve and 
resultant loss of dorsiflexion function, commonly referred to as 'dropped foot' can result from 
trauma in the spine or more distally. Nerve trauma also commonly occurs during childbirth 
resulting in impaired sphincter muscle control and subsequent incontinence [Monk, Mills et al. 1998]. 
Trauma to the child during birth can result in damage to the brachial plexus (e.g. Erbs Palsy, 
Klumke's paralysis) and in some cases a complete flaccid paralysis of the arm, with subsequent 
diminutive growth [Kaye 1991].
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2.2.2 Types of Peripheral Nerve Injury
A classification of nerve injuries developed by Seldon in 1943 and supplemented by Sunderland in 
1951 describes the extent of damage, the degree of impairment and process and prospects for 
recovery [Irwin 1999],(Fig.2.2.1). In Neurapraxia, (class 1) such as occurs with compression of the 
nerve, conduction is blocked by transient ischaemia or paranodal demyelination. However as the 
continuity of the axon is preserved, once the compression is removed function is restored, within 
hours in the mildest form or after remyelination, usually within 6-8 weeks. Autonomic function is 
usually preserved. In Axonotmesis,(class2) such as from a crush or blow injury, traction or 
ischaemia or closed fracture, it is the continuity of the axon which is interrupted which degenerates. 
Continuity of the Schwann cell, basal laminar and endoneurial tissue are preserved and these guide 
the regenerating axons to reinnervate the muscle fibres, with typically complete recovery. Class 3 
injuries involve axonal disruption and partial tear of the endoneurial tube, whereas with class 4 
injuries, only the epineuriqm remains intact. In Neurotmesis (class 5), all neural and connective 
tissues are severed. The formation of fibrosis scar tissue hinders regeneration and if the nerve is 
completely divided (class 4 & 5), a neuroma forms in the proximal stump preventing reinnervation 
unless removed surgically. Neurotmesis often results from laceration and missile injuries as well as 
traction or crush injuries [Schaumburg,Spencer et al. 1983; Kaye 1991; Wynn-Parry and Cowan 1994]. A 
sixth class has been introduced to cover combinations of these damage classifications [Irwin 1999].
Figure 2.2.1
Peripheral Nerve Injury Classification
1 Neurapraxia,
2 Axonotmesis
3 Neurotmesis
[after Schaumburg et al 1983]
Urvife. W ovi\d. i  w eek  iofcer g weeks Loètr
j i t y
i
Atrophy 
Z Month»
§2.2_______________________________________________________________Peripheral Nerve Injuries __________________________________________________________________ 2-8
2.2.3 Peripheral Nerve Regeneration
Following division of the axon with injury, the proximal and distal segments retract with leakage of 
axoplasm. Isolated from the cell body and the CNS, the nerve stump distal to the site of injury 
continues to function until its metabolic and neurotransmitter supplies are exhausted which 
therefore depends upon the stump length (2hrs/cm) and the level of synaptic activity. Without 
axoplasmic replenishment, and typically after 10 days, Wallerian degeneration of the axon occurs 
progressively along the stump, phagocytosed by macrophages and Schwann cells. The 
degeneration also triggers proliferation of fibroblast and Schwann cells, forming a new endoneurial 
tube for the regenerating proximal nerve to the original muscle fibre endplate and including Bands 
of Bungner to bridge the gap at the lesion site [Vrbova, Gordon et al. 1994; Irwin 1999].
The proximal nerve stump degenerates to the next proximal node of Ranvier, but injuries close to 
the cell body can lead to complete neuronal death. Within 12 hours, neurotransmitter synthesis 
decreases in favour of protein synthesis, triggered, it is suggested, by interruption of the 
axioplasmic transport or degeneration of the distal stump. With this, the cell changes function, from 
one of a transmitting and conducting channel to a growing state. Sprouting occurs from the growth 
cone, with daughter axons attracted by neurotropic substances to grow down the distal stump 
endoneurial tubes to the endplate, bridging gaps of up to l-2cm is possible but with more variable 
recovery. Elongation is initially slow and accelerates to a constant velocity by day 3 after injury 
[Sjoberg,1990 quoted by Vrbova,Gordon et al. 1994 p200]. The growth rate decreases with lesion 
distance from the cell body, from 2.5mm per day in the upper arm or leg to 1mm per day in the 
wrist and ankle [Sunderland 1978]. At this rate, the hand for instance, may remain denervated for up 
to a year following a brachial plexus injury.
Re-generating nerves may have up to 100 branches and may innervate more muscle fibres to form a 
larger motor unit than normal, in order to compensate for the reduced number o f axons. These can 
exhibit specificity of target organ in terms of tissue, motor or sensory or topographically [Irwin 
1999], however this is rare clinically [Lundborg 1999] and inappropriate matching of neurone and 
muscle fibre type can occur [Vrbova,Gordon et al. 1994 p200]. Prolonged denervation can result in the 
failure of the regenerating axon to locate the original endplate, which instead forms an ecoptic 
endplate. However, the plasticity of the motor neurone is less than that of muscle fibres [Gordon 
1988], and it determines the fast or slow type of new neuromuscular junctions, whereas existing 
junctions retain their original type [Waerhaug, Lomo et al. 1994]. If maintenance of fast muscle 
contraction properties is as neural dependant as in post-natal differentiation [Vrbova, Navarrete et al.
1985], then impairment due to nerve-muscle incompatibility on re-innervation may be greater in 
fast then slow muscle. The extent of re-innervation (at lOOdy) was found to be greater in soleus
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(slow) than peroneus tertius (mixed) [Brown and Ironton 1977a] or flexor digitorum longus (FDL) 
(fast) muscle [Luff and Torkko 1990].
In addition to terminal sprouting of the regrowing original nerve axon, muscle fibre reinnervation 
can also occur by collateral sprouting of functional axons innervating adjacent fibres. A small 
amount of sprouting occurs in normal muscle [Barker 1966 quoted by Brown and Ironton 1977a], but is 
greatly increased with prolonged inactivity, inflammation, or the interruption of neuronal or trophic 
axon conduction. Numerous neurotrophic factors and other biochemical agents have been proposed 
as stimuli to nerve sprouting, growth and reinnervation including the endoneurial Schwann cells 
[Lundborg 1988] and the denervated muscle fibre membrane associated with its increased 
extrajunctional AChR density (§2.3.2) [Pestronk and Drachman 1978]. The latter stimulus is 
considered to operate only in very close proximity to the muscle fibres (0.01pm [Eberstein and 
Eberstein 1996]) to enhance both terminal sprouting of the regenerating nerve and colateral 
sprouting from innervated fibres. It appears that these neuronal growth factors (NGF) also sustain 
the functioning contact of the neurone by retrograde axonal transport and without which, neurones 
withdraw from the muscle fibre. By this means, polyneurial reinnervation is suppressed, to ensure 
each muscle fibre is under the control of only a single nerve preferably of the appropriate type, in a 
similar manner to embryonic muscle [Lundborg 1988; Gates and Ridge 1992].
2.2.4 Prognosis for Functional Reinnervation
The extent of muscle reinnervation depends upon the ability of neuronal cells to maintain growth 
synthesis capability, the quality and length of the endoneurial tube through which they must grow 
and the capability of the muscle fibre to receive reinnervation and reverse its atrophy, each of 
which declines with prolonged denervation. [Vrbova,Gordon et al. 1994 p210].
The duration of denervation and therefore the extent of the atrophy is related to the type of nerve 
injury and associated tendon and soft tissue damage, the quality of the nerve repair, the distance for 
nerve re-growth as well as many other factors such as the age and health of the patient [Williams 
1996a]. The regeneration time varies between sites, typically 6 months for median, ulnar and 
peroneal nerve injuries and up to 21 months for brachial plexus and sciatic nerve injuries making 
appropriate or any re-innervation less likely [Boonstra, Van Weerden et al. 1987]. Nerve growth may 
be hindered by endoneurial gaps, the neuroma scar, blood clots, and tension induced perfusion loss 
or ischemia [Irwin 1999]. Although muscle fibres denervated for a year have been shown to be 
capable of still accepting reinnervating nerve fibres [Fu and Gordon 1995], the prospects of 
successful reinnervation after 18-24 months are considered almost impossible, due to irreversible 
changes in the muscle cells [Wilgis 1982 quoted by Lundborg 1988 pl97]. However the primary cause 
of poor recovery is cited as the profound reduction in the number of successfully regenerating 
axons due to deteriorating intramuscular nerve sheaths. Even the ability of axons to reinnervate
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three to five times more muscles fibres than normal, does not compensate for this or the incomplete 
recovery of muscle fibres from denervation atrophy [Fu and Gordon 1995]. In cases of partial 
denervation, enlargement of still functioning motor units can compensate for up to 80% neurone 
loss, and complete recovery is probable with less than 85% denervation [Gordon, Yang et al. 1993; 
Gordon and Mao 1994].
2.2.5 PNI Intervention Treatments
The prognosis for peripheral nerve injuries may be improved by a number of means, aimed at 
enhancing the nerve re-growth, the epineural tube through which it grows or the target muscle 
fibre. Micro-surgical nerve repair has been refined to improve both the prospects and quality of 
functional recovery, typically involving nerve grafts, transplants or artificial implants and suturing 
of either of both perineurium and epineurium, as reviewed extensively in the literature [Lundborg 
1988]. Interestingly, allowing up to 5mm gap between nerve endings inside a silicon tube has been 
found to be more successful than close apposition [Lundborg 1999]. However, despite the 
sophistication of such techniques, functional recovery from PNI is usually less than complete (19- 
65%) especially in high level lesions [Williams 1996a].
A number of methods and substances have been found to enhance nerve regrowth and it is probable 
that their effect is linked to the multitude of factors which initiate and control the process of the 
nerve growth and re-innervation of the endplate. Nerve growth factors (NGF) have been identified 
including, fibronectin, ganglioslides, adrenocorticotropic hormone (ACTH). Nerve sprouting is 
increased by a second injury and has been used advantage surgically, by conditioning a nerve graft 
prior to transplant by a period of degeneration [Lundborg 1988].
Peripheral nerve growth has also been shown to be enhanced by pulsed electromagnetic fields and 
direct currents of a few micro-amperes passed through the re-growing nerve tip [reviewed by 
Lundborg 1988 pl83]. The latter is usually generated by implanted simulators and nerve growth is 
specific to the direction of a distally placed cathode and to the initial regenerative period [Sisken 
1983; Zanakis 1988; Zanakis 1990]. The effect is attributed to an increase in endoneurial vessels 
improving the ischaemic state of the damaged nerves and enhancing their degeneration and 
regeneration processes [Shen and Zhu 1995].
Physiotherapy of peripheral nerve injuries has traditionally been conservative, with positioning and 
passive exercises. These are aimed at maintaining the muscle tissue and limb condition during the 
period of nerve re-growth, seeking to minimise muscular atrophy and contractures and preserve 
mobility. Active exercises and re-education is undertaken on recovery of function [Cummings 1985; 
Wynn-Parry and Cowan 1994]. Artificially induced muscle contractions by electrical stimulation has 
also been employed and will be the subject of following sections.
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2.3 Denervated Muscle Properties
Without connection to a functioning lower motor neurone, muscle fibres are said to be 'denervated'. 
This may be temporary while awaiting nerve regeneration, or permanent when reinnervation fails, 
and may affect some or all of the fibres in a particular muscle or muscle group. A functioning nerve 
conducts both neuronal (electrical) signals and trophic (metabolic) substances to the muscle fibres 
[Vrbova,Gordon et al. 1994 pl45] and their absence or restriction, results in bio-chemical, electrical 
and morphological changes. Their extent and reversal or modification with reinnervation, depends 
on the duration of denervation and the degree of loss of muscle activity, which is thought to be the 
predominant influence [Eberstein and Eberstein 1996]. Co-incident with the fibre degeneration and 
dependant on the proportion of fibres affected, is the loss of voluntary control of the contraction of 
the muscle or limb, its progressive atrophy, reduction in blood flow and deterioration in tissue 
quality. These clinically significant changes are described briefly here and in greater detail in other 
texts [Sunderland 1978; Vrbova,Gordon et al. 1994]; some also provide means of assessing the extent 
of denervation (§2.4).
Much of the analysis has been conducted in the animal model involving histological methods and 
invasive tests, however there is some evidence from biopsies of human muscle [Williams 1996a; 
Neumayer, Happak et al. 1997]. Differences between studies therefore occur due to response variation 
with species and muscle type [Frykman, McMillan et al. 1988; al-Amood and Lewis 1989] and the 
techniques of denervation and analysis. Methods of denervation include cutting, crushing or 
excising the nerve, or blocking its conduction, mechanically [Gmener, Baumbach et al. 1974] or by 
drugs. The latter act on the nerve itself (e.g. tetrodotoxin (TTX), or at the motor endplate synapse, 
inhibiting neurotransmitter release (e.g. Botulinum Toxin) or its reception by the muscle fibre (e.g. 
a-bungarotoxin) and are mainly derived from snake venoms. The relevance of the results of these 
studies is determined by the extent to which these techniques simulate the conditions of human 
peripheral nerve injuries and the subsequent clinical treatment.
2.3.1 Contraction Response
The most obvious consequence of central and peripheral nerve injury is the loss of voluntary 
control of the muscle or limb. With central or spastic paralysis, the reflex arc of lower motor 
neurone and afferent fibres (Fig.2.1.1) remains intact and the absence of the normally inhibitory 
signals from the CNS results in spontaneous, transient contractions of the muscle, termed spasms, 
which can help to maintain muscle, skin and bone condition. In contrast, lacking both background 
tone and spasms, denervated muscle is often referred to as flaccid paralysis, with poorer tissue 
condition and appearance.
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The contraction characteristics of denervated muscle have been deduced by externally applied 
electric fields (§3), inducing either single twitch contractions or sustained tetanic contractions, and 
observations depend upon the stimulation parameters employed. Some of the changes in 
contraction characteristics observed are associated with other changes in the muscle, though 
unfortunately, few studies have correlated the morphological, physiological and functional 
changes.
Isometric contraction speed is quantified by twitch duration, which is dependant upon twitch time 
to peak tension (TPT) and half relaxation times (RT) of the decline in tension, measured for 
isometric twitch contractions. Denervation results in a decrease of contraction speed, though 
greater in fast muscle (rabbit extensor digitorum longus (EDL) at 4wk post denervation (EDL) 
TPT+50%, 1/2RT +100% [Nix 1990]) than slow muscle (rat soleus and gastrocnemus at 6wk post 
TPT +17%, 1/2RT +30% [Wicks and Hood 1991]). However there is evidence in later stages of 
denervation of a spontaneous slow to fast transformation of slow muscle (TPT-16% at 15wk post 
relative pre-denervation levels) and associated with changes to fast myosin [al-Amood, Finol et al.
1986].
Latency is the delay between the nerve or electrical impulse and the contraction of the muscle fibre. 
Latency increases on denervation due to membrane changes [Nix 1990] to 20ms or more compared 
to 2-8ms in normal muscle [Raimbault 1984, Petrofsky 1991] and accounts for the 'sluggish' response 
of denervated muscle to stimuli. Fibre refractory period also increases on denervation [Mihelin, 
Trontelj et al. 1991]. Denervated muscle therefore tetanises at lower frequencies (8-12Hz) than 
normal muscle albeit with longer stimuli [Eichhom, Schubert et al. 1984].
Isometric contraction force is measured for both twitch and tetanic contractions, and may be 
expressed as specific tension, the force per unit muscle fibre area. On denervation, tetanic tension 
decreases exponentially before equilibrium is reached after approximately 4months (EDL -0.75% 
of control, soleus-0.2-0.3%) [al-Amood, Lewis et al. 1991] Twitch tension is initially little changed 
after denervation [Finol, 1981 quoted by Vrbova,Gordon et al. 1994 pl55], probably due to prolonged 
contraction time. It then decreases (in rat soleus to 25% at 6wk [Wicks and Hood 1991], and to 5% at 
9wk [al-Amood and Lewis, 1987], perhaps less so in fast muscle (to 50% at 4wks in rabbit EDL [Nix 
1990].
Fatigue is the decline in muscle force or tension during a sustained contraction Fatigue resistance is 
greater in oxidative than glycolytic fibres but is not necessarily related to the oxidative capacity of 
the whole muscle [Degens and Veerkamp 1994]. Fatigue susceptibility index (§3.5.9) increases on 
denervation (from 35% to 62% at 4wks after complete denervation of rabbit fast EDL muscle [Nix 
and Dahm 1987] with a corresponding decrease in oxidative rhetabolism [Nix 1990].
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2.3.2 Membrane Excitability Changes
Denervation results in the loss of muscle fibre membrane conductance and neuromuscular 
transmission, though this occurs gradually as a result of many individual changes. The decline in 
non-quantile ACh neurotransmitter release from the endplate is probably the first detectable change 
[Stanley 1986 quoted by Hiilser, Wissmeyer et al. 1997]. The motor endplate shrink [Jones, Tuffery et al. 
1973] and the miniature endplate potential (MEPP) from spontaneous ACh release, ceases faster 
[Vrbova, Gordon et al. 1994 p i66] with a decrease in amplitude and frequency as neurotransmitter 
supplies diminish [Jacob and Robbins 1990]. Conversely, it increases progressively at newly formed 
junctions and has been used to indicate reinnervation [Brown and Ironton 1977a].
On denervation the Na, K, Ca and Cl ion transfer capabilities of the muscle fibre membrane and its 
ability to spread irritations are reduced [Hiilser,Wissmeyer et al. 1997]. Membrane resting potential 
decreases almost immediately [Thesleff 1974 quoted by Eberstein and Eberstein 1996], associated with 
the decline in transport down the axon of a proposed regulator factor [Hiilser, Wissmeyer et al. 1997].
The less efficient sodium transport with prolonged outflow [Vrbova,Gordon et al. 1994 p i70] results 
in spontaneous variation in the reduced membrane potential and asynchronous contractions of 
individual fibres, visible as a persistent fine rippling of the exposed surface of denervated muscle, 
and known as fibrillation. That, this ceases following application of calcium ions onto the muscle 
or injected into the blood stream, implies a link with the calcium dependant contraction 
mechanisms, though it was not stopped by dietary application [Speilholtz 1987]. Fibrillation 
potentials are a characteristic feature of the EMG signal obtained from denervated muscle (§2.4.3), 
but as these originate only at the neuromuscular junction (NMJ) zone, the concurrent disseminated 
ACh hypersensitivity is not thought to be the cause of fibrillation [Kimura 1983]. In animal studies, 
fibrillation has been observed to commence 3 days after denervation [Vrbova,Gordon et al. 1994 
pl8,170], with a peak at 5-10 day [Midrio 1992 quoted by Eisenberg and Hood 1994] and decline 
thereafter, depending on species [Robinson, Tufft et al. 1991] . In human muscle it commences after 
approximately 20 days, and continues as long as fibre contractile ability remains but is barely 
detectable after 1 year [Barwick, 1981 quoted by Eberstein and Eberstein 1996]. The frequency of 
fibrillation (typically 2-16Hz) is proportional to the membrane potential and changes in twitch 
speed. It is greater in fast than slow muscle and also varies with species [Robinson,Tufft et al. 1991], 
the NMJ acting as a pacemaker [Belmar et al (1966), Purves et al (1974) quoted by Speilholtz 1987]. 
Fibrillation as an indicator of continued membrane excitability can be interpreted as its ability to 
accept re-innervation and its persistence is prolonged by mechanical working of the muscle by 
physiotherapy or electrotherapy [Raimbault 1984].
In normally innervated muscle, AcetylCholine neurotransmitter receptors (AChR) are localised in 
the NMJ by an apparently activity mediated neurotrophic element [Andreose, Fumagalli et al. 1995].
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The repression in extra-junctional locations is associated with the activation of protein kinase C 
(PKC) [Changeux 1991]. The number of AChR per junction is regulated by these neurotrophic 
factors by a continuous process of degeneration and subsequent regrowth [Vrbova,Gordon et al. 1994] 
and varies with fibre diameter [Andreose,Fumagalli et al. 1995]. The innervating motor neurone also 
metabolically stabilises the AChR by muscle activity via calcium-dependent reactions [Caroni, 
Rotzler et al. 1993].
Removal of this neural control on denervation, therefore results in a dramatic increase ACh 
sensitivity in extra -junctional areas [Axelson and Thesleff 1959 quoted by Lomo and Rosenthal 1975] 
including the re-appearance of fetal ACh receptor Ô subunits [Changeux 1991]. Conversely, 
junctional AChR numbers remain unchanged for up to 3 weeks after denervation and decreases to 
35% of normal after 8 weeks [Andreose,Fumagalli et al. 1995]. In animals, the disseminated ACh 
hypersensitivity commences 2-3 days after nerve section, [Lomo, 1976 quoted by Eberstein and 
Eberstein 1996]], with a peak at 3-4day [Jones,Tuffery et al. 1973] and no further increase in adult rat 
muscle when fibrillation commences [Jones and Vrbova 1970]. In human muscle the increase occurs 
5-10 days after injury [Sunderland 1978]. AChR destabilisation also occurs about 3 days after 
denervation [Andreose,Fumagalli et al. 1995]. The removal of activity mediated ACh receptor 
stability results in a reduction in their half life up to day 33 post denervation [Fumagalli, Balbi et al. 
1990].
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2.3.3 Muscle Fibre Type
Muscle fibres are classified according to their contraction speed, contractile protein isoforms and 
their energy metabolism. (§2.1). Transformation of fibre type in terms of myosin isoforms or 
metabolic enzymes following denervation, may accompany the changes in muscle contraction 
speed, but not necessarily [Reichmann 1985 quoted by Mokrusch, Engelhardt et al. 1990] and 
unfortunately few studies include concurrent measurement Changes in the proportions of different 
fibre types within a muscle following denervation may occur due to conversion of fibre type or by 
preferential atrophy or growth o f one fibre type over another (§2.3.5).
Myosin is one of the predominate proteins in muscle and is formed into molecular chains which 
interact with those of other proteins in a layered structure to achieve the contraction. Heavy and 
light myosin chain isoforms occur in muscle and differ between slow and fast muscle and during 
muscle fetal differentiation. The slow to fast transformation of muscle type contraction speed 
observed in denervated slow muscle, after 15 weeks (§2.3.1) is accompanied by changes to fast 
myosin [al-Amood, Finol et al. 1986]. There is also evidence of a changed myosin phenotype and re­
innervation in partial denervated muscle results in multiple myosins forms including pre-natal type 
[Sawchak, Simeon et al. 1989].
Myogenin and MyoD are proteins that bind to the regulatory regions of a battery of skeletal 
muscle genes and can activate their transcription during muscle differentiation. Transcript levels of 
each begin to increase 8-16 hr and 16-24 hr respectively after denervation and reach levels 
approximately 40 and 15 fold higher respectively than those found in innervated muscle and 
changes are some of the earliest changes after nerve injury [Eftimie, Brenner et al. 1991].
Muscle fibre metabolic enzymes are considered to be regulated by neural control of muscle 
contractile activity as they can be transformed by cross innervation or different exercise pattern or 
external stimulation pattern [Nemeth 1982]. Most forms of long term exercise of normal muscle 
increase oxidative capacity [Brown, Cotter et al. 1976] but without fibre transformation as fibre 
recruitment is normal [Vrbova, Gordon et al. 1994 p i20]. Chronic denervation results in anaerobic to 
anaerobic metabolic transformation with decreases in oxidative enzyme activity and mitochondria 
[Nemeth 1982; Wicks and Hood 1991; Eisenberg and Hood 1994].
However, the study by Mokrusch et al. [Mokrusch, Engelhardt et al. 1990] of fast rabbit flexor 
digitorum sublimis muscle denervated for 4 months, perhaps illustrates the discepancies between 
studies and analysis methods. Histological staining with myofibrillar ATPase showed a shift in 
fibre type composition towards type 11, (type 1:11 18.7:81.3 changes to 24.5:75.5) which also 
showed greater diameter reduction (1 51.3%, 11 71.1%). However analysis with NADH dependant 
tétrazolium reductionase identifying type 1, llA  and IIB fibres, showed nearly equal diameter
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reduction (60%) but dramatic decrease in glycotytic white (IIB) fibres an increase in oxidative 
intermediate (IIA) fibres (21.9:23.7:54.4 to 33.7:64.2:2.1). A predominance of type II fibres was 
also observed with paralysis, though greater in spastic (84%) than denervated (73%) in vastus 
lateralis muscle [Neumayer, Happak et al. 1997].
In reinnervated muscle, fibre metabolism is dictated by the neurone type. As the reinnervated motor 
units may be larger to compensate for the fewer nerves, the balance of fibre types and metabolism 
in the overall muscle may be altered. A homogeneous type I histology (previously mixed fibre 
type) was observed in reinnervated rat soleus muscle, attributed to reprogramming by the soleus 
motor-neurone [Davis, Harris et al. 1991]. Conversely in denervated superficial mouse tibialis 
anterior muscle, glycolytic type IIB fibres were virtually restored within 2 months of reinnervation 
due to the activity of peripheral and deep muscle fibres or perhaps a resistant phenotype [Parry and 
Wilkinson 1990]
2.3.4 Blood Flow and Tissue Perfusion
Denervation, as with any limb immobilisation, results in loss of muscle pump action leading to 
potential prolonged intramuscular vascular stasis (pooling of blood in muscle) and thrombosis 
[Speilholtz 1987]. For instance, amongst chronic SCI paraplegics (on average 6.7 years post injury), 
thigh blood flow is reduced to approximately 65%, with lower, but not significantly different 
cardiac output; though the analysis did not differentiate flaccid from central paralysis [Taylor, Ewins 
at al. 1993]. Peripheral blood flow is further diminished by vaso-motor spasticity. Conversely, 
removal of autonomic neural vaso-constrictive tone resulted in an immediate increase in tibialis 
anterior blood flow to 10 fold at day 7 after denervation and remained elevated until reinnervation 
and followed closely the timing of sympathetic innervation. However during contractions, muscle 
metabolic influence predominates (e.g.adenosine, K+,H+,C02) and muscle blood flow is more 
closely related to endurance performance than oxidative capacity [Eisenberg and Hood 1994]. In 
terms to muscle perfusion, the ratio of perfused microvessels per muscle fibre (PV/F) decreased 
with denervation [Clemente and Barron 1993].
2.3.5 Muscle Atrophy and Fibre Structure
Muscle atrophy is perhaps the most visible physical change with denervation, and can be viewed 
macroscopically in terms of the muscle weight, thickness or volume and microscopically in terms 
of the diameter or cross sectional area of muscle fibres their structure and quality. Non-muscle 
elements (connective tissue, blood vessels and fat) constitute a proportion of this, which may 
increase with denervation and so fibre calibre is considered a more accurate measure of denervation 
changes [Speilholtz 1987].
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Sunderland produced a summary of muscle weight loss on denervation as an initial rapid decrease 
of 30% in the first month, 50-60% after 2 months and thereafter the process slowed and reached an 
approximately stable value of 60-80% after 3months [Speilholtz 1987]. The residual weight is 
attributed to the non-muscle elements. The rate of decline is thought to be related to metabolic rate, 
and is therefore greater in fast muscle [Wicks and Hood 1991]. It also varies considerably between 
species, individuals, muscles in the same individual, even between fibres in same muscle [Eberstein 
and Eberstein 1996]. For instance, in rat soleus muscle, the initial decrease to 50-60% after 7-14 days 
was followed by a more gradual decline to stable value o f20-30% after 45 days and 18% after 6-10 
months [Schmalbruch, al-Amood et al. 1991]. Whereas the loss in humans may be less, but dependent 
on the type of injury. The decline in quadriceps muscle thickness amongst a sample of acute SCI 
paraplegics was compared with that of age matched normals, though without differentiation 
between spastic and flaccid paralysis [Taylor,Ewins et al. 1993]. Four cases were monitored from the 
day of injury and showed a 16% reduction in muscle thickness and 6.5% reduction in subcutaneous 
fat over the first five days. Over 20 days post injury, this extrapolates to a loss in thickness of 50% 
in muscle and 14% in fat, as confirmed by measurements in 16 case from day 5 to day 20. No 
further significant reduction occurred in another six cases monitored to 40 days post injury, though 
is possible in cases of flaccid paralysis.
The atrophy and degeneration of muscle fibres is attributed to the impaired nutritional state from 
reduced circulation but also as a consequence of subsequent trauma, including from temperature 
changes and potentially from induced contractions [Speilholtz 1987]. The extent of atrophy is 
affected by the nature of the injury, changes in proportions of non-contractile elements, 
endogenous hormones, blood flow and the degree of passive stretching of the immobilised muscle 
which affects protein composition and synthesis rate [Eberstein and Eberstein 1996 quoting others].
The process of fibre atrophy is one of progressive degeneration. Initially simple fibre atrophy arises 
from loss of myofibrillar material, protein synthesis and intracellular structure. Myofibrillar content 
decreases with fibre diameter progressing from peripheral to central [Vrbova, Gordon et al. 1994 
pl59&164]. By 2-4 months, necrosis degeneration occurs, with disruption of fibre organisation, and 
migration of cell nuclei from the cell periphery to centre (Fig.2.3.2). This leads eventually to cell 
destruction, which by 4-6 months is extensive but species dependant [al-Amood, Lewis et al. 1991]. 
The myofilaments of the remaining muscle cells do not form a regular sarcomere structure without 
the stimulus of activity or stretching [Schmalbmch, al-Amood et al. 1991], such that striations begin to 
fade after a year in human muscle and the fibres fragment to be replaced by fat cells. However, 
contractile function by external stimulation can be possible 3 years after denervation [Eberstein and 
Eberstein 1996]. Therefore initial loss of muscle bulk is due primarily to atrophy of fibre diameter 
[Anzil 1989 quoted by Vrbova, Gordon et al. 1994 p i59] followed by a reduction in the total number of 
muscle fibres (>50% in rat soleus after 6-10 months [Schmalbmch, al-Amood et al. 1991].
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Figure 2.3.2 Muscle Fibre Atrophy with Denervation and Stimulation [after Willliams 1996a]
Langley (1916) established that the atrophy of denervated muscle is not entirely due to its inactivity 
but the suggestion that it might be due fibre fibrillation has been refuted [Speilholtz 1987]. Nemoto 
et al (1988) differentiated between atrophy due to muscle disuse predominately of type I fibres and 
atrophy as a consequence of denervation occurring mainly in type 11 fibres, though no explanation 
of the possible mechanism for this was provided. If atrophy is related to metabolic rate, greater 
atrophy would be expected in type II fibres, which are also more dependant on neuronal input. 
However there is conflicting evidence [Speilholtz 1987; Eberstein and Eberstein 1996] (e.g.Mokrusch 
et al (1990) §2.3.3) and some concluded no evidence of preferential atrophy between fibre types 
[Wicks and Hood 1991]. Some of this variation is attributed to differences in the amount of passive 
stretch of the muscle affecting the rate of protein synthesis, muscle activity from surrounding 
functional muscular, endogenous hormones and blood flow levels and other influencing factors 
(§2.3.1) [Eberstein and Eberstein 1996].
2.3.6 Chronic Denervated Muscle Conditions
Chronic denervated muscle condition arises from the failure of the peripheral nerve to regenerate or 
to achieve functional reinnervation following injury, and if it has not occurred after typically 2 
years is unlikely to do so (§2.2.4). This risk is obviously greatest, with most proximal injuries, 
where regeneration distances are greatest, following damage at the nerve root or plexi. Common, 
chronically denervated muscles are those of the lower limb following cauda-equina (T 12/Ll) SCI, 
tibialis anterior causing 'dropped foot' from peroneal nerve damage and upper limb muscles 
following brachial plexus lesion or cervical level SCI . Partial denervation of sphincter and facial 
muscle paralysis can also become chronic as can denervation from the progressive deterioration of 
the nerve from disease or infection (§2.2). Some of the changes and symptoms observed in 
denervated muscle may also occur with muscle weakness inactivity or enforced immobilisation due 
to other causes, referred to disuse atrophy.
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Secondary complications of flaccid limbs include subnormal temperature, susceptibility to 
infection and contractures due to unopposed antagonist muscles in cases of partial limb 
denervation. As many cases of flaccid paralysis are also or become wheelchair bound, then 
additional secondary conditions include decubital ulcers from impaired circulation, urinary 
infections from residual urine and kidney damage from bladder dysfunction [Critchley, Eisen 1997].
2.3.7 Treatment of Denervated Muscle
Whereas, in acute PNI cases, treatment is aimed at maximising the prospects of functional recovery 
through re-innervation, by assisting nerve re-growth and maintaining muscle fibre integrity 
(§2.2.5), with chronic denervation conditions, the objective of treatment is to minimise the 
secondary complications arising from the muscle immobility, tissue atrophy and reduced blood 
flow. Skin quality deterioration may also affect cosmetic appearance of the affect limb and further 
compound the psychological impact of the condition. Contributing to this is any resulting 
functional impairment and associated disability.
In some cases of partial limb denervation it is possible to restore limb function by transfer 
attachment of the tendon attachment of an innervated muscle to that of the denervated muscle, 
which may then be operated voluntarily or by means of electrical stimulation. [Adams and Wood 
1981; Wiessemann 1981]. Another means of restoring function, is the use of orthoses, such as those 
for the ankle and foot (AFO) in the case of dropped foot from peroneal nerve injury. Although this 
can aid mobility, it does not enhance the tissue properties or circulation and is often not liked by 
the users, because of resulting muscle cramp in remaining functional muscles, the discomfort of 
wearing, and the need for larger shoes. Similar splints may be used in the upper limb to supplement 
wrist or finger control. Larger, exoskeletal devices (e.g.Reciprocating Gait Orthosis RGO) enable a 
limited degree of independent mobility for SCI cases and offers the advantage of a period of 
vertical posture and activity, though opinions vary over the benefits regarding circulation and bone 
density [Nene, Hermans et al. 1996].
Physiotherapy applied to denervated muscle is aimed at preserving the range of movement of joints 
to avoid any disabling contractures especially in cases of partial limb denervation, by stretching 
and heat therapy, however there is concern regarding ‘over-use’ damage of muscles weakened by 
peripheral neuropathies [Herbison, Jaweed et al. 1983]. Passive standing in suitable support frames is 
advocated for the benefits to internal organs including bladder drainage, of weight bearing and to 
help prevent ankle contractures. Attempts to enhance blood flow in denervated limbs, is largely 
through artificial means of assisting venous return, such as pneumatic cyclic pressure devices (e.g. 
Flowtron). There is evidence that contraction of muscles induced by electrical stimulation may 
enhance muscle bulk, blood flow and skin temperature (§3.4) and forms the basis for this study, but 
this is not in routine clinical use in the UK for chronically denervated muscle.
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2.4 Clinical Assessment of Muscle Innervation
The changes in properties and contraction characteristics of muscle once denervated provide a 
means of assessing the extent and progress of any re-innervation. Some of these techniques may 
therefore provide means of assessing the effects and effectiveness of any intervention treatments on 
nerve growth and re-innervation, though no one single parameter is recommended [Frykman, 
McMillan et al. 1988]; clinically available methods are described here.
2.4.1 Ultra-structural Analysis
A muscle biopsy is the removal of small amount of tissue by the insertion of a needle for 
histological and microscopic analysis for fibre size, metabolism and structure. Clinically, this can 
obviously only be performed at irregular intervals. Histological staining can delineate the endplate 
area and sprouting termini, allowing determination of the sprouting index (average number of 
terminal branches in a muscle * average endplate length) [Pestronk and Drachman 1978]. Electron 
and light microscopy has also been used to visualise endplate re-innervation [Frykman, McMillan et 
al. 1988; Ribaric, Stefanovska et al. 1991].
Increased ACh sensitivity or extra-junctional AChR density is associated with the production of a 
nerve sprouting stimulus. However the relationship to actual nerve terminals is largely through 
correlation of results rather than causal [Brown, Holland et al. 1978] and re-innervation has been 
reported to be independent of extra-junctional ACh tension [Frank, Jansen et al. 1975]. AChR density 
and stability (half-life) may be determined in vitro and in vivo by labelling with radio-active (1251) 
a-bungarotoxin which binds with AChR [Andreose, Fumagalli et al. 1995]. AChR sub types can also 
be identified in vivo and in vitro with molecular probes [Changeux 1991] and adenovirus [Bessereau, 
Stratford-Perricaudet et al. 1994].
Biochemical assays for myelin may have a direct relationship to nerve regeneration and assays for 
collagen may indicate scar formation hindering axon re-growth [Frykman,McMillan et al. 1988].
2.4.2 Muscle Cross Section Imaging
Non-invasive, macroscopic imaging of muscle cross section is possible with magnetic resonance 
imaging (MRI) and is particularly suitable for accurate location in repeated measures, albeit at 
considerable expense and inconvenience. The technique has been shown to identify sub-acutely 
denervated muscle (1-12 months post injury) by hyper-intensity of the image, perhaps by increased 
extra-cellular water content, but is not condition specific, as this also occurs with post trauma 
oedema. Conversely, acutely denervated muscle shows no unique image characteristic, and 
chronically denervated muscle is only identifiable by muscle atrophy and fat infiltration. However
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in determining the extent of atrophy, the method does confirm the absence of reinnervation or 
allow its reversal with reinnervation to be monitored. In this it has proved useful in cases where the 
motor unit anatomy is unconventional resulting in fibre denervation in unexpected locations and 
thereby directing EMG evaluation and surgical repair [Fleckenstein, Watumull et al. 1993]. 
Ultrasound imaging (§3.5.1) has also been used in muscle denervation examination [Gunreben 
1991 quoted by Fleckenstein, Watumull et al. 1993].
2.4.3 Muscle Electrical Characteristics
Electromyography (EMG) is the recording of the electrical signals produced by the muscle fibres 
as a result of the action potential depolarisation process during contraction. It may be detected 
either by skin surface electrodes or by percutaneous needle electrodes. By correct positioning, the 
latter can detect the signal from individual muscle fibres in a selected part of the muscle, needle or 
single fibre electromyography (SFEMG). However this is invasive, potentially painful and 
therefore unsuitable for evaluation of certain subjects, such as young children or those on anti­
coagulant drugs. It also relies upon conventional innervation pattern and the operator for precise 
location of electrodes, which are not confirmed independently, nor easily reproduced for serial 
evaluation [Fleckenstein, Watumull et al. 1993].
The signal obtained transcutaneously is a compound signal from an indeterminate number of 
mainly superficial fibres and therefore known as the Compound Muscle Action Potential (CMAP). 
Analysis of this 'raw EMG' signal is either of its frequency components allowing identification of 
some individual motor units or from the amplitude of the 'integrated EMG'. In addition to EMG 
recording of voluntary contracted muscle, it may also be monitored following contraction induced 
by electrical stimulation, though electronic blanking is usually employed to minimise the 
stimulation artefact. This technique is obviously of relevance to denervated muscle, and employed 
by Nemoto et al.(1988) stimulating the nerve distal to the site of nerve injury. However the long 
pulse duration typically for transcutaneous stimulation treatment of denervated muscle (§3.2), can 
mask out the signal of interest from the muscle fibres.
The needle EMG signal recorded from denervated muscle (Fig.2.4.1) is significantly reduced and 
characterised by occasional positive sharp waves and fibrillation variation, known as pathological 
spontaneous activity (PSA) and increased latency (§2.3.1). This is the first detectable in the muscle 
about 14 days after injury and the amount of activity is influenced by the muscle fibre type [Hiilser, 
Wissmeyer et al. 1997] With partial denervation high amplitude potentials indicate the enlargement 
of some motor units [Raimbault 1984]. Reinnervation is indicated by the absence of the 
characteristic PSA and progressive return of a mixed interference EMG pattern [Boonstra,Van 
)Veerden et al. 1987]. Vain and Humal have derived the oscillating period (T) and common logarithm 
(O) to characterise the biomechanical status o f abnormal muscles [Lasn 1995].
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Figure 2.4.1 EMG Characteristics of Denervated Muscle [after Patten 1977]
The CMAP amplitude is also decreased by nerve injury, dependent upon its severity and can occur 
within 2 days, therefore preceding changes in needle EMG signals. It has advantages of being non- 
invasive, and less sensitive to electrode positioning that component EMG analysis. However it is a 
comparative rather than absolute measure, and therefore for diagnosis relies upon the contralateral 
side having the same pattern of innervation and being unimpaired [Hiilser,Wissmeyer et al. 1997]. The 
progressive increase in compound action potential from recruitment of individual motor units in 
response to incremental increases in stimulation level, allows estimation of their number and size 
and therefore any progress of reinnervation. Automated measurement has been developed to 
compensate for the effects of fibre position relative to the electrodes, for errors due to units with the 
same or very similar thresholds and intra-operator variability [McComas, Galea et al. 1993].
2.4.4 Electrical Mluscle Stimulation Testing
The response of any tissue to an applied electric field is determined by its excitability (in terms of 
the intensity required for a given stimulus duration), its refractory period (the time after being 
excited before further excitation is possible) and its capability or not to accommodate to the 
stimulus [Cummings 1985]. A number of diagnostic techniques have been developed based upon the 
response of muscle tissue to externally applied electrical stimuli, the principles of which are 
described elsewhere (§3). The axolemma is depolarised by smaller electric fields than the 
sarcolemma and so innervated muscle fibres respond to stimuli of smaller duration and intensity 
than denervated fibres. These tests can therefore provide an indication of the extent o f denervation 
of a muscle, though not the exact quantification offered by electromyography. However they have 
the advantage of being non-invasive, convenient and require minimal equipment or operator 
training. They are perhaps most useful as comparative measures, in monitoring the progress of 
innervation following injury or application of treatment.
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Muscle Excitability Testing - Strength Duration Curve
Muscle excitability is assessed by using isolated stimuli and therefore without the influence of 
refractory or accommodation mechanisms. The Strength-Duration or Time-Intensity curve is a 
graphical characterisation of the excitability of a muscle or muscle fibres, in terms of the 
relationship between the intensity and the duration of stimuli. Typically, surface electrodes are used 
to apply isolated, uni-polarity (monophasic), rectangular stimulation pulses of approximately 10 to 
20 different widths between lOps and 300ms. For each width, the intensity of stimulation required 
to just elicit a minimum contraction of muscle is plotted and the resulting curve has an exponential 
shape for normal skeletal and cardiac muscle [Geddas and Bourland 1985]. The stimulation threshold 
intensity diminishes as pulse width increases, for innervated muscle until approximately 3ms and 
thereafter remains approximately constant at a value referred to as the Rheobase. The pulse width 
corresponding on the curve to twice the Rheobase intensity, is known as the Chronaxie, which is 
typically less than 1ms in innervated muscle. For denervated muscle fibres, depolarisation and 
subsequent contraction necessitates longer pulses, so the curve is shifted to the right, with increase 
in Chronaxie to typically 10ms (Fig.2.4.2).
The Rheobase value is influenced by a wide variety of factors and cannot be used as a quantitative 
measure. Chronaxie does provide some independence from these effects but can only be used 
reliably to identify denervation. Attempts have been made to produce other quantitative values 
from the curve [Geddes and Bourland 1985] and a single point value at 1ms has been employed to 
successfully diagnose sphincter muscle dysfunction [Monk, Mills et al. 1998]. However, it is 
generally accepted that the usefulness of the curve for PNI treatment is derived from its overall 
shape when monitored serially. In cases of partial denervation/reinnervation, a combined 
characteristic is obtained; the nerve and therefore the innervated fibres are excited by the shorter 
pulse widths, whereas the denervated fibres are excited only by the longer pulses. The resulting 
’kink' in the curve appears typically 6-8 weeks before the first voluntary movement and can be used 
to monitor the progress of innervation though it does not guarantee the eventual functional outcome 
(Fig.2.4.2). In some cases this does not occur, for instance, in larger muscles where the 
reinnervated fibres are deep and not reached by the stimulation. Conversely the curve may indicate 
small regions of denervation before onset of muscle weakness [Lenman and Ritchie 1987 p.96-100].
The threshold measurements are influenced by a wide variety of factors, such as the equipment 
output impedance, the electrodes used, the skin condition and impedance, the patients state, and the 
measurement environment. In addition there is inter-rater and intra-rater variability some o f which 
is attributable to the method of detection of contraction, either by palpation or visually. Even so, 
with experience and careful technique, clinically useful results can be obtained [Alexander 1974; 
Arsenault and Stevens 1979; Low 1979; Lenman and Ritchie 1987; Monk,Mills et al. 1998].
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Figure 2.4.2 Strength Duration Curves [after Lenman and Ritchie 1987]
Note: Curves in left plot may correspond to different patients or different measurement 
conditions, thereby accounting for the location of the curve for partial innervation above 
that for denervated muscle
Muscle Refractorv Period Measures
The refractory period is the period after one stimulus before the muscle fibre is able to respond to 
the next. Muscle action potential duration has been shown to increase from 5ms to 16ms with 
denervation [Petrofsky 1991]. Hence denervated muscle looses the ability to respond to repetitive 
(faradic) stimuli and requires progressively longer and stronger (galvanic) stimulation pulses. This 
Faradic-Galvanic response test of the absence of response to faradic stimulation to the normal 
limit of tolerance of the individual, has been used from the earliest days of stimulation, and remains 
the easiest way to discriminate innervated from denervated muscle. However tetanic contractions 
can be achieved in denervated muscle given sufficient pulse width (§3.2), and without 
standardisation, the test is only correct in 50% of cases and has no value in assessment of prognosis 
[Lenman and Ritchie 1987 p.87].
A more quantitative measure is the Intensity-Frequency curve, a plot of the intensity for a 
minimum contraction at a given frequency of stimulus. This is typically performed with sinusoidal 
alternating current, but is then a combined accommodation measure, as the intensity rise time 
varies with frequency and the optimum frequency, of lowest intensity, occurs when these two 
effects balance. Although this minimum is not sharp and varies by about 20%, it is approximately 
60Hz for normal muscle and 2Hz for denervated muscle. However, with continuous alternating 
current, the risk of tissue damage is significant and may exceed the tolerance of the patient [Lenman 
and Ritchie 1987 p.103].
Muscle Accommodation Measures
Not only is the axolemma more excitable than sarcolemma, it is also more accommodating to 
gradually changing stimuli, a fact that can be taken advantage of in both diagnosing and treating 
denervated muscle. The Galvanic-Tetanus ratio is the ratio of intensity o f contraction threshold of
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a twitch contraction from a single stimulus compared to that of a continuously increasing 
stimulating current. In normal muscle this ratio is about 5, in denervated muscle about 2. The form 
of the stimuli is not defined and again there is danger of skin bums [Lenman and Ritchie 1987 p. 102].
In progressive current testing the comparison is between an instantaneous stimuli and one which 
increases gradually, according to a set pattern, linearly, exponentially or logarithmically. This 
enables the denervated muscle to be stimulated without the innervated muscle (Fig.2.4.3.b). For 
instance. Le Flohic (1994) finds a linear slope of 20% is necessary to accommodate innervated 
muscle. However it is essential that the rate of decrease of the stimulus is equal to its increase, to 
avoid a 'break effect' of rapidly reduced intensity [Lenman and Ritchie 1987 p. 102]. More useful in 
monitoring the progress of innervation is a Strength/Intensity-Duration curve for such 
accommodating stimuli, which in the case of the triangular pulse Intensity-Duration curve shows a 
clearly differentiable minimum between innervated and denervated muscle (Fig.2.4.3.a).
ms
SD Curves for a) Triangular Stimulation Pulses -b) Exponential Pulses 
[after Stephens 1973] [after Cummings 1985]
Figure 2.4.3 
2.4.5 Sensory Innervation Assessment
Re-generation of sensory neurones can accompany that of motor neurones, through re-innervation 
o f the target organ may not be concurrent However, since monitoring the progress of sensory 
neurone re-growth is in some respects easier than that of motor neurones, it may give a uesful 
indicator regeneration. In particular the Tingel-Hoffman sign is a means of monitoring the sensory 
nerve as it regrows by percusion of the skin [Sunderland 1978; Buck-Gramcko and Lubahn 1993]. 
Sensory evoked potentials allow determination of nerve conduction to the sensory cortex. Tactile 
sensation sensitivity and distribution can be determined statically and dynamically with two point 
discrimation [Chassard, Pham et al. 1993] and monofilaments [Bell and Tomancik 1987].
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3. R e v i e w  o f  L i t e r a t u r e
3.1 Neuromuscular Electrical Muscle Simulation
Neurones can be depolarised by externally applied electric fields (Fig.3.1.1). The action potential 
then propagates in the normal manner to cause muscle fibre contraction referred to as indirect 
electrical stimulation. The generating electrodes may be attached to the skin superficial to the nerve 
for transcutaneous stimulation or now more commonly, implanted beside or surrounding the nerve 
to reduce the required stimulation intensity and improve selectivity. With subcutaneous 
stimulation, the stimulating device is also implanted or with percutaneous systems connections are 
made externally. As the membrane is bi-directional, the action potential of depolarised afferent 
neurones also propagates proximally to the cell body and may cause a second, later contraction via 
the spinal reflex arc.
The current density at the membrane surface from the externally applied field is influenced by the 
electrode size and orientation, the impedance of the skin interface and intervening tissue, and the 
nature of the stimulus itself. With electrodes placed too close together the current may only pass 
through superficial tissue and not penetrate to deeper neurones. Nerves are most easily depolarised 
at their endplate termini, where unmyelinated. Commonly referred to as the motor point, this is the 
usual position for the negative active electrode. Current density at the electrode is increased by 
decreasing its size, but if not optimally located over the motor point, then excessive levels may be 
required to obtain effective stimulation, causing patient discomfort and possible tissue bums. 
Unequally sized electrodes are also less suitable for biphasic stimulation when the direction of the 
applied field is reversed during the pulse, so that no net current flow occurs. This prevents possible 
deterioration of electrodes and tissue, from migration of ionic concentrations. The stimulation 
current applied is discontinuous to allow repolarisation of the neurone between pulses. Pulse 
frequency is determined by the refractory period for the fibre type and typically 10-40Hz. Typical 
pulse widths for transcutaneous stimulation are 100-300ps, the intensity requires varies with pulse 
width according to the Strength Duration curve (§2.4.4), and is typically 20-50mA [Baker, McNeal 
et al. 1993].
Recruitment order is the reverse of normal physiology. The larger diameter axons innervating fast- 
type II muscle fibres are depolarised by lower stimulation intensities because of their lower 
threshold and their more superficial location in the nerve bundle [Baker, McNeal et al. 1993]. For 
maximal contractions, all fibres are recruited synchronously, rather than normal asynchronous 
recruitment. Both of these effects lead to fatigue of the induced muscle contractions sooner than 
normal physiology. Techniques to alleviate this include using stimulation patterns derived fi-om a
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normal EMG signal [Kidd and Oldham 1988] or with varying frequency, making use of the 'catch 
like' property of muscle, and its dis-habituation properties [Michael 1996], Alternatively, multi-polar 
implanted electrodes have been developed to provide selectively depolarisation in terms of axon 
diameter, allowing selective recruitment of particular muscles fibres or particular muscles [Rattay 
1990],
The precise control of sustained muscle contraction and consequent limb movement, with minimal 
fatigue is required for the application of functional electrical stimulation (FES) to achieve 
functional outcomes such as compensation for 'dropped foot' following peroneal nerve damage, 
multiple sclerosis or stroke, standing and walking for cases of paraplegia, or arm, hand and 
respiratory control for cases of tetraplegia. By use of appropriate stimulation frequency and pattern, 
transformation of muscle type and metabolism can also be achieved, for instance, slowing the 
contraction speed of fast type skeletal muscle for cardio or aorta myoplasty [Salmons 1995].
Stimulation has been employed for therapeutic benefits for SCI and other neurological conditions 
to compensate for reduced or absent muscle contraction by improving the quality and viability of 
tissue with increasing bulk and perfusion with some evidence of a prophylatic effect towards 
pressure sores [Rischbieth, Jelbart et al. 1998]. Through bicycle ergometry, it can also acts as 
cardiovascular exercise [Baldi, Jackson et al. 1998]. Neuromuscular stimulation has also been shown 
to assist contracture prevention, tremor alleviation for Parkinson's disease, spasticity reduction in 
stroke and SCI cases and for neurological re-education following stroke [Baker, McNeal et al. 1993]. 
All of these techniques rely on the depolarisation of a functional lower motor neurone and in the 
absence of which direct muscle stimulation is required.
SKIN S U R F A C E
N E R V E  BUN DLE
Figure 3.1.1 Transcutaneous Neuromuscular Stimulation [after Baker, McNeal et al. 1993]
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3.2 Direct Stimulation of Denervated Muscle Techniques
Reid in 1841, is credited with the first published work on electrotherapy for denervated muscle and 
advocated it in order to prevent atrophic changes [Mokrusch and Neundorfer 1994], Erb in 1868, 
documented that denervated muscle retains its excitability to electric current, though compared to 
normal muscle, its response is no longer instantaneous but, slow and sluggish [Cummings 1985], 
Also observed, was that to elicit a contraction, the stimulating current is required to be of greater 
intensity, duration and applied to the denervated muscle directly, not indirectly through the nerve, 
as with innervated muscle. This technique of applying electric fields to depolarising the muscle 
fibres themselves because of the absence of a functioning lower motor neurone has therefore 
become known as direct electrical muscle stimulation.
Such stimulation has been suggested as a treatment for denervated muscle on the assumption that 
muscle activity rather than neurotrophic influence is the most important factor in regulating muscle 
fibre physiological and bio-chemical properties such that the changes on denervation may be 
reversed by artificially induced contractions. In reviewing 25 years of studies mainly in the animal 
model, Eberstein and Eberstein [1996] concluded the evidence is that direct electrical stimulation 
can indeed to a large extent substitute for innervation to preserve and restore normal muscle 
properties providing appropriate stimulation parameters are employed. This is aimed at the clinical 
objective; for acute nerve injuries, of minimising muscle atrophy in order to maximise function 
recovery on re-innervation, and for chronic denervation cases, of enhancing tissue viability with 
respect to secondary complications and where appropriate achieving functional muscle 
contractions. However, contractile activity is not the sole determinant of muscle properties and the 
multiplicity of influencing factors may account for some of the difference in effect of stimulation 
observed between studies (§3.3). The Eberstein’s went on to highlight that, at that time, the 
appropriate stimulation techniques for human denervated muscle (§3.4) had yet to be fully 
prescribed.
Changes in the electrical properties of the sarcolemma with denervation diminish its ability to 
propagate the depolarisation action potential. The stimulation electric field is therefore required to 
cause localised release of calcium ions, it is suggested, by permeating throughout the membrane as 
in smooth muscle, rather than by their normal release from the SR cisterns [Eichhom, Schubert et al.
1984], Deterioration of the muscle fibre contractile protein structures and fibrosis of the muscle 
tissue, also contribute to the progressive decrease in the muscle excitability with denervation and 
this is influenced by the degree of immobilisation, the action of surrounding functional musculature 
and movement impeding contractures. The duration and amount of stimulation charge flow is 
greater than that with indirect stimulation to ensure sufficient penetration, to recruit deeper fibres.
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3.2.1 Stimulation Pulse Width
The stimulation pulse width (PW) required to achieve a contraction increases with the period of 
denervation as demonstrated by the Strength-Duration curve (§2.4.4) especially during the first two 
weeks, such that tetanic contractions are no longer possible. After 2 years post injury, reinnervation 
is unlikely (§2.2.4) and the condition is considered chronic. Pulse widths of 100-300ms are then 
typically required with surface electrodes to achieve a muscle contraction, with Chronaxie used as 
the minimum or guide value [Cummings 1985; Boonstra, Van Weerden et al. 1987; Campbell and 
Meadows 1995]. However it has been found that continued treatment with stimulation increases the 
excitability of the muscle with the membrane resting potential and capacitance are restored 
[Westgaard 1975 quoted by Nemeth 1982]. The muscle fibres then respond to progressively shorter 
pulse widths down to the order of 10ms (transcutaneous) and eventually permitting frequencies of 
tetanic contractions, typically up to 20Hz (§3.4.2). The improved response may be attributed to 
reversal of some of the fibre changes with denervation; in the electrical properties o f the 
sarcolemma, the contractile proteins and tissue fibrosis tissue and in the fibre metabolism and 
perfusion (§3.3). Pulse widths required with implanted electrodes are much lower than with surface 
electrodes, and typically less than 1ms (§3.4.1).
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3.2.2 Stimulation Puise Shape
The contraction of denervated muscle results in fatigue to a greater extent than innervated muscle. 
In addition to the non physiological recruitment, this may be due to the altered biochemical 
mechanisms of contraction, which may lead to the temporary exhaustion of calcium supplies, 
especially if the return mechanisms are impaired [Eichhom, Schubert at al. 1984]. The transfer to 
largely anerobic fibre metabolism, with reduced mitochondria and perfusion (§2.3) may also 
contribute to fatigue. With indirect stimulation, it is important to ensure no net transfer of charge 
into the tissue to avoid altering the ionic balance of the axon membrane, which could eventually 
fatigue contractions [Baker, McNeal et al. 1993]. This is commonly achieved passively, by allowing 
the body to discharge into the stimulator, however with pulses of 100 to 1000 times longer used for 
direct stimulation, it is quite probable that some ionic effect may occur during the pulse. Active 
charge balancing, achieved with symmetrical biphasic (opposite polarity) impulses (Fig.3.2.1), has 
been shown to avoid fatigue in sustained tetanic contraction of denervated muscle, attributed to 
variations in the tissue current flow paths with the reversal of polarity, causing different fibres to be 
recruited [Eichhom, Schubert et al. 1984]. Charge balancing also reduces the risk of skin damage at 
tetanic frequencies probably from excessive heat [Guttmann 1976, p.573].
Stimulation pulse shape has generally been rectangular as this maximises the tissue current flow for 
a given pulse width. However the near instantaneous application of current, and resulting sudden, 
non-physiological contraction, it is thought, may over fatigue and damage the denervated muscle 
[Cummings 1985]. This is avoided with indirect faradic stimulation, by gradually increasing the 
intensity of successive pulses within the stimulation burst envelope (§3.2.4). For the pulses of 
longer duration required for stimulation of chronically denervated muscle the intensity of the pulse 
can be gradually increased or decreased, either linearly [LeFlohic 1994], exponentially [Cummings 
1985][Carraro & Zmnek quoted by Mokmsch, 1994] or sinusoidally [Osbome 1951; Petrofsky 1991]. In 
cases of partial denervation, this can have the significant advantage of selectively contracting the 
denervated muscle fibres, while the still innervated fibres accommodate to the stimulus (§2.4.4). 
These fibres would otherwise contract at lower intensities than the denervated fibres, resulting, 
either in their possible damage from fatigue or the ineffectual contraction of the denervated fibres 
[Cummings 1985]. Nerve accommodation requires linear rates of change of less than 20% [LeFlohic 
1994], or 30*Rheobase/s [Stephens 1973] as reflected in their respective Strength-Duration curves 
(Fig.2.4.3). Stimulation pulse widths to achieve LMN accommodation are typically 300-1000ms 
for which inter-pulse intervals 4-5 pulse widths are recommended [Thom, 1955 quoted by Cummings
1985].
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3.2.3 Stimulation Puise Pattern
Considerable investigation has been undertaken, largely in the animal model, to identify the effects 
of particular stimulation patterns on denervated muscle, mainly in respect of contraction
characteristics and atrophy. Contrasting results, have led opinions to vary as to the relative
importance of the frequency or the total number of impulses, the duration of bursts of impulses or 
the interval between them. In reviewing these, Eberstein and Eberstein [1996] concluded that the 
optimum stimulation for fast muscle is intermittent bursts of impulses at high frequency 
(e.g.lOOHz), and for slow muscle is continuous low frequency pulses (e.g.lOHz). Some researchers 
have advocated a stimulation pattern derived from the normal EMG signal of the particular muscle 
[Petterson, Smith et al. 1994]. However the duration of stimulation pulse required for transcutaneous 
direct stimulation of chronically denervated muscle (> 100ms), limits the frequency to 2Hz or less, 
producing a series of twitch contractions which has been the conventional electrotherapy 
employed. Even with the conditioning effect of treatment (§3.2.1), pulse widths of greater than 
10ms are required to ensure all fibres are depolarised, and so limits the range of possible variation 
in parameters for tetanic contractions, though fusion frequency is reduced (§2.3.1). Frequencies of 
5-8Hz, producing 'shaking' clonus type contractions have also been employed as an intermediate 
treatment between twitch and tetanic contractions to account for different rates conditioning 
between muscle fibres [Kern, Hofer et al. 1999].
There seems general agreement that tetanic are more effective than twitch contractions at
preserving muscle fibre properties. Denervated rat muscle weight increased by 10% with 
transcutaneous stimulation by 100ms at 2Hz but by 10-30% with 25ms at 20Hz [Herbison, Teng et 
al. 1971]. Studies in human muscle also confirm the absence of effect on atrophy of twitch 
contractions [Boonstra,Van Weerden et al. 1987] compared to significant benefit from tetanic 
contractions, albeit necessitating biphasic pulses (§3.4).
3.2.4 Contraction Pattern
The tetanic contractions are sustained for a short period by employing a burst o f the stimulation 
pulses the trend of the intensities of which form the stimulation envelope (Fig 3.2.1). With indirect 
stimulation, this envelope is often trapezoidal in shape. Compared to rectangular envelopes, the 
gradual increase and decrease of the consequent contraction more closely resembles physiological 
muscle contraction force and helps to minimise muscle spasm. A typical pulse train envelope shape 
for indirect quadriceps stimulation muscle training is 4 seconds of ramp up of intensity, 4 seconds 
at peak intensity level and 4 seconds of ramp down followed by 12 seconds off-period with zero
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intensity of stimulation^ This form is based on typical physiological muscle use for standing, as for 
functional stimulation the envelope is of necessity defined by the desired functional outcome. The 
envelope off-period (Fig.3.2.1) is intended to allow for reperfusion of the muscle, which is more 
than likely ischaemic during the contraction. However, it is suggested that off-periods of minutes 
are required for reperfusion and that any less time is equivalent to ischaemic continuous stimulation 
[Lexell, Jarvis et al. 1997]. This study also revealed that fibre damage induced by indirect stimulation 
was less with intermittent (Ihr on/1 hr off) than continuous lOHz, suggesting that reperfusion 
following the ischaemic contractions, is not responsible for the damage.
Stimulation patterns used with denervated muscle vary considerably. Some have adopted those 
used for indirect stimulation [Taylor, Ewins et al. 1992] or rectangular envelopes of 6 seconds 
[Mokrusch and Neundorfer 1994][Müller, 1970 quoted by Herbison, Jaweed et al. 1983]. Off-periods 
between contractions are at least equal to or double contraction duration. A quite different approach 
has been adopted by Kern et al.[1995] in using a series of 6 to 8 contractions of 2 seconds duration 
with 2 sec off period and a minute or two rest between consecutive sets of contractions (§3.4.2).
3.2.5 Treatment Pattern
The treatment patterns adopted have been dependent on the stimulation pattern. The majority of 
animal studies employed continuous stimulation whereas clinical studies largely used session based 
stimulation for practical reasons. Mokrusch et al. [1990 and 1994], demonstrated that atrophy 
benefits may be obtained by relatively short periods of treatment each day (6min per muscle 
twice/day) with near maximal contractions. Williams [1996a,b] applied continuous treatment but at 
a low contraction duty cycle (e.g.O.ls every 4s) with minimal contractions. Both claim the key to 
success being that all fibres were stimulated, the former transcutaneously using long pulses (20ms), 
the latter using subcutaneous wire electrodes and less then 1ms pulse width. Wakim and Krusen 
[1955] demonstrated that over 25-30 days, 5 minutes of stimulation every 30 minutes for 8 hours 
per day, was just as beneficial as longer sessions at the same frequency and more beneficial than 30 
minute sessions once or twice a day [Speilholtz 1987]. The considerable variation in stimulation and 
treatment pattern may account for the differences in response observe between studies, and means 
there is as yet no definitive treatment protocol for clinical application.
3.2.6 Electrode Type and Location for Direct Stimulation
Electrode location is optimum for transcutaneous indirect stimulation over the motor point (§3.1), 
whereas with direct stimulation, electrodes are positioned at either end of the muscle belly to
* Quadriceps training pattern used at SDH for FES.
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maximise the field distribution along the fibres [Eichhom, Schubert et al. 1984], and the response of 
denervated fibres is generally accepted to be indifferent to polarity [Sunderland 1978]. A 
compromise in electrode positioning may be required in the case of partially denervated muscle, so 
as to optimise recruitment of the innervated or denervated fibres according to the treatment aim. 
Generally surface electrodes have been employed for clinical applications of direct stimulation, 
however these necessitate much greater pulse widths and intensities to reach all fibres. There is the 
potential for tissue damage at the skin interface and the intensity may be limited by patient 
tolerance. Guttmann [1976] minimised this by moving the electrode position during treatment, 
which also altered the current path to different fibres. Some researchers have sought to improve the 
field distribution, especially in the less superficial fibres by super-imposing fields from a number of 
pairs of electrodes. [Arndt, Eichhom et al. 1987] and this has also been suggested as a means of 
minimising antagonist co-contraction [Mokmsch and Neundorfer 1994].
Implanted electrodes permit the use of smaller pulse widths and therefore offer greater flexibility in 
stimulation pattern parameters. However percutaneous systems introduce the risk of wire breakages 
and infection, whereas fully implanted, subcutaneous systems eliminate any problems of animal or 
patient compliance but at the expense of greater technical complexity. Implanted electrodes have 
generally been employed on the stimulation studies in animals probably for practical reasons given 
that stimulation has often been continuous, though they have also been advocated over surface 
electrodes by some to ensure all fibres are contracted [Nix and Dahm 1987]. Conversely, others argue 
the intensities required to reach all the fibres of larger muscles have the potential for tissue damage 
with implanted electrodes from excessive localised current density [Eichhom, Schubert et al. 1984]. 
Clinical implantation has been employed successful for continuous stimulation using wire 
electrodes along the length of the forearm and hand muscles [Williams 1996a], which may ensure a 
more uniform current distribution, though the response in these acute nerve injuries, may also be 
due to the greater retained muscle excitability.
Attempts have been made to model the fields within the tissue induced by direct stimulation and to 
produce an electrical circuit model of surface direct stimulation [Reichel, Mayr et al. 1999]. However 
as yet there are few studies relating the measured stimulation current flow to the biochemical 
processes occurring during stimulation induced contractions, in order to facilitate optimisation of 
the stimulation parameters, electrode design and location.
3.3 Effects of Stimulation of Denervated Muscle
Much of the early work focused on whether stimulation could retard muscle atrophy and the 
conflicting observations were inconclusive [Speilholtz 1987]. Research in more recent decades has 
also included the selection of stimulation parameters to best achieve the effects of clinical benefit.
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in terms of muscle properties and reinnervation [Mokrusch, Engelhardt et al. 1990; Eberstein and 
Eberstein 1996]. This has necessitated invasive histological analysis in various animals to permit the 
frequency o f measurement and statistically significant sample sizes. A few studies in humans have 
included analysis of muscle biopsies, though of necessity, these are limited to samples before and 
after treatment. Unfortunately few of the studies correlate the structural and functional measures. 
This section details some of the results of the animal studies pertaining to those of the clinical 
studies (§3.4).
The effect of stimulation is predominately on those denervation changes occurring due to the 
absence of muscle contraction, (§2.3), and therefore greatly influenced by the stimulation, 
contraction and treatment patterns employed (§3.2). Also important is the muscle loading and 
length during contractions, which is known to influence protein synthesis rate and damage 
mechanisms (§2.3). In some studies, the muscle was partly or wholly excised from the animal for 
post treatment evaluation measurements, which are influenced by the extent to which normal blood 
supply is preserved, the maintenance of body temperature by artificial means and the use or 
otherwise of anaesthetic. The duration of denervation and immobilisation of the muscle determine 
the extent to which tissue properties deteriorate or alter and the effect o f stimulation depends on 
whether these are reversed or compounded [al-Amood and Lewis 1987]. The observed effect of 
treatment is also influenced by the proportion of fibres stimulated, the level of blood, and hormone 
perfusion [Eberstein and Eberstein 1996]
The clinical relevance of many studies has been questioned in terms of how representative they are 
o f typical nerve injuries [Speilholtz 1987]. The stimulation treatment employed in many animal 
studies applied continuously for periods of days or weeks, whereas reinnervation in humans is 
typically months or up to a year. As with studies of denervation tissue properties (§2.3), variability 
between studies is introduced by differences in the methods of denervation and histological 
techniques employed. Direct comparison of studies in animals and humans must also be done with 
caution given the large differences in parameters required to produce tetanic contractions, 
especially between transcutaneous and subcutaneous stimulation and because of differences in 
muscle physiological response to denervation (§2.3). This complexity of influencing factors, makes 
comparison of individual studies and their conclusions on the effectiveness of stimulation 
parameters, difficult to correlate and draw overall conclusions from, not least because of the 
variability of detail in the information [Speilholtz 1987; Eberstein and Eberstein 1996].
3.3.1. Contraction Characteristics
Chronic stimulation of long-term denervated muscle almost completely restored the specific 
tension of fast and slow muscle fibres (tension per unit fibre area) but overall muscle tension was 
still about 5% of normal as fibre atrophy was not fully reversed [al-Amood, Lewis et al. 1991]. The
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effect of stimulation on tension in fast muscle is largely related to the frequency correspondence of 
normal physiological firing rates. High frequency stimulation is required for maximum contraction 
force [Gunderson and Eken 1992; Vrbova, Gordon et al. 1994 p72]. No significant frequency 
dependence was observed in stimulation of slow muscle [al-Amood and Lewis 1987]
In some, studies the decrease in fatigue resistance \vith denervation was reduced by low frequency 
stimulation [Stein 1982 quoted by Vrbova,Gordon et al. 1994 p238] in others, it had no observed effect 
[Nix 1990]. This is related to the extent of increase in oxidative capacity and fibre metabolism. 
Stimulation can either maintain an existing muscle fibre type or effect a change, in its contractile 
structure, metabolism or contraction characteristics. This plasticity of muscle to its activity pattern, 
has been used to greatly increase the fatigue resistance of skeletal muscle by indirect stimulation 
for its application in cardiac assistance and considerable research has been undertaken into the 
optimum indirect stimulation pattern especially for minimising muscle damage [Salmons 1995].
In denervated slow muscle stimulation produced an increase in contraction speed (decrease in 
twitch TPT and RT) though some is attributable to denervation changes (§2.3.1). Gunderson and 
Eken [1992] reported a frequency dependency, with a progressive increase in muscle twitch speed 
with increasing frequency (20,75,150Hz) but similar increase in isotonic shortening speed with all 
frequencies. al-Amood et al.[1987] observed a similar response (though greatest with 40 & 60Hz) 
providing intermittent stimulation was used. Only continuous (lOHz) stimulation maintained or 
restored normal slow muscle contraction speed contrary to denervated changes. They therefore 
consider the time interval between contractions (contraction frequency) to have greater influence 
on muscle contraction speed than stimulation pulse frequency, postulating a chemical agent which 
falls below a critical level when the interval is too great as in all but continuous stimulation [al- 
Amood, Finol et al. 1986; al-Amood and Lewis 1987]. Similarly, others reported that lOHz direct 
stimulation maintained denervated rat soleus and that lOOHz transformed it from slow to fast 
muscle irrespective of the total number of impulses [Mokmsch,Engelhardt et al. 1990 quoting 
Lomo.1980,1985].
In denervated fast muscle, Gunderson and Eken [1992] suggest a dependence on the amount of 
stimulation (number of pulses) rather than their frequency. Low frequency intermittent stimulation 
(20Hz) produced a slight increase in twitch TPT and no change in isotonic shortening velocity. 
With high frequency intermitant stimulation (150Hz), twitch TPT was unchanged but isotonic 
shortening velocity was decreased. Using physiologically based high frequency (lOOHz) 
intermittent burst stimulation (average 1.6 Hz) produced no significant effect on latency or 
contraction speed of rabbit EDL [Nix 1990]. The increase in refractory period of the fibre membrane 
with denervation, is considered to limit the effect of fast stimulation patterns, which cannot respond 
to every pulse. Whereas, with innervated muscle the synapse acts as a filter, such that both high and 
low frequency stimulation can produce a slowing of muscle [Nix 1990].
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3.3.2 Membrane Electrical Changes, Nerve Sprouting and Reinnervation
The muscle fibre membrane passive electrical properties and resting potential are restored to 
normal values by stimulation, and attributed to the muscle activity rather than regulation by 
neurone derived agents [Lomo and Rosenthal 1975]. Stimulation has also been shown in many studies 
to suppress the disseminated ACh sensivity into extra-junctional areas of denervated muscles, 
producing a rapid increase in PKC activity (§2.3.2) in the chick muscle nucleus within lOmin 
[Huang, Tong et al. 1992]. The level of ACh sensitivity, increased following denervation, is reduced 
by stimulation in slow and fast muscle (rat soleus [Jones and Vrbova 1970], mouse soleus and 
peroneus tertius [Brown and Ironton 1977b], rat EDL [Gruener, Baumbach et al. 1974]. Indirect 
stimulation of rat soleus distal of a nerve block started after 4 days was shown to reverse the extra- 
junctional supersensivity, and to prevent it altogether when started earlier. Direct stimulation of the 
muscle proved only slightly less effective at his suppression but ACh sensitivity of the original 
endplate was of the order of normal muscle [Lomo and Rosenthal 1972] (Fig.3.3.1). This suppression 
of ACh hypersensitivity was shown to occur with only very small amounts (average 0.005Hz) of 
stimulation but occurred at an increased rate with increasing frequency, (up to lOOHz) and also 
dependent on the interval between bursts [Lomo and Rosenthal 1975]. These authors suggested this 
accounts for the greater extra-junctional sensitivity in normal slow muscle than fast, regulated by 
free calcium released by muscle activity.
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Figure 3.3.1 Muscle Fibre Membrane ACh Sensitivity following Stimulation (Lomo at al.l975)
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Similarly junctional AChR numbers were maintained at normal levels for at least 2 months in rat 
soleus muscle by lOOHz but not 10 or 20Hz stimulation, and only when started on the day of 
denervation and with progressively less effect thereafter, to none if started after 7 days. These 
authors postulated that such muscle activity is able to maintain a trace of, but not replenish, the 
neuro-trophic element regulating AChR distribution, which otherwise disappears within a week of 
denervation [Andreose, Fumagalli et al. 1995]. Metabolic stability of AChR has also been maintained 
at normal levels by immediate stimulation of rat soleus [Andreose, Xu et al. 1993], by activation of 
additional calcium channels [Caroni, Rotzler et al. 1993]
Hence electrical muscle stimulation can, to varying degrees, reverse the activity related AChR 
changes with denervation by limiting AChR to junctions and increasing their half-life, however that 
this is specific to the type of activity is indicated by the concurrence of fibrillation and 
hypersensitivity [Lomo and Rosenthal 1972]. However, Gruener, Baumbach et al. [1974] reported 
that the suppression of ACh hypersensitivity by both subliminal and maximal stimulation induced 
contractions, suggested a non-activity specific regulation, as does the absence of hypersensitivity 
following immobilisation from tenotomy [Lomo and Rosenthal 1972]. Therefore, stimulation does not 
overcome the effect of non-activity dependant ACh regulators such as nerve degeneration products, 
which may still cause increasing effect on ACh sensitivity [Vrbova, Gordon et al. 1994].
The association of extra-junction ACh hypersensitivity with innervation is suggested by its 
suppression following cross-innervation by a foreign nerve at ectopic junctions [Frank, Jansen et al. 
1975]. Electrical stimulation, known to suppress the ACh extra-junctional sensitivity, also 
suppressed foreign nerve cross-innervation, whereas regeneration and reinnervation by the original 
nerve was unaffected [Jansen, Lomo et al. 1973] and occurs without measurable extra-junctional 
sensitivity [Frank, Jansen et al. 1975 ]. As noted above, junctional ACh sensitivity is maintained at 
normal levels during stimulation. It therefore appears that the effect of simulation is mainly to 
inhibit colateral sprouting and reinnervation at ectopic junctions, probably by suppressing the 
growth stimuli associated with the increased extra-junctional AChR. Whereas the regenerating 
nerve is less affected in seeking to reinnervate the original junction, where ACh declines more 
slowly and may even be enhanced by stimulation [Andreose, Fumagalli et al. 1995]. This was also 
suggested in the study of Brown and Holland (1979) who observed a reduction (11 cf 62%) in 
terminals with sprouts due to high frequency (lOOHz and 150Hz) intermittent burst stimulation in 
mouse soleus partially denervated by spinal root section. However indirect stimulation of the 
innervated fibres alone produced no significant reduction in sprouting, leading the authors to 
authors conclude that activation of the denervated fibres suppressed a sprouting agent they would 
otherwise release and induce sprouting from neighbouring innervated muscle fibres. Similarly, 
direct stimulation of the muscle completely denervated by nerve crush produced no significant 
reduction in muscle tension, and was taken as indication of no effect on sprouting. Stimulation
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current was therefore assumed not to have damaged the regenerating nerve, as also indicated by the 
positive benefits demonstrated of micro-ampere direct currents (§2.2.5).
Other studies have also demonstrated successful reinnervation with stimulation, largely attributed 
to the preservation of fibre properties [Williams 1996a,b]. Williams adopted a clinical model, in 
which the nerve injury was repaired using normal micro-surgical techniques and stimulation 
continued until EMG changes occurred or nerve stimulated contractions were possible. Stimulation 
consisted of 0.1s or 1.5s bursts of 36 or 85Hz pulses, and 2.5% or 6.25% burst duty cycle, applied 
continuously though implanted wire electrodes along the muscle length. Reinnervation took 8 
weeks for the rabbit femoral nerve severed 40mm from the rectus femoral muscle, 16 weeks for a 
120mm growth of the common peroneal nerve in dogs and 10 months for re-innervation of the 
frontalis muscle following facial nerve severing and cross facial nerve grafting. Unfortunately the 
course of reinnervation of the unstimulated controls was not described [Williams 1996b]. A previous 
study with similar protocol but higher frequency (130Hz) demonstrated fibre changes, but failed to 
show any signs of reinnervation after 8 weeks, for the common peroneal nerve severed 40mm from 
the peroneus longus muscle in dogs [Nemoto, Williams at al. 1988].
Conversely other studies have reported detrimental effects of stimulation on innervation, prompting 
the controversy over its efficacy. However, it has been noted that where nerve growth and 
reinnervation was affected by stimulation, it was reduced rather than abolished completely, perhaps 
because not all fibres were stimulated; for instance Hennig [1987] observed that long term 
stimulation in rats prevented reinnervation in 5-20% of muscle fibres [Eberstein and Eberstein 1996].
If  stimulation suppresses colateral reinnervation but enhances regeneration reinnervation by 
retarding atrophy changes, then it poses a dilemma as to the timing and efficacy of treatment, as 
both have limitations. Colateral reinnervation is limited by the extent of motor unit expansion 
possible. Regeneration reinnervation is limited by the process of nerve regrowth, and in some 
instances, the appropriateness of reinnervation (§2.2.3). Where the prospects of nerve regeneration 
and successful re-innervation are high, then arguably stimulation should not be applied if it is likely 
to hinder this process in any way. For instance, colateral cross-innervation may maintain the 
muscle fibre condition until reinnervation by the regenerating nerve at the original endplate, and 
therefore advocates no or delayed start to stimulation. However for complete proximal nerve 
lesions, where colateral innervation is limited or absent, muscle fibres will be subject to 
denervation for up to a year with consequent severe deterioration in condition limiting the 
prospects of full functional recovery (§2.2.3). Stimulation treatment commenced as soon as 
possible after injury would take advantage of the continued muscle fibre excitability to maintaining 
muscle fibre properties, with almost complete prevention of atrophy achieved when started 
immediately and diminishing results thereafter [Eberstein, and Eberstein 1996 quoting others]. Also, 
Andreose et al.[1995] showed the regulatory mechanism maintaining junctional AChR only appear
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to be susceptable to influence by stimulation during the first weeks after denervation, though 
muscles fibres are still capable of reinnervation after a year of denervation [Fu and Gordon 1995].
However it was apparent that the stimulation pattern is critical to its effect on ACh hyper­
sensitivity and various techniques have been adopted clinically (§3.4.1). Some have demonstrated 
functional reinnervation to be at least not prevented and in cases, enhanced by the stimulation 
treatment, though none of these studies evaluated colateral sprouting or motor unit count The 
studies by Williams [1996a] and Mokrusch and Neundorfer [1994] used similar protocols of 
stimulation in animals and humans with similar beneficial results. With Williams’ studies, this was 
despite the use of high frequency stimulation suggested by Lomo and Rosenthal [1975] as most 
detrimental to ACh hyper-sensitivity, albeit at threshold contraction strength.
3.3.3 Muscle Fibre Type
For denervated muscle, the retarding of muscle and fibre atrophy and the preservation of contractile 
ability is probably of greater clinical importance to the recovery prognosis than preservation of the 
normal fibre type balance of the muscle, given that muscle plasticity will probably allow reversion 
of fibre type if nerve reinnervation occurs. However inappropriate reinnervation is common 
following facial paralysis, and therefore is a consideration for stimulation treatment applied in such 
cases. Changes in the fibre type proportion and contraction characteristics of a particular muscle 
may occur through transformation of fibre type or through preferential hypertrophy of one fibre 
type over another (§3.3.5). Whether these effects are observed depends greatly on the stimulation 
pattern. Some of the reported effects of stimulation are in fact a reversal of the changes occurring 
with denervation which results in a dominance of fast, fatigable type IIB fibres with anaerobic 
metabolism and fast contraction speeds (§2.3).
Mvosin Contractile Proteins
Denervation changes in contractile myosin are enhanced when stimulation increases the rate of 
protein synthesis and therefore the generation of new myosin. These are of fast isoforms which 
become predominant over, no longer replenished, slow forms [al-Amood and Lewis 1987]. 
Conversely, fast to slow fibre transformation with stimulation is associated with changes in heavy 
and light myosin chains to slow or hybrid forms [Pette 1992 quoted by Jones,et al. 1994] concurrent 
with changes in myogen [Carraro, Catani et al. 1986] ,SR system, Z-band thickness and 
mitochondrial volume [Eisenberg and Salmons 1981]. These have not been observed in all studies 
perhaps because of insufficient stimulation duration [Mokrusch, Engelhardt et al. 1990].
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Mvogenin and MvoD Proteins
Electrical stimulation produces an immediate decline in the denervation increase in myogenin 
subunit mRNAs and MyoD transcripts [Eftimie, Brenner et al. 1991]. However, that the increase is 
only partially repressed by stimulation activity, implies an additional neurotrophic regulation factor 
[Maltin, Delday et al. 1993].
Muscle Fibre Metabolism
Direct electrical stimulation results in a biochemical change from anaerobic to aerobic metabolism 
[Mokrusch, Engelhardt et al. 1990], including in human muscle [Eichhom, Schubert et al. 1984]. 
Glycolytic enzymes are reduced [Weber and Pette 1990] and oxidative enzymes increased within a 
few minutes of stimulation [Eichhom, Schubert et al. 1984] especially in fast muscle fibres [Khaskiye, 
Sine et al. 1990] though not necessarily in the muscle as a whole [Nemeth 1982]. Mitochondria 
volume, as shown by electron microscopy, is also increased [Eisenberg and Salmons 1981], especially 
in the subsarcolemmal space [Mokmsch,Engelhardt et al. 1990]. The increase in enzymes was not 
correlated to fibre diameter or necessarily to contraction speed. [Nemeth 1982]
Muscle Fibre Tvpe Composition
These changes in fibre metabolism are reflected in the relative proportions of fibre types within the 
muscle. Twice daily tetanic contractions of rabbit fast muscle (flexor digitorum sublimis) produced 
a predominance (91%) of fast, mitochondria rich intermediate fibres (type IIA) compared to both 
normal and denervated muscle apparently due to a transformation of type I and type IIB fibres 
controls [Mokmsch,Engelhardt et al. 1990]. Others reported this accompanied by changes in myosin 
[al-Amood,Finol et al. 1986]. Type II fibre increase was also observed in dog orbicularis oculi muscle 
[Salerno, McClellan et al. 1991] and human quadriceps muscle [Neumayer, Happak et al. 1995].
This transformation is attributed to the nature of fibre recruitment with supra-maximal stimulation, 
that is all fibres/motor units simultaneously rather than in physiological size order from type I to 
type II, oxidative to glycolytic. Type II fibres are recruited for much longer periods and this may 
promote enrichment of the oxidative processes and mitochondria of type IIB fibres [Pette and Tyler 
1993 quoted by Mokrusch,Engelhardt et al. 1990]. Conversely, Nemoto et al (1988) reported an 
increase in the proportion of type 1 fibres, even to the extent of being significantly greater than 
normals (46%(stim), 28.4%(control), 33.7% (normal)) in mixed peroneus longis muscle in dogs, 
with an associated rise in fatigue resistance. This may be attributable to the high frequency 
(130Hz), low burst rate (1.5s in 60s) stimulation pattern, causing prolonged twitch type 
contractions
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3.3.4 Muscle and Limb Perfusion
Indirect electrical stimulation is capable of producing an increase in overall blood flow due to the 
greater muscle activity as well as increasing the blood capillary capacity associated with the 
transformation or predominance of oxidative fibre metabolism. However these are dependent on an 
appropriate stimulation pattern and visible tetanic contractions were found necessary for oxidative 
increases [Clemente and Barron 1993]. A delayed or reduced increase in capillary density occurred 
with intermittent compared to continuous lOHz indirect stimulation. The absence of change with 
intermittent 40Hz or 50Hz stimulation is attributed to blood supply occlusion during contractions. 
The increase in capillary density is prompted by increased muscle activity and the resulting 
increased oxygen availability in turn prompts the increased oxidative capacity of the muscle cells 
[Brown, Cotter at al. 1976]. Limb blood flow typically decreases to 65% of normal following SCI. 
This was restored by indirect stimulation and correlated to increase in muscle bulk [Taylor, et al. 
1993].
3.3.5 Fibre atrophy, Structural Changes and Damage
The atrophic effects of denervation may be reduced by stimulation patterns and contractions 
appropriate to the muscle type. Atrophy in slow muscle is largely prevented by any stimulation 
pattern but this may also be associated with transformation of fibre type and at high frequency, 
firing becomes irregular [Vrbova, Gordon et al. 1994 p83]. Results in fast muscle are more variable. 
Short term low frequency stimulation reduced atrophy by 10% (7ms, 1 Hz, 20 min/day) [Nix and 
Dahm 1987] and tetanic frequency by up to 40% (20ms, 25Hz 6min/day) [Mokrusch,Engelhardt et al. 
1990, Herbison, Teng et al. 1971]. Conversely high frequency (lOOHz) had no effect [Nix 1990 quoted 
by Eberstein and Eberstein 1996] In mixed peroneus longus muscle in dogs, 130Hz, 24hr/day burst 
stimulation produced a 14% increase in weight compared to unstimulated control contralateral up 
to 67 of normal [Nemoto, Williams et al. 1988]. Greatest preservation of muscle weight (up to 80% 
normal) was achieved by similar technique continued to the time of muscle reinnervation [Williams 
1996b]. The failure to fully prevent atrophy is attributed to the inability of stimulation to provide the 
neurotrophic control of muscle fibres causing denervation atrophy as opposed to disuse atrophy 
[Nemoto, Williams et al. 1988] and where current penetration is insufficient to effect all fibres 
[Eberstein and Eberstein 1996]. Induced damage (metabolic or structural) may also be a cause of the 
lack of observed beneficial effect of stimulation treatment, for instance strong tetanic contractions 
at 40Hz resulted in severe fibrosis [Nix and Dahm 1987].
Some of these changes in muscle weight were also correlated to increases in fibre diameter in slow 
muscle (rat Soleus with lOOHz [al-Amood,Finol et al. 1986] and fast muscle (rabbit EDL, IHz [Nix 
and Dahm 1987]. However the response is not uniform, with hypertrophic (32%), atrophic (31%) 
and normal (35%) fibres arising from stimulation [Nemeth 1982]. The largest fibre diameters were
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observed close to electrodes due to the greater current density and strength of contractions [Nix and 
Dahm 1987 quoting Gutmann 1944, Schaffer 1954]. The number of muscle fibres was increased 
[Nemeth 1982] or restored to approximately normal levels by stimulation [al-Amood,Lewis et al. 1991]
A preferential effect on one fibre over another was not consistently observed and probably highly 
dependent on the stimulation pattern used. Pachter et al. [1982] [quoted by Speilholtz 1987] observed 
retarded atrophy in both types but to a greater extent in type II fibres and this is consistent with 
their increase in the proportion of fibres. Girlanda, Dattola et al. [1982] observed accentuated 
atrophy in type I fibres, whereas Nemoto, Williams et al. [1988] observed their greater 
preservation.
The stretch activity is thought to restore the sarcomere structure of the myofilaments and thereby 
increasing the contraction force [Schmalbruch, al-Amood et al. 1991]. However contractions should 
not be so as to cause fatigue and thereby prevent proper contraction: Short tetany (40Hz) in fast 
muscle resulted in atrophy and joint contracture due to connective tissue proliferation together with 
laceration, microtrauma and single fibre rupture [Nix and Dahm 1987]. A chemical agent released by 
fibres is postulated to induce connective tissue growth also released by intensive exercise. 
Stimulation induced increase in perimysial is attributed to abnormal contraction (increased heat, 
blocked blood flow) and therefore minimised to the extent that the stimulation is able to mimic 
normal contraction [Nemeth 1982]. Appropriate stimulation can therefore decrease connective 
tissue, fatty degeneration, central cell and fibre necroses [Mokrusch, Engelhardt et al. 1990] and 
restore the filament order [Schmalbruch, al-Amood et al. 1991][al-Amood, Lewis et al. 1991], with fewer 
atrophied fibres and less fibrosis compared to controls [Nemoto, Williams et al. 1988].
Muscle fibre damage
Muscle fibre damage by indirect stimulation induced contractions, when it occurs, is clearly 
evident with histological staining techniques, in terms of disturbed internal fibre architecture, 
rounded cross-sectional appearance, activated macrophages and lysosomes within and between 
fibres, increased RNA and the presence of neonatal myosin isoforms in some fibres. This was 
quantified as the volume percentage of degenerating muscle fibres within a sample area, and varied 
considerably between animals (of the same species), between muscles (TA>EDL), between 
locations in the same muscle (proximal > distal in EDL) and with the stimulation pattern. The 
damaged observed was after 9 days of continuous stimulation and was reported to subside to 
almost zero after 3 weeks. This type of damage has a similar time course to the transformation of 
fibre type, but as it affects far fewer fibres, is not thought to be the mechanism of transformation 
[Lexell, Jarvis at al. 1997].
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Observed fibre damage may be due to excessive contraction strength or duration, excessive pulse 
duty cycles or just excessive periods of stimulation. Some evidence refutes the suggestion of 
reperfusion damage following ischaemic contractions induced by indirect stimulation [Lexell, Jarvis 
et al. \991](§2.6.1), however it is possible that the diminished perfusion and metabolism of 
denervated muscle fibres may make them more susceptible to such damage. Certainly, it is known 
that various damage effects occur from muscle overuse of weak or denervated muscle [Herbison, 
Jaweed at al. 1983]. However Guttmann [1976] concluded the fatigue response of normal muscle is 
highly variable and that excessive caution with regard to denervated muscle had hindered the 
application of effective stimulation treatment. Research has also been conducted into the effects of 
nutritional deficiency during indirect stimulation however there seems little evaluation of the 
nutritional, fatigue or damage mechanisms in the stimulation of denervated muscle and warrants 
research.
3.3.6 Conclusions from Animal Studies
The general conclusion from the animal studies is that stimulation can have beneficial therapeutic 
effects on denervated muscle but this has done little to direct the potential clinical applications, and 
further research was necessary to conclude the optimum parameters for human muscle [Eberstein 
and Eberstein 1996]. More pessimistically, Spielholtz [1987] observed that stimulation at best only 
retarded muscle atrophy and degeneration due to denervation and could never replace the 
neurotrophic loss, so complete degeneration is inevitable if reinnervation does not occur. In 
identifying those in whom reinnervation was delayed beyond 24 months as most in need of the 
treatment, he pointed out that issues of finance and patient compliance to the rigorous treatment 
pattern may well preclude its viability. However, far more promising results were produced 
subsequently by the clinically based model of Williams [1996b], leading to reinnervation and 
functional recovery.
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3.4 Clinical Application of Denervated Muscle Stimulation
Clinical application of direct electrical stimulation to denervated muscle has been both as a 
diagnostic tool (§2.4.4) and treatment for peripheral nerve injuries. Early work occurred around the 
first world war and the second world war prompted considerably more research [Speilholtz 1987]. 
Studies in animal models questioned the efficacy of such stimulation given its ineffectiveness at 
retarding atrophy and evidence of its deleterious effect on nerve regeneration, however more recent 
studies have demonstrated favourable effects (§3.3). Reinnervation stimulation treatment is aimed 
at retarding muscle atrophy and fibrosis following nerve injury and thereby maintaining the muscle 
fibres and connective tissue in a state suitable for reinnervation [Campbell and Meadows 1995]. 
Latterly these aims have been extended to the therapeutic stimulation treatment of chronically 
denervated muscle where reinnervation is not expected, and the objective is to maintain tissue 
viability. In some cases, researchers have gone on to seek to restore function to chronically 
denervated limbs through functional electrical stimulation treatment, as now employed routinely 
for innervated paralysed muscle (§3.1).
3.4.1 Reinnervation Stimulation Treatment
The conventional clinical treatment of denervated muscle has employed transcutaneous galvanic 
stimulation, producing low frequency twitch contractions. Typical treatment involved pulses of 
100-500ms at 0.5Hz or less for 15 minutes a day, 3 times a week [Kern, Hofer et al. 1999]. This was 
largely based on the assumption that over-fatiguing of the muscle would exacerbate atrophy, a 
suggestion dismissed by Guttmann [1976] who advocated that its ineffectiveness was due to its 
insufficiency of intensity, number of contractions and frequency of treatment sessions, which led 
many to question its clinical benefit [Mokrusch and Neundorfer 1994]. The infrequency of treatment 
can be attributable to the reliance on a therapist, given the danger of skin damage from 
inappropriate use and the unavailability of home-use stimulators.
Guttm ann [1976] advocated treatment once or preferably twice per day, initially of 15 minutes 
with 50-100 contractions and building up to 30-45 minutes with 600-800 powerful contractions and 
a few seconds rest in between. To minimise the ionising effect of unidirectional current, balanced 
pulse galvanism was recommended with the high amplitude rectangular stimulating impulse 
followed by a subliminal amplitude impulse of opposite polarity and longer duration [Wickham 
1948 quoted by [Guttmann 1976]. Electrode positions were moved during the session to minimise skin 
damage and to recruit more muscle fibres. The treatment is advocated for acute cases as soon as 
possible after injury, including with faradic stimulation where possible. For partial lesions non- 
rectangular pulse shapes may be employed to minimise sensation.
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In terms of quantitative studies, that by Jackson [1945] on 54 patients including ulnar nerve 
injuries is highlighted amongst the early research [Guttmann 1976; Boonstra, Van Weerden et al 1987]. 
Using treatment of 30 contractions at 0.5Hz, 3 times each day, 6 days a week. Jackson claimed 
beneficial effect on atrophy, though this was measured volumetrically and therefore did not account 
for changes in other tissue. A study by Roselle et al [1977] on over 300 patients concluded in 
favour of stimulation, but did not precisely define the treatment pattern of the outcome measures 
[Mokrusch and Neundorfer 1994]. Clinical galvanic stimulation treatment has been conducted for the 
past 20 years by LeFlohic [1994] for a wide range of acute nerve injuries including more than 130 
individual nerves following surgical repair. Treatment is commenced within 1.5 months of the 
lesion, initially daily and subsequently 3 times a week as outpatient. Using widths of 100-300ms 
and inter pulse intervals of at least 3 times this, 20 reasonable strength contractions are conducted 
at each location before moving the electrodes to another sector of the muscle. Trapezoidal shaped 
pulses are used to selectively stimulate muscles in partially denervated limbs. A number of muscle 
excitability tests are used to monitor the progress of recovery but measurements o f nerve growth or 
atrophy were not reported. Functional reinnervation has been achieved, it is claimed, in 80% of 
cases but the author has not published a case control trial.
More quantitative evaluation was conducted by Boonstra, Van Weerden et al. [1987], who 
studied 81 nerve injuries on 73 patients, including medial, ulnar, brachial plexus and peroneal 
injuries, the majority following primary repair, and starting treatment on average 7 weeks later 
because of immobilisation for suture healing. Evaluation measures were EMG pattern, handgrip 
force, muscle grading and muscle bulk by CT or Ultrasonography. Control groups with each type 
of injury received no stimulation. Treatment consisted of one session per day for 5 days until a 
mixed interference EMG pattern or no further change revealed reinnervation. Treatment sessions 
consisted of 30 contraction at IHz with pulse width at 70, 100 or 200ms according to the muscle 
excitability. For the medial and ulnar nerve injuries, there were sufficient cases to permit additional 
treatment groups receiving two sessions of 60 contractions each day, 7 days a week, and for each 
treatment pattern, one group continuing treatment until reinnervation, and one group until muscle 
grade 2 was achieved. A subjective assessment of the quality of the contraction and the patient 
compliance indicated that treatment 7 days a week until reinnervation was more effective. Only 
two statistical differences were found in the qualitative measures between control and treatment 
groups, either as individual groups or collectively. Stimulation reduced the frequency of the EMG 
pattern in totally denervated cases. In ulnar nerve injury cases, stimulation reduced the mean period 
to achieve muscle grade 4- of abductor digiti V by almost half, from 46 to 24 weeks, though the 
eventual numbers reaching the grade were the same. The authors therefore concluded no beneficial 
effect on muscle atrophy had been demonstrated by this stimulation treatment and did not 
recommend it clinically, though no detrimental effect on nerve growth had occurred.
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Given the confusion surrounding the efficacy of stimulation in the animal model, there seemed 
insufficient justification for clinical application of the subcutaneous stimulation that would permit 
tetanic contractions. However the studies by Williams [1996b] showed significant improvements 
in muscle bulk and contraction force, without hindering reinnervation and a clinical study was 
conducted based upon these [Williams 1996a]. By using high frequency (130Hz), low burst rate 
(1.5s every 25.5s) continuous stimulation, the treatment pattern is in fact similar to that of the 
galvanic stimulation but with tetanic contractions at the isometric threshold. The programmable 
implanted system with wire electrodes passed l-2cm apart through the muscle of interest allowed a 
pulse width of 1ms and continuous (24hour) stimulation at the level of isometric contraction. The 
13 cases included injuries to the medial, ulnar, medial and ulnar and radial nerves, all of which had 
been micro-surgically repaired previously. Although treatment is advocated as soon as possible 
after injury, the stimulator was implanted on an elective basis from 3 to 101 days after repair and 
treatment started 7 to 10 days thereafter. It was stopped when there were signs of muscle 
reinnervation from muscle movement or EMG assessment. This varied from 123 to 317 days, 
corresponding to nerve growth rates of approximately 1 mm/day. Assessment of the effect of the 
stimulation was in terms of muscle bulk (method not stated) and fibre structure from biopsies, 
muscle contraction grading and functional measures of handgrip; all where expressed as a 
percentage of the uninjured contralateral. Reinnervation occurred in all cases with a remarkable 
restoration of function, with the majority graded as good to excellent. Muscle bulk was restored to 
100% of normal in 8 cases, greater than 92% in 3 cases and hypertrophy (105%) in 2 of the radial 
nerve cases. The histological analysis showed a near normal fibre structure. Comparison of results 
was made with 5 concurrent and 20 retrospective cases of the same clinic that did not receive the 
stimulation treatment. Results of the functional measures were reported as inferior to those 
stimulated, the biopsies showed degenerated fibres with centrally placed nuclei, great variability in 
diameter, with fibrous and fatty infiltration (Fig.2.3.2). The authors cited a number of other reviews 
of nerve injury repair without stimulation treatment had resulted in both a lower proportion of cases 
recovering function and poorer quality of recovery, than in their study. The authors attribute the 
success of the functional restoration to the near complete prevention of muscle atrophy during the 
period of nerve re-growth. The preceding animal studies showed that it is type 1 fibres disuse 
atrophy that is reduced by this stimulation pattern, though the histological analysis to confirm this 
was not reported on. This is somewhat surprising given the high frequency of the impulses 
especially given the deterioration in muscle for those commencing treatment 103 days after 
denervation. Direct comparison with the results of transcutaneous stimulation studies is difficult. 
The rate of reinnervation appears unaffected by the stimulation but the prevention of atrophy and 
quality of restored function is remarkably good. That this was achieved with far less vigorous 
contractions than employed with transcutaneous stimulation, is probably attributable to its 
continuous application for which the implanted system has very significant advantages.
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Kim and Kim [1999] have also reported similar improvements from stimulation treatment in the 
quality and speed of restored function from reinnervation following brachial plexus injury. 
However, their study differs from Williams, in that the percutaneous electrodes were implanted in 
18 acute cases into the nerve at the proximal point of suture repair, primary with a view to 
enhancing nerve regeneration, rather than muscle atrophy, though the ground electrode was located 
more proximally at the shoulder. Stimulation was applied intermittently with 5s on, 5s off for six, 
30min sessions each day, and consisted of 0.2ms pulses at 20Hz of IV amplitude. Comparison with 
other non- clinical studies of stimulation for nerve regeneration (§2.2.5) is difficult without in vivo 
measures and calculation of the currents and fields involved. However, compared to 24 
unstimulated cases (matching not stated), initial biceps motor recovery commenced after 3.4 
months instead of 9.1 months, initial medial nerve sensory recovery commenced after 4.5 instead 
of 9 months and elbow flexion and shoulder abduction strength remained greater throughout the 2 
year follow-up period. 2 sub-acute cases (2 year post injury) with poor biceps muscle power 
recovery were also treated with the electrode positioned at the muscle motor point and 
improvement was reported within 2 months [Kim and Kim 1999].
Mokrusch and Neundorfer [1994] treating cauda equina and brachial plexus lesions by 
transcutaneous stimulation with long biphasic pulses and tetanic contractions (§3.4.2), commenced 
stimulation, in some cases within one month after injury, with confirmation of muscle denervation. 
In three of the brachial plexus lesion cases, sensory reinnervation occurred during the course of the 
treatment (7, 9 and 21 months after start o f treatment, 8,20 and 27 months respectively after injury). 
No motor reinnervation occurred, which is said to be common after nerve transplant. Motor nerve 
growth was not measured so the effect of the stimulation cannot be judged. However in the case of 
a partial lesion, evidence of increased innervation was cited in terms of increased peroneal nerve 
action potential 26 months after trauma. These cases at least demonstrate that sensory reinnervation 
was not inhibited by the stimulation treatment.
Partial Denervation Treatment
The work of LeFlohic [1994] cited above is predominately with cases o f partial limb denervation 
and trapezoidal shaped pulses are used to selectively stimulate the denervated muscle by means of 
accommodation (§3.2.2). Similarly, Cummings [1985], citing the work of Kowarschik [1952] and 
Thom [1955], recommended the use of exponentially progressive current stimulation, as effective 
at retarding atrophy in such cases, though no details of clinical results were given.
Denervated facial muscles do not atrophy as rapidly, probably because of the good blood supply 
and passive movement of underlying muscle activity [Lenman and Ritchie 1987 p. 100]. However their 
treatment with stimulation is particularly difficult as sensory innervation of the overlying skin by 
the trigeminal nerve is often preserved, and the minimum of pulse width and intensity is
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recommended [Campbell and Meadows 1995]. Some have not observed any benefit effect of 
stimulation [Wynn-Parry and Cowan 1994]. A stimulation pattern based on the EMG pattern of 
normal muscle has been advocated by others for the treatment of facial paralysis arising with Bells 
palsy and this has restored function and resolved much of the typical inappropriate reinnervation 
[Farragher, Kidd at al. 1987]. Similar, Patterned Neuromuscular Stimulation (PNMS) has been shown 
to reverse the denervation type EMG pattern and increase the CMAP of first dorsal interosseous 
muscle (FDI) in the case of a wasted and weakened hand following ulnar nerve entrapment and 
subsequent nerve transplant 2 years previously [Patterson, Smith at al. 1994]. The pulse width 
employed in this case was 80ps, it is unclear whether the resulting palpable contraction is due to 
denervated fibres or any remaining innervated muscle fibres. It is possible that this type of 
stimulation avoids the detrimental effect on colateral spouting (§3.3.2), which is particularly 
important in cases of partial denervation, but it has been less successful with the larger, quadriceps 
muscles (§3.4.5). Another form of stimulation with parameters derived from the muscle EMG 
signal has been applied to large segment nerve-muscle transplants to the upper limb, while awaiting 
reinnervation [Lasn 1995].
These clinical studies have contributed further to the debate on the effect of stimulation on muscle 
reinnervation (§3.3.2). Many of the above clinical studies have continued stimulation, throughout 
the period of nerve regeneration and reinnervation until muscle movement is possible, without 
apparent adverse effects on nerve growth and perhaps even enhancement, though this was not 
monitored directly. Both the time to functional reinnervation and the eventual functional outcome 
was improved in studies by Williams [1996b] and Kim and Kim [1999], but not with the low 
frequency stimulation used by Boonstra, Van Weerden et al [1987]. The multiplicity of influencing 
factors makes the selection of matched controls almost impossible and so a multi-centre trial has 
been planned [Williams 1996b] which should provide additional evidence. That, nerve growth has 
not been inhibited by the stimulation used would seem to advocate its commencement as soon after 
injury as possible, however its effect on the initial period, when co-lateral sprouting may be 
expected has not been evaluated. Also of interest, is whether the benefits achieved by Williams 
with subcutaneous stimulation, may also be obtained by transcutaneous stimulation without 
effecting nerve growth, and the necessary parameters and treatment pattern required. With a 
pragmatic approach, Mokrusch and Neundorfer [1994] and Valencic and Vodovnik [1986] both 
argue that the proportion of the day for which stimulation is applied (say Ihr = 4%) is insufficient 
to have any effect on nerve growth, though the above observations refute this, and it is not 
applicable to the continuous stimulation applied by Williams.
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3.4.2 Therapeutic Direct Stimulation Treatment
In cases of chronic denervation, typically greater than 2 years post injury, where reinnervation has 
not occurred, then stimulation treatment is aimed at the long-term maintenance of the muscle and 
extremity and the prevention of secondary complications (§2.3.6). The effects on muscle atrophy 
and fibre degeneration are therefore of primary importance, which may be related to restoration of 
contraction force. Also of relevance is the effect on blood flow, tissue perfusion and in many cases 
the cosmetic appearance of the limb. As transcutaneous galvanic stimulation appears only to delay 
muscle atrophy, then, although potentially useful for acute reinnervation therapy, it has not been 
considered of benefit or practical for chronic cases [Mokrusch and Neundorfer 1994]. This is 
attributed to the small size of electrodes the low stimulation intensities and the infrequency of the 
treatment sessions and the stimuli [Kem, Hofer et al. 1999], with higher frequencies limited by 
muscle fatiguing and potential skin damage.
Eichhom, Schubert et al. [1984] avoided these limitations by using symmetrical rectangular 
biphasic pulses to ensure charge balancing and stimulator devices suitable for use by patients at 
home. Although initially pulse widths of 100ms or more were required, with continued treatment, 
this was reduced until tetanic contractions were possible with 20ms at 15-20Hz. Two or three, 1 
minute contractions each day were sufficient for a stable condition and patients used a home-use 
stimulator device and surface electrodes of 2-3cm diameter. Successful treatment of Erb’s palsy in 
children is cited, with the treated arm attaining the length and circumference of the normal arm, 
whereas without treatment this remained diminished. The stimulation was also shown to increase 
the limb blood flow and aerobic metabolism for up to 30 minutes after the treatment but no 
increase in the resting value was reported. Unfortunately none of the articles published in English 
contain details of larger scale studies or clinical application of the treatment, however equipment 
was developed to exercise denervated muscles in a functional manner (§3.4.3).
Mokrusch and Neundorfer [1994], working out o f the same laboratory, refined the application of 
this daily biphasic transcutaneous stimulation treatment and undertook a clinical investigation 
following favourable results from animal studies [Mokrusch, Engelhardt at al. 1990; Mokmsch, 
Engelhardt et al. 1992]. The majority of limbs receiving treatment were completely denervated and to 
maximise the overall benefit, stimulation was applied separately to extensor and flexor muscle 
groups via 4 sets of electrodes on upper and lower limbs as appropriate. Each was activated in turn 
for 10s, with an overall contraction time per muscle group, per 48min session, of 2-6 min, which 
represents 12 to 36 contractions. Pulse width was initially 70ms and reduced to 50ms, as the muscle 
became more excitable. As the interval between pulses was the same as the pulse width (50% pulse 
duty cycle), frequency was initially 7Hz, then increasing to lOHz. Of the cases of complete limb 
denervation, 3 suffered bilateral lower limb denervation following cauda equina lesion and 10 were
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upper limb following brachial plexus ruptures and/or multiple root avulsions with age from 17-46 
years. Sensory loss was complete and motor denervation was confirmed before and during 
treatment by the absence of tendon reflexes, muscle action potentials (including in response to 
proximal stimulation), cortical somatosensory evoked potentials, F-wave or Hoffmann's reflexes. 
Treatment was started 1-21 months after trauma and continued for up to 38 months. Contraction 
force and endurance of foot and hand flexors was measured by portable dynamometer and muscle 
volume of lower limbs by MRI.
It is claimed that all patients benefited from the treatment with a distinct reduction in foot oedema, 
panaritia occurrence and improved trophism. Muscle volume increases of between 9 and 29% in 
the calf and between 33 to 84% the thigh were obtained. Contraction force increases of between 16 
and 400% were obtained, up to one third of normal values in foot flexors and up to one half in hand 
flexors. Contraction endurance increased by between 13 and 135%. The response of extensor 
groups was delayed compared to that of flexor groups in one case by up to a year. In another case, 
when treatment started, 15 months after trauma, no visible quadriceps muscle contraction occurred 
initially, but after 6 months of treatment, 90° knee flexion was possible and after 38 months, this 
could be maintained for over a minute. Interruption of treatment, lead to a rapid decline in muscle 
force, though some contractile ability was retained initially. The greatest increases were seen 
during the initial 3 months and especially the first week, with two sessions per day. The reason for 
reducing the sessions to one a day is not given. One patient withdrew after 8 months due to lack of 
motivation, and 4 other patients of younger age withdrew from the trial after 6 months treatment or 
less for unspecified reasons. In 3 other cases involving nerve transplantation, treatment was ceased 
after sensory reinnervation occurred (§3.4.1), observation continued, but without motor 
reinnervation. It was not stated whether the withdrawal of treatment was because the stimulation 
became intolerable, or so as not to affect possible motor reinnervation.
Apparent from this study, is that beneficial results can be achieved from a quite minimal treatment 
regime, even within 12 months, however it left several questions unanswered as to the general 
applicability of the treatment. As a therapeutic treatment, it was unfortunate that blood flow and 
skin temperature were not reported in this study. Also, that muscle bulk measurements were not 
conducted on arm cases or progressively through the course of treatment period to know when 
most changes occurred. The muscle volume changes recorded, although significant, may not be 
sufficient to fully halt the progressive denervation atrophy. Surprisingly, it was stated that muscle 
volume increases were not correlated to force increases, which therefore questions the relevance of 
the latter as a therapeutic outcome measurement with regard to tissue viability. It was also pointed 
out that the contraction forces of one third of normal are still insufficient to permit functional use 
and more intensive treatment would be necessary, however those of the hand flexors were greater. 
For those for whom treatment was interrupted, the force regained on subsequent occasions was
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never as great as at the initial occasion, which would appear to advocate as early intervention as 
possible to achieve functional objectives, and for which confidence about the absence of effect on 
reinnervation would be required.
Some of these deficiencies were addressed in the study by Kern et al. [Kem 1995; Neumayer, 
Happak et al. 1997] in which similar biphasic rectangular pulse stimulation was applied to spastic 
(10) and flaccid (4) paralysis patients concurrently. The quadriceps muscles of the 4 cases of 
complete, chronic lower limb denervation following conus cauda injury, were stimulated using 
large flexible conductive rubber electrodes of 200cm^ surface area and a constant voltage output 
stimulator. Cases were on average 3.4 years post injury with advanced muscle fibre atrophy or 
approximately 25% of normal (50% in spastic cases). For the first two months a pulse duration of 
200ms at 1.25 Hz was required, but thereafter 30ms applied at 20Hz with a 2-3s on, 5s off periods 
for 30 minutes (15 minutes initially), twice a day for 8 months (1.3ms at 27Hz for spastic cases). 
Measurement was made of muscle cross sectional area (CT), isometric knee extension force, skin 
perfusion (IR thermography) and muscle perfusion (thallium scintigraphy) before and after 8 
months of treatment. Muscle biopsies of vastus lateralis, also allowed examination of structural 
changes.
In reviewing the results, it is interesting to compare those of the denervated and spastic (in 
parenthesis) cases. By the end of the 8 months, the denervated cases where able to achieve full 
knee extension against gravity; (the spastic groups achieved this after 2 months and after 6 months 
were able to lift 3-5kg). The average cross sectional area of the quadriceps femoris was increased 
by 10% (27.5%) and the adductor and flexor muscles by 7% (22%). However the increase was 
concentrated beneath the electrodes, proximal 12% and distal 8% compared to only 1.8% in 
between. This led to the conclusion that electrodes should cover as large an area of the muscle as 
possible. Average fibre diameters increased by approximately 72% (+42%) although remained at 
about half that of normal muscle. The mean diameter of type II fibres increased to a greater extent 
than type I fibres in denervated muscle, 67% cf. 54% (34% cf. 65%), the reverse of spastic muscle, 
though their initial atrophy was greater. In the denervated muscle, the proportion of type II fibres 
increased from 73% to 81% (84% unchanged). The smaller relative change in muscle cross 
sectional area compared to fibre diameter probably reflects a decrease in the amount of connective 
and fat in the muscle, which was not reported on in detail. Both aerobic and anaerobic enzyme 
activity increased by 60% (53%) almost to the levels of normal muscle Quadriceps muscle 
perfusion increases of 500% (950%) were reported but not stated whether this was resting or in 
response to stimulation. Small but not significant increases were also observed in the lower leg. 
Skin perfusion measurements were not cited for denervated subjects. Skin hyperemia of the order 
of 1.6°C occurred in the thigh region after about 25 minutes and lasted for up to an hour, but did 
not spread to the lower leg.
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Comparing these results with those of Mokrusch and Neundorfer [1994] for similar patients shows 
a smaller increase in muscle cross sectional area despite a more intensive treatment regime. 
However, given the small numbers, individual responses dominate and this may reflect differences 
in measurement technique and the greater initial atrophy with longer denervation periods in the 
study by Kem et al.(1995). Unfortunately, the force measurements are not comparable as only 
stated for spastic cases and limb blood flow was not measured to correlate with the dramatic 
increases in perfusion.
Kem et al. have subsequently refined this biphasic stimulation technique for chronic lower limb 
denervation [Kem, Hofer et al. 1999] with the primary objective of achieving functional stimulation 
(§3.4.3). The training period aimed at developing the required muscle strength is typically 2 years. 
As previously, patients start with twitch contractions from pulse widths of 120-150ms at l-2Hz. 
Once the muscle membrane has stabilised and metabolism increased, unfused, clonus type 
contractions at 5-8Hz with 70-80ms pulse width are employed for a while before progressing to 
tetanic contractions at 16-25Hz with 35-50ms pulse width. In transitioning between these 
stimulation modes, two may be used concurrently, which helps to ensure all fibres are conditioned. 
The major difference from previously is the use of 80% pulse duty cycle for tetanic contractions 
(e.g. 40ms pulse width at 20Hz) compared to the more typical 50%, although contractions are only 
sustained for 2s with 2s off period in between. Increasing the pulse width thus, has been found to 
maximise the contraction force and reflects the primary functional aim. Despite the intensity of 
treatment, the average increase in quadriceps muscle cross sectional area is 48%, which perhaps 
reflects that atrophy in chronically denervated muscle cannot be entirely reversed. Muscle density 
recorded by the CT increased by 62% indicating an improvement in the quality of the muscle. The 
less intensive stimulation (Ix/d 15min) of the lower leg and gluteal muscles is not able to prevent 
mild atrophy. However the primary aim is to increase the generated force to 1/4 of body weight to 
permit standing, and average increases of 53-73% have been achieved over 24 months. The format 
of this training is a series of 6 sets of 15 (initially 8) isotonic tetanic contractions of 2s with 2s off 
and 2min between sets (usually while training the other leg), initially against gravity and then with 
weights on the leg.
The intensity of the stimulation pattern, with near continuous current flow (albeit biphasic) and 
minimal reperfusion time between contractions within each set, raises the question o f possible 
inducement of structural or metabolic damage which might hinder muscle development. As yet 
muscle biopsies have not been performed, but the general absence of fatigue during sets of 
contractions and progressive increase in muscle strength, is taken by the authors as indication o f the 
absence of adverse muscle damage. However they also stress the importance of the preceding, 
prolonged twitch and shaking stimulation treatment periods to condition the muscle fibre structural 
and membrane properties. When fatigue does occur, the muscle is rested for several days to
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recuperate, without apparent permanent damage. The treatment appears successful as a preliminary 
training for the eventual functional aims, however it is possible that it is not optimum for 
therapeutic purposes, in terms of the limb as a whole and it is unfortunate that measurement of 
resting blood flow and skin perfusion are not reported.
Taylor and Ewins et al.[1992] confirmed some of the therapeutic value of the transcutaneous 
biphasic technique by evaluating the effect on muscle bulk by ultrasound, resting skin temperature 
asymmetry by IR thermography and resting limb blood flow by impedance plethysmography. 
Stimulation of the lower arm of a subject with a brachial plexus lesion Smonths post injury with 
rectangular biphasic pulses of 10ms at lOHz, twice a day for up to 15 minutes for 8 weeks, 
produced an increase in muscle bulk of 22% and an increase in resting skin temperature asymmetry 
of 3°C, but no significant change in resting limb blood flow. Similar treatment of the quadriceps 
muscles of a subject with a T12 level SCI, 3 years post injury, resulted in an increase in muscle 
bulk of 23%. Prior treatment with 30ms monophasic pulses at 0.5Hz for 7 weeks produced no 
detectable changes in the tissue measurements [Taylor, Ewins et al. 1992].
Petrofsky [1991] has also confirmed the efficacy of transcutaneous biphasic long pulse stimulation 
treatment but using sinusoidal current of 20ms period at lOHz. The denervated quadriceps muscles 
of 11 paraplegics following SCI at LI level at least 2 years post injury, were treated for 15 min/day, 
3day/wk for 6months. The stimulation current was increased gradually over 3 s up to 100mA 
followed by a 3s off period before repeating the sequence. Measurements were made of isometric 
knee extension tension at the ankle, limb girth around the midpoint of the quadriceps correlated to 
body weight and EMG single fibre action potential amplitude at the beginning and end of the 
treatment period. During this period the muscle tension from stimulation at 20ms and 250ps 
doubled and the frequency of maximum response increased from lOHz to 20Hz and 15Hz 
respectively. Response to frequencies greater than 35Hz remained negligible. This change in the 
muscle fibre electrical characteristics was reflected in the duration of the action potential, which 
decreased from 16ms to 8ms, nearer to the 5ms of normal muscle and indicates a decrease in 
refractory period. From mere muscle bulging at the start of treatment, by the third month, 9 of the 
subjects were able to move their knee joints and by the end of 6 months were able to lift the leg 
with an average knee extension force was approximately 3 ON. Limb girth showed a progressive 
increase from the start of treatment, with an average increase of 41% over the 6 months.
The choice of muscle girth measurement although easier, includes non-muscle tissue and precludes 
direct comparison with other studies. The muscle response in terms of tension, appears to be more 
rapid that that of the more intensive rectangular biphasic pulse technique advocated by Kem, 
though no where near the 5CON typically achieved by indirect stimulation in similar cases [Petrofsky 
1991]. However this may reflect differences in the state of degeneration of the muscle fibres of 
these particular individuals, as much as any advantage of the stimulation technique; that any
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muscle response was achieved at all to 250ps pulses implies at least some fibres were still in 
reasonable condition, though “complete” denervation was confirmed by needle EMG recordings.
3.4.3 Functional Direct Electrical Stimulation Treatment
Attempts have been made to provide stimulation treatment with some functional outcome in cases 
of chronic muscle denervation. This, not only makes the treatment more purposeful, enhances 
patient motivation, provides cardiovascular exercise and other health benefits, but it is hoped, also 
increases quality and perhaps, independence of life for the individual. In these applications 
concentration is on maximising the contraction force and control of limb movement with measures 
to quantify the desired functional outcome.
Bicycle ergometry, stimulating the appropriate leg muscles to rotate the pedals of a bicycle against 
resistance, is used extensively for indirect stimulation muscle training with demonstrated benefits 
in terms of muscle bulk, perfusion and cardiovascular exercise [Baldi, Jackson et al. 1998]. It has also 
been developed for transcutaneous direct stimulation of denervated muscle, with motor assistance 
to compensate for the inability to selectively stimulate all the required muscles [Arndt, Eichhom et al.
1987]. However this has not been widely adopted because of the complexity of the multi-channel 
system and is considered inferior to rising and walking functions for muscle strength development 
and cardiovascular exercise [Kem 1995].
Regular passive standing, with stimulation induced leg muscle contractions to maintain vertical 
posture, will assist the functioning of internal organs and it is claimed have a positive influence on 
the growth of bones and the flexibility of joints [Eichhom, Amdt et al. 1987]. Far more effective as 
exercise and functionally is the transfer from sit to standing through stimulation induced 
contractions, however this has only become possible after prolonged conditioning of the muscles to 
develop the necessary strength (§3.4.2) [Kem, Hofer et al. 1999]. Quadriceps muscles are stimulated 
to produce isometric torque values measured at the knee of the order of 38Nm, though this appears 
low compared to the recommendation of INm torgue per kg of body weight for indirect FES 
[Taylor, Ewins et al. 1993]. However, standing has then been achieved and maintained with the upper 
body support of parallel bars, stimulating each leg in turn, as a preliminary training towards 
stimulated walking. However precise or energy efficient ambulation with direct transcutaneous 
stimulation is unlikely, unless techniques are developed for the selective contraction of the required 
muscles; even with the greater refinement of indirect stimulation, functional walking is not yet 
routinely clinically available.
These examples of functional stimulation have been applied to regions of complete denervation 
without any sensation limit to the stimulation intensity. In many cases of chronic partial limb 
denervation, direct stimulation may be used to restore functional use, supplementing voluntary
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movements or in conjunction with indirect stimulation. However given the long pulses required for 
transcutaneous stimulation, intensities may be limited by recruitment of functional sensory nerves 
and unwanted co-contraction of surrounding or antagonist muscles.
One of the few studies in this area is that by Valencic and Vodovnik et al [1986] who attempted to 
restore dorsiflexion and thereby aid gait, in 8 cases of ’dropped foot' resulting from unilateral 
traumatic sciatic nerve lesion at hip level and one case following spinal LI fracture. Treatment was 
started 2-40 months after injury and “complete” tibialis anterior denervation was confirmed by 
needle EMG and SD curve testing. Plantaflexor muscles remained innervated in 3 cases but not 
under voluntary control. In order to deduce the optimum stimulation parameters, at each week of 
the treatment, the ankle angle was measured from stimulation with pulse widths of between 5 and 
50ms. From this, 20ms at 25Hz was deduced as 'optimum' for the treatment, however this perhaps 
just reflected the best combination of pulse width, frequency and duty cycle, all of which were 
varied by maintaining the pulse pause constant at 20ms. An initial week of conventional 
physiotherapy alone produced no significant difference in the stimulated ankle angle. For the 
subsequent 3 weeks, stimulation treatment was applied concurrent with physiotherapy consisting of 
3 s contractions followed by 3s rest for 20 minutes twice a day, 5 days/week. Intensity of 
stimulation was kept at the same level for the particular individual for all treatment and testing, at 
the limit of their tolerance (5-40mA).
There was an improvement in dorsiflexion angle in all cases, greatest in those with higher 
intensities, with a mean of 15.8° and positive dorsiflexion in 5 cases of up to +10° flexion. With 
four cases, stimulation was applied to achieve successful dorsiflexion during gait, though no 
quantitative measurements of gait were made. The improvement in some cases was limited by the 
tolerable level of stimulation intensity or the recruitment of innervated antagonist muscles and the 
development o f associated contractures. The authors suggest that the majority o f improvement was 
due to increases in muscle strength but recognise the contribution of possible reduction of existing 
contractures, though this was not quantified.
There were no signs of reinnervation at the end of the treatment. The greatest improvement in 
dorsiflexion angle was in fact achieved in one case of over 3 years post denervation, without 
innervated plantaflexor muscles. It is somewhat surprising, given the experience in other studies, 
that muscle denervated for this period of time responded to pulses as short as 10ms and fi-equencies 
as high as 3 3 Hz without prior eonditioning with galvanic stimulation and without mention of 
fatigue; furthermore that such muscle strength development was possible with just 3 weeks of 
stimulation treatment. It is possible for the activity of surrounding musculature to preserve the 
contractile properties of denervated muscle, but it was stated that none of these cases had any 
volitional control over the ankle joint. It is unfortunate that no follow up studies have been
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published, for this relatively common denervated condition which is frequently mis-referred 
clinically for the available indirect 'dropped foot' stimulators (§1).
3.4.4 Other Applications of Direct Stimulation
Direct muscle stimulation may also have clinical application to a number of conditions producing 
denervation like symptoms where the voluntary or indirect stimulation induced contractions are not 
possible or ineffectual (§2.3.6). However little work has been published to develop appropriate 
stimulation treatments for these conditions, LeFlohic (1994) has treated cases of GBS, and PPS, but 
without detailed reporting.
Muscle subject to inactivity due to disuse or immobilisation, undergoes some of the changes of 
denervated muscle, including a progressive atrophy and loss of contractile ability. For such cases. 
Patterned Neuromuscular Stimulation (PNMS) using an 80ps pulse width and pattern derived from 
the EMG signal of normal but fatigued muscle, has been shown to be more effective than a uniform 
frequency or random frequency pattern. It produced increases in muscle strength and endurance 
following severe muscle wasting of the hand due to rheumatoid arthritis [Oldham and Stanley 1989] 
but was less effective in treating quadriceps femoris muscle weakness in elderly subjects with 
osteoarthritis of the knee [Oldham, Howe et al. 1995].
However as disuse continues, muscle excitability decreases until contraction is only possible with 
the longer pulses widths of direct stimulation. It is possible that this applies to case 15 of the study 
by Mokrusch and Neundorfer [1994], a brachial plexus lesion, who experienced partial 
reinnervation during the initial 3 years post injury but no thereafter. During the stimulation 
treatment started 20 years post injury, hand flexion and extension became possible with some 
sensation, which was cited as evidence of reinnervation, but may have been the reversal of disuse 
atrophy following earlier reinnervation.
3.4.5 Summary of Clinical Applications of Stimulation of Denervated Muscle
If  anything, the clinical studies to date give more cause for optimism than those in animals, with 
beneficial results obtained in terms of functional reinnervation, muscle tissue properties and 
restored function through FES. The treatment regimes for both acute and chronic cases have proved 
acceptable to patients and benefits suggestive of clinical value. The controversy over the effect o f 
stimulation on nerve growth, although unresolved in its mechanisms, has at least been 
demonstrated to be beneficial to the overall aim of functional reinnervation, though so far 
widescale clinical application is still dissuaded.
For the treatment of acute injuries, continuous subcutaneous stimulation appears to offer real 
improvement in functional reinnervation, though this has yet to be confirmed in a wider clinical
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trial. The exact effect of the stimulation on the processes of nerve sprouting, growth and endplate 
formation remain to be determined, but it has at least been demonstrated not to be precluded, even 
if not actually enhanced. A means of in vivo monitoring of nerve growth and reinnervation would 
provide greater confidence in the application of the technique and especially in the timing of its 
commencement after the nerve injury, which as yet has not been immediate. This may also assist in 
determining whether similar benefits can be achieved with transcutaneous stimulation of 
appropriate parameters for cases where implantation is not feasible. The modelling of the electric 
currents induced in the tissue concurrent with biological processes will provide an important 
contribution to this.
For the treatment of chronic denervated muscle the utilisation of the change in electrical and 
contractile properties of the muscle fibres for tetanic contractions, has heralded a treatment 
technique with conclusive benefits and the prospects of functional standing for complete flaccid 
paraplegia. It is tempting to project the application of the sophisticated techniques developed for 
indirect FES for these eases, however, refined functional control will require the means of selective 
direct stimulation of individual muscles. This will also be essential in cases of chronic partial 
denervation, such as 'dropped foot' or brachial plexus, where arguably the restoration of a smaller 
functional goal may offer greater rewards in terms of independent living. The techniques of 
selective stimulation therefore deserve further investigation, such as accommodating waveforms, 
multiple electrodes fields and sensory fibre blocking through stimulation with higher frequency or 
other techniques [Eichhom, Schubert et al. 1984; Rattay 1990]. Also the energy per pulse of the 
biphasic stimulation technique are more than ten times the recommended maximum (MED-GV, 
ÔNORM) and applications for amendment of the regulations have been made [Kem, Hofer et al. 
1999] and will need to be accepted prior to its clinical adoption.
However it is the therapeutic benefits, in terms of prophylactic improvements to tissue properties 
against decubital ulcers and circulatory disorders, which may be the ultimate justification for the 
clinical adoption of stimulation treatment in cases of chronic denervation, rather than the functional 
benefits. There remains the need to establish with statistical significance, the improvements seen in 
tissue bulk and perfusion. In particular the need to quantify the change to resting or average blood 
flow, rather than just during the stimulation session, and to determine whether these are sufficient 
to have a preventative influence. Such evaluation means may also be used to determine the 
optimum stimulation parameters and treatment pattern for the therapeutic benefits, whereas studies 
to date have largely focused on maximising contraction force. There is also scope for evaluated 
comparison of stimulation pulse shapes other than rectangular, including sinusoidal, for which 
similar benefits have been shown. Evaluation monitoring through the initial treatment period, while 
the muscle is undergoing the property changes may also help optimise this process. The Strength-
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Duration curve (§2.4.4) has been demonstrated as a means of selecting the stimulation parameters 
initially and as the muscle excitability alters with treatment.
In determining treatment and interpreting results, the need for precise diagnosis of the muscle 
innervation has been shown, especially in cases of partial denervation. SD testing provides a ready 
means of differentiating flaccid from spastic paralysis, to ensure the appropriate stimulation 
treatment be applied, should it be of proved of clinical value. The earlier after nerve injury, that 
stimulation is commenced, the lesser the muscle fibre degeneration and the greater the benefit that 
will accrue, though the appropriate parameters and treatment pattern may differ with the end 
objective. For instance where reinnervation is expected, ensuring no detrimental effect on nerve 
growth is paramount while preserving fibre type or contraction speed for appropriate reinnervation. 
For therapeutic rather than functional gain, consideration of work performed and fatigue resistance 
may be more applicable than maximising contraction force, and may allow more comfortable 
stimulation patterns, especially in cases of retained sensation or the elderly [Campbell and Meadows 
1995]. Part of the optimisation of stimulation parameters, must be the consideration of the bio­
chemical mechanisms operating during direct stimulation and consequently the possible causes and 
extent of damage, including cellular analysis, ischaemic effects of contraction and nutritional 
impairment. Considerable research has already been conducted into the effects during indirect 
stimulation, and warrants application of the knowledge to direct stimulation of denervated muscle. 
The need is therefore for a holistic approach with a role for combination therapies, not least in the 
management of contractures and maintenance of soft tissue.
For conditions with denervation like symptoms, careful investigation into the potential contra­
indications, will be required as part o f the research into the application of direct stimulation 
treatment. For instance with GBS and PPS, a major worry is that stimulation may exacerbate the 
underlying muscle and general fatigue. The retained and possibly hyper-sensitive sensory 
innervation of such conditions, may limit the tolerable intensity of stimulation and hence its 
effectiveness. It is also possible, that autonomic dysreflexia prompted by the stimulation may be 
more likely, leading to symptoms such hypertension, headaches, temperature disturbances or loss 
of bladder control. As with partial denervation, co-contraction of antagonist muscles will requiring 
monitoring for contracture formation.
Finally, or perhaps foremost, should treatment of denervated muscle become a clinical possibility, 
is consideration of the needs and aspiration of the users. For instance, surveying the opinions of the 
UK SCI population as a whole, highlighted that improved muscle bulk and cosmetic appearance 
ranked as highly as the ability to stand, though this did not differentiate the nature of the paralysis 
[Maxwell, Granat et al. 1999]. Also, the acceptability of the proposed treatment patterns have not 
been evaluated outside of research studies, for which subject compliance may not be typical of 
clinical practice.
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3.5 Clinical Assessment of Stimulation Treatment
The primary aim of the treatment of chronic denervated muscle is to increase the tissue viability, 
enhance cosmetic appearance and where possible restore function (§2.3.7). The criteria for 
assessment of any such treatment must therefore reflect these aims and the appropriate evaluation 
measures may also be employed to optimise the treatment, for instance in terms of the stimulation 
parameters. Although the incidence of ulcers is dependent on a multitude of influencing factors, 
there is evidence of these including a minimum tissue thickness, circulation and tissue perfusion 
levels [Clark, Rowland at al. 1989; Livesley 1990; Negus 1995]. These parameters provide the basis of 
evaluation of many therapeutic stimulation studies and are also of relevance to cosmetic 
appearance. Assessments of functional value range from the degree of contraction force and limb 
movement to improvements in daily living tasks. When treatment is applied to muscle in the acute 
stage after nerve injury or to degenerative diseases, then the extent of muscle fibre innervation and 
the progress of any nerve regeneration is the measure of primary clinical interest, especially to 
monitor for any hindrance of it. Techniques for the assessment of innervation and nerve growth are 
discussed in §2.4. Considered here, are those evaluation measures applicable to the evaluation of 
stimulation treatment of chronically denervated muscle in a routine clinical environment, which is 
the focus of this study
3.5.1 Muscle Thickness Measurement
By far the simplest measure of peripheral limb muscle bulk is circumferential girth, measured with 
a simple flexible tape measure and Petrofsky [1991] used this technique in evaluation of 
stimulation of denervated muscle. Apart from variability of measurement due to stretching o f the 
tape and distortion of the tissue, the method suffers the obvious disadvantages of measuring total 
tissue bulk, without differentiating the muscle tissue or the particular muscle of interest. It is 
therefore subject to other factors influencing total body weight and composition, and is also only 
suitable for treatment of peripheral limbs.
Changes in muscle bulk are most easily determined in cross-section at particular locations. X-ray 
Computer Topography (CT) provides such an image from which muscle, fat, bone and other 
tissues are differentiable and individual muscles within muscle groups can be delineated allowing 
estimation of cross sectional areas. Kem and Hofer et al. [1999] have used this technique in the 
evaluation of stimulation of denervated muscle, by assessment of each of the quadriceps muscles 
Qualitative CT has been developed for the evaluation of FES bicycle ergometry training [Block, 
Steinbach et al. 1989]. CT has the advantages of clarity of interpretation and consistency of 
measurement location, as this can be determined from imaged bone landmarks. However, the 
technique suffers disadvantages of complexity, availability and cost of the equipment and
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limitation of the frequency of measurement due to ionising radiation exposure. Magnetic 
Resonance Imaging (MRI) avoids the exposure limitations and provides much greater image 
contrast of soft tissues, but at greater cost and time for scanning. It is hoAvever unsuitable for those 
with heart pacemakes and other implanted metal objects, which also cause distortion in the CT 
image. MRI has also been used for evaluation of stimulation treatment [Mokrusch and Neundorfer 
1994] and the diagnoses of denervation (§2.4.2). Resolution and accuracy of CT and MRI are 
dependent on the image size and 0.5mm is typical of clinical systems [Liang 1999].
Real time Ultra-sound imaging with a portable scanner is quick, convenient and non-invasive and 
avoids the major disadvantages of CT of MRI. However, this is at the expense of some of the ease 
of interpretation of the resulting image, and cross-sectional area can only be measured for small 
muscles or with a static scanner. Ultrasound has no established adverse biological effects at 
diagnostic power levels, is non-invasive and painless and therefore is particularly suitable for 
measurements of children or those with sensitive conditions [Schmidt and Volt 1993]. A-scan 
ultrasound offers perhaps the most accurate measure of tissue thickness, but requires considerable 
experience in the interpretation of the signal. The measurement signal is derived from the 
reflections of a single point source of ultrasound waves transmitted through the skin surface. 
Reflections and refractions occur at discontinuities of conductivity and therefore predominately at 
interphases between different media, such as tissue/bone, to a lesser extent intermediate fat/muscle 
boundaries, as well within the tissue layers/ To avoid the air/tissue interface dominating, water 
based conductive gel is used to couple the source to the skin surface. With B scan ultrasound, the 
source is scanned across the skin surface or an array of sources is employed, with appropriate 
processing of the signal to produce a 2D image. The resolution of the image increases with the 
frequency of the ultrasound, but this also reduces the possible penetration depth. Identification of 
the boundaries between muscles within a muscle group is usually possible, allowing their 
individual thickness' to be determined using electronic callipers. Typical, systems employ a 5MHz 
source signal, allowing measurements to tissue depths of the order of 100mm with a resolution of 
1mm [Foster, Pavlin et al. 1993]. The depth of tissue boundaries is calculated from the time for 
reflection and an estimation of the speed of sound in tissue. As an average value is employed by the 
device, this typically over-estimates the thickness of fat by 6% and under-estimates the thickness of 
muscle by 3% [Heckmatt, Pier et al. 1988] and is the major source of accuracy error in most systems 
[Liang 1999].
Ultrasound has been shown to be a reliable technique for measurement of quadriceps thickness. 
Repeat measurements showed a coefficient of variance of 8.3% [Schmidt and Volt 1993] and a 
reproducibility standard deviation of 2mm for fat and 3mm for muscle thickness [Heckmatt,Pier et al.
1988]. Measurement of cross sectional area demonstrated a high intra-rater reliability (p>0.05) and 
a significant (p<0.01) but consistent (8%) inter-rater effect between two operators [Oldham, Howe et
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al. 1995]. The technique has been used for assessment of FES training [Taylor, Ewins et al. 1993], for 
measurement of facial soft tissue thickness [Liang 1999], for evaluation of muscle to subcutaneous 
fat ratios in children, particularly those with SMA [Heckmatt, Pier et al. 1988; Schmidt and Volt 1993] 
and as a predictor for skin diabetic foot lesions and sacral pressure sores [Clark, Rowland et al. 1989]. 
Degenerative tissue is characterised by increased echo-density, although this is not unique to 
denervated muscle [Schmidt and Volt 1993].
For repeated measures with each of the above techniques, it is necessary to standardise the location 
of the measurement for consistency. For measurement of the quadriceps muscle group, Block et al. 
[1989] used 100 and 175mm proximal to the tibial plateau. For single site measurements, the 
midpoint between trochanter and patella is typical [Petrofsky 1991; Oldham,Howe et al. 1995] 
[Heckmatt, Pier et al. 1988; Schmidt and Volt 1993] or 150mm proximal of the patella [Taylor, Ewins et 
al. 1993]. Measurements are typically taken with the knee extended and the subject seated or supine 
but without the thigh touching the supporting surface to avoid tissue distortion. Measurement has 
also been performed with the knee flexed to 90° [Schmidt and Volt 1993]. Distortion of the tissue due 
to pressure applied to the skin by the hand held scanning probe, is avoided by using a soft, but 
ultrasonically transparent, stand-off block [Clark, Rowland et al. 1989] or copious amounts of the 
coupling gel combined with care by the operator and monitoring of the image [Heckmatt, Pier et al. 
1988; Schmidt and Volt 1993].
3.5.2 Muscle Structural Damage
Even given a positive effect on muscle atrophy, evaluation of damage to muscle fibres due to 
stimulation is of interest to optimise parameters and treatment patterns. Of particular interest is 
damage due to overuse or reperfusion arising from the type or pattern of contractions induced. 
Histological analysis and microscopy structural analysis are possible from muscle biopsy samples 
and have been used in some clinical studies [Neumayer, Happak et al. 1997; Williams 1996a]. However 
the frequency of measurement is obviously limited and non-invasive clinical measures have yet to 
be refined for application to stimulation studies.
Blood serum assays for creatine kinase (CK II and III) and myoglobin (Mb) are used to identify 
damage in cardiac muscle following an ischaemic event and to assess skeletal muscle damage, 
though carbonic anhydrase III (CAIII) is considered more suitable for acute events in skeletal 
muscle. Even though levels are raised by common exercise in normal muscle, condition specific 
increases occur following exercise with some neuro-muscular disorders [Dop Bar, Reijneveld et al.
1997]. Also dramatic increases in CK are observed following eccentric exercise muscle damage and 
revascularisation reperfusion damage, associated with capilliary endothelium trauma, muscle fibre 
necrosis, oedema and tenderness. [Jones and Round 1997]. It is recognised that these techniques still 
require further development to differentiate normal from abnormal damage, especially arising from
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stimulation treatment. Urine assay analysis may also be possible, although slightly easier to collect, 
research will be required to determine the optimum time of sample, especially given impaired 
urinary function in SCI patients.
3.5.3 Bone Mineral Density (HMD)
Immobilisation following SCI doubles the risk of bone fracture, primarily from low energy 
fractures of the lower extremities, with upper extremities protected by increased loading activity 
[Vestergaard 1998]. This is associated with a significant decrease in bone mineral density, (BMD) 
especially in high trabecular bone around the knees and ankles, where fracture incidence is highest. 
In the first year following injury, BMD decreases to 90% normal levels over most of the lower 
extremities, decreasing in the second year to approximately 80% and continues to decrease in the 
distal femur to 65% after 3 years. Conversely, BMD levels in the lumbar spine, remain 
approximately unchanged [Inman, Sharp et al. 1998]. Comparing paraplegic and tétraplégie SCI, 
upper limb BMD loss is greater in tetraplegics, whereas the greater loss in the lower limb is not 
significantly different. BMD loss is greater amongst ‘complete’ than incomplete SCI and greater 
with flaccid compared to spastic paralysis, though not observed in all studies [Demirel, Yilmaz et al.
1998].
Despite the decrease in BMD with SCI, only 25% may be classified as osteoporotic in the femoral 
neck, by having levels in excess of 2.5 standard deviations from normal The fracture risk 
stabilises 3 years after SCI [Vestergaard 1998] and may reflect an adaptation of lifestyle, such that 
treatment of reduced BMD is of low priority, though perceived as high by persons with SCI The 
condition is, however, of concern for FES for standing or walking, because of the risk of fractures 
from increased loading and from the risk of falling. Those classified as osteoporotic in the femural 
neck are therefore typically excluded from participation The increased risk of ankle fractures, 
may also be of concern in selecting candidates for FES ergometry.
BMD is determined by dual X-ray absorptiometry (DXA) and dual photon absorptiometry (DPA), 
with pDXA single x-ray absorptiometry (SXA) and radiographic absorptiometry (RA) used for 
peripheral location to a precision of 1-2%. Quantitative ultrasound scanning (QUS) of the 
calcaneus has been developed with high correlation to BMD measurement and significant 
advantages in the cost and portability of equipment and in the use of non-ionising radiation [Blake 
and Fogelman 1998; Geusens 1998; Ross 1998].
Clinical practice at Salisbury District Hospital (SDH)
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3.5.4 Cardiac Output
Artificially induced muscle contractions by electrical stimulation offer the potential for improved 
circulation and therefore a positive contribution towards conditions caused by its deficiency. 
General circulation as indicated by cardiac output and limb blood flow may be increased by 
enhanced venous return, especially in the lower limb, and any cardiovascular exercise component. 
Improved muscle perfusion is associated with the capacity for greater contraction force and 
endurance (§3.4). Skin perfusion can be enhanced by the heat generated from the underlying 
muscle contraction [Grant & Pearson 1938 quoted by Woodcock 1975 p229] and due to the direct effect 
o f the stimulation on vaso-motor control. However, treatment and therefore muscle contractions, 
are typically limited to a portion of the day, and it is the effect on the resting or average blood flow 
which may be of clinical significance. Difference techniques may be required for measurement of 
blood flow at rest or during exercise or electrical stimulation.
Conventional techniques for the assessment of cardiac output are based on Pick and dilution 
methods, are invasive in terms of catheters or injections and require precise procedures for accurate 
results [Woodcock 1975]. Cardiac output can also be determined from the average stroke volume of 
individual heart contractions and the heart rate. One of these methods is impedance cardiography, 
by which changes in the electrical impedance of the thorax are measured and assumed to be caused 
predominately by blood flow, as the most conductive element of the body [Porter 1986]. Two 
circumferential electrodes are placed around the neck and two around the trunk below the level of 
the heart. An alternating current of known amplitude is passed between the outer electrode poles 
and the resulting voltage across the inner poles measured, typically with a bridge circuit. A high 
frequency current (100-250kHz) is used, as skin impedance is then much reduced and the risk of 
ventricular fibrillation negligible given the typical 4mA maximum current employed [Geddes 1969 
quoted by Woodcock 1975]. The change in blood volume during each heart pulse, the stroke volume, 
is determined from the change in impedance assuming a uniform current density distribution and 
homogenous conductor of uniform cross section, which is only approximate for body segments. 
The value of blood resistivity varies with frequency, temperature, velocity of flow and with the 
haemocrit level [Woodcock 1975]. Many studies have used a resistivity of 150Q/cm, but a value of 
135Q/cm has been suggested as an average in-vivo value corresponding to a range of haemocrit 
levels [Porter 1986]. Impedance changes are also attributed to changes in the quality of electrode 
contact with tissue swelling [Woodcock 1975]; movement and inspiration/expiration introduce 
artefacts into the measurement [Porter 1986].
Absolute calibration of impedance cardiography is difficult, and evaluation of its accuracy is 
largely by comparison with concurrent measurements by other established methods [Porter 1986]. 
The values obtained by impedance cardiography tend to be higher than other methods, attributed by
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some to the additional flow from the right ventricle, but by Porter [1986], also to an excess value of 
blood resistivity. Correlation coefficients are therefore wide ranging (0.55-0.98) but comparison 
with electromagnetic flowmeter measurement is most appropriate and yields correlation 
coefficients 0.82-0.85 for cardiac output [Porter 1986]. Taylor et al. [1993] used the same impedance 
cardiograph to demonstrate that cardiac output is not significantly altered from normal, in those 
with paraplegia following spinal cord injury or by their participation in 3 months of electrical 
stimulation treatment of the quadiceps which greatly increased thigh blood flow.
3.5.5 Limb Blood Flow
For peripheral limbs, plethysmography is conventionally used to measure the change in volume of 
the limb arising from the blood flow into the limb segment. The volume is either measured directly, 
by the displacement of fluid or air from a surrounding chamber or inferred from weight changes, a 
circumferential strain-gauged cuff or from changes in electrical impedance or capacitance 
[Woodcock 1975; Porter and Swain 1986]. The displacement method is considered most accurate and 
used as a comparative benchmark, even though results are probably affected by hydrostatic 
pressure and it assumes all arterial flow is translated into tissue expansion. Flow is typically 
measured with proximal venous occlusion for at least 15s and is based on the assumptions that 
occlusion is instantaneous and complete and does affect arterial flow, which is the sole cause of 
tissue expansion. Occlusion methods are somewhat cumbersome, time consuming, and dependent 
on precisely controlled conditions for accuracy. They are therefore considered unsuitable for 
continuous or immediate measurements post trauma, surgery or exercise [Porter, Swain et al. 1985].
Alternatively, determination of pulsatile blood flow in peripheral limbs may be performed by 
measuring the change in tissue impedance in a similar manner to Impedance Cardiography (§3.5.4). 
The impedance measured is that of the blood in parallel with that of the tissue, and changes occur 
as blood perfuses through it, whereas other methods such as the ultrasonic doppler technique 
measures only arterial flow. Comparison of impedance plethysmography with electromagnetic 
flowmeter measurement yielded correlation coefficients of 0.91-0.96 for limb flow. Direct 
comparison of pulsatile and occluded flow measurements, is questionable given that the former is 
vascular expansion due to the unobstructed pulse pressure wave propagating down the limb, the 
latter due to the accumulation of fluid in an occluded limb However, pulsatile measurement is 
criticised for ignoring any steady arterial flow [Porter, Swain at al. 1985; Porter and Swain 1986].
Using Impedance plethysmography, considerable variation was observed in repeat measurements 
on a single occasion (2*SD as % of mean: 6.9%-45%, average 15.7%) [Porter 1986 p.96]. Peripheral 
blood flow with its many influencing factors, is in a constant state of fluctuation, particularly in the 
hand, where the skin flow dominates and plays a major role in thermoregulation [Porter and Swain 
1986]. The blood flow ratio of concurrent measurements of both limbs o f an individual has
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provided greater discrimination of unilateral abnormalities, where ratios are outside the normal 
range of 0.66 -1.5 for forearm [Porter, Swain et al. 1987]. However Impedance plethysmography has 
significant benefit of simplicity and versatility, allowing measurement of cardiac output and 
bilateral limb blood flow with the same equipment and therefore concurrently. It is non-invasive, 
causes minimal disturbance to the patient and is not critically dependent on room environment or 
elaborate setting up procedures. However it is subject to low signal to noise ratio in cases low 
tissue impedance or low flow rate for which ultrasonic Doppler technique is considered more 
suitable, providing precise control of incidence angle is feasible [Porter and Swain 1986].
3.5.6 Muscle Tissue Perfusion
Vascular measurement of blood flow into muscles is difficult in cases of dual arterial supply and so 
indicator clearance methods are employed, typically using Xenon (133Xe) [Woodcock 1975]. A 
quantity is injected locally into the tissue of interest and the rate at which it is removed, measured 
by means of scintillation counters, which may be strapped to the limb for measurement during 
exercise. The method assumes the removal of the indicator is solely due to blood flow and that it is 
not metabolised, altered or stored by the tissue. Variation in measurement is introduced in the site 
of initial injection. The rate of removal is reduced during exercise or muscle contraction, attributed 
to ischaemia but greatly increased immediately post exercise. Lassen [1964] found this hyperaemic 
response is predominately in the initial minute and lasted not more than 3 minutes with prolonged 
response symptomatic of a pathological condition (Fig.3.5.1) [Woodcock 1975].
normal
arterial
disease
Figure 3.5.1 Post Exercise Anterior tibialis Blood Flow by Xe 133 Clearance [after Lassen 1964 ]
Kern [1995] used Thallium 210 scintigraphy to measure the long term effect of direct electrical 
stimulation on quadriceps muscle perfusion (§3.4.2). Measurements were relative to brain 
perfusion, on the assumption that this remains approximately constant over a year, though the 
method or difficulties of doing this were not alluded to. The effect o f stimulation treatment has also 
been evaluated in terms of the capillary and micro-vessel density by histological analysis of tissue 
samples [Clemente and Barron 1993]. Radio labelled microspheres of 15pm diameter allow 
measurement of muscle blood flow on denervation and reinnervation [Eisenberg and Hood 1994].
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3.5.7 Skin Perfusion
Skin blood flow has a fundamental role in body temperature regulation under sympathetic nervous 
system control and therefore highly dependent on the temperature of the environment. In the hand 
and particularly the finger, at times the majority of blood flow is through the skin [Porter and Swain 
1986], whereas for other body segments, skin blood flow was not observed to significantly effect 
limb blood flow in normals [Woodcock 1975],
Skin perfusion has been measured by Xenon clearance, calorimetry, impedance plethsymography 
or photo-electrically. Xenon clearance may be monitored following intramuscular injection or 
epicutaneous application to the skin surface, though not if sweating occurs [Woodcock 1975, p.232]. 
Kern [1995] employed Xenon clearance in evaluating direct muscle stimulation (§3.4.2). 
Photoelectric methods measure the variation in opacity of tissue with blood flow through it. In 
particular, laser doppler measures flow to a depth of 1mm and is suitable for continuous, though 
very localised measurement, providing the probe orientation remains constant [Porter and Swain 
1986].
Skin temperature has also been measured as an indicator of skin perfusion levels. This assumes that 
the body temperature is steady and in equilbruim with the surroundings, which necessitates at least 
20 minutes for acclimatisation, no sweating and a stable environment. Skin temperature depends on 
the arterial and capillary blood flow, the capillary density and degree of vasoconstriction/dilation 
and therefore varies over the body. Eddy & Taylor [1931] measured average skin temp as 32.5°C 
with a reduction of 1-2°C in the upper extremities and 2-3°C in the lower and variations of 4-6°C 
over the hands, and 6-8°C over the feet [Woodcock 1975, p.64]. Localised variation also occurred 
due to arteries or veins making measurement at the skin surface with thermocouples or thermistors 
(thermometry), more variable.
Thermography infers the temperature of an object from its radiated energy, which depends on the 
object’s absolute surface temperature and its emissivity [Woodcock 1975, p.65]. Modem 
measurement is performed with semiconductor detectors sensitive to emitted radiation and array or 
scanning systems to produce a direct thermal image of the object, for display and analysis per 
computer graphical packages. Calibration is achieved by means of objects of known temperature 
and emissivity. Errors in sample measurement arise from estimation of skin emissivity poor image 
focusing onto the detector and local variation in the ambient temperature. There is also some 
question over whether the temperature recorded is in fact that of the skin layer or that of the 
underlying tissue radiating through the skin. Even so infra red thermography may provided a 
useful, non-invasive comparative study measure and has been employed in the evaluation of direct 
muscle stimulation [Taylor, Ewins et al. 1992; Kern 1995] (§3.4.2).
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3.5.8 Joint Movement Range and Ease
Goniometers for measurement of joint range of motion wary from simple plastic protractor type to 
electronic units. The former are used typically and provide reasonable accuracy and consistency. 
The majority of inter-rater variation is due to differences in the technique of measurement 
alignment, but correlation coefficients of 0.8 or greater are achievable [LaStayo and Wheeler 1994].
3.5.9 Contraction Characteristics
The simplest assessment of muscle contraction strength is with respect to a standardised 
numerical grading scale, such as that of the MRC used by Williams [1996a];
MRC Classification of Motor Recoverv 
MO No contraction
M l Return of perceptible contraction in proximal muscles 
M2 Return of perceptible contraction in proximal and distal muscles
M3 Return of function in proximal and distal muscles to such a degree that all important 
muscles are sufficiently powerful to act against gravity 
M4 All muscles act against strong resistance, and some independent movements are possible 
M5 Full recovery in all muscles 
Additional intermediate levels are typically employed [Boonstra,Van Weerden et al. 1987];
M4‘ . . . . . .muscles act against light resistance,
M4  muscles act against 'normal' resistance,
M4"^ muscles act against heavy resistance
Where movement against gravity is possible, strength may also be quantified in terms of the 
possible angular movement of a joint. More precise quantification of contraction strength is 
possible by measurement of the isometric force exerted, usually for a particular limb movement. 
Hand held dynamometers can provide reasonable results but care must be taken to isolate the 
contraction of the muscle of interest and an instrumented rig to achieve this is usually more 
accurate. For instance, measurement o f quadriceps muscle strength may be achieved with subjects 
seated in a adjustable chair, to maintain knees and hips at 90° flexion, a webbing strap around the 
waist to prevent further hip flexion and upper body movement and force measurement at the angle 
[Oldham,Howe et al. 1995].
The capability to measure contraction force also allows determination of other contraction 
characteristics. During a sustained contraction, the force produced will decrease due to fatigue. 
This is usually quantified in terms of the ratio of initial to final force over a certain period of 
contraction or the time taken for the force to decrease by a proportion. This may be a maximal 
voluntary contraction (MVC), or a contraction induced by a set of standard stimulation parameters
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[Binder-Macleod and Snyder-Mackler 1993]. The task of defining a standard is made more difficult 
when the muscle excitability varies between subjects and with the period of treatment, however is 
still valid as a comparative measure for the individual [Degens and Veerkamp 1994].
3.5.10 Functional Tests
When the stimulation treatment has a functional objective, then various standard tests have been 
developed to evaluate either a functional movement or completion of a relevant task in terms of 
both quality and time taken. For hand function this includes evaluation of the strength of different 
grips [Patterson, Smith at al. 1994; Williams 1996a], the completion of certain repetitive manipulative 
tasks, or the dynamics of movement with tracking tests [Wright 1998]. For the lower limb, such as 
cases of compensation for 'dropped foot', the quality of gait may be assessed simply by measuring 
the physiological cost index (PCI) over a set distance walk (§4.5.10). More sophisticated analysis 
of gait is possible with evaluation of ground reaction force and position tracking of joints.
3.5.11 Quality of Life Assessment
Several standardised questionnaires have been developed to allow quantifiable assessment of 
quality of life, [Wade 1992], although these will not necessarily reflect the priorities of life quality 
of the individual and are dependent on their subjective judgement. The health service quantifies the 
benefit of treatments in terms of added quality of life years (QUALYS) in order to justify its 
clinical application.
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4. C l i n i c a l  S t u d y  O u t l i n e
4.1 Study Hypothesis and Objective
The literature suggests that considerable benefits can be obtained from electrical stimulation of 
denervated muscle (§3.4), but that further research is necessary to investigate the physiological 
mechanism of its effects, to confirm its treatment efficacy and to develop the appropriate 
techniques for routine clinical application. In particular, for the treatment of acute peripheral nerve 
injuries, it remains necessary to establish the exact effect on nerve regeneration and muscle 
reinnervation. However the methods to monitor these, which are routinely available, (§2.4), infer 
the extent and changes in muscle fibre reinnervation, rather than measure nerve growth directly. 
Also, given the variability in the timing and success of nerve regeneration and reinnervation, the 
selection of individually matched controls is difficult and it is anticipated that any study will 
require a sizeable sample for statistical significance. In regard of these considerations and the 
clinical need and experience of a previous study at Salisbury District Hospital MPBE (§1), this 
study concentrated on treatment of chronically denervated muscle, when the effect on nerve 
regeneration is not of primary concern.
Clinical studies have demonstrated considerable benefits to chronically denervated muscle from the 
application of long pulse biphasic (LPB) stimulation waveforms, but latterly these have 
concentrated on the restoration of function, especially in the lower limbs of those with flaccid 
paraplegia (§3.4.2). The extent of the therapeutic value of the treatment to tissue properties and 
particularly to resting limb perfusion, which may in the long term be of greater clinical priority, 
remain to be quantified with a statistically significant sample size and the optimum stimulation 
parameters to achieve this, are yet to be confirmed. Also, there are few current attempts to address 
the difficulty of achieving therapeutic or functional benefits in cases of chronic partial denervation, 
such as ‘dropped foot’ or brachial plexus injury.
Before its adoption as a routine clinical treatment, it is necessary to establish the hypothesis that;
“transcutaneous biphasic rectangular stimulation can produce clinically significant 
therapeutic tissue property and appropriate functional benefits fo r  chronically 
denervated muscle o f peripheral limbs and that similar benefits can accrue though the 
treatment ofpartially denervated limbs with trapezoidal shaped pulses. ”
§4.1___________________________________________Clinical S tudy Hypothesis and Objectives___________________________________________ 4-2
However prior to a formal clinical trial to rigorously test this hypothesis, it is necessary to develop 
suitable stimulation equipment and standardised, but condition specific, treatment protocols. The 
purpose of this work was to facilitate these and to provide further supportive evidence for the 
benefits of the treatment, through the following study objectives;
1. quantify the therapeutic tissue benefits, throughout the treatment period of transcutaneous 
biphasic rectangular stimulation of chronically denervated muscle in cases of complete 
limb flaccid paralysis
2. evaluate the effectiveness of trapezoidal shaped stimulation pulses in alleviating sensory 
and motor nerve recruitment and to quantify the therapeutic tissue benefits of such 
stimulation in cases of chronic partial limb denervation
3. to optimise the stimulation parameters with respect to the therapeutic benefits, both during 
the process of conditioning of the muscle and thereafter.
It was recognised that the study would be of an exploratory nature, particularly for the cases of 
partial limb denervation, and that the exact treatment regime would depend upon the condition and 
response of the individual. Some initial clinical investigations were therefore planned with a small 
number of subjects with the following preliminary objectives;
4. familiarity with the LPB stimulation technique
5. confirm and quantify the changes in muscle excitability using Strength-Duration testing
6. quantify changes to tissue properties in terms of muscle thickness, resting limb blood flow 
and skin temperature and confirm the likely treatment period for these to occur
7. evaluate the effectiveness of accommodating trapezoidal shaped pulses for the treatment of 
partial limb denervation and quantify changes to tissue properties as 6
8. investigate and quantify functional benefits of treatment where appropriate to the condition
9. confirm the suitability of the stimulation equipment and treatment protocol
10.confirm the suitability of the chosen measurements techniques and protocol for treatment 
evaluation
These preliminary investigations form the basis of this thesis and using the experience gained, a 
subsequent clinical study would seek to achieve the overall study objectives (1-3), with a restricted 
range of neurological condition, a more defined treatment protocol and sufficient number of 
subjects to be permit numerical statistical analysis.
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4.2 Study Outline
A one year investigative study has been conducted at SDH MPBE with 5 subjects with peripheral 
limb denervation, commencing July 1998, Given the variability in condition and response 
expected, subjects acted as their own controls and are analysed on an individual case basis. The 
study was of an ABA design, with initial baseline measurements, against which measurements 
during the treatment period are compared, and a follow up period, without treatment, to confirm 
any changes observed. Given the experience of other studies for the time taken for tissue changes 
to occur [Taylor, Ewins et al. 1992], a 6 month treatment period was chosen, with equal follow-up 
period. Unlike some other studies, treatment was of a single limb, with the contralateral limb 
untreated to serve as control against measurement changes due to influences other than the 
treatment. The technique is limited by the possibility of treatment also having an effect on the 
contralateral limb, however the trend of changes in both limbs during the study were correlated to 
likely influencing factors (e.g. body weight, room temperature) in order to try to identify this.
Treatment consisted of twice daily stimulation of a single chronically denervated muscle or muscle 
group with long pulse biphasic pulses and surface electrodes. Stimulation parameters were chosen 
according to the muscle condition and were reviewed and adjusted regularly with the anticipated 
increase in muscle excitability. This was quantified by means of Strength-Duration testing to guide 
the choice of stimulation parameters and to aid the development of the standardised treatment 
protocols. The treatment was evaluated by qualitative and quantitative measurements, including 
muscle thickness, limb blood flow, skin perfusion and joint motion. These were performed at 
regular intervals throughout the treatment and follow-up periods. Subject participation was purely 
voluntary and unpaid, though travelling expenses were reimbursed by the generous donation of the 
INSPIRE foundation \  Approval for the investigations was obtained from the Wiltshire medical 
research ethics committee and the agreed protocol appears in Appendix B.
4.3 Subject Selection
The number of subjects (5) was based on the feasibility of completing the schedule of evaluation 
visits specified in the protocol, given that all were conducted by the researcher and given the 
availability of the clinical space at Salisbury District Hospital MPBE. All subjects were selected 
from previous referrals to SDH MPBE for electrical stimulation treatment but which had proved 
unsuitable, probably due to lower motor neurone damage. To avoid possible effect on reinnervation 
and the variability of response that might be expected from degenerative disease denervation, 
subjects were sought with denervation arising from peripheral nerve injury, at least one year and 
preferably two years previously. The potential candidates attended for an initial assessment visit.
* INSPIRE Foundation for Integrated Spinal Rehabilitation, Salisbury District Hospital, Wiltshire, SP2 8BJ
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which included evaluation of the extent of limb denervation, and the muscle contraction, skin 
reaction and other response to stimulation with various pulse widths and frequencies. An adverse 
response, was one of the possible contra-indications to participation in the study, others included 
active wounds or skin problems in the treatment area, excess muscle spasm, contractures or joint 
problems. Subjects were eligible for participation, given the absence of contra-indications and 
following their own written informed consent and that of their general practitioner and the medical 
consultant of the study {Appendix B).
For the later, larger study, maximum commonality of condition amongst subjects was intended to 
permit inter-subject comparison and evaluation of different stimulation parameters. This was not 
possible with the small sample size of this preliminary study, however it was at least desirable to 
compare the use of rectangular shaped pulses used in other studies (§3.4.2) for complete limb 
denervation with trapezoidal shaped pulses for cases of partial limb denervation. Cases of flaccid 
paraplegia from T12/L1 level SCI and stimulation of the quadriceps muscle were favoured as this 
would permit comparison with the previous studies and given the number of such referrals to SDH 
MPBE with the proximity of the Spinal Treatment Centre. For upper limb, brachial plexus injuries 
are also of clinical concern to those at SDH. Consideration was given to the feasibility and expense 
of subjects attending for evaluation visits at SDH.
The five selected subjects who commenced treatment separately, comprised three paraplegics 5-10 
years post T12/L1 SCI (subjects LC and LD with near complete denervation apart from the toes 
and subject LE with more extensive innervation), subject LB with unilateral brachial plexus lesion, 
23 years post injury with denervation of the triceps and wrist extensors and subject LR with 
unilateral loss of dorsiflexion (‘dropped foot’) following a spinal infarct 3 years previously (§6 for 
details). Subject LR, differs from the original study aim, in that the primary treatment objective was 
to restore the dorsiflexion muscle function but participated as a previously selected paraplegic 
candidate was unable to do so due to illness. However, as one of many such, lower motor neurone 
‘dropped foot’ referrals to SDH, the condition is of considerable clinical interest and for which the 
accommodating stimulation waveforms under investigation are particularly appropriate. The triceps 
of subject LB in fact transpired to be partially innervated with some of the muscle fibres under 
voluntary control. Subject LD had to withdraw from treatment at week 17, due to an infected 
pressure sore following urinary tract infection. All other subjects completed the treatment and 
follow up periods, with some extension to the treatment period to compensate for weeks without 
treatment due to holiday, illness or recovery from skin reaction. For subject LR, the treatment 
period was extended to 12months as the follow-up period to confirm tissue property measurement 
changes was of lesser significance to the functional outcome and given the likely dominating 
influence of still functioning plantaflexor and other surrounding muscles. The study subjects 
therefore represent 3 groups for which direct stimulation is applicable, with appropriate parameters; 
1) complete limb denervation, 2) partial limb denervation, 3) disuse atrophy o f innervated muscle
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4.4 Treatment Protocol
4.4.1 Stimulation Equipment
To perform the daily stimulation treatment, subjects were each supplied with a portable, 
rechargeable stimulator unit which was custom designed for the project, given that no suitable 
alternative could be found. The LPSTIMIO unit (§5), is capable of producing a single channel 
stimulation output with a wide adjustment range of parameters, and in particular the long duration, 
biphasic pulse form, found to be of benefit in other studies (§3.4.2). The stimulation pattern is 
programmed into the unit from a personal computer (PC) connected to it during the clinical visit to 
the hospital. The PC link also permits monitoring of the stimulation output during use in the 
clinical setting and for Strength-Duration testing (§2.4.4). The unit maintains a record of the total 
duration and number of uses, which can be downloaded to the PC. The unit control available to the 
user allows adjustment of the stimulation intensity. Indication is provided during the stimulation 
output pulse and when the battery is in need of recharging. The stimulation output is inhibited and 
appropriate audio and visual warning provided, in the case of very low battery, excessive 
stimulation output or the detection of a fault.
Full instruction in the use of the stimulator was given to subjects, both verbally and written 
{Appendix J), who were required to demonstrate competent use, prior to participation in the study. 
This included adjustment of the stimulation intensity to achieve the desired level of contraction. As 
this depends on the skin impedance and may vary, indication of the absolute value of intensity was 
not provided on the unit, to avoid subjects setting it to a particular value irrespective of the muscle 
response. In particularly, most subjects observed an improvement in muscle response during the 
course of the treatment session as the skin impedance decreased, necessitating a reduction in the 
setting of the intensity control to avoid excessive current or contraction. However in two cases (LB, 
LR), where no contraction was visible initially, and sensation was impaired, such an indication was 
found necessary and provided by an externally connected meter and modified software (§5.7).
Commercially available Axelgaard PALS®  ^ reusable transcutaneous neurostimulation electrodes 
were employed for this study, as used routinely at SDH. These consist of a conductive wire mesh 
overlaying a layer of conductive gel, which self adheres to the skin surface. The gel is kept 
hydrated and clean by regular washing, which was found most effective after the treatment session, 
thereby removing any adhered dry skin. The PALS® Blue electrodes with approximately 1.5mm 
gel thickness are typically used for people with high skin sensitivity and were used as a
available from Nidd Valley Medical Valley Ltd, Conyngham Hall, Knaresborough, N.Yorks HG5 9AY, UK
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precautionary measure in this study, in sizes 50mm by 50mm (LB, LD) and 40mm by 90mm (LE, 
LR). The PALS® Flex electrodes, more typically used for indirect stimulation treatment, are 
available in larger sizes; the 130 by 80 mm oval size were used for subject LC and are more 
comparable with the electrode size used by [Kem, Hofer et al, 1999]. However the thinner gel layer 
of the PALS® Flex, allows the skin to more easily come into contact with the electrode mesh, and it 
is thought the fraying ends of some wires on the perimeter of these electrodes were responsible for 
the occurrence of some localised skin bums (§6.1.3). The oval electrode size was therefore 
abandoned in favour of the 75mm diameter round size PALS® Flex and were positioned away from 
the skin bums, which subsequently healed completely. These electrodes were not specifically 
designed for direct stimulation and the supplier accepts no responsibility for this application.
In addition to the LPSTIMIO long pulse stimulator unit, subject LB was also issued with a Microstim^ 
(MSTIM) unit for stimulation of innervated muscle. This produces a stimulation output of 300ps 
passively charge balanced pulses at a range of selectable frequencies and was used with 20Hz 
pulses and 20x40 mm PALS® Flex electrodes for treatment of the triceps where some fibres are 
innervated.
During the treatment period, subject LB regained voluntary control of at least some of the triceps 
muscle fibres and to encourage his voluntary exercising of these, he was issued with surface EMG 
equipment (§2.4.3). His normal stimulation electrodes in their normal position were connected to a 
BEAC^ pre-amplifier, and this in tum to a small portable interface unit, whose analogue meter 
indicated the amplitude of the integrated EMG signal after selectable gain amplification. The 
interface unit also permitted the 'raw' EMG and integrated envelope signal to be displayed on an 
oscilloscope or to be captured and stored by a PC based data acquisition package. In practice the 
EMG output was dominated by simultaneous recmitment of the biceps, unless the subject exercised 
caution to isolate the triceps recmitment. It is possible that with further training from a therapist, 
this may be possible providing the subject has the motivation. The EMG value was not pursued as 
an evaluation measure for this study, but the subject was encouraged to practice what voluntary 
recmitment of the triceps he could manage, as often as possible.
4.4.2 Stimulation Protocol
The stimulation treatments were performed twice daily by subjects in their own home, using the 
equipment described above. Treatment sessions were generally performed at the beginning and end 
of the day for convenience. Session duration was 5min for the first week, and gradually increased
produced by Salisbury District Hospital MPBE 
BEAC Biomedical Div 
Fax:- 010 39 385 48923
 ^ ision, Via E. Montale, 3 1-27040 Portalbera PV, Italy Tel:- 010 39 385 43378
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in approximately 5min increments each week up to 30min. This was to permit the skin, muscle 
fibres and the general body systems to adjust to the treatment, as gentle exercise is advocated for 
weak muscles and allows the increase in muscle perfusion necessary for development and 
endurance (§2, §3). When stimulation parameters were altered significantly and especially at the 
transition to tetanic contractions, the session duration was reduced once more, to allow adjustment 
to the increased metabolic demand and then progressively increased again to 30min. At times, 
subject LB performed treatment of the triceps with both the long pulse stimulator unit for the 
denervated fibres and a Microstim unit for the innervated fibres. Sessions consisted of up to twenty 
minutes with each unit, typically starting with the Microstim unit. Details of the session duration 
for each subject through the study are given with the results (§6).
The stimulation parameters for each subject were chosen according to their muscle excitability, 
which increased with treatment in the manner of other studies (§3.4.2). This was monitored by 
means of the Strength-Duration curve, determined at the regular evaluation visits, and guided the 
choice of pulse width (which progressively decreased) and pulse frequency (which progressively 
increased) (§6). Initially pulse widths of the order of 100ms at IHz or less were necessary to 
produce any contraction. Frequencies of IHz or less were used, so as not to overuse the muscle, 
and resulted in twitch contractions. Pulses were rectangular in shape, except in cases of partial limb 
denervation (LB, LE, LR), where trapezoidal shaped pulses were used with twitch contractions to 
minimise recruitment of the neighbouring innervated muscles. All pulses were of a symmetrical 
biphasic form (Fig.3.2.1) for charge balancing and to minimise the risk of skin damage (§3.2).
For lower limb subjects, the initial twitch contractions and isometric tetanic contractions were 
performed by the subject when semi-recumbent, usually on their bed, with a pillow or cushion 
placed beneath the knees to ensure they were slightly flexed. As contraction strength increased, 
isotonic contractions were possible. Given that protein synthesis and muscle development is 
greatest when loaded at the normal physiological length (§3.3), isotonic contractions against 
gravity were considered optimum for therapeutic benefit. For the SCI subjects (LC, LE) these were 
performed seated with the knees flexed at 90° and the lower legs able to swing freely. This 
provided a progressively increasing load against gravity as the lower leg was raised by the 
quadriceps contraction, and cushioning protected the heels on release. The level of stimulation 
intensity and therefore strength of contraction was limited to when localised autonomic skin 
dysreflexia in the form of sweating occurred (§6.1.3).
For subject LE, co-contraction of toe flexors, was of concern given existing mild ankle contracture. 
This was monitored and the subject encouraged to stand at least 30min each day. For stimulation of 
the dorsiflexor muscles of subject LR, initial isometric contractions were performed with the foot 
supported in the neutral position (90° flexion), whereas isotonic contractions were with the foot 
unsupported (approximately 40° flexion), with loading provided by gravity and the shortened
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Achilles tendon. With concern over exacerbating the latter, intensity was maintained at the 
threshold of co-contraction of plantaflexor muscles and the subject similarly encouraged to stand 
and exercise with the Achilles tendon stretched each day. Treatment of the triceps and wrist 
extensors of subject LB was performed with the elbow flexed and the lower arm supported on a 
cushion on the lap. Isotonic contractions were not achieved, but considerable co-contraction of the 
biceps occurred.
The stimulation envelope and therefore the duration of tetanic contraction was based on that for 
direct and indirect muscle stimulation of other studies (§3.2), though the unit only produced 
rectangular shaped envelopes. Initially the envelope duration was restricted to 3 s with an off period 
of 8-10s. This was gradually changed to 4s on and 8s off for the triceps and dorsiflexors and 8s on 
and 16s off for the quadriceps, (i.e.with the off period was maintained at double the on period).
In terms of skin care, subjects were instructed to wash the skin of the treated limb segment, before 
and after treatment, to minimise the risk of skin irritation and to ensure skin hydration, which 
notably improved contraction response. Contraction response was always notably better at the 
evaluation visits than at home and this was attributed to prior hydration of the skin by the 
application of a water based gel for approximately 15mins for the ultrasound tissue thickness 
measurement and then washed off (§4.5.6). Subject LR was therefore supplied with this gel for use 
in a like manner prior to treatment at home. The application of moisturising oils or creams to the 
skin is not generally advocated at electrode locations to ensure uniform electrode adherence and to 
minimise the risk of chemical reaction or transmission of substances into the skin. However 
moisturising agents  ^were found essential by some subjects to control the skin drying due to the 
treatment (§6.1.3), but were applied at times separated from treatment sessions. Subjects LR and 
LE also varied the position of the electrodes slightly from week to week to allow skin recovery.
Electrodes were positioned to optimise the contraction response, achieved by placement at 
approximately either end of the muscle (§3.2). For the quadriceps muscle (LC, LD, LE), this was 
on the anterior aspect of the thigh, 50-80mm and 220-250mm proximal of the proximal patella 
border. For the tibialis anterior (LR), 40 x 90 mm electrodes were placed longitudinally over the 
muscle with 20mm separation or 50x50mm electrodes at approximately 200 and 300mm proximal 
of the lateral malleolus. For subject LB electrodes were positioned on the triceps at 70mm and 
170mm proximal of the lateral humeral epicondyle and at approximately 80mm and 180mm distal 
for the wrist extensors on the dorsum forearm. These electrode positions were also maintained for 
the SD curve testing (§4.5.8), even though it is not necessarily optimum for indirect stimulation of 
any innervated fibres.
Aloe Vera water based gel (subject LR), Vaseline Intensive skin care cream (LC), Dipo Base (LE)
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4.5 Evaluation Measurement Equipment and Protocol
To assess the effect of the stimulation treatment a number of evaluation measurements were 
performed at regular intervals throughout the treatment and follow-up periods. The selected 
measures reflect the clinical aims of the treatment, to enhance the tissue condition, viability, and 
cosmesis, in terms of muscle thickness, resting limb blood flow and skin perfusion and these were 
all measured quantitatively. Co-variant measurements of blood pressure, heart rate, body weight 
and room temperature were also made to help identify any non-stimulation induced changes. The 
subsidiary aim of improving muscle function was assessed qualitatively and where possible 
quantitatively, in terms of contraction response and appropriate functional measures. The muscle 
excitability was monitored for possible changes in the extent of innervation and to guide the 
selection of stimulation parameters as the muscle became more responsive. Sensory innervation 
was also monitored because changes may occur due to enhanced innervation or re-education, and is 
both desirable to subjects and may enhance skin condition.
The techniques used were chosen for being non-invasive and suitable for the frequency of 
measurement envisaged. These are well established methods, and the equipment has been used in 
other studies of direct electrical stimulation and therefore capable of measuring the magnitude of 
parameter change expected [Taylor, Ewins et al. 1992]. Of some importance to the logistics of the 
study, these methods were also apparently easily performed by the researcher alone with minimal 
training, in the routine conditions of the hospital environment, thereby avoiding excessive visit 
duration. Not, least the equipment and consumable supplies were available at Salisbury. All 
measurements were performed by the researcher.
The evaluation measurements were performed at the initial assessment visit, the baseline visit at the 
commencement of treatment and then at regular intervals throughout the treatment and follow-up 
periods. During the first month, these were every week, during the second and third month, every 
two weeks, then monthly till the seventh month and thereafter at 6-8 week intervals until the end of 
the follow-up period. Some variability occurred in this schedule to accommodate individual 
subjects arrangements, illnesses and when reaction to the treatment required investigation. The 
visits for each subject were arranged at approximately the same time of day and followed a 
standard protocol, which lasted between 2 and 3 hours (Appendix D,E). Subjects changed into 
shorts and a short sleeved shirt to permit access for measurement and were seated, semi-recumbent 
on a therapy plinth and where appropriate on their wheelchair pressure relieving cushion. During a 
period of approximately 20min for acclimatisation to the room environment and the measurement 
position, the preceding weeks of treatment and any changes in medical condition were discussed. 
On occasions, sensory perception evaluation was performed during this interval (§4.5.2) and the 
skin condition photographed, but without touching the skin. The tissue property evaluation
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measurements were then performed, followed by refreshments as required and then the stimulation 
assessment. To avoid influencing the measurements, subjects were requested not to eat, drink or 
perform vigorous exercise for 1 hour prior to the visit, nor to consume alcohol for 24 hours before 
hand (though in fact none of the subjects consume alcohol regularly). A request to refrain from 
smoking for 1 hour before the visit was inadvertedly omitted, and it transpired that subject LB 
consistently smoked one cigarette immediately prior to the visit.
Details are given of evaluation measures in the approximate order which they were performed
4.5.1 Subject Observations
Subjects were issued with blank Observation Sheets (Appendix F) and encouraged to record the 
time and duration of treatment each day, the nature of the contraction, including fatigue, the 
intensity control setting or output current (LB, LR) and any observed effects. These were 
completed consistently by subjects LB, LD and LR, but not at all by LC or LE. A record of the 
duration and number of uses is maintained automatically by the stimulator (§5.6) and was noted 
and zeroed at each visit.
At the beginning of each evaluation visit, while the subject was acclimatising to the room 
environment, these observations were reviewed, and supplemented by questioning about the 
treatment; the nature of the contraction and limb movement, any delay in its start and fatigue, the 
co-contraction of other muscles, the effect on the skin, sensation and other effects. Subjects were 
also asked whether their exercise, diet, medical condition or medication had changed in any respect 
since the previous visit.
4.5.2 Sensory Perception
Sensory perception was measured at the beginning and end of treatment and follow-up periods. The 
standard static two point discrimination assessment (§2.5.4) was performed on the hands of subject 
LB on seven occasions during the study. Single point touch perception was assessed initially on 
other subjects using a single metal rod of 0.5mm diameter. Semmes-Weinstein Aesthesiometer 
monofilaments  ^(2.83, 4.31, 4.56, 6.65) were available in the latter part of the study but only used 
once on each subject due to lack of time during evaluation visits.
Supplied to SDH by Neuro Corporation, Cleveland USA
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4.5.3 Skin Temperature
Infra red thermography (§3.5.7) measurement of apparent skin temperature was made using an 
AGA Thermovision® 782  ^system consisting of germanium detector based camera, scanner unit 
and PC based graphical analysis package, BTHERM  ^ (Fig.4.5.1). The latter displays an image of 
the measurement object with the temperature of each pixel represented according to a colour scale.
0
Figure 4.5.1, AGA Thermovision System and BTHERM Image on PC
(n.b. tripod raised for measurement of subjects recumbent)
The spot temperature of individual pixels can be displayed and data analysis performed on selected 
areas of the image. Those used were in common with the routine clinical procedure at SDH; 
anterior aspect of the thigh, shin, dorsal aspect of the foot; lateral aspect of biceps and forearm with 
the elbow flexed at 90° and dorsum aspect of each hand. A non-absorptive thin foam cushion was 
placed between the upper limb and the body for these measurements to enhance contrast. For each 
defined area, the package calculated the minimum and maximum, mean and standard deviation of 
pixel temperatures, which were transferred manually to a spreadsheet for analysis calculations 
(§6.2). Typical distances between the object and detector unit were Im for hands and feet and 2m 
otherwise, the latter giving an estimated pixel resolution 4mm. A macro adapter giving 0.5mm 
resolution was fitted for close-up examination of potential current concentration. Calibration o f the 
system to within 2% was performed by the manufacturer on delivery. Calibration with the 
BTHERM software at SDH in 1998 demonstrated agreement with thermocouple measurements 
within 0.3°C on black body sources.
 ^AGEMA Infred Systems Ltd, Arden Ho. West St. Leighton Buzzard BEDS LU7 7ND UK 
 ^BTHERM Version 1.1 ISOTEC Imaging Ltd. 15,Lon-y-Rhyd, Rhiwbina, CARDIFF CF4 6JS
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Previous studies of denervated muscle stimulation have demonstrated changes in resting limb 
temperature asymmetry of the order of 1.5°C, using this equipment [Taylor, Ewins et al. 1992]. 
Standard values o f asymmetry between limbs in normals have been recorded at SDH {Appendix G). 
Thermographic measurements were performed at the start of each evaluation visit to avoid 
influence from other measurement and skin examination. Subjects were measured seated, with legs 
extended except subject LB. The detector camera was positioned as near vertically above the limb 
segment as possible, using a tripod stand and trolley. Room temperature and relative humidity were 
not controlled but monitored using an RS thermometer  ^with respective precision of 1% and 5%. 
Although a room with more stable, but not controlled, temperature was available elsewhere in the 
hospital, it was considered that measurement of all parameters in one location was preferable to 
avoid prolonging the visit duration with additional intervals for temperature and heart rate 
stabilisation in more than one location.
4.5.4 Skin Condition
Skin condition was assessed visually and by touch. Note was taken of skin dryness, clamminess, 
temperature to touch and any blemishes, sores or irritations, especially around the electrode sites. 
Photographs were taken of the treated and contralateral limbs, at the beginning and end of 
treatment and follow up periods and on intermediate occasions to record any usual skin condition.
4.5.5 Limb Segment Blood Flow
Limb blood flow was measured by electrical impedance plethysmography (§3.5.5) using an IFM 
Minnesota Impedance Cardiograph 304A*° (Fig.4.5.2), generating a 4mA constant current at 
lOOkHz. This is the same equipment used at SDH MPBE for previous studies evaluating blood 
flow in normals [Porter 1986] following electrical stimulation treatment [Taylor, Ewins at al. 1993], 
including of denervated muscle [Taylor, Ewins et al. 1992].
The output signals from the Cardiograph unit (dZ/dt, AZ, Zq) are connected to the National 
Instruments (§5^) DAQ 7000 analogue interface card of a PC for capture, display and analysis 
using a general purpose data acquisition software package written within the BME group using NI 
Lab VIEW graphical programming language. Given the upper frequency component of dZ/dt in 
normals adults is 12Hz for adults and 33Hz in those with arterial obstruction [FiUio, Brum et al. 
1983], the sampling rate of 200Hz was felt adequate without generating excessively large data files.
 ^RS High Accuracy Thermo Hygro RS 204-072 
Surcom Inc. 4180 Edmond Boulevard Minneaplos Minnesota 55406
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Figure 4.5.2 Minnesota Impedance Cardiograph 304A, Electrodes and PC Analysis Package
Blood flow measurements were taken after the subject had been rested for 20-30 minutes in semi- 
recumbent position as used by Porter [1986]. The electrode pairs consist of lengths of stainless steel 
wire braiding mounted 4cm apart on a cloth backing strip. One such pair was placed around either 
end of the limb segment of both limbs and secured with crocodile clips to ensure skin contact over 
the complete limb circumference [Porter 1986]. Electrodes were placed to maximise the separation 
distance L (measured between inner electrodes), whilst retaining them on one limb segment, given 
that a uniform cross section is assumed. The separation distance chosen for each subject was 
maintained approximately equal on each limb and for each measurement visit. Prior to that of the 
limb impedance, a sample or recording was made of the instrument calibration signal and stored 
using the PC analysis package. Two recordings were then made of the dZ/dt signal from each limb 
with approxhnately two minutes between recordings, always starting with the left limb and then 
swopping the connections to the previously positioned electrodes on the right limb. Care was taken 
not to talk or excite subjects during the course of this procedure and they were asked to sit quietly 
without moving. Just prior to recording, subjects were asked to stop breathing after a small 
inhalation. A sample tune of 6s (6-8 beats) was chosen, as for subject LR after this the dZ/dt pulses 
became lengthen and distorted, coincident with a decrease in heart rate. This was extended to 10s 
on occasions for other subjects to reduce heart rate error. For each recording the associated value of 
baseline impedance Zo, displayed on the instrument front panel and the electrode separation were 
noted. On some occasions, recordings were also taken after the period o f stimulation.
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The PC analysis package was used for display and measurement from the dZ/dt recordings, after 
software filtering to remove unwanted noise and interference, notably 50Hz. An 8 pole Bessel filter 
with 40Hz 'cut-off (-3dB) frequency was used on all sample waveforms, as this sufficiently 
reduced the interference with minimal effect on the signal amplitude or timing. The filtered dZ/dt 
waveform is displayed and adjustable cross hairs allow the determination of dZ/dtmax and blood 
beat flow time (tg) (equivalent to Lvet ) The recorded calibration signal is used to determine the 
correct zero and scaling factor (Q/sA^) for the dZ/dt signal. The instantaneous heart rate is 
determined from the time of a complete number of beat cycles in the dZ/dt recording. On some 
occasions, heart rate was also measured simultaneous using a chest mounted Polar heart monitor, 
and found to be approximately equal, with both showing a declining heart rate during the sample 
period. This was always less than that recorded by the automated blood pressure cuff because of 
the error in estimation from the small sample time and therefore underestimates blood flow.
The measured values for dZ/dt^ax, tg, Zo, L and HR were entered into a spreadsheet for calculation 
of the average blood volume per beat (Eqn.4.5.1) and the average blood flow (Eqn.4.5.2) for each 
recording in the manner of Kubicek for pulsatile cardiac measurement [Kubicek, Kamegis et al. 
1966]. As Porter [1986], a value of blood resistivity of 135Q/cm was used, and the flow duration 
(x in Fig.5.5.3) differs from the left ventricle ejection time (L vet ) of cardiac measurements.
Equation 5.5.1 BV = AV = p (L/Zo)^ C ( d Z / d t ) m a x  tg 
BV = beat volume (ml/min) 
p = blood resistivity 135 (Q cm)
L = distance between inner electrodes (cm)
Zo = mean body impedance (Q)
( d Z / d t ) m a x  derived from d Z / d t  waveform (V)
C — calibrabrion scaling for dZ/dt (Q s'W ) 
t g  (x) = beat duration from dZ/dt waveform (s)
Figure 4.5.3 Signal Waveforms of Blood Flow
Measurement [after Kubicek et al.l966]
m-zi
Hh-
Equation 5.5.2 Blood flow (BF) = Beat Volume (BV) x Heart Rate (HR)
The same Impedance Cardiograph with electrodes on the thorax was used to measure cardiac 
output of subjects LC and LE on one occasion during the follow-up period, towards the end of the 
study, to obtain a value of Lvet. Blood pressure and heart rate were measured at intervals 
throughout each visit to obtain a reliable resting value and to monitor for any excessive changes 
arising from the stimulation using an automated inflation cuff on the ISOmmHg setting.
" A&D Co.Ltd. Tokyo, Japan - Digital Blood Pressure Monitor model UA767
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4.5.6 Tissue Thickness and Limb Girth
Real time ultrasound measurement of muscle tissue thickness (§3.5.1), is particularly suitable for 
this project given the required regularity of repeat measures, avoiding ionising radiation and being 
quick and convenient to perform within the clinical space at Salisbury. A Dynamic Imaging 
^^System XLP B-scan linear array device was used. This operates at 2.5MHz with a hand held 
measurement probe, allowing imaging of tissue to a depth of approximately 50mm. This same 
instrument has been calibrated and used at SDH MPBE for evaluation of tissue thickness changes 
following stimulation [Taylor, Ewins et al. 1992; Taylor, Ewins et al. 1993].
Lower limbs were measured fully extended, upper limbs with the elbow at 90° flexion and the 
forearm supported anteriorly on a pillow. To avoid tissue distortion, the measured limb segment 
was unsupported as far as possible, for quadriceps, this was achieved by the subjects seated on their 
wheelchair cushion, though the thigh was supported proximally. Measurements were made on the 
limb segment at specific distances from readily identifiable anatomical landmarks, which 
approximated to the locations of proximal and distal electrodes and at the mid-point between. For 
the quadriceps (subjects LC, LD, LE), this was on the anterior surface of the thigh at 50, 150 and 
200 or 250mm from the proximal patella border. For the tibialis anterior (subject LR), this on was 
anterior surface of the lower leg at 200 and 300mm from the lateral malleolus. For the triceps 
(subject LB), this was on lateral aspect of the supported upper arm at 50, 100, 150 and 200mm from 
the lateral epicondyle of the humerus. To avoid distorting the tissue, measurements are take though 
a 3 cm 'stand-off block of Kitecho gel, which cushioned the tissue from the pressure applied to the 
scanner probe, but is transparent to the ultrasound signal. A water based transmission gel is 
generously applied to both sides of the block before positioning at the measurement site to ensure 
coupling. Care was taken to minimise measurement error due to an oblique signal path in the tissue 
by tilting the scanner probe about the perpendicular to the skin, to minimise the bone depth on the 
displayed image on the basis that the underlying bone is approximately parallel to the skin surface.
The instrument displays a real time image of the underlying tissues, which can be 'frozen' and 
relative distances measured by means of adjustable electronic cursors, with a resolution of 1mm. 
These were recorded at the time of measurement as unfortunately the image storage and camera 
facilities were not available to record the image and therefore Fig.4.5.4 shows a typical tissue 
image of the innervated quadriceps muscle of a SCI subject from a previous trial [Taylor, Ewins et al. 
1993]. This clearly identifies the underlying bone, fat and boundaries of the rectus femoris and 
vastus intermedius muscles.
Dynamic Imaging, 16 Young Sq. Brucefield Ind.Pk, Livingstone, GH54 9BX , UK Tel: 01506 415282 
Aquasonic ©100 Hypoallergenic Parker Labs Inc. Orange NJ 07050 USA Tel. 201-676-5000
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Figure 4.5.4 5 MHz Ultrasound Scanner and Probe
(n.b. measmt not performed by subject)
Quadriceps Image from 2.5MHz Unit 
(denervated muscle after Taylor et al. 1992)
Unfortunately, the image quality obtained from the unit during this project was far inferior, with 
muscle boundaries often too indistinct to be identified For the tibialis anterior muscle, located 
between the tibia and fibula, but without an underlying bone, thickness measurement was rendered 
highly unreliable. The variability in image quality was attributable to poor internal connections of 
the instrument due to age prohibited servicing. In the latter stages of the project a new Dynamic 
Imaging Concept MC 5 MHz scanner unit became available, providing a far superior image with 
greater anatomical detail and cursor resolution of 0.1mm. Several concurrent measurements on 
different study subjects were made with both instruments and confirmed consistently equal results 
to within cursor resolution (+/-lmm), when image definition of the older machine was good As 
image quality of the 2.5MHz unit became increasing poor with diminished use, the 5MHz unit was 
used for the remainder of the study.
Limb girth was measured concurrent with tissue thickness at each of the measurement locations, 
using a simple tape measure with 1mm resolution and care was taken not to pull this tight during 
measurement. Because of difficulties in rehably finding the tape at SDH, a new one was procured 
in early 1999 and used for the rest of the study. Body weight was also measured to monitor for 
concurrent changes in limb or overall body composition. Wheelchair bound subjects (LC, LD, LE) 
were measured clothed in the Spinal Treatment Centre at SDH. Subjects LB and LR measured 
themselves unclothed at home with bathroom scales.
4.5.7 Joint Range of Movement
The passive and where appropriate voluntary (active), range of motion of both limb joints was 
measured with a protractor goniometer, to an estimated accuracy of +/-5°. Angles are defined with 
respect to 0° when limb segments are aligned diagonally across the joint. The severity of joint 
contractures was also assessed by a physiotherapist by passive movement, (subjects LC, LR).
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4.5.8 Muscle Excitability
Muscle excitability was determined at most evaluation visits by recording of the Strength-Duration 
(SD) curve (§2.4.4) using the stimulator unit issued to the particular subject. Uni-polarity 
rectangular pulses at 0.67Hz were employed, with specific pulse widths, between 200ms and 0.3ms 
in descending order. Electrodes were positioned as for the stimulation treatment, typically at either 
end of the muscle, rather than over the motor point conventional for innervated muscle. The 
stimulation intensity was gradually increased until a minimal contraction was detected, which was 
assessed visually, because the weakness of the contraction during initial treatment made the 
palpation method difficult. The corresponding value of stimulation current displayed on the 
stimulator PC user interface monitor screen (§5.6) was noted for each pulse width, and later plotted 
using Excel Spreadsheet.
Each SD curve determination took approximately 15-20min, and a number of difficulties were 
encountered which, it is expected, decrease the reliability of the measurement, even though all were 
performed by the researcher. For several subjects, current flow through the tissue gradually 
increased over the course of 5-15min of stimulation, as skin impedance decreased, in a manner also 
noted by [Guttmann 1976]. It was therefore necessary to perform a limited period of treatment, prior 
to SD testing, but without fatiguing the muscle. The location and nature of the minimal contraction 
often varied as the pulse width was decreased, because of the variation in excitability of different 
fibres. This was particularly so, in the case LB, where some of the triceps fibres remain innervated. 
In the cases of partial limb denervation (LB, LE, LR), as the pulse width was decreased, the 
surrounding innervated muscles are recruited at smaller intensities than the denervated muscle of 
interest. The limb movement resulting from their contraction as the intensity was further increased, 
precluded reliable detection of the minimal contraction of the denervated muscle.
4.5.9 Contraction Response
At each visit the contraction response to the chosen stimulation parameters was evaluated 
subjectively by the researcher in terms of its strength, the location and proportion of the perceived 
muscle volume recruited and the extent of any fatigue. Contraction response was also recorded on 
video tape with the corresponding stimulation parameters. As isotonic contractions became 
possible, this extended to assessment of the limb movement. For subjects EC and LE, this was from 
a seated position with the knee swinging freely, the projected linear movement of the foot with 
respect to a scale on the ground was recorded during stimulation of the quadriceps with a variety of 
parameters. For subject LR, dorsiflexion angle was assessed. The contraction force and torque 
exerted by the limb movement, was not sufficient for measurement on the available rigs at SDH 
MPBE.
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4.5.10 Functional Measures
For subject LR, where the purpose of the treatment was to compensate for absent dorsiflexion 
function, the Physiological Cost Index (PCI) was measured as an indication of the energy 
consumption of gait. As used for evaluation of indirect stimulation systems for 'dropped foot' 
[Burridge, Taylor et al. 1997], this involves the subject walking a set 10m distance at their normal 
pace, which is timed and the final heart rate measured by a chest worn Polar monitor with respect 
to a resting heart rate previously measured after at least 3min of silent seated rest. The mean PCI 
(Eqn.5.5.3) from 3 such walks is calculated.
Equation 4.5.3 PCI (bt/m) = change in heart rate (bt/min)
walking speed (m/min)
For subject LR in this study, PCI was only measured without stimulation.
4.5.11 Subject Questionnaire
Within the first week after completion of the treatment period, subjects were asked to complete a 
questionnaire {Appendix H). Subjects were requested to identify what changes, if any, they thought 
had occurred in a number of aspects, both during the stimulation session (Qu.l9) and in their 
general condition from the start of the study (Qu.20). This was to compare any quantifiable 
changes in the evaluation measures to the subjects' own perception of treatment effects. Subjects 
were also questioned about their aspirations of benefits from the treatment, whether these had been 
fulfilled and whether they would like to continue with it, if it were available to them. At evaluation 
visits during the follow-up period, subjects were asked verbally about any perceived changes in 
their condition (Qu.20) with respect to during the treatment period and before its start. At the end 
of the follow-up period, subjects were once again asked about their expectations and overall 
opinion of the treatment.
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5. S t i m u l a t o r  U n i t  D e v e l o p m e n t
This chapter describes the development of a versatile stimulator unit for the direct electrical 
stimulation of denervated muscle by surface electrodes to achieve the research objectives outlined 
(§4). Its specification allows for a wide variation of stimulation parameters but with particular 
emphasis on the ability to generate long duration, biphasic stimulation pulses, which have proved 
of benefit in the recent studies (§3.4.2). The flexibility of output is required to allow investigation 
of the physiological effects of various stimulation patterns and to permit Strength-Duration curve 
and accommodation testing (§2.4.4).
5.1 Stimulator Unit Specification
As the stimulation evaluation study envisaged involves several months of operation away from 
clinical environment and personnel, the device is required to be portable and capable of safe 'stand­
alone' operation by the user. It was therefore envisaged to be powered from internal rechargeable 
battery, which offers the additional advantage of inherent isolation from the mains supply. For use 
in the clinical environment the device was also required to interface with and operate under the 
control of a personal computer (PC). This was to permit operation of the device with stimulation 
parameters derived either directly 'on-line' from the PC when connected to it, or from those stored 
internally when operating independently from the PC. Controls on the stimulator unit accessible to 
the user were required to permit switching on/off, selection of the stimulation pattern mode (sets of 
parameters) and adjustment of stimulation intensity. The intensity control may alternatively be 
configured by the PC to control pulse width (PW) or inter-pulse interval (IPI). The stimulator was 
also required to monitor and store information on usage of the stimulator and from physiological 
transducers (e.g. gait detection foot switches) which can transferred to the PC.
From the review of previous studies and clinical experience at SDH, the following functional 
requirement specification for the unit and PC interface was compiled.
Stimulation operation
1.1) Two electrically isolated stimulation output channels, each with independently controllable 
stimulation parameters (defined as per Fig.3.2.Q over the following ranges
. 1 ) Pulse amplitude 0-150mA, 0-100V( 1 kQ), ripple variation <5%,
.2) Pulse width 1 - 1000ms, resolution 1ms for PW up to 100ms, 10ms thereafter
.3) Inter-pulse interval l-5000ms resolution: 1ms for IPI 0-250ms, 20ms for IPI >250
non-regular inter-pulse intervals (e.g. for multiple frequency or dehabitulation)
.4) Pulse train envelope 0-255s with 1 s resolution on/off periods 
.5) Session duration l-30min with resolution Imin
.6) Pulse type monophasic or biphasic (with separate parameters for each impulse)
.7) Pulse shape rectangular, triangular, trapezoidal, sawtooth pulse shape, linearity 5%
.8) Pulse rise/fall time O.l-lOOOms with resolution 0.1ms<10ms, 1ms thereafter
1.2) Operational endurance up to 1 hr/day 'Stand alone', mains free from internal supply
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1.3) PC programme and user interface to stimulator unit to allow 'on line' control of:
. 1 ) stimulation parameters (as per 1.1)
.2) parameter to be controlled by operator control (default to intensity)
.3) limit o f variation of parameter under operator control 
.4) stimulator output indication parameter
.5) enable/disable of audio stimulation indication (PC operation only )
.6) transfer from stimulator and analysis of usage/transducer data 
.7) definition of usage/transducer data to be stored by stimulator when in use 
.8) definition and transfer to stimulator of stimulation pattern modes (up to 10) for ‘stand alone 
use, each consisting of a set of the above parameters
1.4) non-volatile storage of stimulation parameters for up to 10 modes and usage/transducer data as
defined by PC or selected mode
Operator Controls -
2.1) ON/OFF switch - disables unit and stimulation output
2.2) Variability control of stimulator parameter for each channel (default to intensity)
- parameter selection and range of adjustment defined by PC or stored mode)
- to be inhibited when stimulation channel switched off
2.3) stimulation pattern mode selection (up to 10) for each channel
Indicators & Warnings
3.1) Visual indication of stimulation channel output related to pulse frequency, intensity, envelope
3.2) Audio indication as 3.1, enabled by PC, inhibited during 'stand alone' operation
3.3) Indication/display of stimulation parameter selected for external control
3.4) Audio and visual warning of the following, (prioritised and distinguishable)
. 1 ) adverse stimulation output or fault condition
.2) initialisation of unit or reset in use whence no stimulation output
.3) stimulation intensity set too high at initialisation
.4) low battery warning - visual and audio prior to and after output inhibited
.5) end of treatment session -audio & visual
External Connections
4.1) Serial interface to PC (mains isolation provided externally)
4.2) Serial interface to other stimulators (e.g. Inter IC for transfer of transducer data)
4.3) Digital stimulation timing signal for synchronisation of multiple stimulators
4.4) Stimulation electrodes -2 pairs
4.5) Transducer analogue signal inputs (4) and outputs (2)
4.6) Reference voltage output (5V) for transducers
4.7) External power supply input (>12V), mains isolated for stimulator operation
4.8) External battery charger input, using same connector as 4.4 to prevent stimulation operation
Safetv
5.1) Conform with relevant sections of BS 5724 Parts I and 2.10 (nerve and muscle stimulators)
5.2) Patient isolation with isolated stimulation outputs
- mains free 'stand alone' patient operation
- mains isolation of PC RS232 interface provided externally
- inhibition of stimulator output during battery charging
- enabling of stimulation output with external supply operation inaccessible home user
5.3) Protection against spurious stimulation output during;
- switch on and shut down
- low battery A^cc condition
- micro-controller failure
5.4) Limit of maximum amplitude and rate of rise of output current
5.5) Monitor of output current and voltage to detect electrode peeling
5.6) Limit on duration of stimulation session in case of patient falling asleep
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Packaging
6.1) Size <190x130x50 mm
6.2) Weight < 1kg
6.3) Cost <£500/unit
6.4) Portable & durable casing
6.5) Cosmetically acceptable appearance and ease of use of controls
The following additional requirements became apparent during the Failure Mode and Effects 
Analysis (FMEA) {Appendix M) into single fault failures as required by BS 5724 {Appendix L).
5.7) Limit or warn when pulse duty cycle exceeds 50% (i.e. (PW/(PW+IPI)>0.5)
5.8) Limit on the degree of asymmetry and therefore charge imbalance between biphasic impulses
5.9) Monitor and limit of the output current between pulses due to circuit failure
5.10) Protection against damage to operator or unit in case of output short or open circuit
5.2 Stimulator Unit Development and Design Outline
No suitable commercially manufactured device could be found, the majority being for stimulation 
of innervated muscle and do allow sufficient adjustment of parameters up to the levels required for 
denervated muscle. Those clinical models which do, were not considered suitable for ‘home based’ 
operation either in terms of portability or flexibility of pre-programming the stimulation pattern. 
Enquiries to centres involved in denervated muscle research studies revealed that custom made 
stimulators were used, but none were forth coming with a full specification or an offer of 
equipment for use in this study. Also, none of these units appear to meet all the specification 
requirements for this project without some adaptation and it was considered that the dependence 
upon another centre for technical support would be potentially time consuming and expensive.
It was therefore decided to produce an ‘in-house’ stimulator for the project drawing on the 
experience with existing stimulators in the department and having the advantage of potential 
commonality between stimulators for different purposes, especially in terms of the user interface, 
and embedded programmable controller. The CompustimlO, is a four-channel unit that was 
modified for a preliminary investigation of denervated muscle simulation at SDH [Taylor, Ewins at 
al. 1992] but would require extensive modification to fulfil the full specification of this project. In 
particular, the controller module is of older technology and less suitable for expansion, however the 
output power stage was eventually adopted for modification for this project (§5.4).
In common with existing stimulators produced in the department, the function but not the physical 
layout of the stimulator unit may be partitioned into three modules (Fig 5.2.1). The unit is based 
around a programmable Micro-Controller module (MCM §5.5), whose embedded programme 
generates the stimulation pattern and control signals necessary for the Output Power module (OPM 
§5.4) to produce the corresponding stimulation output. The stimulation parameters are defined by 
the clinician using a Personal Computer based User Interface (PCUI §5.6), and downloaded into 
the stimulator when connected. The serial communication also permits transmission o f other data
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as defined in the specification. The MCM also receives information from the operator controls 
(INTENSITY and MODE SELECT) and performs the output monitoring and warning indication functions. 
The Power Supply module (PSM §5.3) supplies power to the other modules as required.
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Figure 5.2.1 Functional Schematic of Stimulator
Monitoring of output current and voltage levels is included in the requirements for reasons of 
safety; to permit detection of failure of the stimulator, poor contact of the electrodes and break 
down of the tissue. Comparing the actual output with that desired and using the difference to 
dictate the output is known as closed loop feedback control. This permits more accurate control of 
the stimulation intensity throughout the long pulse widths of direct stimulation and the desired 
control of pulse rise and fall shape. It also compensates for differences in load impedance between 
stimulation sites and between patients. Closed loop control of the stimulation output was therefore 
incorporated into the unit specification, as it was deemed unlikely that output monitoring could be 
continuous throughout the pulse.
The effectiveness of muscle contraction induced by external stimulation is related to the current 
density in the tissue [Eichhom, Schubert et al. 1984], and it is arguably most appropriate to control the 
stimulation output using current feedback. However, should the patient load impedance increase for 
instance due to deterioration in electrode contact, then as the feedback attempts to maintain the 
output current constant, the current density in the tissue will increase, perhaps to dangerous levels. 
Conversely maintaining the output voltage constant with voltage feedback may result in excessive 
current and tissue bums should the load impedance decrease or the electrodes is too close together. 
Whether output current or voltage is used for the feedback control, it is important to monitor both 
to detect adverse conditions.
The stimulator therefore monitors output current and voltage and has the option of either type of 
feedback. Voltage feedback was implemented for initial development, as it was previously found 
superior to current feedback in terns of output ripple variation [Andijani 1992], though probably a 
consequence of the characteristic of the sensing device. The closed loop control is implemented by
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analogue circuitry in the OPM, as digital implementation in the MCM may not be sufficiently fast 
given the current consumption requirement limitation on controller frequency. The MCM does 
however receive the feedback signals, to retain this option and to perform the monitoring function.
Feasibility studies conducted into the choice of micro-controller device for the MCM and 
implementation of control software revealed the difficulty of achieving full independent control of 
two channels and it was decided to opt for a single channel unit for the initial clinical study. From 
these it would be concluded whether such flexibility of control, particularly of pulse rise and fall 
shape has clinical treatment value and should remain in the requirements for a future unit. Multiple 
channel stimulation can still be achieved by using additional single channel units with the option of 
synchronising outputs.
The completed unit is 170 x 150 x 60mm, weighs 1.2kg and contains two circuit boards, a re­
chargeable battery, interconnect wiring and connectors (Fig.5.2.2). The lower circuit board is 
constructed with prototype solderable strip-board and consists of the analogue circuitry of the OPM 
and PSM and all connections to the upper circuit board. The latter has the digital circuitry of the 
MCM and is constructed using Road-Runner® * inter pin soldered wire connections. The high 
voltage components of the OPM are physically segregated from other circuitry to minimise their 
electrical interference effect, with the opto-isolator devices forming a division on the board. 
Experiments with electrostatic screening of the output transformer, inductor and blocking diodes 
demonstrated no beneficial effect on the output quality. Magnetic screening was not considered 
practical given size restraints, however there is no evidence of interference o f the MCM operation.
xAi»i«.v o
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(open -  battery, lower circuit board, upper circuit board)
Figure 5.2.2 Subject Stimulation Equipment
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5.3 Power Supply Module (PSM)
The function of this module is to provide power to the stimulator unit circuits either from the 
internal re-chargeable battery or a mains isolated external source, though the latter is only to be 
possible in the clinical environment. Appropriate buffering and smoothing is incorporated to 
accommodate any voltage drop due to current flow especially during generation of stimulation 
pulses. The supply voltages generated are;
Vp +12-14V pulse transformer primary supply
Ve +12V power stage supply
Vcc +5 V micro-controller module supply
Vref +5V reference supplies for external transducers
Warning is given for the loss of any supply and the unit rendered safe. Fuse protection is provided
in the case of excess current flow due to component failure or misuse.
5.3.1 Internal Battery Supply and Charger
The battery capacity (>lAhr) is based on a requirement for at least 1 hour operation per day at 50% 
stimulation duty cycle (100mA, lOOV output) and assuming 12 hour over night charging of the 
battery. A Dryfit  ^ A500 12V 1.2AHr lead acid cell was selected as this provides the required 
capacity with the convenience of a compact (approximately 50x50x100mm), single package. With 
a maximum discharge current rating of 40A, the lead acid cell was also considered most suitable to 
supply the large peaks of current required by the OPM circuit. The battery gel electrode allows 
charging and discharging in any orientation without leakage, though venting of the unit casing is 
necessary.
A commercial Lawtronics  ^ SLA480MU mains powered battery charger is used which provides 
indication of continuing and completed charging conditions. This is connected to the battery, 
without requiring its removal from the unit, via the same external connector (S3-Fig.5.3.1) used for 
the stimulator electrodes. This prevents stimulator operation whilst charging and isolation of the 
circuit modules from the battery due to the absence of the interconnection link fitted in the 
electrode connector. The unit may also be powered from an external supply via the appropriate pins 
of connector S3.
5.3.2 Supply Voltage Regulation
All current from the battery to the stimulator passes through a 5A quick blow protection fuse 
(Fig.5.3.2), and the operator controlled ON/OFF switch, integral with the operator STIMULATION 
INTENSITY control which therefore inherently prevents stimulator output with the unit switched off 
(Fig.5.3.1).
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The Vp (+12V) supply is derived directly from the battery and supplies only the OPM transformer 
primary current, which in normal operation may have a sub-pulse peak value of 20A and average 
value at 50% pulse duty cycle of lA. Capacitor C9 supplies some of the current during sub-pulse 
conduction, but is only able to maintain voltage for short duration pulses. It also reduces 
oscillations at primary FET gate voltage at switch on (Fig 5.4.4) and so is mounted as close as 
possible to the transformer (Trl) and FET (Q3) (Fig.5.4.2a), with its negative terminal adopted as 
the zero volt equipotential (single common ground point) for all the low voltage circuitry.
Ve supplies the remainder of the 12V circuitry of the OPM and Vcc with normal quiescent 
consumption up to 36mA, but dependent on stimulation pattern. CIO provides sub-pulse smoothing 
and diode D4 prevents it from discharging into the lower impedance primary circuit. The values of 
C9 and CIO (lOOOpF) are a compromise between their physical size and the acceptable voltage 
variation.
Vcc (+5V) is produced from the Ve supply by a constant voltage regulator (U9) and supplies the 
MCM and circuitry of the OPM. The 250mA capacity Maxim MAX 667 device is used because of 
its low quiescent power consumption (20pA), low voltage drop between input and output (150mV) 
and low drop-out voltage, (the minimum input voltage before the 5v output is effected). Capacitor 
C ll  provides voltage smoothing and individual ‘de-coupling’ capacitors are fitted across the 
supply pins of each IC device in the circuit.
5.3.3 Power Supply Monitoring
The regulator U9, also includes a comparator monitor, the output of which (LBO) is set low, when 
its input (LBI) decreases below 1.225V. Resistors R42 and R43 are selected to generate this 
warning (PWDN) to the MCM when Ve falls below 7V, otherwise it is pulled high by R44. This 
indicates failure of Ve or that the battery is significantly depleted, such that the micro-controller 
should save data before Vcc is affected and corruption occurs. Vcc is monitored by the MCM 
Watchdog monitor (MCM/U7), which resets the controller if  Vcc falls below 4.5V. Voltage Vp, 
scaled by potential divider (R45/R46) is supplied as an MCM analogue input (AnPwr) and 
monitored by the micro-controller at each stimulation pulse to warn of battery depletion. When Vp 
reaches a certain threshold, the stimulation output is inhibited with a continuous warning and this 
level is chosen to allow battery recharging overnight (§5.5).
^5.3 Stim ulator Power Supply Module 5-8
'as
SS.SSS,
O 0 O 0 o o o d o o o o o o â
firfn
/7 —T
Figure 5.3.1 Stimulator Unit Interconnect wiring diagram
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5.4 Output Power Module (OPM)
The function of this module is to produce the stimulation output pattern in response to the pulse 
amplitude demand and timing signals from the MCM, within the specified range of stimulation 
parameter values (§5.1). This is essentially a task of dc to dc conversion, from the low voltage 
demand signals into the high voltage stimulation output. It is also required to provide monitoring of 
the output current and voltage to the MCM.
5.4.1 Alternative Design Concepts for OPM
The feasibility o f a number of alternative designs was considered to perform the OPM functions. A 
transformer is the conventional means of voltage conversion and provides inherent output isolation, 
however it is optimised for alternating currents waveforms.
a) Commercial dc-dc converter modules
The commercially available miniature dc-dc converters are of insufficient power rating for this 
application and unlikely to be suitable for the repeated pulse operation and fine control of pulse 
shape, especially if connected in parallel to increase output current.
b) Pulsed transformer technique
Current is passed directly through a transformer primary coil for the duration of the stimulation 
pulse and the output voltage is sustained so long as the primary current continues to increase, 
limited by flux saturation of the transformer core. However the size of transformer required to 
sustain the longer pulse widths for denervated stimulation would be probably be prohibitively 
large with typically used materials. The technique is also less amenable to fine control of pulse 
shape or amplitude control as is dependent upon the magnetising characteristic of the core. 
Demagnetising of the core between pulses would be essential to avoid saturation and limitation 
of pulse duty cycle, though this may be possible with bi-directional control of the primary 
current to generate biphasic pulses.
c) Switched Mode Power Supplv (SWPS) techniques
This problem of transformer core magnetic saturation may be avoided by discontinuous pulses 
of current, allowing de-magnetisation in between. As the duration of continuous primary current 
is much reduced, then so is the core magnetic capacity required to avoid saturation and the 
transformer size, which is dictated by the frequency of the sub-pulses. The secondary current 
must be smoothed by a filter to produce a continuous dc output for stimulation. The frequency 
of primary current switching should be much greater than that of the stimulation pulses to 
minimise the output ripple variation, however as switching losses are proportional to the power 
of frequency, loss of efficiency and heatsink requirements can negate the advantages of
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frequency increases above a certain level. This ‘switch-mode’ technique is commonly used in 
power supplies and is essentially one of pulse width modulation (PWM), the output amplitude is 
determined by the duration of the primary current sub-pulses (§5.4.2). The maximum output 
value is limited to when the sub-pulse width equals the switching period and the primary current 
becomes continuous or by core saturation if this occurs earlier. The arrangement for producing a 
‘step-up’ in voltage is known as a ‘Forward Converter’ [Mohan, Underland et al. 1989]. The 
primary current is required to be switched at a high rate for which Field Effect Transistor (FET) 
devices are typically used. However their switching characteristics introduce non-linearly and 
instability into the output control, which is only partly compensated for by closed loop output 
control (§5.4.4). The high frequency pulsed current can result in significant electro-magnetic 
interference (EMI).
d) Rectified Sine Wave Converter
The limitation imposed by core saturation with uni-polarity transformer primary current pulses 
can be avoided by using a symmetrical alternating current with zero average (d.c) value. The 
secondary current must then be rectified and smoothed in order to produce a d.c output for 
stimulation. This is most efficiently achieved by using sinusoidal primary current, as the single 
frequency allows optimisation of the transformer efficiency and minimises EMI. However, the 
advantage may be reduced because flow is continuous, albeit varying. A powerful dual polarity 
amplifier is required to supply the large transformer primary currents and its characteristics, 
including probable crossover distortion, may influence the stimulator output amplitude and 
quality.
e) Continuouslv Active High Voltage Rail
For both the forward and rectified sine-wave converters, where the primary switching waveform 
is modulated by the stimulation pulse pattern, there is an inherent compromise between a filter 
capable of producing a reasonably smooth output and its consequent limitation of the maximum 
rate of rise of the output pulse. This may be avoided if either circuit is employed to produce a 
constant, smoothed high voltage rail, from which the stimulation output pulse is obtained via a 
modulating switch or amplifier. This amplifier determines the pulse duration, rise/fall time and 
amplitude, under the control of the MCM and closed loop output feedback. The advantage this 
approach offers in terms of quality of output may be at the expense of reduced efficiency, 
though overall efficiency will be influenced by a number of factors. For instance, primary 
current is continuous, even without a stimulation output. The output controlling device must be 
rated for the higher voltages of the transformer secondary circuit and switching losses may be 
greater especially as it must accommodate any voltage difference between the rail and the 
output. A continuous active high voltage rail and large storage capacitors also have significant 
safety implications necessitating careful circuit monitoring. A compromise may therefore be to
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vary the rail voltage according to the maximum selected amplitude. With an approximately 
constant or slowly varying rail voltage, advantage can be taken of the 'soft-start' design 
techniques for improve efficiency, component stress and EMI emissions [Hnatek 1981; Billings 
1989]. The circuit is also more applicable for investigating the efficacy of pulse width rather 
than amplitude modulation of pulses to achieve the desired stimulation envelope.
Prototype circuits of the rectified sine-wave and forward converters were constructed for evaluation 
and highlighted their deficiencies as mentioned above. A comparison of primary current 
consumption revealed both circuits to be approximately 30% efficient. Although the sine-wave 
converter demonstrated superior smoothness and controllability at low output voltages, maximum 
output amplitude (70V) and pulse rise times were limited. This was attributed to the inadequacy of 
the amplifier supplying the primary current and further development would have been required to 
investigate performance with closed loop or digitally controlled gain. It was therefore decided to 
concentrate the limited development time available on the already proven forward converter 
design.
The Compustim 10 unit incorporates a forward converter power stage and the circuit has previously 
been reviewed [Andijani 1992]. The stimulation output has considerable ripple variation at the 
switching frequency and instability at low output voltages. These were largely attributed to 
coupling of the switching currents onto the feedback signal, and improvements were achieved by 
single point grounding and shielding. The design was adopted for this project and a number of 
modifications and component changes were incorporated to improve output ripple, controllability 
and accuracy, especially during long (> 100ms) and trapezoidal pulses and high pulse duty cycles. 
Failure tolerance was also improved and single fault 'fail-safe' operation was demonstrated (§5.7). 
The majority of applications of SMPS circuits are to provide a continuous output with 'soft-start' 
design techniques employed to limit output rise rate. However these were not evaluated for this 
application, as the requirement is to maximise the control over the output waveform.
The OPM consists of low voltage circuitry generating the variable duty cycle lOOkHz switching 
waveform (§5.4.2) for the switch controlling the current through the transformer primary (§5.4.3), a 
filter to smooth the high voltage secondary output (§5.4.4) and an 'H-bridge' switching network to 
produce the biphasic stimulation output (§5.4.6) which is monitored and fedback to low voltage 
circuitry for closed loop control of the output (§5.4.5). This section concentrates on the 
modifications to the Compustim circuit as the basis of its operation is described elsewhere [Mohan, 
Underland et al. 1989].
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5.4.2 PWM Switching Waveform Generation
The sub-pulses of current through the transformer primary required for forward converter operation 
are achieved using a FET switch (§5.4.4) and the duration of the conduction period determines the 
level of output voltage. The control signal for this switch consists of a series of regular pulses, 
whose duration are proportional to the desired final output. Although this switching waveform may 
be generated directly by the MCM it is unlikely to be able to this and the necessary closed loop 
control, without excessive power consumption due to high processor speed. The primary switching 
waveform is therefore produced with analogue circuitry by comparing a continuous demand signal 
of amplitude proportional to the desired final output, with that of a regular waveform at the sub­
pulse switching frequency. In this circuit, a sawtooth shape was used, although triangular or 
sinusoidal waveforms were also evaluated. The comparator output is high, to close the primary 
current switch, whenever the demand signal amplitude exceeds that of the switching waveform. 
The proportion of time for which the switch is closed and when primary conduction occurs is 
referred to as delta (5), the peak primary current during the sub-pulses and therefore the final 
output amplitude increase with 5.
VsAWTOOTH
V error
VcOMPARATOR
ONOFF OFFON ONON
/C o r e
saturation
Continuous conduction
Figure 5.4.3 PWM Switching Waveform Generation and Primary Current
In this circuit (Fig.5.4.2.a), closed loop control of the output is achieved by the PWM comparison 
being performed on an error signal (V error) from a differential amplifier (UID), proportional to 
the difference between the demand signal from the MCM (V demand)  and a scaled version of the 
output voltage or current (V feedback)- The lOOkHz sawtooth switching waveform is generated by a 
separate oscillator circuit based on a standard 555 timer device (U3) [Pippenger, Tobaben 1985]. 
External components determine the waveform frequency, with circuit layout chosen to minimise 
interconnection distance and parasitic capacitance. These functions are also available in a standard 
SMPS integrated circuit device [Andijani 1992], but this did not provide the level o f control and 
fault monitoring required for this application.
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This PWM circuitry is supplied by the regulated Vcc supply for direct compatibility with the MCM 
and for isolation from the variations in Vp and Ve during stimulation pulses and with battery 
depletion. If the supply voltage to the switching waveform generator circuit is allowed to decrease, 
then so does the maximum amplitude of the waveform, thereby increasing toN and the stimulator 
output for a given V error level. I f  toN increases such that 5 =1, then primary conduction becomes 
continuous and the circuit acts like a pulsed transformer. In this condition, after an initial output 
peak, the transformer core becomes saturated and the secondary output collapses to zero as the 
power source is unable to supply the high primary current. The maximum voltage of the sawtooth 
waveform is 3.2V and the differential amplifier gain is adjusted so that with feedback, V error is 
just less than this at the maximum output level. However this will not altogether prevent toN 
increase and continuous primary conduction. As the battery charge level decreases, so does the sub­
pulse peak primary current and the final output, the resulting decreased feedback, increases V error 
and toN for the same V demand- The output level corresponds only to the peak primary current 
occurring during the sub-pulse, which depends upon the subpulse duration and the battery charge 
level. Therefore, with operation from a depleting battery supply and feedback, there is no unique 
correspondence between the demand from the MCM (V demand)  and the sub-pulse duration (toN) or 
the final stimulator output level.
The maximum output level is therefore limited by the duration and amplitude of the primary 
current sub pulses but ultimately by saturation of the transformer core. The shape of the output 
stimulation pulse determines the point of maximum primary current and therefore of potential 
output collapse due to continuous conduction. The greater the demanded rate of rise of output, the 
greater the primary current flow to achieve it, and the lower the maximum output level before 
continuous conduction occurs. For instance, at the start of rectangular pulses the primary current 
has a rectangular form, due to the initial high current flow to charge up the capacitance of the 
output filter. Continuous primary conduction (6=1) was avoided by limiting the value of V error 
and 5 to 0.8, using the reverse breakdown conduction of a zener diode (D l) controlled by R5. The 
maximum output amplitude possible for rectangular pulses is thereby increased.
Continuous primary conduction (5=1) can also arise from a number of the modes of failure o f the 
sawtooth waveform generator which reduces its output level (Appendix M). Most significant are the 
failures causing the waveform output to be reduced to zero and thus below the level of the V error 
offset of UID (0.6V), when the demand is zero. This results in continuous primary conduction at 
all times, irrespective of the demanded pulse pattern and so the output must be monitored by the 
MCM during the off pulse period (§5.5.2). Although the stimulation output collapses in this 
instance, the switching FET power rating is exceeded with consequent device failure. To ensure 
reliable and instant detection of failure of the sawtooth waveform, its output is averaged by a high 
input impedance low pass filter (R18 and C6) of IkHz comer frequency and monitored by
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comparator U2A/B. Exceeding the sawtooth waveform monitor thresholds results in the PWM 
comparator output being clamped to OV, thereby switching off the primary FET switch and 
reducing the primary and secondary current to zero.
The stimulation output can be similarly inhibited by the enable/disable (E/D) control from the 
MCM via transistors Q5 andQ6, for instance, following detection of a fault or spurious output or 
micro-controller reset (§5.5.2). Inverter Q5 is powered from the Ve supply to ensure the output is 
inhibited when Vcc fails. Resistor R25 is included to ensure the inhibiting clamp is still applied in 
the case of spurious micro-controller operation causing the control lines to ‘float’ in neither a high 
or low state.
5.4.3 Primary Current Switching
A controllable switch is required to produce the pulses of transformer primary current, and a 
transistor is the obvious choice because of its speed of operation and high current rating. A metal 
oxide semiconductor field effect transistor (MOSFET) is chosen in preference to a bipolar because 
of its ease of control without biasing, greater operating range at high power dissipation and the 
absence of secondary breakdown effects. However a bipolar may have a more linear switching 
characteristic.
The IRF530 MOSFET '’[Int.Rectifier 1993] (Q3) used in the circuit has a maximum continuous 
current rating of 14A ( V d r a i n = 1 0 v o l t ,  T c a s e = 2 5 ° C )  and a pulsed current rating of 50A, providing the 
junction temperature is maintained below 175°C. Calculation of thermal conductivity predicted 
that, without any external heatsink attached, the device can tolerate an average current of 2A, and 
with the 21°C/W heatsink used in the circuit, a current of 3.3A continuously (Appendix N). This 
was demonstrated during fault testing of the circuit; a short circuit failure of the FET results in 
continuous primary current of 1OA until ceased by failure of the circuit fuse (FI).
The switching operation of the FET is dominated by its gate input capacitance 
(Ciss=670pF@Vds=25V), which consists of that between the gate and source (Cgs) and that 
between gate and drain (Cgd), but varies considerably with drain-source voltage (Vds) [Clemente 
1993; Pelly 1993]. The IF530, is an n-channel enhancement mode device, so the drain-source current 
flow (that through the transformer primary Ip) is determined by the magnitude of the positive gate 
voltage supply from the switching comparator. The gate threshold voltage (Vy = 3volts for IRF530) 
must be exceeded to establish the drain-source conducting channel and permit current flow. As the 
gate voltage is increased above the threshold, drain current increases and current also flows in to 
the gate to charge Cgs. Only when this is fully charged, at gate voltage of Vgsp (5-7volt for 
IRF530), is the drain-source channel established. However the drain voltage can only decrease at 
the rate at which Cgd is discharged by current flow into the gate, the so-called Miller effect. The
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gate voltage is held almost constant (at Vgsp) during this period, and the charge flow is in fact 
greater than when Cgs is charged. Only with Cgd fully discharged and drain voltage at its 
minimum is the device fully switched on and acts as a resistive channel. A maximum gate voltage 
greater than Vgsp is used to ensure the device remains fully switched on as drain conduction 
increases, and to increase the charging speed)[Clemente 1993; Pelly 1993]. When the transistor turns 
off at the end of the sub-pulses, then this process occurs in reverse with similar form to the gate 
voltage (Fig.5.4.4).
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Figure 5.4.4 Primary Current MOSFET Switching Characteristic (not to scale)
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Figure 5.4.5 Output Response to Linear Ramp Demand (not to scale)
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The switching characteristic of the MOSFET is reflected in a non-linear open loop output response 
to a linearly ramped demand (Fig.5.4.5). The sub-pulse duration (ton) of the switching waveform 
supplied to the gate increases as the demand amplitude increases. At low amplitudes, toN is 
insufficient for Vt or Vgsp to be reached and to fully charge Cgs, so minimal primary flow or final 
output occurs (ABC). Hence, after a delay compared to the demand, as toN progressively increases, 
so does the primary current and the final output voltage, but in a non-linear fashion (CD). A 
transition to a linear output response occurs (D) when toN is sufficient to fiilly discharge Cds 
allowing primary current to increase linearly and for the stimulation output to be proportional to 
toN.-
A high gain, high current capacity complementary push-pull gate drive circuit (Q l, Q2) was chosen 
to increase the rate of charging of the gate capacitance and thereby reduce the output voltage at 
which the transition occurs, to approximately 20V. This also serves to reduce the power dissipation 
in the MOSFET during the charging when both drain current and voltage are large. Increasing the 
closed loop voltage feedback gain by means of resistor R14 reduces the transition voltage level 
further. The initial delay until Vt is reached can not be eliminated entirely but results in a step of 
only a few volts. However, because they is no unique relationship between V d e m a n d  from the 
MCM and the stimulator output level (Vo) (§5.4.2), the FET switching characteristic cannot be 
compensated for by translating into a non-linear demand characteristic, as used in the Compustim 
lOB unit [Michael 1996].
With its load dominated by the secondary inductor, the transformer primary current (Ip) increases 
linearly during the sub-pulse (Fig.5.4.4), to 10mA for 100mA output current and up to 20A at the 
start of a rectangular pulse. However at the start of the sub-pulse, it is subject to considerable 
oscillation (~2MHz) of up to 5A, gradually decaying as the base level current increases, but 
extending beyond the period of MOSFET switch on. The amplitude and frequency of oscillation are 
affected by the output inductance and load resistance but particularly by the output capacitance, 
and is therefore attributed to its charging. Corresponding oscillations also occurred on the gate 
voltage and transformer secondary voltage. These were reduced by means of capacitor C9 
connected across the transformer primary supply and mounted as close as possible to the 
transformer and Q3. Further oscillations, but of higher frequency (28MHz) are measured following 
transistor switch off on the primary current, drain voltage and output current, the amplitude of 
which was increased by reduction in the switch off time.
The decay in primary current is opposed by the magnetic flux stored in the transformer inductance 
until de-magnetised. The rise in drain voltage due to this does not occur until after these 
oscillations have decayed away and reaches a peak of 55V on the primary side and greater than 
lOOOV on the secondary. This is blocked by diode D2, but the magnitude of the voltage 
necessitates a high current rating, heatsink mounting and limits the pulse duty cycle to 50% at
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100mA output current, to avoid thermal runaway breakdown and component failure. A 'free­
wheeling' diode across the transformer primary or a 'snubber' network connected to the FET drain is 
commonly employed to reduce this 'inductive kick' voltage peak. However these necessitated a 
very low reverse recovery time diode (< 100ns) in order to switch fast enough, and although 
reducing the amplitude of the voltage peak, increased its duration. Alternative methods of de­
magnetising the core include employing dual switching devices and diodes or the more usual, third 
transformer coil [Mohan, Underland et al. 1989]. However all these techniques involve returning 
current into the supply at potentially elevated voltages which is not suitable for the lead acid cell 
used, and therefore none were pursued further.
Resistor R8 serves to limit the amplitude of primary current, especially in failure case conditions 
and therefore protects the battery from short circuit. In normal operation it limits the high peak 
current at the start of pulses, and at high toN values, thereby avoiding output diode failure without 
greatly reducing the final stimulation output.
5.4.4 Secondary Output Circuit
During the MOSFET (Q3) on period (ton), the primary current increases linearly because of the 
inductive load, predominately that of the output filter. This changing current induces a flux into the 
transformer core and hence current flow in the secondary circuit. The series diode D2 permits 
circulation of the secondary current through the inductor to the load. At Q3 switch off, the primary 
current decays to zero opposed by the flux stored in the transformer inductance and causing a 
transitory peak in Q3 drain voltage. However diode D2 blocks any reverse current flow in the 
secondary winding with output current maintained by the magnetic flux in the output inductor (LI) 
through the shunt diode D3. The capacitor C7 maintains the output voltage approximately constant. 
The inductor current and stored magnetic flux change approximately linearly as the integral of the 
voltage across it and over a complete switching period has zero net value, so the input to output 
voltage ratio of the circuit is proportional to the switch duty ratio (8) and the transformer ratio 
(N1/N2) [Mohan, Underland et al. 1989]. The capacitor C7 is alternately charging and discharging 
during the switching period corresponding to the variation in inductor current, the ripple 
component of which flows through the capacitor and the average component through the load. At 
small values of ton, the flux in the secondary inductor may decay to zero during toFP so the inductor 
current becomes discontinuous, and the current to the load is supplied entirely by the capacitor.
The capacitor voltage and therefore the stimulator output varies with this charging cycle but this is 
minimised with the filter 'cut-off (-3dB) frequency (fc=l/27iLC) very much smaller than the 
switching frequency (fs). However, the charging and discharging periods of the capacitor C7, limits 
the minimum output pulse rise and fall times, and necessitates rapid discharge by the output clamp 
circuit for biphasic pulses (§5.4.6). With rectangular pulse shape, the initial charging of capacitor
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C l results in a peak in the output at the start of the pulse. With closed loop control of the output, 
this is compensated for by sense capacitor C8, which increases the initial feedback, thereby 
reducing the primary current, compared to purely resistive feedback. With the llm H  inductor of 
the Compustim 10 circuit, a value of C7=680nF (fc=1.8kHz) was found necessary to reduce the 
output ripple when operating with closed loop voltage feedback. Attempts to reduce the ripple by 
increasing the switching frequency from lOOkHz, were not persued as this would require re­
optimisation of the transformer and consequent delay in the project.
5.4.5 Output Monitoring and Feedback Control
A signal proportional to the magnitude of the output is derived to permit closed loop control of the 
output and monitoring by the MCM to protect the patient and the unit in the case of adverse output. 
Both output current and voltage are monitored by U4 and U5 respectively, whose opto-isolation 
ensures the necessary isolation of the output from the low voltage circuitry when it controls more 
than one output channel. As it is the output voltage that is used for the closed loop control, its 
sensing device is located after that of the output current. The output current measurement therefore 
includes that through the voltage sensing path (approximately 10mA). Reversing the order of these 
sensing elements would result in an error in the voltage measurement (approximately 1.5V).
The opto-isolators consist of an input sense diode, whose current optically controls the current 
through the output transistor. However due to the temperature sensitivity of the device, its output 
varies over a period of continuous conduction in respect to pulse width and frequency and 
introducing an error of up to 10%. Input-output characteristics also vary considerably between 
devices, which had to be individually matched to standardise the circuit and calibration. Scaling 
resistors R13 and R14 are chosen to allow output monitoring up to 350mA and 150V respectively 
to accommodate short circuit and open circuit conditions, before device saturation occurs. Resistor 
R9 limits the output current to approximately 600mA when the output leads are shorted circuited, 
which U4 can withstand for several seconds at least, permitting detection by the MCM. R14 also 
determines the closed loop feedback gain, which is set to minimise non-linearity in output due to 
the MOSFET Q3 switching characteristic and zener diode Dl conduction. The monitor signals are 
buffered and available at connector 811 (pin 5 V o m o n ,  pin6 I o m o n )  for external monitoring on an 
oscilloscope, though saturation of the buffer amplifiers (U1C,D) corresponds to approximately 
270mA and 90 V.
5.4.6 Biphasic Switching and Clamp of Stimulation Output
To achieve the biphasic output pulses, two impulses are generated in quick succession and an H - 
bridge arrangement of switches reverses the direction of current flow through the load between 
these pulses. The MCM provides the appropriate control signals to the switches (Fig.5.5.4) via opto-
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isolation to maintain isolation of the output. MOSFET based solid state switches (International 
Rectifier  ^PVR3301 U7 & U8) are used as these can withstand up to 300V and are controllable 
even with the output terminals floating. However it was found that for output voltages greater than 
approximately 32V, the switches failed to remain closed for the duration of the pulse, unless the 
secondary OV was connected either to the primary OV, or to an oscilloscope (even battery powered) 
or to the operator. It is assumed that this provides the necessary path for leakage currents and 
pending further investigation, the secondary and primary OV were connected by capacitor C l2, of
0.1 pF, the minimum value to obtain correct operation. Isolation of the secondary from the low 
voltage circuitry is no longer essential while only one channel is being controlled and because the 
device is inherently mains free during stimulation operation. The biphasic switch control circuitry 
is supplied from Vcc, so that in the case of its failure, which would also effect the MCM, the 
switches will open to inhibit any stimulation output. Power rating of the switch devices limits the 
stimulation output current to 150mA at 50% pulse duty cycle.
The large value of output capacitor (C7) limits the minimum fall time of a lOOV stimulation output 
pulse to 3.5ms, which is typically within the period for the following second impulse. To ensure the 
biphasic pulse switching occurs without delay and only when the output is at zero, thereby 
maintaining impulse symmetry, any residual charge on C l is discharged through resistors RIO and 
R12 via switch U6. A solid state opto-isolated controlled device is used as for the biphasic 
switching (PVR3301) with its two switches in parallel to reduce the current loading. However 
considerable difference in the speed and conducting resistance between the switches of the same 
device was consistently found and prevented effective current sharing, except in short circuit 
conditions. With a value of lOOQ for RIO and R12, the pulse fall time from lOOV is reduced to 
approximately 0.7ms and so the minimum inter-impulse interval used is 1ms. The output clamp 
switch is controlled by a logic signal (0/PClmp) from the MCM via Q7 and is held closed between 
biphasic impulses and after each pulse to allow discharge of the body capacitance. Inverter Q7 is 
supplied by Ve, so remains operational in the case of failure of Vcc and resistor R28 is included to 
operate the clamp switch, in the case of spurious, floating MCM signal.
With a patient equivalent 'dummy load' (0.5-5kQ resistor in parallel with lOOnF capacitor), the 
OPM circuit has been demonstrated to produce satisfactory biphasic output up to 95V (IkQ  load) 
and 150mA for pulse widths from 0.3ms to 3s at 50% pulse duty cycle, with controllability of pulse 
rise and fall times to 0.5ms, linearity for ramped demand within 10% and current ripple of 12.
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5.5 Micro Controller Module (MCM)
The main functionality of the MCM is provided by the embedded software of its programmable 
micro-controller device, and also operates in conjunction with the User Interface programme of the 
Personal Computer (PCUI) (§5.6) via the serial data connection, to allow changes to the stimulation 
parameters. Following in this section are brief details of both the MCM circuit (§5.5.1) and the 
embedded controller software (§5.5.2). These were designed 'in-house' in the department in 
accordance with the core requirements specified by the author, who also performed the conceptual 
design and all verification and validation testing on the unit. Additional software requirements were 
introduced and incorporated as a result of the Failure Mode and Effects Analysis (Appendix M).
5.5.1 MCM Hardware Circuit
The MCM is a general-purpose micro-controller based circuit for the processing and synthesis of 
signals from various sources with stored data and was originally intended to form a generic 
controller module suitable for a wide range of stimulator applications. A number of ‘state of the art 
micro-controller devices were considered with the intention of fulfilling the specification with a 
single integrated circuit, however this introduced the difficulty of ensuring regular communication 
with the PC for transfer of stimulation and monitored parameters. Especially, as it was desired to 
maintain a common PC serial communication format with existing stimulators produced by the 
group, which transmit data asynchronously in blocks of 8 bytes and requires dedicated time periods 
of 20msec [Michael 1996]. Also, with the requirement for independent control of two stimulation 
channels, maintaining the amplitude demand to the 0PM  during long pulse rise or fall ramps may 
require the controller to operate at higher frequency and therefore increased current consumption or 
necessitate interrupting the stimulation pattern.
A number of alternative designs solutions were considered to avoid this compromise;
a) Separate controller devices for PC communication and stimulator output functions, with 
intervening Dual Ported Memory (RAM) device used for the transfer of data between them.
b) An autonomous external digital to analogue converter (DAC), capable of generating the ramped 
amplitude demands from rise time or rate information and avoiding the need for continual 
updating. Such as PWM control of an incremental DAC, however available devices or 
programmable logic arrays have high current consumption and discrete counter logic, many ICs.
c) Separate but simple micro-controllers for each channel connected in a bus structure to a master 
communication micro-controller with appropriate arbitration protocol.
d) Direct micro-controller generated 0PM  primary switching waveforms from the processor PWM 
output, however speed would have to be sufficient for the micro-controller to also perform the 
closed loop feedback summation with consequent increase in controller current consumption.
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Given these complications of providing continuous independent amplitude control of two 
stimulation channels with trapezoidal shaped pulses, it was decided to construct a single channel 
unit to allow the initial clinical investigations to be performed (§4), which may establish whether 
these functions are indeed necessary for the clinical treatment. This resulted in a much reduced 
MCM specification for which the Arizona Microchip  ^ PIC 16C73 micro-controller was selected, 
because it provides many of the desired functions in a compact package (28pin) with low operating 
current consumption. With only a single channel to control, direct parallel output to an external 
DAC is possible and serial access to external memory is adequate. The completed single MCM 
board is a general purpose micro-controller circuit based around the PIC 16C73A device (U12) 
with external non-volatile Electrically Erasable Programmable Read Only Memory 
(EEPR0M)(U13), serial RS232 communication, analogue and digital Input/Output connections 
(I/O), audio and visual indications and warnings and various supervisory features (Fig.5.5.1, 5.5.2).
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Serial communication (RS232 standard 19k baud rate) to the PC and User Interface is 
accomplished by specially configured pins of the micro-controller device and line-driver device 
(U ll)  to boost signal levels. Other digital signals emanate from the 8 bit port RB of the micro­
controller and are arranged into a data bus, with selectable 8 bit latches for input (U9) and output 
(U8 and UlO). The timing signals (0/P Bph, Cph, Clmp) associated with the stimulation output are 
generated by the micro-controller and output to the 0PM  synchronised to the required analogue 
stimulation pulse demand ( V d e m a n d ) -  The Mode Selector switch position is read in ( M O D E  1 - 4 )  and 
output lines control the front panel indicator light emitting diodes (LEDs) and audio buzzer. 
Unallocated I/O (digital D05,6, DI4-7 analogue AI5-6, AOl) is also connected via connector 
P6/S6 and the 0PM  board to connector SI 1 for possible external monitoring or signal input.
Analogue outputs from the MCM are generated by a dual 8 bit digital to analogue converter (DAC) 
(U2) connected to the data bus and associated amplifiers (part U l). One channel provides the 
instantaneous stimulation intensity demand ( V d e m a n d )  to the OPM and therefore defines the 
stimulation pulse and envelope shape and timing. Signals proportional to the output current ( I o f / b )  
and voltage ( V o f / b )  and the OPM sawtooth waveform (VstMON) are fedback to the micro-controller 
analogue to digital converter (ADC) via an 8 to 1 channel analogue multiplexer (U3). The value of 
the front panel intensity control is also input to the controller by this means, with a 'pull down' 
resistor to D g n d  (OPM/R48) to ensure zero value in the case of loss of Vcc supply to the control 
potentiometer. From MCM software version R l, the analogue output channel B is the stimulation 
intensity envelope, for display to the user on an analogue meter connected to SI l/pin8.
The PIC 16C73A micro-controller includes 4k (xl4bit) of 'on board' Electrically Programmable 
Read Only Memory (EPROM), in which is stored the unit programme and the set of default 
stimulation parameters. User programmable, non volatile storage for up to 10 sets (modes) of 
stimulation parameters and the unit usage data is provided by 2k byte of Electrically Erasable 
Programmable Read Only Memory (EEPROM) (U3). Data transmission to this device is performed 
serially using the micro-controller device pins specially configured for such Inter-Integrated Circuit 
(I^C) communication.
The logic signals to select or control the various circuit devices at the appropriate times, are 
generated by U6 and U5 derived from signals from the micro-controller. This includes the E/D 
signal to enable or disable the stimulation output from the OPM. A Watchdog monitor (U7) resets 
the micro-controller in the event of the Vcc supply falling below 4.5V, the reset button being 
pressed or the micro-controller failing to provide the strobe signal within the specified 1200ms time 
interval, indicating the controller programme has stopped operating correctly. On reset the E/D 
signal is set low to disable the OPM stimulation output, and is only enabled again when the micro­
controller successfully performs its initialisation routine.
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The circuit operates from Vcc supply, with -5V generated by device U4 for the DAC and 
associated amplifiers. Separate Vcc and OV connections are provided for analogue ( + 5 V a n , A g n d )  
and digital ( V c c , D g n d )  circuits, with the Vcc regulator on the OPM board (0PM/U9) acting as the 
common ground point.
5.5.2 MCM Software Programme
The MCM software is operated by the PIC 16C73A micro-controller device (U12) and is stored 
within its programme memory. The programme has been written in the PIC mnemonic assembler 
language, complied into machine code and tested using an in-circuit emulator system, before 
downloading into the device. The device is operated at 3.579MHz (derived from Crystal XI) to 
minimise current consumption, the machine cycle is therefore approximately 1.1 ps. The 
programme is synchronised by means of regular interrupts generated by one of the device Timer- 
counters. The interval between interrupts is specified via the PCUI (§5.6), to allow flexibility in the 
stimulation pattern. As only one stimulation pulse is generated in each interrupt cycle, this allows 
stimulation frequencies of up to 182Hz.
Upon occurrence of an interrupt, the programme performs a sequence of operations, known as the 
interrupt service routine (ISR)(Fig.5.5.3), some of which is dependant on the status of a number of 
flag parameters which are set by appropriately by corresponding events. These flags also determine 
the priority given to performing the various programme tasks as follows;
1. safety monitoring and warning,
2. saving usage data to EEPROM and closing down,
3. generating stimulation pulse
4. serial communication to PC.
In addition, frequently performed tasks use subroutines such as;
• stim-fail - provides appropriate warning indication/buzzer and includes shut down
• RS232 - serial communication to PC
• analogue input - read in the value o f an analogue channel and convert to digital
• analogue output - output a value and convert (using the DAC) an analogue channel
• digital input/output - using the port RB data bus and selected digital latch
• EEPROM - read or write to serial memory
At switch on, an initialisation routine is performed which configures the micro-controller registers 
and stack pointer, sets the stimulation output to zero, loads in the stimulation parameters of the 
default or selected mode, enables the stimulation output and produces a continuous warning if the 
intensity control is above zero.
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Figure 5.5.3 MCM Controller Interrupt Service Routine (see Fig.5.5.4 for definitions)
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Figure 5.5.4 Stimulation Pulse Segments and Biphasic Switching Waveforms
Safety Monitoring and Warning
The stimulation output current (lo) and primary voltage (Vp) are monitored on a number of 
occasions during the generation of the stimulation pulse (Fig.5.5.3) corresponding to some of the 
defined points (Fig.5.5.4). This involves sampling the analogue input channels I o f / b  and AnPwr 
respectively, by means of the analogue input sub-routine. The output current is monitored at a to 
check for any fault causing continuous stimulation output. The output current is also monitored at c 
and g to ensure the maximum specified value is not exceeded in each half of the biphasic pulse and 
then both are compared to ensure approximate pulse symmetry and therefore charge balancing. The 
output current is not sampled at b, because of the transient current peak that occurs with 
rectangular shaped pulses as the body capacitance is charged. Vp is monitored to warn of the 
impending (intermittent warning) or immediate (continuous warning) need for battery charging. 
Stimulation can continue during the former, but output is inhibited in the case of the latter. 
Thresholds typically correspond to 11.OV and 10.5V respectively, which permits the battery to be 
fully recharged in the typical, 12 hour overnight charging period. Although the battery voltage at 
both a and g are sampled, the former is used for monitoring as the latter is considerably lower 
because of the current flow during the pulse. A count of the duration of the current stimulation in 
seconds and minutes is maintained and monitored for the end of the specified session length.
The warning threshold of each of the monitored parameters is specified by the 'Fault Levels' User 
Interface screen (§5.6) and when exceeded, a corresponding warning fail-flag is set and the sub­
routine 'stim fail' is called. This sub-routine performs the following tasks;
I. sets the stimulation output to zero by clearing the analogue output (DAC) value
II. updates the usage statistic values (total usage time and number of uses)
III. saves the updated usage statistics to the EEPROM,
IV. operates the indicator and audio warnings according to the fail-flag set (Tab.5.5.1)
V. repetitive loop to strobe the watchdog monitor to prevent a micro-controller reset
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Items II and III are included, as this sub-routine is also entered when the unit is switched off, when 
the declining primary voltage is detected.
Fail
flag Warning Meaning
OPM
output LED Indicator warning Audio warning
A lo a > continuous current limit Disabled Fault (continuous) Continuous
B lo c>  max. current limit D
G 1 lo c- lo g 1 > asymmetry limit D
R Intensity or Intensity rate > limit D - " .
S Tsession = session limit D Fault (flashing) Intermittent
T1 Vp at a < upper limit Enabled Battery low (flashing) Intermittent
T2 Vp at a < lower limit D Battery low (continuous) Continuous
Table 5.5.1 Stimulator Operating and Failure Warnings
Stimulation Pulse Generation
At any moment, the instantaneous stimulation intensity required is output from the MCM to the 
OPM as an analogue value ( V d e m a n d )  by DAC channel A and derived from an 8  bit value from the 
controller. The resolution of output intensity control is therefore approximately 1mA. Throughout 
the stimulation pulse, the intensity value output to the DAC is updated at regular intervals by a 
programme loop performed repeatedly. This loop incorporates a 16 bit software counter 
decremented to zero to produce a known delay (Fig.5.5.3). During the first pulse, the B-phase 
switches conduct, then the switching signals are reversed during the inter-impulse interval so C- 
phase conducts during the second pulse. The output clamp path is connected at the end of each 
pulse to discharge the output capacitance (0PM/C7) and reduce the voltage across the switches, 
before switching occms.(§5.4.6). A 1ms switch settling time is also incorporated. The C-phase and 
output clamp remain connected during the pulse-off period to allow the body to discharge into the 
stimulator (Fig.5.5.4). On completion of the second pulse and clamp interval, the programme sets 
the 'finish-pulse flag' and returns from the I SR. On return from the ISR, if a pulse has not been 
produced in that interrupt interval, the programme sends out the RS232 communication 
initialisation byte to the PC and awaits communication with it. If  this is not completed before the 
next interrupt, it is abandoned. An interrupt can occur during a long pulse, however in the initial 
steps of the ISR, the 'finish-pulse' flag is checked to confirm this and after incrementing the usage 
statistics and checking the session time, the programme continues with the pulse generation 
(Fig.5.5.3). The stimulation envelope is also controlled by means of a flag checked at the start of 
each ISR and counters incremented at each ISR. Currently only rectangular shaped envelopes are 
possible.
Serial communication to PC
Serial communication with the PC is in accordance with the RS232 standard and in common with 
other stimulator units developed in the group [Michael 1996]. Data is transmitted in blocks of 8 
bytes, preceded by a command byte defining the data and type of transmission (TXD or RXD). The 
command byte is returned by the MCM before and after the data to confirm initialisation and the
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end of the transmission. The returned command byte is verified but no parity or other checking is 
included, as credit is taken for the correct receipt of data being checked by means of the PCUI 
(§5.6). Communication is performed by the MCM subroutine RS232, which is entered when an 
ISR is not required to generate a pulse. This sends out an initialisation byte to inform the PCUI it is 
available for communication. When wanting to communicate, the PCUI sends out the command 
byte, which is returned by the MCM, followed by the data block in the appropriate direction and 
then the confirmatory command byte. Each data block requires a minimum of 20ps to complete 
transmission and some PCUI communications require transmission of two such data blocks (§5.6). 
If  an interrupt occurs during a transmission, then it is abandoned and repeated by the PCUI in a 
subsequent interrupt interval. Hence for interrupt/stimulation frequencies of greater than 34Hz, 
PCUI communication can no longer be sustained, but this was not a limitation in this application.
EEPROM data saving
Access to the non-volatile memory is performed serially by sub-routine 'EEPROM'. The stimulator 
usage statistics (total usage time and number of uses) are saved to the respective memory locations 
at switch off as described above. These locations are cleared when a TXD STATS command is sent 
from the PCUI. The EEPROM is also accessed for retrieving stimulation parameters on initialisation 
or saving parameters and fault levels following the corresponding PCUI TXD[P] commands.
5.6 Personal Computer User Interface software package (PCUI)
The PCUI is written in National Instruments Lab VIEW  ^graphical programming language. This is 
orientated around a series of display screens, known as 'virtual instruments' (VI) as they mimic the 
appearance of conventional electronic instruments, with elements for input of operator variables 
(numerical dials, logical selectors and switches) and the display of output parameters (numerical, 
graphical and logical indicators). The programme coding is represented by a diagram of 
interconnections between these and other standard computational elements.
The PCUI consists of a series of nine screens, (example Fig. 5.6.1^, each selected by means of the 
Mode Select menu and performing one of the functions of the interface as follows;
RXD-STIM Displays the current stimulation parameters
RXD-Monitor Displays the monitored parameters (output current, voltage and Vp)
RXD-Fault levels Displays the current monitored parameters warning thresholds
RXD STATS Displays the current session and cumulative usage statistics
TXD[T]-STIM Enters stimulation parameters for temporary use, until switch off
TXD[P1-STIM Enters stimulation parameters for permanent storage
TXD[T]-Fault levels Enters monitored parameter thresholds for temporary use
TXD[P]-Fault levels Enters monitored parameter thresholds for permanent storage
TXD STATS Clears the current session and cumulative usage statistics
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Each of these modes involves communication with the stimulator MCM (§5.5.2), to either receive 
(RXD) or transmit (TXD) data. Transmitted data is either stored temporarily [T] in the micro­
controller memory or permanently [P] in the EEPROM, only the latter is retained after the unit is 
switched off. Definition of the parameters available for each mode are given in Appendix K, each 
consists of one 8 byte block of data for transmission, except for the SUM modes, which have two 
such blocks. The appropriate Communication Status Indicators indicate successful communication, 
though it is assumed that parameters transmitted to the stimulator using a TXD mode, will be 
verified by the corresponding RXD mode. The programme includes calculation of the intensity at 
which 50% pulse duty cycle occurs for the specified stimulation parameters. This is displayed on 
all mode screens and acts as a guide to the clinician, to minimise the risk of excess current flow 
into the patient, however the stimulation intensity itself is not limited.
o m n
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Mode Select 
^TXDlTj^M
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Figure 5.6.1 PC User Interface Screen for Transmitting Stimulation Data TXD[T]-STIM
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5.7 Unit Testing and Clinical Use
The completed unit design has been demonstrated to fulfil the majority of the specified 
requirements (§5.1) and be capable of producing a single channel of stimulation output under 
closed loop control within the following range of parameters;
.1) Pulse amplitude 0-15 0mA,max, 0-95V(lkQ load), ripple variation
.2) Pulse width 0.3 - 450ms rectangular pulses, resolution
Inter-impulse interval 1 - 25ms (i.e. between positive and negative impulses)
.3) Inter-pulse interval 5.5ms - 20s, fixed frequency 0.05 - 182Hz
.4) Pulse duty cycle 50% maximum at max intensity (PW/IPI+ PW)
.5) Pulse train envelop 0-255s with 1 s resolution on/off periods
.6) Session duration l-45min with resolution Imin
.7) Pulse type monophasic or symmetric biphasic impulses
.8) Pulse shape rectangular, triangular, trapezoidal pulse shape
.9) Pulse rise/fall time 750mA/ms to 2.3mA/s +/-10% (i.e. 0.04ms to 16s at 40mA)
Linear pulse rise/fall rate is maintained within 10% up to 90mA with slight differences in
calibration between units because of the individual characteristics of the feedback devices.
However during the initial 0-10mA region, the rate of increase is governed by the Q3 MOSFET
switching characteristic and has a minimum 166mA/ms (Fig.5.4.5), when the output amplitude is
also less controllable. With a patient equivalent 'dummy load' (0.5-5kQ resistor in parallel with
lOOnF capacitor), pulse amplitude remains within 1% of the stable value after the initial peak, for
the duration of even the longest pulses, providing the battery does not become depleted. However
in patient use, output ripple is approximately 20% and the amplitude can decrease at the end of
pulses (§5.7.2). With the battery low warning threshold at 10.5V, nearly 5 hours continuous
operation has been demonstrated with 25ms pulses at 20Hz and 50mA output. In typical clinical
use with twice daily 30-minute sessions twice a day, 7 days a week, battery recharging has only
been necessary, at most once a week. Quiescent current consumption is typically 35mA.
Non-compliance with the original requirement specification is in terms of the single output 
channel, a single stored stimulation pattern mode with only symmetrical impulses, operator control 
of intensity only, absence of audio stimulation indication and that interfacing with transducer input 
data await definition. As the indication of stimulation output is implemented in a single LED 
indicator, it was considered inappropriate to relate this to intensity (requirement 3.1) given the 
difficulty of identifying this at very low levels in bright lighting conditions. The function was in 
fact provided by an external meter connected to SI 1, when found necessary (§5.7.2).
5.7.1 Failure Conditions and BS 5724 Compliance
Compliance with the requirements of BS 5724 for medical devices and the particular requirements 
of Part 2.10 for stimulation devices are detailed in Appendix L. This requires the unit to operate in a
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fail-safe manner in the event of any single fault or failure mechanism. In this application 'fail-safe' 
is interpreted as inhibiting the stimulation output or reducing it to zero, with an unmistakable 
warning to the user, (continuous visual indication and audio warning). Short circuit and open 
circuit output conditions are not considered as failure conditions, the unit is rendered safe, but 
remains usable after resetting the warnings (i.e. without necessitating changing a fuse). As a result 
of a Failure Mode and Effects Analysis (FMEA) into all single fault and failure mechanisms, 
compliance with BS5724 has been demonstrated in each condition, taking credit for the safety 
features and monitors incorporated in to the unit {Appendix M). These also protect the user in case 
of misuse. Faults detected by the MCM result in a continuous red FAULT indicator and audio 
warning and inhibited stimulation output until the unit is switched off. The User Manual, instructs 
the user to do this and if the warning re-occurs on switching on again to inform the clinical team. 
The units were therefore considered safe to use in the clinical investigations. Suggestions for 
improvement of the design are given in §8.
5.7.2 Clinical Use
Six units for clinical use have been constructed and tested in accordance with a defined procedure. 
During the six months treatment period of the study, five of these units have been in daily use, 
including overseas, with no reports of failure, unexpected operation or battery replacement.
In the course of the clinical use, two modifications were incorporated into the MCM software. 
Software Version Rl enables a visual indication of the stimulation intensity envelope to be 
provided on an external meter connected to and mounted on S ll .  This was found necessary for 
treatment without visible contraction, which is usually used as the guide to the intensity for 
treatment. Software version R2 was produced for a particular subject, to initiate the stimulation 
envelope by an external switch connected to S ll  for synchronisation with the gait cycle..
Of particular concern with stimulation with long pulse is to minimise the risk of tissue damage 
arising from net charge transfer. Although the symmetry of biphasic pulses was established with a 
'dummy load' (of 0.3-3kQ in parallel with lOOnF), it was noted in clinical application that the 
current decreased over the course of the second impulse, though the resulting charge imbalance 
was less than 3%. At frequencies of greater than 30Hz, this effect occurred on both impulses. It is 
largely attributed to the electrodes, as also occurs when these are placed in contact separate from 
the skin. In the course of these investigations, it was noted that no discharge of the body in to the 
stimulator occurred after monophasic pulses, despite the clamp circuit and one phase of the 
biphasic switch pairs remaining closed. Also noted, was that for inter-impulse intervals of less than 
1ms, the incomplete discharge of the output capacitor 0PM/C7, results in its discharge into the 
patient.
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Figure 5.7.1 LPSTlMl 0 Unit in Use for stimulation of Tibialis Anterior of Subject LR
(with rear mounted stimulation current display meter)
1. RoadRunner - available from Farnell Components Ltd. Canal Rd, Leeds, LSI2 2TU, UK
2. Manufactured by Sonnenschein, available from CMP Batteries Ltd, 14 Gunnels Wood Park, 
Stevenage, Herts, SGI 2BH UK. Telephone +44(0)1483 359090
3. Lawtronics Ltd. Unit 8, Enterprise Way, Edenbridge, Kent TN8 6HF, UK.
4. International Rectifier, Hurst Green, Oxted, Surrey, RH8 9BB UK. Tel. +44(0)0883 714234
5. Arizona Microchip Technology Ltd, Unit 3, The Courtyard, Meadow Bank, Furlong Road, 
Bourne End, Bucks SL8 5AJ UK. TEL.+44(0)1628 850177
6. National Instruments Corp.(UK) Ltd. 21 Kingfisher Court, Hambridge Rd. Newbmy, Berks, 
RG14 5SJ UK.Tel.+44(0)1635 523545
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6. St u d y  R e su l t s
6.1 General Study Observations
Some general comments are made about observations from the study treatment before detailing 
those for each subject individually. The 3 SCI subjects are presented first with treatment of the 
quadriceps; LC and LD with near complete bilateral denervation, for whom rectangular shaped 
stimulation pulses were employed and LE with greater residual innervation and for whom 
trapezoidal shaped pulses were used initially. Following is subject LB with partial arm denervation 
arising from unilateral brachial plexus lesion, for whom the triceps was treated. Finally, subject LR 
with unilateral lower motor neurone damage 'dropped foot' condition but otherwise normal lower 
limb innervation, and for whom the desired treatment outcome is largely functional. Measurements 
of subject LD have not been analysed, as treatment was interrupted by illness and periods in 
hospital leading to cessation of treatment at week 17, however comments on the response to 
treatment are given.
6.1.1 Subject Compliance and Motivation
The stimulator unit usage data log and observation of the tissue indicated that all subjects 
completed treatment according to the protocol on the selected muscle only, some with breaks due 
to skin problems and illness, as detailed. All found the stimulation equipment and protocol 
convenient and did not suggest any changes; setting up took between 2 and 5min. Similarly all 
have attended SDH regularly for the evaluation measurements.
From subject comments during the evaluation visits and from the questionnaire at the end of the 
treatment period, all the subjects remain enthusiastic about the treatment, and consider it to have 
been of overall benefit. Not least was the psychological benefit all felt from participating in an 
activity which brought visible movement to their paralysed limb or muscle and which they 
considered was improving their condition, when no other treatment was available to them. In 
particular, subject LB benefited from restoration of voluntary control of part of the triceps, 
although not functional use. The subject also reported increased ease of motion o f passive wrist and 
finger joints with a release of muscle tightness and increased sensory perception of the upper arm, 
which 'feels more normal’. Subject LC also reported greater sensation in the lower limbs and 
abdomen from the start of treatment, with the highly important benefit of the ability to reliably 
detect full bowel.
All subjects (though to a lesser extent LR) said they would like to continue with the treatment and 
stated that the 6 months period was too short. Subject expectation from the treatment is realistic;
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improvement in tissue bulk and/or temperature being the primary objectives, with restored function 
remaining an ultimate hope for LC and LD through standing and for LB some voluntary arm 
movement. Functional restoration had always been the primary objective for subject LR. Subject 
LE primarily hoped for increased sensation, even though it was explained that further reinnervation 
is highly unlikely.
6.1.2 Contraction Response
Treatment started with low frequency (0.5Hz) twitch contractions with rectangular pulses of 100- 
150ms width (unless trapezoidal pulses are used), though no visible contraction occurred initially 
with subject LR. The muscle response, effect of electrode position and sensation were found to 
alter in the first weeks of treatment, so attempts at their rigorous optimisation at this stage are not 
thought worthwhile. The strength and endurance of contraction and excitability of the muscle (in 
terms of pulse width) progressively increased allowing a reduction in pulse width and increase in 
frequency and session length. Except for subject LR, once reasonable twitch contractions with 
40ms were achieved (LB-wk6, LC,LD-wk7, LE-wk8), then tetanic contractions at lOHz were 
performed. Initially these were localised to between the electrodes (especially distal), with more 
peripheral areas of the muscle ‘quivering’ in non fused contraction (e.g.vastus medialis of the 
quadriceps). In these cases, the twitch contractions are continued until the tetanic response 
improved. Progression to smoother tetanic contractions at 10-20Hz was possible for all subjects, 
eventually; (LB-wk6, LC-wk7,LD-wk 10, LE-wk 12, LR-wk44).
Trapezoidal (almost triangular) shaped pulses with gradual increase in stimulation intensity were 
used with subjects LB, LE and LR, to reduce and sometimes eliminated recruitment of innervated 
muscle in the same limb. This was possible providing the ramp rate was less than approximately 
0.67mA/ms (i.e. ramp duration greater than 50ms at typical treatment intensities). These long ramp 
times result in pulse widths of up to 400ms, and the two impulses of the biphasic pulses produce 
distinct ‘double-let’ contractions. Recruitment of functioning sensory fibres was also reduced but 
not eliminated with these pulses. Muscle fibre excitability altered with the trapezoidal pulses, in a 
similar manner as with rectangular pulses and tetanic contractions were achieved in a similar 
timescale for LE, compared to LC and LD. However, with the shorter pulse periods required for 
tetanic contractions, the ramp possible shows no appreciable reduction in motor nerve recruitment 
over rectangular pulses.
For most subjects, the contraction response took time to develop at the start of each session and 
was associated with a gradual increase in the output current, through a decrease in apparent skin 
impedance. This process occurred faster with tetanic contractions (LD) and response was 
immediate with the 0.3ms Microstim unit (§4.4.1) used by subject LB. The delay was also reduced 
by washing or wetting of the skin prior to treatment and keeping the electrodes clean and hydrated.
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It was not usually observed to a great extent at evaluation visits as the skin was hydrated by the 
water based ultrasound gel (§4.5.6), which is then washed off prior to stimulation, except with 
subject LR when the epidermis became hardened to a thin shiny film. Due to their condition, all of 
the subjects suffer from varying degrees of dryness and coldness of the skin in the treatment area 
resulting in high skin impedance. With subject LB, the muscle response decreased to almost 
nothing following sun-tanning. Consequent peeling of the dry skin and stimulation on the fresh 
skin produced a markedly greater contraction response, which in turn diminished after about 2 
weeks. Skin hydration was therefore monitored carefully, and moisturising agents used with 
caution (§4.4.2).
As expected the denervated muscle response was largely indifferent to electrode polarity, however, 
that of the co-contracted innervated muscle varied, and with subject LB appeared to respond more 
to positive going pulses. The level of sensation to the stimulation was reduced when only 
monophasic negative pulses were employed with subjects LB and LE.
6.1.3 Skin Reaction to Stimulation
Although the reaction of the skin to stimulation treatment varied between individuals and from day 
to day, it typically consisted of mild to moderate erythema, concentrated around the electrodes 
(Figure 6.1.1), which usually dispersed within one or two hours of the treatment session. Eyrthema 
was less severe with the larger area electrodes used by subject LC and generally decreased with 
isometric contractions as pulse width was reduced, (though skin dryness and hardening became a 
problem with some subjects LE and LR, as described later). At higher stimulation intensities, and 
especially with isotonic contractions when the tissue is stretched thinner, erythema was greater and 
very localised sweating occurred adjacent to the electrode and sometimes spreading to between the 
electrodes. This was of the form of a dampness of the skin or small area o f visible liquid rather than 
beads of sweat. Typically this was accompanied by 'goose-pimples’ on the skin surface, but again 
localised to between the electrodes. On these occasions, there were no symptoms of general 
autonomic dysreflexia, such as raised blood pressure, heart rate, or other observation of the subject.
O f particular concern was the isolated occurrence of what were assumed to be localised bums from 
excessive current density. With subject LC, this took the form of about 10 small dark red marks of 
approximately 1mm diameter in a semi-regular grid pattern at approximately 3-5mm spacing, 
located beneath the distal patella (positive) electrode and to a less extent beneath the proximal 
electrode following stimulation with 100ms pulses at 2.5Hz. At first glance, these had the 
appearance of small surface scabs, but on closer inspection were thought to extend deeper into the 
tissue, and the uniform colour was not the same as a ‘normal’ wound scar. These occurred at one 
particular stimulation session, though not the first with these parameters, and full recovery was 
made within 7 days without stimulation. Although not observed by researcher, subject LD reported
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a similar occurrence but to a lesser degree with only a few such scars, which healed within 2 days. 
On one occasion, close inspection of the electrode sites of subject LB upper and lower arm 
revealed tiny ‘pin-prick’ size scabs with a similar regular pattern, when stimulating with 400ms 
triangular pulses using PALS® Flex electrodes (§4.4.1), Concurrent with this, was more severe skin 
damage at about six dispersed locations beneath the electrodes on the lower arm, where tissue 
thickness is minimal. One scar was up to 4mm diameter, indented and located over an underlying 
bone towards the wrist, beneath the distal (positive) electrode (Figure 6.1.2). These took about 20 
weeks to heal completely, and stimulation was continued with electrodes at slightly different 
locations.
Similarly, but more severe ‘cigarette like bum’ scars occurred around the periphery of the oval 
shaped PALS® Flex electrodes (§4.4.1) used by subject LC and which exactly corresponded to 
where the conductive mesh of the electrode protmdes from the underlying gel layer (Figure 6.1.2). 
The electrodes themselves also had a bumt appearance at these locations, mainly on the proximal 
edge of the proximal electrode, where tissue bulk is greater, but also on the extreme medial edge of 
the distal electrode. At the time of occurrence, the subject reported diminished contraction 
response, the electrodes became hot around the edges and the stimulator unit current limit waming 
was activated (set at 75mA). This shape of electrodes was withdrawn from further use and the 
supplier informed. After a week without treatment (wk 13), it was resumed using smaller electrodes 
positioned away from the damage sites, which were completed healed after approximately 15 
weeks. This perhaps confirms the origin of skin damage on this and other subjects as due to excess 
current density, but not necessarily its cause, as only in this case is it clearly attributable to the 
electrodes.
Subject LR suffers intermittent skin problems with dryness and inflamed pores on both lower legs. 
This was generally exacerbated by the stimulation, especially at the beginning of the study, when 
long pulses were applied. In particular, after the first 2 weeks of stimulation with 400ms triangular 
shaped pulses, subject LR developed approximately five inflamed and enlarged pimples 
(approximately 1mm diameter) capped by a small scab, beneath the proximal (negative) electrode 
(Figure 6.1.2). Some were concentrated together, but with non regular spacing in an area of 
approximately 200mm^ where thermography showed the greatest temperature rise (+5°C). 
Thermographic imaging of the skin to 0.5mm resolution using a macro lens, did not reveal any 
local ‘hot spots’ on the skin after removal o f electrodes following stimulation, with and without the 
skin immediately covered by cling film to retain the generated heat. However whilst viewing the 
upper surface of the electrodes during stimulation, ‘cold spots’ of approximately 0.5 to 1mm 
diameter were observed momentarily with temperatures of 26.6°C compared to the surrounding 
28.5°C. The skin reaction lessened as the study continued with altered stimulation parameters and 
careful skin care, so no further investigation into the phenomenon was conducted.
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Figure 6.1.1 Erthym a arising from  long puise biphasic stim ulation treatm ent 
a)Subject LB, b)Subject LD, c) Subject LE
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Figure 6.1.2 Skin dam age at stim ulation electrode sites on subjects a) LB, b) LC, c) LR
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Excess stimulation current can occur if intensity control and therefore output voltage remain 
constant, due to the decrease in skin impedance as the treatment session progressed. With this 
experience of skin damage, subjects were asked to monitor their contraction and skin response 
during the treatment session more carefully, and to reduce the intensity setting if these became 
excessive. For subjects LB (forearm) and LR, stimulating without any muscle contraction response 
to monitor, an indicator display of stimulation current was provided (§5.7). The stimulator unit 
current limit was set at a level just below that when localised skin dysreflexia was observed, in 
terms of sweating or goose pimples. With these precautions, no further incidents of skin damage 
occurred and no investigation were conducted to confirm whether the ‘bum’ damage was due to 
current concentration in sweat pores, activated by the stimulation.
It must be emphasised that the electrodes used in this study were not specifically designed or 
recommended by the manufacturers fo r  this application. The suppliers, Nidd Valley (§4.4.12) co­
operated in this investigation but do not accept any responsibility or their use in this application.
6.1.4 Adverse Stimulation Effects
Apart from the manageable skin reaction, no other adverse effects of the treatment were observed 
or reported by any of subjects. There was no evidence of generalised autonomic dysreflexia 
induced during the treatment session; blood pressure was increased in the case of subject LR, and 
on occasions with LE but by no more than routine exercise and this did not prompt any 
complications. For the other subjects, blood pressure was unchanged or decreased slightly, 
attributed to their relaxed state during the treatment. None of the subjects reported any adverse 
sensory disturbance during the treatment period and none were adverse to the sensation of the 
stimulation, tolerance of which generally increased with continued treatment.
6.2 Measurement Data Analysis
For the analysis of the evaluation measurements collected, subjects were treated on an individual 
case basis because of the variability in their neurological condition and other factors such as age, 
weight and lifestyle. Even amongst those with common T 12/Ll SCI (subjects LC, LD, LE), inter­
subject comparison must take into account differences in the extent of motor and sensory 
innervation, muscle atrophy and skin condition. Given the small number o f subjects and high inter­
subject variability, no statistical sample analysis was performed. As muscle on only one limb of 
each subject was treated, the contralateral limb served as a control to compensate for changes to the 
measured parameters arising from effects other than the stimulation treatment, such as systematic 
body changes from dietary, hormonal or seasonal variations, and the changes in the measurement 
environment. However, both the absolute value of measurements of each limb and the asymmetry 
between them are evaluated, to investigate any differential limb effect and because it is possible for 
the treatment to have also had an effect on the contralateral limb.
§6.2 ___________________________________________________________Measurement Data Analysis ______________________________________________________________ 6-8
The trends of measured and asymmetry values throughout the treatment and follow-up periods are 
evaluated and plotted in terms of the study week number for the individual subject, with respect to 
the value at the baseline visit at the start of the treatment (week 0). Measurements were also 
performed on some subjects at the initial assessment visit, which preceded the baseline visit by 4 
weeks (subjects LB and LE) or 10 weeks (subject LC); though the later is stated as 4 weeks for 
commonality of presentation. However these measurement values may be expected to differ from 
those at baseline because of the familiarisation of the subject and the researcher on that initial 
occasion. Similarly measurement values at week 1 may differ from baseline due to some reaction to 
the treatment even without strong muscle response. Nevertheless, confirmation of baseline values is 
sought from these neighbouring measurements.
Skin temperature and blood flow measurement values are obtained by manual processing of the 
recorded signal, in terms of defining analysis areas and determining waveform shape respectively 
(§4.5). For consistency, this data extraction process for each subject was performed by one 
individual usually over one or two consecutive days. The processor was not made aware of which 
limb received treatment and therefore was less likely to bias the results, however for skin 
temperatures of subject LB, the effected limb is quite obvious from its diminished size.
Limb segments are defined proximally to distal as follows:
Upper limb: Arm, Forearm, Hand Lower limb: Thigh, Leg, Foot
6.2.1 Skin Temperature Measurement
Skin temperatures were evaluated for each limb segment separately, as absolute limb values and 
their ratio. For all or part of the limbs of some subjects there was very poor contrast between the 
skin temperature and the background making exact determination of limb segment area unreliable, 
especially on warmer days. For subject LB with unilateral injury and to a lesser extent in other 
subjects, the limbs responded differently to the variation in measurement room environment during 
the course of the study. Skin temperatures are therefore plotted separately for each limb and 
correlated to room temperature and relative humidity. Correlation is also given for the absolute 
asymmetry between limbs. Inconsistencies in this correlation may reflect insufficient 
acclimatisation by the subject, though a minimum of 15min was allowed.
To assess the repeatability of the measurement and processing technique, 5 images were captured 
on one occasion in successive seconds, with the subject (LR) and equipment in the same position. 
These were each processed twice by the same operator with approximately one hour interval 
between. The standard deviation of the 10 values is 0.11°C for both limbs and two standard 
deviations represent 0.9% of the mean value.
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6.2.2 Limb Segment Blood Flow Measurement
In processing the recorded dZ/dt waveform to extract values for the beat pulse duration (tg) and 
magnitude ( d Z / d t m a x )  (§4.5.5), some variation in the pulse shape was found, rendering 
determination of tg more difficult. This was largely due to variations in the waveform at 
frequencies below that of the filter cut-off, which distorted the expected shape (Fig.6.2.1). The beat 
duration (tg), was defined as the zero crossing before the beat pulse to the minimum after it. 
(§4.5.5). Although, typically this minimum for a particular individual was quite consistent 
(approximately 0.2), a second minimum often occurred (between 0.3 and 0.34s i.e.approximately 
equal to Lvet ) and was sometimes of greater magnitude. Conversely, for some pulses, there was an 
unmistakable minimum immediately after the peak (e.g.O.lSs). Porter (1986) also reported tg 
values less than L vet for finger blood flow and used a value of tg dervied from the impedance 
waveform. Whereas, Taylor et al. [1993] used the value of Lvet derived from concurrent cardiac 
output measurements in place o f tg for lower limb blood flow measurements, and found this to vary 
little over the course of 3 months^ As much of the uncertainty appeared due to low frequency 
variation in the dZ/dt trace (Fig.6.2.1), and allowed some interpretation of tg value, the limb blood 
flow values presented are with t g  equal to a constant value (approximately 0.2s) equal to the mean 
value for that subject. In fact, compared with t g  derived from the waveform, this did not greatly 
alter the trend of averaged blood flow values (Fig.6.6.4).
Two impedance measurements were taken on each limb at each evaluation visit, always starting 
with the left limb. Averaging the calculated blood flow values for each limb produced considerable 
variation between study weeks. Attempts were made to determine whether this was due to a 
measurement or analysis artefact masking any underlying trend in the value, or whether this is 
natural variation of the manner observed by Porter (1986). The first and second measurements of 
each limb are therefore shown separately together with their mean for each subject. Differences 
between first and second values are typically less than 10% of the mean value. Those weeks 
showing greater difference, did not necessarily correspond to when the averaged blood flow values 
were ‘out of trend’, and setting t g  equal to a constant value did not greatly alter the differences 
(Fig.6.6.4). Neither between study weeks or between limbs was their any apparent consistency to 
the polarity of measurement difference, for instance as would occur if the first measurement were 
always greater than the second. This was further investigated by performing up to six repeated 
measurements of the same limb on one occasion at approximately 2min intervals for subjects L C  
(wk 47-Fig.6.6.2) and L E  (wk 50-Fig.6.6.3). Values for t g  are taken from the dZ/dt waveform, as is 
the heart rate (instantaneous HR = number of complete beat cycles/corresponding time interval).
* Personal communication; Medical Physics and Biomedical Engineering Salisbury District Hospital §4.4
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Figure 6.2.1 Examples of Thigh Blood Flow dZ/dt waveform from Minnesota Cardiograph
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Figure 6.2.2.C Subject LC Cardiac Output (Supine) - repeated measurements
Measurement Data Analysis 6-12
LE_Uclflw2/RE-rep
150
140
BEAT VOLUME
130
120
- -  1.2
BLOOD FLOW
§3 - -  0.6
-- 0.4
HEART RATE
0.2
50 4
1 2 3 4 5 6
-BF-LEFT
-BF-RIGHT
HR-instan
LEFT
■HR-lnstan
RIGHT
■ avgBV- 
LEFT
■ avgBV- 
RIGHT
MEASUREMENT NUMBER
Figure 6.2.3.a Subject LE Thigh Blood Flow (Recumbent) - repeated measurements
150
140 -  1.6
BEAT VOLUME
130
1.2 S '
^ â 110
Is™LL
Q Œ 90 O <
BLOOD FLOW
- - 0 .6  m
- 0.470
HEART RATE
- -  0.2
1 2 3 4 5 6
-BF-LEFT
-BF-RIGHT
HR-instan 
LEFT 
■HR-instan 
RIGHT 
• avgBV- 
LEFT
' avgBV- 
RIGHT
MEASUREMENT NUMBER
Figure 6.2.3.b Subject LE Thigh Blood Flow (Supine) -repeated measurements
LE_t«lw2/G0
1 1;
104. 
0
- -  7
- -  6 •
8
i
•  HR 
instantaneous
♦  avgSV 
■» CO
1 3 4
MEASUREMENT NUMBER
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Subject LC showed a gradual increase in beat volume (BV) and blood flow (BF) on the second and 
subsequent measurements over the first (Fig. 6.2.2.a). The increase is more pronounced with 
subject LE, but returned to initial values at the third or fourth measurement (Fig. 6.2.3.a). 
Expressing twice the standard deviation of these values as a percentage of their respective mean 
and averaging for both limbs is 13.9% for LC and 22% for LE. Porter [1986.p96] reported such 
2*StDev values of between 6.9% and 45% (average 15.7%) for 10 concurrent measurements on 10 
different subjects and values of between 7.4% and 37.7% (average 20.7%) for measurements 
repeated on 10 subjects taken at different times on the same day.
Porter [1986] also reported considerable variability in blood flow when measured in a recumbent 
position. Repeated measurements taken in the supine position showed similar trend to when 
recumbent for subjects LC and LE, and variability was little changed (Fig. 6.2.2/3b). However the 
shape of the dZ/dt waveform beat pulse was far more repeatable, with consistent values of tg of 
0.2s for LC and 0.21s for LE, the latter being slightly greater than the 0.19s when recumbent The 
dZ/dt waveform was similarly very repeatable during cardiac measurement of LC and LE supine, 
providing consistent values of L vet of 0.31s and 0.34s respectively (Fig.6.2.2/3c). Apart from a low 
initial low with subject LC, cardiac output recorded was reasonably constant, even after a 10 
minute interval for LC, with 2*SD/mean variation of 5.9% for LC and 4.6 % for LE. The change in 
stroke volume with repeated measures was compensated for by a reciprocal change in heart rate, 
though these were of the opposite sense for LC and LE. Measurement of cardiac output recumbent 
produced a less regular dZ/dt waveform.
When recording the impedance signal waveforms, subjects were asked to hold their breath for a 
period of 6 or 10 seconds, after a small inhalation. Typically, (especially subjects LC and LR), 
during this period the calculated beat volume increased (by up to 30%) and the instantaneous heart 
rate decreased (by up to 20%) as determined from the interval between pulses and confirmed by a 
chest worn monitor. Such changes were also recorded with subject LE but of inconsistent direction, 
and did not result in significant change in, for instance cardiac output (Fig.6.2.2c). When 
measurements were taken surreptitiously with the subject quiet, but breathing normally, up to 6% 
variation in heart rate and beat volume occurred but without consistent trend in either direction. 
Hence for subject LR breath holding produced blood flow values of approximately 10% less than 
that without breath-holding in both limbs. After exercise by subject LR, the pattern of change was 
altered and after an initial decline, heart rate recovered during the measurement period.
Determination of tg and therefore blood flow values was particularly difficult for the contralateral 
right arm of subject LB, because the very low mean impedance (Zo) of approximately 200 resulted 
in very small dZ/dt amplitude and a low signal to noise ratio. Blood flow values for this subject 
were similarly reduced on some occasions, but generally there was no significant correlation 
between variation in mean impedance values and measured blood flow. The influence o f  the
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measurement environment is evaluated by correlation of blood flow values with room temperature 
and relative humidity. This showed some significance with relative humidity, but only of one limb 
and not with all subjects.
Blood flow was also measured after a typical period of stimulation for subjects LE and LR. For 
subject LE thigh blood flow showed an appreciable increase of perhaps 72% in the treated limb and 
22% in the contralateral limb (§6.5.6), Whereas, for subject LR, neither stimulation nor walking 
exercise produced appreciable change in leg blood flows
6.2.3 Tissue Thickness Measurement
The poor quality of the ultrasound image for the majority of the study, precluded consistent 
identification and measurement of intermediate tissue boundaries and those shown for subjects LC 
and LE are presumed to be that between quadriceps muscles and superficial subcutaneous fat. The 
bone was more clearly identifiable, but at least some of the apparent variability in its depth may be 
attributed to misinterpretation of the image. The quality of the ultrasound image with the old 
(2.5MHz) instrument varied considerably from week to week, and those with particularly poor 
quality are mentioned. Such ambiguity was avoided with the clearer images of the new (5MHz) 
scanner unit (§4.5.6). Tissue thickness values obtained when both units provided good images, 
were in agreement to within 1 or 2mm, but greater difference occurred where interfaces were less 
well defined in the image of the old unit. For subject LR, measurement of the tibialis anterior 
muscle thickness, necessitates identification of non bone tissue boundaries and this was only 
possible reliably by using the new scanner unit and therefore are not presented. Tissue thickness 
and limb girth measurements are presented with body weight, which altered in all subjects during 
the treatment period.
The tape used for girth measurements was changed at the start of 1999 and may account for some 
of the measurement variation. Measurements of the quadriceps of subjects LC, LD and LE are 
made with them seated on their wheelchair cushion, and contact with this may contribute to 
variability in the measurements at locations 200mm and 250mm proximal o f the patella
6.2.4 Correlation Significance Levels
Detailed are correlation coefficients of significance for the sample sizes of interest in this study.
Sample size n 9 11 14 15 16 17 18 19
P=0.1 0.582 0.521 0.457 0.441 0.426 0.412 0.400 0.389
P=0.05 0.666 0.602 0.532 0.514 0.497 0.482 0.468 0.456
P=0.01 0.798 0.735 0.661 0.641 0.623 0.606 0.590 0.575
Table 6.2.1 Pearson Correlation Coefficients for 2 Sided Distribution [Powell 1982].
§6.3 Subject LC Results 6-15
6.3 Subject LC Results
6.3.1 Subject Profile
Subject LC (male) was aged 32 at the start of the study and involved in a motor cycle accident 5 
years previously resulting in T 12/Ll level spinal cord injury but initially with some retained lower 
limb muscle control and sensation. Unfortunately, nine days after the accident, transfer into a 
wheelchair resulted in complete lower limb paralysis and loss of all sensation in the legs, bladder 
and bowel. There had been little change in his condition since this, with occasional pains and 
soreness in the hips and discernment of touch, though not identification of exact location. The left 
leg was particularly cold to touch with ulcer like discoloration of the foot since injury, though no 
active sore. The subject reports the left limb took time to heat up at night, whereas the right leg 
became very warm. Tissue wasting of the leg was visibly appreciable but not of the thigh. There 
was no motor response to stimulation with 0.3ms pulse stimulation in any of the main muscles of 
either limb. Occasional involuntary foot movements occur from mild extensor spasms, especially 
on the right. Sensation was felt when stimulation was applied to the quadriceps. The subject had 
not received any active therapy since initial rehabilitation, but performed knee flexing exercises 
every day and stoods in a standing frame for approximately 30 min, 3 to 4 times per week.
6.3.2 Contraction Response to Direct Stimulation
At the initial assessment visit, response to quadriceps stimulation was approximately the same in 
each leg with good twitch contractions possible from pulse widths of 95ms necessitating intensities 
in excess of 120mA but without overflow into other muscles of the leg. The stimulation did 
however initiate some spasm of the abdominal muscles, which caused the subject no apparent 
adverse effect. Threshold contractions were achieved with pulse widths down to 20ms (Fig.6.3.1). 
The left quadriceps were chosen for treatment because of the greater potential benefit to limb 
temperature, even though the contraction response was slightly inferior.
Treatment started 10 weeks after the initial assessment using 50mm square PALS® Blue electrodes 
(§4.4.1) on the anterior of the quadriceps, centred at 70mm and 270mm proximal to the proximal 
patella border. Rectangular shaped pulses were used throughout the study, as there was no co­
contraction or excess sensation to alleviate. Initial response occurred in vastus medialis, which 
appeared warmer on the thermography. The strong muscle contraction and absence of fatigue 
allowed an increase in session length and frequency to 2.5Hz by week 4, equivalent to the ‘shaking 
contraction’ treatment used by Kern et al. (§3.4.2). It was these stimulation parameters which 
resulted in the regular pattern of current bums (§6.1.3), necessitating a week without treatment 
Treatment was resumed in week 6 when the scars had almost disappeared, with IHz twitch
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contractions and using larger PALS® Flex oval shaped electrodes (80mm x 130mm) positioned 
away from the damaged areas. This size of electrode is more akin to the size of those used by Kern 
et al., but required a greater stimulation current than the smaller PALS® Blue electrodes (e.g. 
52mA cf. 40mA) to achieve a contraction of comparable strength, however a greater proportion of 
the quadriceps were recruited.
At week 7, the response to stimulation at 40ms was sufficient to allow isometric tetanic 
contractions at lOHz throughout the muscle, without significant fatigue, and allowing a progressive 
increase in session length over succeeding weeks to 30min at week 11. Unfortunately a later 
replacement set of electrodes resulted in the skin bums described previously (§6.1.3), necessitating 
another week without treatment. This resumed (wkl3) with 75mm diameter PALS® Flex 
electrodes positioned away from the areas of skin damage, once more at approximately 70mm and 
270mm proximal of the patella. A pulse width of 20ms and frequency of 20Hz was used, which 
avoided the unfused contraction at the proximal electrode at lOHz.
By week 21, the strength of contraction was sufficient to permit isotonic contractions when seated 
with the knee flexed at 90° and the leg able to swing freely; the distal electrode was positioned 
more proximally so not over patella tendon. At the limit of skin dysrelexia (§6.3.4), approximately 
85mA, the foot swung out by approximately 20mm with respect to a scale on the ground and 
continued to increase in subsequent weeks. Treatment was halted during weeks 23 and 24, due to a 
period of nosebleeds, jaw pain and feeling hot, but these were not attributed to the treatment and 
did not reoccur when treatment restarted. At week 25, the duration of isotonic contraction was 
extended from 4s to 8s, akin to that used for training of innervated muscle (§3.2.4), though some 
fatigue occurred during the session and leg movement decreased if the stimulation intensity was 
kept constant. The amount of anterior movement of the foot during contractions varied with the 
pulse width for a given intensity and frequency (Tab.6.3.1). A pulse width of 40ms at 20Hz is 
recommended by Kern et al. (§3.4.2) for maximising contraction strength, with 2s contractions at 
4s intervals, in sets of 8-10, separated by a 2min rest period. This stimulation pattern was adopted 
from week 28, for the remainder of the treatment period, initially with 5 sets of 10 contractions, 
though fatiguing was still found to occur. Unfortunately treatment was stopped for weeks 29-31 
due to influenza, which resulted in some body weight loss. When treatment was resumed for a 
further 2 weeks, the amount of foot movement for each pulse width was less than that achieved in 
week 28, however measurement was preceded by 2 sets of the 10 contractions.
The treatment period was ended at week 33, after 26 weeks of actual treatment, including 20 weeks 
with tetanic contractions, of which 7 had been isotonic. During the follow-up period, the muscle 
continued to respond to stimulation with tetanic isometric contractions, but the amount o f foot 
movement for the given parameters continued to decline and the rate of fatigue increased. The
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smaller foot movement in week 37 compared to week 47 may be due to prior fatigue with other 
periods of stimulation.
Week 28 Week 33 Week 37 Week 47
Pulse Width (ms) Foot movement anteriorly (mm)
10 10 10
20 60 40 30 35
30 95 70 40
40 105 75
Table 6.3.1 LC Isotonic Contraction Response to Stimulation Pulse Width at 20Hz and 86mA
SD Curve Measurement
Comparison of SD curves (Fig 6.3.1.a) between study weeks is hindered by differences in 
Rheobase. However, those with equal Rheobase values (wks 0&4, 7&9, 33&47) show an apparent 
shift to the left (decrease in intensity for given pulse width), which may be interpreted as increased 
excitability with treatment. This is also indicated by the declining Chronaxie values, as treatment 
progressed and the rise during follow-up. The shift in values from week 7 corresponds to the use of 
the larger size of electrodes and different form of muscle recruitment from thereafter. Given this 
and with the exception of week 2, Rheobase values decreased during the treatment period.
The SD curves at the beginning of the study are almost identical for both limbs (Fig 6.3. l.b). Both 
curves show a decrease in Rheobase and increase in excitability, but to a greater extent for the 
treated limb. Considering Chronaxie values, both limbs had equal values after the treatment which 
is greater than that before treatment and perhaps illustrates the disadvantage of a single value 
characterisation of the curve, especially when Rheobase differs. A simpler indication of the 
increase in muscle excitability is that by the end of the treatment period, the muscle responded to 
pulse widths of 0.5ms (though not with tetanic contractions), and this was maintained throughout 
the 14 week follow-up period, whereas prior to treatment, the minimum pulse width was 10ms.
6.3.3 Sensation and Sensory Perception
Prior to the study, sensation was limited to the groin area and upper leg but was not specific. 
During the stimulation session, including at the initial assessment visit, the subject reported 
sensation which spread progressively down both legs and into the abdomen, including a burning 
sensation in the upper leg and tightness in the feet. This was sustained for some time after the 
stimulation and the subject reported the lower leg and foot felt warm for days after the initial 
session. With isotonic contractions, the subject reported feeling a surge of blood flowing into the 
leg and tinkling into the calf and foot. Aching of the hips and knees, was no longer felt by the 
subject on the left after the first few days of treatment and returned during the follow-up period. By 
week 4, the subject reported increased level of sensation in the abdomen, including feelings of
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hunger and being able to reliably predict full bowel, which had not been possible previously and 
which continued into the follow-up period, though gradually diminished. During the follow-up 
period, the subject reported ‘pins and needles’ sensation, whenever either leg was touched or 
moved, which was not present before starting the treatment and which is desirable to the subject. 
However, sensory perception assessment revealed that reliable location discrimination of touch was 
not possible at any time during the study.
6.3.4 Skin Response and Condition
Skin reaction to the stimulation was minimal from the start of treatment, with mild erythema, 
which was lessened by use of the larger PALS® Flex electrodes. However the treatment did result 
in some dryness of skin at the electrode sites, necessitating the use of moisturising cream (§4.4.2), 
applied approximately 30min after the treatment session. At higher intensities (>85mA) at tetanic 
frequencies (20Hz) erythema occurred between the electrodes accompanied by slight localised 
sweating and occasional ‘goose pimples’, but without appreciable change to blood pressure or heart 
rate. The subject was instructed to maintain the stimulation intensity just below this level, however 
with treatment sessions of 30min a slight skin discoloration persisted between some sessions but 
did not progressively worsen. In particular, with isotonic contractions, the distal electrode was 
positioned proximal of the patella tendons to avoid excess erythema of these tissues. Initially with 
these contractions, ‘goose pimpling’ occurred with intensities of approximately 65mA, but 
sweating not till 85mA, the limit for treatment. This segregation was attributed to stretching of the 
skin when seated affecting the skin dysreflexia. After 2 weeks of isotonic treatment, skin reaction 
had diminished to mild erythema lasting approximately 15minutes after treatment. The skin 
response to the 40ms, 20Hz stimulation was no different from that of other treatment patterns. 
During the follow-up period, the subject reported goose pimples on the left leg around the knee, as 
per the right leg. The subject considered skin condition over the left quadriceps had improved 
slightly as a result of the treatment, though was reasonable before the study, as indicated by the 
successftil healing of induced localised skin damage.
6.3.5 Skin Temperature Measurement
The measured skin temperatures showed a significant (p<0.05) correlation with room temperature 
for most segments of both limbs and greatest on the contralateral limb. Also a significant (p<0.1) 
correlation with relative humidity on the treatment limb (Fig.6.3.2). Increases in skin temperature 
at weeks 4, 7 and 28 appear due to environment changes. In the higher room temperatures at the 
start study, asymmetry of skin temperature between limbs was minimal in all segments. However, 
at lower temperatures, the lower limb segments were appreciably colder on the left as experienced 
by the subject.
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Neither the isometric or isotonic contraction treatment overcame the fluctuations in room 
temperature affecting skin temperature, though in weeks 18 and 21 are contrary to them. During the 
first month of the follow-up period, skin temperatures of all segments of both limbs rose without a 
rise in room temperature. However during the remaining 10 weeks of follow-up only the right leg 
followed the room temperature increase, whereas the left actually decreased in the shin and foot. 
Therefore, the measurements do not substantiate the subject's opinion that treatment had improved 
the temperature of the treated limb.
6.3.6 Blood Flow Measurement
Blood pressure and heart rate show some variation over the course of the study and with room 
environment changes; heart rate was raised for weeks 21 and 25 (Fig.6.3.3). Blood flow measured 
in the thigh showed considerable variation in both limbs and there is no discernible significant 
differential effect of the stimulation on the treated limb (Fig.6.3.4). There is some negative 
correlation to relative humidity especially of the contralateral (p<0 .1), however for a given relative 
humidity, blood flows in both limbs appear higher in the later stages of the treatment period than 
without treatment.
Cardiac O utput
Cardiac output was measured on one occasion at week 47. For the six repetitive measurements 
(Fig.6.2.2.c), the average cardiac output was 4.2 1/min and average stroke volume 71.4ml, which lie 
within the range for normals specified by Porter [1986]. On the same occasion average thigh blood 
flow was approximately 75ml/min, and therefore constituted approximately 1.8% of cardiac output 
If a value of t g  equal to Lvet ( 0 . 3 4 s )  is used as per Taylor [1993], this implies a thigh blood flow of 
128ml/min or 3% of cardiac output.
6.3.7 Tissue Thickness and Limb Girth
To the subject and the researcher, the treated limb segment appeared to thin during the treatment 
period, especially just proximal of the knee. This was reflected in the thigh girth measurements 
(Fig.6.3.5) but is not easily discernible from those of tissue thickness (Fig.6.3.6). Both 
measurements were affected to a greater extent by the weight loss with influenza in weeks 29 to 31, 
and which coincided with the period of isotonic contraction treatment.
Girth measurements of the treated limb closest to the knee show an initial slight decline at the start 
of treatment, are relatively stable during the period of isometric contractions but decline further 
from the start o f isotonic contractions (wk21), which continues during the period of infection with 
recovery during the follow-up period. However measurement values from the right limb show a 
greater degree o f variability and decline. Some of the variability in the proximal thigh measurement 
values may be due to the distortion of the underlying cushion and at week 21, the change in tape
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measure used. At 250mm from the patella there is no trend of change in the treatment limb, but at 
200mm it appears to increase during the period of isometric contractions and thereafter decrease, 
though this also occurred in the contralateral limb. Proximal measurements of both limb appear to 
show a progressive decline following the infection, till the end of the follow-up period.
On the occasions when the ultrasound image was clear the image was noticeably different for the 
contralateral limb, compared with the treated limb, with greater echogenity and less pronounced 
layer structure as reported for denervated muscle [Schmidt,Volt 1993]. This made identification of 
tissue interfaces more difficult and may account for the greater variability of the contralateral limb 
measurements and some of the 'out of trend' values. The old and new instruments showed 
agreement to within 1mm in most bone depth measurements. If  the initial increase in both limbs is 
due to probable operator familiarisation, and discounting those values when image quality was 
poor, then the treated limb shows no appreciable change in bone depth or interpreted muscle 
thickness, except for a marked decline at 150mm during the period of body weight loss and some 
increase at 200mm during isometric treatment, followed by a decline with isotonic treatment.
6.3.8 Joint Range of Motion
Prior to treatment, knee joints appeared swollen and mis-shapened due to numerous motor cycle 
accidents and emphasised by the muscle atrophy, however range of motion was maintained by 
passive exercising by the subject. By week two, the subject reported the knee joint on the treated 
side, no longer ‘cracked’ when flexed, whereas the contralateral limb continued to do so. Joint 
range of motion was measured from the start of isotonic contractions (wk21) (Tab.6.3.2). After a 
couple of weeks of isotonic contractions, the subject commented that the knee flexor muscles felt 
‘tight’, but measured joint angles suggest only a marginal decrease on knee extension, which was 
also measured in the follow-up period. Therefore, although perceived by the subject, there were no 
discernible changes in measured joint mobility during the treatment period. Changes during the 
follow-up period may have arisen from the subject not performing standing exercises; decrease in 
left ankle extension, increase in right ankle flexion and increase in right knee flexion.
Ankle Knee
W eek
No.
EXTENSION FLEXION EXTENSION FLEXION
Trtm t C ontrl Trtm t Contrl T rtm t Contrl Trtm t Contrl
21 46 48 72 85 0 0 96 104
25 48 40 98 3 3 104 101
33 44 77 0
37 46 44 74 88 7 0 102 113
47 37 52 78 72 4 0 96 112
Table 6.3.2 Subject LC Lower Limb Joint Range of Motion (°)- passive.
^6 .3 Subject LC Results 6-2J
SD ALL3/LC1
wk 0 (23ms) (Chronaxie)
wk 2 (19ms)
wk 4 (13ms)
wk 7 (22ms) large electrodes
wk 9 (16ms)
wk33 (16ms) end treatment 
wk47 (24ms) end follow-up
1000
200
: 8 0  ALL3 / LG2
180
160 ■ ♦ ----- w k 0 (23ms) (Chronaxie)
—  O wk 0 -Contralateral (23ms)
" #  ' wk37 -Treatment limb (30ms)
—  "0  —  wk37-Contralateral (30ms)
S  140
120
100
i k:
10 10000,1 1 100
P U L SE  WIDTH (m s)
Figure 6.3.1 Subject LC Strength Duration Curve and Chronaxie Values
a)Treatment limb b)Treatment and contralateral
Week N o . 0 1 2 4 6 7 9 11 13 18 21 25 28 33 47
Chronaxie ms 23 22 19 13 22 16 16 24
Treatmt param eters isoM n/c n/c n/c isoT n/c end end
intensity at max mA 46 46 52 60 52 60 70 70 70 80 85 85 85 trtmt folw
overall pulse width ms 100 100 60 100 60 40 20 40 -up
impulse width at max ms 50 50 30 50 30 20 10 20
ramp duration ms 0 0 0 0 0 0 0 0
ramp rate mA/ms rect rect rect rect rect rect rect rect
frequency Hz 0.5 0.67 1 2.5 1 10 20 20
envelope on period sec cont cont 2 5 5 3 4 8 2
envelope off period sec 0 0 2 3 3 10 10 15 2
session length min 8 15 20 20 12 5 20 30 10 25 30 30 5x6
current limit mA 120 120 120 120 120 80 80 75 75 90 90 95 95
Table 6.3.3 Subject LC Treatment Stimulation Parameters
(n/c -no change , isoM -  isometric, isoT - isotonic contractions, parameter definition see Fig. 3.2.1)
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Figure 6.3.2 Subject LC Lower Limb Mean Skin Temperatures
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Figure 6.3.4. Subject LC Thigh Blood Flow
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Figure 6.3.5. Subject LC Thigh Girth at locations proximal of patella border
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Figure 6.3.6 Subject LC Quadriceps Tissue Thickness at loactions proximal 
to patella border (poor image quality for week numbers 2, 1 1 , 2 1 , 2 8 )
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6.4 Subject LD Results
6.4.1 Subject Profile
Subject LD (male) was aged 42 year at the start of the study, with 'complete' T12/L1 level SCI 
from accidental trauma 10 years previously. His condition was therefore comparable with that of 
subject LC though with a greater extent of innervation of the toe flexor muscles of both limbs, 
which were recruited by 0.3ms stimulation, even at upper leg level. These muscles are also subject 
to occasional involuntary recruitment, initially single twitch contractions, which can progressively 
built up to causing foot and toe movement, especially on the right. Voluntary hip control was 
retained. The subject reported no sensory perception to touch in the lower limbs but intermittent 
'roof pains in the top of the left leg. Muscle atrophy was uniform over both limbs and moderately 
severe. Skin condition was reasonable, though a sacral sore which developed one year previously, 
had not healed. From 11 weeks prior to the start of treatment, the subject received laser treatment 
for the sore on Thursday mornings; evaluation visits were therefore arranged for Wednesday 
afternoons. The sore prevented use of the callipers for standing exercise, but otherwise the subject 
maintains an active lifestyle as a wheelchair user.
6.4.2 Contraction Response to Direct Stimulation
At the initial assessment visit, the response to long pulse stimulation of the quadriceps was greater 
than the other subjects, with twitch response to pulse width of 3ms on the right and 10ms on the 
left, where an unfused tetany was also obtained from 10ms, lOHz stimulation. The right quadriceps 
was chosen for treatment because of the greater excitability in terms of minimum pulse width, and 
the lower sensation threshold. As no adverse sensation or co-contraction occurred, rectangular 
shaped pulses were employed for treatment and trapezoidal pulses produced a smaller contraction 
response. Treatment commenced with a pulse width of 100ms at 0.5Hz, with contraction initiated 
in vastus medialis, and possibly sartorius, just proximal of the patella and spreading throughout the 
quadriceps as intensity was increased, with tightening of the patella tendons palpable. PALS® Blue 
50mm square electrodes were used and the optimum positions found to be at 50mm and 240mm 
proximal of the patella. The strength of contractions built up over a period of 2-3min and the lack 
of fatigue permitted an increase in frequency (IHz) and session length up to 25mins in week 6 . 
Contraction of toe flexors occurred intermittently during treatment, but not synchronised to it.
The increase in muscle excitability is reflected in the shift of the Strength Duration curve and 
decrease in Chronaxie (Fig.6.4.1). By week 7, this was sufficient to allow treatment with 40ms 
pulses at 25Hz, which produced a shaking of the whole leg, but only contraction of the quadriceps. 
Sessions consisted of two periods of lOmin continuous stimulation separated by a 5min rest. Skin
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erythema was minimal, but during week 9, small pinhead marks were observed by the subject at the 
electrode sites (§6.1.3), These diminished by the next day and stimulation was continued with the 
electrodes in a new position. At week 10, the frequency was increased to lOHz with 40ms, 
achieving tetanic contraction, without clonus. Intensity was kept low initially and recruitment 
restricted to mainly rectus femoris, rather than the whole of the quadriceps with longer pulse 
widths. The limited fatigue permitted an increase in intensity and session length to 20min. Isotonic 
contractions with the lower leg swinging freely produced foot displacement of approximately 
20mm.
Unfortunately treatment was interrupted in weeks 2, 5, and 9 for hospitalisation due to urinary tract 
infection. From week 12, treatment, was limited to the morning due to subjects deteriorating 
condition following cross infection of the sacral sore and by week 17 this necessitated intensive 
hospital care and stimulation treatment was ceased. After release from hospital, at week 22 tetanic 
contractions of the quadriceps were still possible with 40ms pulses at lOHz, though concentrated in 
vastus medialis, without adverse skin or other reaction. Treatment was continued on an occasional 
basis for a further month with twitch contractions, but no further measurements were recorded.
6.4.3 Sensation and Sensory Perception
The subject reported considerable sensation of the stimulation at the initial assessment visit, with 
’pins and needles' on the right and a muscle contraction sensation on the right. At the start of 
treatment, 5 weeks later, no such sensation from the stimulation occurred however 'root' pains were 
initiated on the right, where not present previously. Tetanic contractions brought an initial surging 
sensation, which diminished during treatment.
6.4.4 Skin Response and Condition
Skin response to stimulation was variable, at its most severe consisted of an initial intense 'salmon 
pink' colour, which as treatment continued, diminished in area and darken to red after about 5min. 
Sometimes this extended between the electrodes, but typically was limited to about 20mm around 
the electrodes (Fig.6.1.1), greater at the distal patella electrode, where it also remained longer after 
treatment, but dispersed within one hour. Tetanic contractions made little difference to the 
response, but the subject reported the knee feeling warmer at night.
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Figure 6.4.1 Subject LD Strength Duration Curve and Chronaxie Values
Week N o . 0 1 2 3 4 5 6 7 9 10 11 12 17
Chronaxie ms 21 14 27 12 10 11
Treatmt param eters n/c n/c n/c n/c n/c isoM n/c n/c end
intensity at max mA 38 39 40 46 37 56 trtmt
overall pulse width ms 100 60 40 40
impulse duration twAx ms 50 30 20 20
ramp duration 1r ms 0 0 0 0
ramp rate mA/ms rect rect cont cont
frequency Hz 0.5 1 2.5 10
envelope on period sec cont cont cont 3
envelope off period sec 8
session length min 5 5 0 10 15 20 25 10x2 0 10x1 10x2 20
current limit mA 150 150 120 120 80
Table 6.4.1 Subject LD Treatment Stimulation Parameters
(n/c -no change, isoM -  isometric, parameter definition see Fig. 3.2.1)
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6.5 Subject LE Results
6.5.1 Subject Profile
Subject LE (male) was aged 30 years at the start of the study and sustained a T 12/Ll level SCI 6 
years previously. Voluntary twitch control of left vastus medialis was retained and stimulation with 
0.3ms pulses revealed innervation of other left quadriceps, also some hamstrings, plantaftexors and 
toe flexors on both limbs. Toe flexors were subject to occasional mild spasm. Sensation was 
limited to the lateral thigh and pelvic area, with considerable 'root pains' in the hips, for which the 
subject took medication. He usually stood in a support frame for 30min, 2 to 3 times a week and 
goes out to office work each day by wheelchair. For the 5 months prior to the study, the subject had 
been using a passive bicycle egometry trainer 2 or 3 times a week, but stopped this for the duration 
of the study. Skin of the lower limbs is pale and dry. The subject is a light smoker (typically 1.5 
hours prior to the appointment). Stimulation treatment was usually performed in the morning, 
approximately 6 hours prior to the evaluation visit in the afternoon.
6.5.2 Contraction Response to Direct Stimulation
At the initial assessment, twitch contractions were obtained in both quadriceps from stimulation 
pulse widths down to 1ms at relatively low intensity (Fig.6.5.1), Given the greater motor and 
sensory innervation of the left lower limb, the right was selected for treatment, with potentially 
greater therapeutic need. PALS® Blue 50mm square electrodes were placed at 50mm and 220mm 
proximal of the patella, with the proximal electrode positioned lateral of the thigh centreline to 
minimise sensory recruitment. Despite this, contraction was initiated in vastus medialis and spread 
to rectus femoris as intensity was increased. To eliminate co-contraction of toe flexors, trapezoidal 
shaped pulses were used, with ramp of approximately 50ms and overall pulse width of 220ms 
initially, increasing to 75ms and 310 respectively as intensity increased in subsequent weeks. It was 
not possible to reduce ramp rate without co-contraction, as occurred when treatment transferred to 
rectangular pulses in week 8. However, this did not appear to worsen the existing Achilles tendon 
shortening and more frequent standing was advised as a precautionary measure.
Tetanic contractions of rectus femoris became possible at week 8, treatment continued for a further 
4 weeks with twitch contractions because of unfused tetany on the medial periphery. Isotonic 
contraction treatment, was commenced in week 12, with 40ms pulses at lOHz for one week, and 
20ms at 20Hz thereafter, with the absence of fatigue allowing a progressive increase in session 
length to 30min. At week 17 the electrode size was changed to 40mm by 90mm in order to recruit 
more muscle fibres and to alleviate the skin drying. At week 24, treatment with isotonic 
contractions was commenced with the subject seated and with the leg swinging freely.
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Displacement of the foot increased with pulse width and 27ms at 17Hz was chosen producing 
almost as much movement (50mm) as 40ms. Fatigue was compensated for by the increasing 
current as skin impedance decreased, but 25min was found to be the limit of endurance. For 
instance, at week 28, 60mA stimulation produced 90mm foot displacement and after 25min, current 
had increased to 68mA with displacement decreased to 60mm. The muscle recovered somewhat 
from a few minutes rest, but the subject seemed unwilling to do this during the treatment session. 
The treatment period ended at week 31, and during this it is estimated there were at most 10 days 
without stimulation. During the follow-up period, the isotonic contraction response in terms of foot 
displacement diminished to about a third at wk40, and fatigue occurred in about half the time.
SD Curve Measurement
Chronaxie as determined from the Strength-Duration curve (Fig.6.5.1), decreased to approximately 
half its pre-treatment value during the first two weeks or treatment, but thereafter remained stable 
at approximately 12ms. This was reduced at week 14 with the increase in Rheobase. By the end of 
the treatment period, Chronaxie had returned to its pre-treatment value. Comparison of SD curves, 
for week 0 and 2, shows a shift in the curve indicating increased excitability, but variation in 
Rheobase hinders comparison of curves for other weeks. However the proximal electrode position 
was changed at week 4 and the electrode size at week 17. Also noticeable are the curve 'kinks' at 
weeks 10 and 31, resulting from slight changes in the location of minimum contraction.
6.5.3 Sensation and Sensory Perception
The subject reported no change in resting sensation of the lower limbs as a result of the treatment, 
and monofilament assessment showed no touch perception over either limb up to mid thigh level. 
Neither were the subject's 'root pains' affected by the treatment. Sensations of the stimulation 
during the treatment session altered from a 'tinkling at the beginning of the study, to a 'sense o f  
being touched with tetanic contractions. Apparent sensation on the medial thigh necessitated a 
lateral distal electrode location and perhaps limited the stimulation intensity used by the subject 
during treatment.
6.5.4 Skin Response and Condition
Erythema extended for approximately 30mm around each electrode and lasted for 1 to 2 hours after 
treatment. This was greater with tetanic contractions (Fig.6.1.1), and when isotonic, the stretched 
tissue around the patella tendons, became moderately warm to touch. At higher intensities 
erythema expanded throughout the inter-electrode area, with localised sweating and 'goose pimples' 
when excessive, but these ceased within minutes of intensity being reduced. Blood pressure or 
heart rate were sometimes raised by treatment as with other exercise or stimulants, but not 
consistently so and there was no evidence of generalised autonomic dysreflexia.
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The delay before contractions started at the beginning of each session lengthened and by week 10, 
the skin at the distal, patella electrode had become dried and flaked, necessitating a change of 
electrode position proximally. These two distal positions (50mm and 80mm proximal of the 
patella) were then used alternately on a 2-4 week cycle, and treated with moisturising agents in 
between (§4.4.2). At weeks 17,24 and 30 during the period of tetanic treatment, 2-4 red skin marks 
(approximately 1.5mm diameter) were observed at the distal electrode position, though the subject 
did not report occurrence at any one treatment session. Skin reaction was less severe with the larger 
electrodes.
6.5.5 Skin Temperature Measurement
The leg and foot of both limbs of subject LE were very cold to touch and barely discernible against 
the background on the thermographic image, precluding exact determination of the limb outline. 
The mean skin temperatures of all segments of both lower limbs show a highly significant 
correlation (p<0.01) to changes in room temperature but not to relative humidity (Fig.6.5.2). 
However all segments also showed a decreased mean temperature in weeks 1 and 28 compared to 
the previous measurement, despite a relative increase in room temperature. Given that the latter 
visit was late February, this may be due to lack of sufficient subject acclimatisation. Thigh skin 
temperature asymmetry between limbs was reversed from week 24 to 28 during the period of 
isotonic treatment, when previously the right limb had been consistently colder. During this period 
the treated limb leg and foot segments also became marginally warmer than those of the 
contralateral limb, as during the initial period of twitch contractions. A 15min session of isotonic 
treatment in week 40 produced an appreciable change in mean skin temperature compared to the 
contralateral limb (Tab.6.5.1).
Mean skin temperature asymmetry (“C) 
(treatment limb - contralateral)
Before
treatment
After
treatment Change
THIGH -0.8 +1.8 +2.6
LEG +0.6 +1.6 +1.0
FOOT -0.7 +1.5 +2.2
Room temp (°C) 24.7 24.2 -0.5
Table 6.5.1 Subject LE Mean Skin Temperature Asymmetry Change with Treatment (wk40).
6.5.6 Blood Flow Measurement
The subjects’ blood pressure and heart rate varied considerably during the study period (Fig.6.5.3), 
though the extreme values do not coincide with those of thigh blood flow (Fig.6.5.4). Correlation 
of thigh blood flow to the room environment is not significant for the study period as a whole, but 
for weeks 0 to 17, greater correlation is apparent between the treatment limb and asymmetry to
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relative humidity. From week 17, for the remainder of the treatment period and the initial nine 
weeks of follow-up period, treatment thigh blood flow exceeds that of the contralateral limb (by up 
to 50%) whereas it had not consistently done so earlier in the study. This occurred within the period 
of tetanic contraction treatment.
Thigh blood flow measurements of the treated limb following a 15min treatment session of isotonic 
contractions were found to increase by up to 72% after 15mins or after lOmin, 49%, when that of 
the contralateral limb was increased by 22% (Tab.6.5.2). It is therefore possible that blood flow 
measurements for this subject may also be influenced by the treatment performed in the morning 
prior to the evaluation visit. However this would not account for the continued elevated values in 
treatment limb during the follow-up period. Blood pressure was also raised by stimulation 
treatment on some occasions, but only to levels equivalent to those of other exertion.
Average Resting 
blood flow (ml/min
After treatment Blood flow (ml/min)
5min 6min lOmin 15min
RIGHT (treatment) 104 147 148 155 179
LEFT (contralateral) 106 124 110 130 -
Table 6.5.2 Subject LE Thigh Blood Flow Change with 15min Treatment session (Wk40) 
Cardiac Output
Cardiac Output was measured in week 50, yielding an average value of 2.7 1/min and an average 
stroke volume of 42ml/min (Fig.6.2.2.c). These are at the bottom of the range of normal values 
specified by Porter [1986]. On the same occasion average thigh blood flow was approximately 
90ml/min, and therefore constituted approximately 3.3% of cardiac output If  a value of tg equal to 
L v e t(0.3Is) is used as per Taylor [1993], this implies a thigh blood flow of 150ml/min or 5.6% of 
cardiac output.
6.5.7 T issue Thickness an d  L im b G irth
Thigh girth measurements show an increase in both limbs over the study period, particularly in the 
contralateral limb and from week 17, with stabilisation during the follow-up period (Fig.6.5.5). 
Body weight increased by 2.2kg (3.8%) during the treatment period, continuing a trend of the 
foregoing year.
The tissue thickness measurements show sporadic variation, some of which are attributable to the 
poor ultrasound image quality (Fig.6.5.6). Measurements at all locations suggest an increase in 
bone depth during the treatment period, perhaps reflecting the increase in body weight, though 
greater on the treatment limb. However, interpreting the intermediate layer (1) shown as that 
between superficial fat and muscle, the quadriceps muscle thickness only shows an appreciable 
change of the treated thigh at 250mm from the patella, particularly during the period of isotonic
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treatment. The measurement as taken, implies an increase from 11mm to 19mm (72%). Given the 
variability in measurement and the over estimation at week 31 at other locations, the increase might 
more conservatively be estimated as 13mmm to 16mm (23%). However the changes earlier in the 
study, with a dramatic decrease in thickness at week 17, imply that measurements at this location 
are subject to other influences, possibly that of the underlying support cushion, though such 
changes were less on the contralateral limb.
6.5.8 Joint Range of Motion
The subject reported no change in ease or range of motion of lower limb joints, however the 
researcher perceived a decrease in ease of motion of the ankle of the treated limb during the period 
of tetanic treatment. This is reflected in the measured range of motion (Tab.6.5.3), with a decrease 
in the ankle flexion and knee extension range, and some recovery during follow-up period. 
Conversely ankle extension and knee flexion increased. Variation in measurements of the 
contralateral limb, may reflect changes or illustrate high intra-rater measurement variability.
An de Knee
W eek
No.
EXTENSION FLEXION EXTENSION FLEXION
Contrl Trtmt Contrl Trtmt Contrl Trtmt Contrl Trtmt
14 40 37 140 132
17 50 28 66 86 5 3 130 131
21 38 27 72 70
28 38 32 63 67 16 5 135 130
31 35 37 75 63 7 8 133 139
34 33 38 65 68 10 7 126 136
40 39 44 65 73 9 0 129 134
50 48 42 65 70 9 7 145 133
Table 6.5.3 Subject LE Lower Limb Joint Range of Motion (°)- passive
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X— wk 14 (8.5ms)
♦ — wk31 (12ms) end treatment 
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Figure  6.5.1 Subject LE Strength Duration Curve and Chronaxie Values
Week N o . 0 1 2 4 8 10 12 13 14 15 16 17 24 28 31
Chronaxie ms 27 16 12 18 11 12 IS 8.5 12
Treatmt param eters isoM n/c n/c n/c isoT end
intensity at max mA 26 35 21 37 32 40 45 50 50 55 60 trtmt
overall pulse width ms 210 310 200 320 80 60 40 20 27
impulse duration twAx ms 5 5 5 5 30 30 20 10 13
ramp duration ms 50 73 45 76 3.5 0 0 0 0
ramp rate mA/ms 0.5 0.67 1.33 0.67 16 rect rect rect rect
frequency Hz 0.2 0.5 0.67 0.67 1 2 10 20 17
envelope on period sec cont cont cont cont cont cont 3 3 4 4 8
envelope off period sec 0 0 0 0 0 0 8 8 8 8 16
session length min 5 15 15 15 15 15 5 10 15 20 20 30 15 25
current limit mA 120 120 120 120 120 80 80 60 65 70
Table 6.5.4 Subject LE Treatment Stimulation Parameters
(n/c -no change, isoM -  isometric, isoT - isotonic contractions, parameter definition see Fig. 3.2.1)
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Figure 6.5.2 Subject LE Lower Limb Mean Skin Temperatures
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Figure 6.5.3. Subject LE Blood Pressure and Heart Rate Variation
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Figure 6.5.4. Subject LE Thigh Blood Flow
160
1140 ^  
Q
120 I
X
UJ
40
20
50
TREATMENT PERIOD FOLLOW-UP PERIOD
--
« \  _  / N "
k in  f v  4? \  /  . : ^ __
■— A V  " — :A__
! 1 - A ■
f .  0 • ' ' Y «  - - 0
o
" 0  0  O ® 0  Ô "
JOG O O a O ^  ft G o  G O o  G
4 _ _
,  I \
A /  X /  X  /  I "  "
’  ^  V  1
3.6
3.4 2  
3.2 3.
 ^ I2.8 X
2.6 I
2.2 oO
1-8 g
-BP systl. 
BP diastl. 
-HR
• o- - Rm tmp 
- o- - Rei.Hm
CORRELATIONS:
RmTep Ré Hum
BPsys -0.30 -0.17
BPdia -0.41 -0.10
HR -0.45 -0.02
- avgBF-LEFT (contrl) 
BF-LEFT 1st meas 
BF-LEFT 2nd meas
- avgBF-RIGHT(trtmtl) 
BF-RIGHT Istmeas 
BF-RIGHT 2nd meas 
Rm Temp
Rel Hum
- BF ratio (R/L)
CORRELATIONS (n=17)
1 z
1.2 <
RmTep
-0.31
-0.28
0.05
Rel Hum 
-0.02 
0.27 
0.22
50
CORRELATIONS (n=9) W k 0-17 
RmTep Rel Hum
0.6
LEFT
RIGHT
ASYM
-0.48
-0.29
-0.23
-0.09
0.50
0.55
440 105
TREATMENT PERICX) FOLLOW-IF PERIOD
A . “  100420
400
380
E
E
I 360 
OC
(3 340
I
320
80
- 75
- 7 0
300
-- 65
ctiange of tape measure
280
260
■5 0 5 10 15 20 25 30 35 40 45 50
WEEK NUMBER
Figure 6.5.5. Subject LE Thigh Girth at locations proximal of patella border
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Figure 6.5.6 Subject LE Quadriceps Tissue Thickness at loactions proximal to 
patella border (poor image quality for week numbers 10, 14, 21, 24, 28)
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6.6 Subject LB Results
6.6.1 Subject Profile
Subject LB (male) was aged 40 at the start of the study and had suffered a unilateral left brachial 
plexus lesion 23 years previously in a motor cycle accident. From initially having no voluntary 
movement or sensation, biceps function was restored within one year and finger flexor movement 
returned after approximately two years. Twice weekly physiotherapy was continued for 3 years 
post injury, including electrical stimulation for wrist extension. No subsequent treatment was 
received for the affected arm, which he makes use of it for certain daily tasks and otherwise enjoys 
a normal active life. At commencement of the study he had voluntary control of deltoid, biceps and 
finger flexors, though movement of the later was minimal due to their almost fully flexed resting 
position. Investigation with 0.3ms pulse width stimulation confirmed these muscles as innervated 
but produced no response from finger and wrist extensors, or triceps with up to 80mA. From this, it 
was deduced that the radial nerve had the principle motor impairment. Sensation throughout the 
limb was limited to an awareness of touch without point discrimination and an aching sensation in 
cold weather. The left limb is severely atrophied with very little tissue except in the biceps and a 
mottled red appearance to the skin. Conversely, the contralateral limb, is visually proportionately 
larger in bulk, fully functional and with typical 2 point hand discrimination ability. The subject 
works for very long hours at a computer, smokes moderately and always had a cigarette 
immediately prior to the evaluation visit. He felt he had ’nothing to loose' from receiving the 
treatment, "any improvement, however slight would be a bonus and any degradation, would not be 
a problem".
6.6.2 Contraction Response to Direct Stimulation
At the initial assessment, stimulation with pulse widths of 200ms produced minimal contraction of 
triceps and barely detectable contraction of wrist extensor muscles, though difficult to identify due 
to considerable co-contraction of surrounding muscles, notably biceps and interestingly, 
brachioradialis, which is normally innervated by the radial nerve. Treatment of the biceps 
commenced with twitch contractions at 0.5Hz. PALS® Blue 50x50mm electrodes were used and 
their optimum position was found to be centred at 70mm and 170mm proximal to the lateral 
epicondyle of the humerus on the posterior aspect, respectively, over the belly of the medial head 
and between the long and lateral heads of the triceps. By the end of the first week, slight voluntary 
contraction of a very small area of the triceps medial head was possible, which the subject 
performed during the '10s off period of the stimulation. This innervation of at least part of the 
triceps accounts for the shape of the Strength-Duration curve and low Chronaxie value (Fig.6.6.1). 
Initially, decreasing the rate of rise of the pulse and therefore increasing its width appeared to
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reduce the response of the triceps, perhaps due to fatigue, without diminishing the co-contraction. 
However by the second week, perhaps due to increased sensory tolerance, 300ms pulses with 
approximately 55ms rise time, reduced the violent jerk of the biceps to a ripple propagating up the 
arm into the deltoids and produced a more sustained triceps contraction. This treatment continued 
until week 6 when tetanic contractions at lOHz with smaller pulse widths could be sustained. 
Although some contraction was possible with pulse widths of 0.3ms, the area of muscle contracted 
was greater with 10ms and this was chosen with the intention of continuing the conditioning of 
these other fibres. The intensity was set at below the level of biceps co-contraction, however during 
a treatment session this usually built up from a clonus to a fused contraction. Although no fatigue 
of the triceps was apparent, it would take 2 to 3 minutes for the contraction to build up, even after 
prior washing of the skin, and the strength of contraction varied from day to day.
Given that at least part of the triceps muscle was obviously innervated, with some under voluntary 
control, the evaluation measurements were no longer able to assess the effects of the stimulation 
treatment alone. At week 12, it was therefore decided to extend the treatment to the wrist extensor 
muscles. The subject was supplied with a Microstim unit (MSTIM) and P A LS ®  Flex electrodes 
(33x54mm) (§4.4.1) for stimulation of the triceps with 0.3ms pulses at tetanic frequencies. The 
LPSTIMiO unit (LPS) was programmed with almost triangular shaped pulses of 450ms for galvanic 
stimulation of the wrist extensors to minimise co-contraction of finger flexors and brachioradialis. 
However, there was no visible or palpable contraction in the wrist extensors during treatment. The 
LPSTIMIO unit was also used on the triceps in order to stimulate the long and lateral heads whose 
fibres only flickered with the Microstim unit. To encourage voluntary contraction, the subject was 
issued with a biofeedback unit displaying the magnitude of the integrated EMG (§4.4.1), however 
it was found that with the lack of arm tissue and without training to isolate triceps contraction, the 
response was dominated by the biceps.
Due to localised current bum on the lower arm (§6.1.3), the IPSTlMlO was withdrawn for two weeks 
for inspection and treatment continued on the upper arm only with voluntary contractions (wkl5) 
and with the Microstim unit (w kl6). Thereafter treatment of the triceps continued with long pulse 
twitch contractions and short pulse tetanic contractions as before. The former usually increased in 
strength over the course of 10 minutes, whereas the latter started straight away. Treatment 
continued with the same parameters and progressively longer sessions up to 30 minutes, but using 
only one type of stimulation at each session. The extent of voluntary contraction and response to 
short pulse stimulation increased in the medial head of the triceps but not in lateral and long heads. 
The last month of the treatment period therefore concentrated on developing these muscle fibres 
using tetanic contraction with 20ms pulse widths from the LPSTIMiO unit and treatment of the wrist 
extensors ceased. The subject found it increasing difficult to perform the treatment in the morning 
due to work commitments, so the evening session was extended to 45min. However this also meant
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the subject was not able, or insufficiently motivated to practice the voluntary contraction, which 
required increasing concentration to perform as it produced no sensation of contraction.
By the end the treatment period (wk 29), 22 weeks of tetanic contractions had been performed. The 
medial, long and lateral heads of the triceps all responded to the stimulation with fused contraction 
though mainly in the medial head. Although the majority of the muscle tissue was recruited, there 
was no appreciable increase in its small size, and no detectable force was generated. This may be 
because the intensities required to produce notable muscle bulging in the triceps (3 0-3 5mA) also 
recruited the biceps forcibly. The 10 weeks of galvanic stimulation of the wrist extensors had 
produced no detectable contraction.
By the end of the follow-up period (wk50), the triceps still responded to stimulation at 20Hz with 
tetanic contractions. Voluntary contraction of part of the triceps was still possible and the subject 
commented that it did not require so much thought to do so.
SD Curve M easurement
The SD curve recorded at the start of the study resembles that of innervated muscle (Fig.6.6.1). In 
succeeding weeks, as more of the muscle responded to the stimulation, the curve shifted to the 
right, developed a ’kink’ and Chronaxie increased. The ’kink’ may reflect the difficulties of 
measurement as much as a differentiation of fibre innervation. With the smaller pulse widths, the 
location of minimum contraction shifted proximally and it became increasing difficult to discern 
the triceps contraction amidst the far greater biceps response, which necessitated restraining the 
arm. The curve for the end of the treatment period with the ’kink’ at greater pulse width may be 
interpreted as reflecting greater excitability in a greater proportion of denervated fibres, which was 
then lost with the cessation of treatment when the Chronaxie increased.
6.6.3 Sensation and Sensory Perception
To quote the subject; ''after the very first 'evaluation' session at Salisbury using long pulses my left 
arm fe lt very much more 'alive' than during the extensive period (20 odd years) without any 
stimulation". He also commented this effect lasted the 4 weeks until the next session. During the 
treatment period the subject perceived an increase in touch sensitivity in the upper arm, which 
diminished somewhat during the follow-up period, though he still felt the upper arm had ’more 
normal touch’ at the end of the study compared to its start. The evaluation assessment showed high 
sensitivity to touch in the treatment limb hand (2.83 monofilament) with a perceived improvement 
in the ability to reliably identify touch of the first, second fingers and palm. However this may also 
reflect greater area of exposure of the palmer surface of the hand as the fingers became less flexed 
at rest. There was no ability to discriminate two point touch at any time. Perhaps most noticeable to 
the subject was that the limb did not ache in cold weather is previously.
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6.6.4 Skin Response and Condition
As a result of the stimulation, the subject experienced at most a moderate uniform erythema 
beneath the electrodes, which lasted about an hour afterwards (Fig.6.1.1). This was more consistent 
with tetanic compared to twitch contraction but was less severe with the 0.3ms pulses of the 
Microstim unit compared to longer pulse widths. The skin was dry rather than oily and this was 
increased at the electrode sites. The electrodes tended to dry out quickly and is thought to be due to 
adhering dry skin.
From week 2, the treated arm appeared a more blotchy red colour, which persisted through the 
treatment period, though comparison was hindered by sun-tanning. The subject considered that skin 
condition had improved slightly as a result of treatment.
6.6.5 Skin Temperature Mleasurement
Skin temperatures of the treated limb remained below those of the contralateral limb throughout the 
study, except in the arm, where asymmetry values approach those of normals {Appendix G). Skin 
temperature measurements of all segments of both arms, show significant correlation to room 
temperature, (treatment limb p<0.1, contralateral limb p<0.01) (Fig.6.6.2). However in the 
segments without voluntary control (forearm and hand), the decrease in skin temperature with 
decreasing room temperature was greater in the affected arm than the contralatera arm, notably in 
week 25, probably reflecting the diminished or denervated vasomotor function. There was also 
some correlation with relative humidity, but only significant (p<0 .01) for the contralateral limb.
It is therefore difficult to discriminate any effect of the stimulation on skin temperature, however 
those of the forearm and hand follow a similar trend which in some respects corresponds to the 
variation of the treatment pattern. For instance, the decline in skin temperature at week 4 is greater 
than expected for the room temperature change, and coincides with when skin peeling following 
sun-tanning precluded effective stimulation treatment. Similarly, the commencement o f tetanic 
contractions with the long pulse stimulation from week 8, coincided with a rise in skin temperature 
despite decreasing room temperature. These levels were sustained whilst this stimulation continued 
until week 12, but declined thereafter when tetanic stimulation was provided by 0.3ms pulses in 
conjunction with longer pulse twitch contractions, though from week 14 to 15 there was no 
stimulation treatment all. However, the resumption of long pulse tetanic stimulation from week 25 
to 29 failed to reverse the decline in skin temperature with room temperature, which continued into 
the follow-up period. The long pulse twitch contraction treatment applied to the forearm between 
weeks 12 and 25 (except week 15) shows no obvious effect on skin temperature.
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6.6.6 Blood Flow Measurement
Blood pressure and heart rate showed no consistent or significant change over study period 
(Fig.6.6.3). A typical stimulation treatment session produced no significant change in blood 
pressure or heart rate and on occasions these decreased with the subject rested.
Blood flow was measured in the arm, with electrodes as proximal and distal as possible but 
separation distance was low at 90mm. The measurements imply that blood flow in the affected 
limb is comparable with that in the contralateral limb (Fig.6.6.4), despite considerable differences 
in tissue bulk and level of activity. This may be a measurement artefact, rising from the very low 
baseline impedance of the affected arm (typically <20Q) and consequently small dZ/dt peaks 
which rendered waveform analysis very difficult. The right arm also showed a greater variability 
between the first and second measurements of each session, though not for weeks 10 and 18, when 
the values are apparently 'out of trend'. Blood flow in the contralateral limb shows greater 
correlation with room environment, which is significant against relative humidity (p<0.05).
Blood flow in the treated limb is seen to rise during weeks 6 to 12 and 25 to 29, which coincides 
with the periods of long pulse tetanic treatment. Conversely, blood flow declined during the period 
of treatment short pulse tetanic and long pulse twitch stimulation (weeks 12-25). However during 
weeks 25-29, contralateral limb blood flow also increased coincident with decreasing relative 
humidity, which may account for at least some of the changes in the treated limb.
6.6.7 Tissue Thickness and Limb Girth
The variation in measured limb girth of the contralateral limb when body weight did not change, 
illustrate the expected reproducibility of the measurement (Fig.6.6.5). The variation during the 
initial weeks of treatment may reflect the inexperience o f the researcher. Given this level of 
reproducability, the measurements do not indicate any noticeable change in limb girth of the treated 
limb period of the study, except perhaps a slight decrease, thereby confirming the observations of 
the researcher. However, the triceps muscle heads were each more discernible, but perhaps still not 
of sufficient bulk to affect the measurements
Similarly the ultrasound tissue thickness measurements show an unexpectantly high degree of 
variability in the contralateral limb (Fig.6 .6 .6), perhaps attributable to variation in the arm position, 
muscle tension and orientation of the probe during measurement. The severity of muscle atrophy of 
the treated limb, made standardisation of probe orientation particularly difficult. Only the tissue 
thickness to the bone is presented, as intermediate interfaces could not be reliably identified. The 
measurements suggest a decrease in tissue thickness from week 18, especially proximally. Changes 
do not appear to correlate to the type of stimulation treatment, though session length was
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progressively increased. The greater changes in the contralateral limb suggest a non treatment 
effect.
6.6.8 Joint Range of Motion
The tightly flexed fingers at the start o f the study, became visibly and to examination, more relaxed 
by week 6 of treatment, requiring less force to extend, an effect also noticed by the subject after 1 
week. The wrist movement also became easier. The measurements of range of motion (Tab.6.6.1) 
show improvements in wrist extension and flexion, but also considerable variability of values 
including of the contralateral limb, perhaps attributable to operator inexperience with the technique. 
The measurements show no obvious change in the elbow range of motion. The subject considered 
the improvements in joint motion and muscle tightness, diminished without the treatment, as the 
measurements also suggest. However he expressed the desire to persevere with the finger extension 
with passive exercising.
ELBOW EXTENSION FLEXION
Week
No.
Left (trtmt) Right contrl) Left (trtmt) Right (contrl)
passive passive passive passive
-12 20 0
12 15 140
20 18 0 150 146
25 30 0 143 138
*29 *72 *148 *141
40 20 140
50 23 0 146 146
WRIST EXTENSION FLEXION
Week
No.
Left (trtmt) Right 1contrl) Left (trtmt) Right 1contrl)
passive active passive active passive active passive Active
-12 -35 -60 85 80
12 -60 88
20 -49 -70 -65 76 79 77
25 -58 -91 -80 76 80 71
*29 *-70 *-90 *-70 *96 *94 *80
40 -63 93
50 -79 -85 -78 86 89 75
Table 6.6.1 Subject LB Upper Limb Joint Range of motion (°). (*wk29 post treatment measmt) 
6.6.9 Additional Subject Comments
The subject considered the main benefit of the treatment had been the return of voluntary 
contraction to at least part of the triceps. Although the treatment encouraged his voluntary 
exercising, he lacked the motivation to perform it consistently without the discipline of a treatment 
regime and he would have liked to have continued with the treatment to determine the extent of 
returned function possible.
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Figure 6.6.1 Subject LB Strength Duration Curve and Chronaxie Values
Week N o . 0 1 2 4 6 8 10 12 15 16 18 20 25
Chronaxie ms 0.5 13 10 12
Treatmt param eters isoM Mstim+LPS Mstim Mstim+LPS n/c n/c LPS
Intensity at max mA 17 16 26 28 13 30 24 21 22 20
overall pulse width ms 220 120 310 260 10 1 10 0.3 240 0.3 450 20
impulse duration twAx ms 100 50 40 5 5 0.5 5 0.3 5 0.3 n/c 5 10
ramp duration ta ms 10 10 55 60 0 0 0 0 50 rect n/c 107 0
ramp rate mA/ms 16 16 0.5 0.5 rect rect rect rect 0.67 rect n/c 0.4 rect
frequency Hz 0.5 0.5 0.5 0.5 10 10 10 40 0.4 20 n/c 0.33 20
envelope on period sec 10 10 10 cont 4 3 3 10 cont 10 cont 4
envelope off period sec 10 10 10 8 8 8 10 0 0 0 8
session length min 5 10 15 15 5 10 10 15 5 15 10 10 20 30 30
current limit mA 150 150 150 120 120 120 120 120 40 40 40 35
Table 6.6.2 Subject LB Treatment Stimulation Parameters
(n/c -no change, isoM -  isometric, parameter definition see Fig. 3.2.1)
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Figure 6.6.2 Subject LB Upper Limb Mean Skin Temperatures
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Figure 6.6.3. Subject LB Blood Pressure and Heart Rate Variation
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6.7 Subject LR Results
6.7.1 Subject Profile
Subject LR was aged 59 at the start of the study and suffered a spinal infarct 3 years previously, 
initially resulting in near complete lower limb paralysis. Motor function returned, except for 
dorsiflexion of the left foot, which previous attempts at electrical peroneal nerve stimulation 
revealed to be lower motor neurone damage. In order to compensate for the consequent 'dropped 
foot', the subject walked with pronounced knee flexion and a stick, which was tiring and used a 
wheelchair for long distances. However she prefers this to the traditional rigid ankle-foot orthosis. 
The Achilles tendon had become shortened but not contractured, and the subject experienced 
occasion spasms in the calf muscles, at night and when using the orthosis. At the start of the study, 
the left tibalis anterior was severely atrophied, but otherwise both lower limbs were in proportion 
with the large body size. Both lower limbs had impaired sensation, especially in the toes and heel. 
The left limb appeared cooler and redder than the contralateral limb. The subject remains active 
and performs weekly swimming exercise.
At the start of the study, the subject was taking Aspirin (75ml) and other medication related to 
thyroid, hernia and cholesterol conditions, which continued throughout the study. The stimulation 
treatment was found to raise an existing high blood pressure. This was reduced by medication 
prescribed by the subjects GP (daily 2.5mg Bendrofloazile) and taken from week 2 of the study. 
The subject stopped smoking 5 years previously and commenced a weight reduction diet at the start 
of the study. Slight oedema and inflammation continued on the anterior contralaterlal leg just distal 
of the patella as a result of a fall 3 months previously. Although, it was anticipated that these 
factors and the surrounding musculature, would influence the tissue property evaluation measures, 
the objective of the treatment was primarily directed at restoring dorsiflexion function, which was 
also assessed. Left voluntary foot eversion control was retained.
6.7.2 Contraction Response to Direct Stimulation
At the initial assessment, stimulation with 200ms rectangular pulses and electrodes on the anterior 
left leg produced no detectable tibialis anterior contraction, but co-contraction of the plantaflexors 
and upper leg muscle spasms. The latter were attributed to a reflex response, as occurred after a 
slight delay. Use of trapezoidal stimulation pulses with a ramp in excess of 100ms, minimised calf 
contraction but not quadriceps response. However, 8 months later, at the start of treatment, the 
quadriceps response only occurred at higher intensities and the treatment was started below this 
threshold with pulse ramp rates of 0.67mA/ms to minimise plantaflexor contraction. Treatment was 
performed with the subject seated and the knee slightly flexed by supporting on a pillow to prevent
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plantaflexor spasm. PALS® Blue electrodes (40 x 90mm) were positioned longitudinally over the 
tibialis anterior from beneath the tibial condyle, with approximately 20mm between them and as 
anteriorly as possible without being over the tibia (Fig.5.7.1). However to avoid the ensuing skin 
reaction (Fig.6.1.2), 50mm square electrodes were used in subsequent weeks and their position was 
altered slightly. By week 4, contraction of tibialis anterior was noticeable at its centre when the foot 
was held in dorsiflexion and no fatigue was apparent after 30min of 0.5Hz stimulation. This 
contraction increased in area and strength as the intensity was gradually increased and by week 6, 
the flexor tendons of the largest toe were visibly tensioned across the foot dorsal surface. The 
square electrodes were continued with, because of the flexibility of position, although the 
contraction was greater with the larger electrodes. By week 12 foot dorsiflexion and inversion of 
approximately 5mm was possible with the long trapezoidal pulses of up to 50mA. However ramp 
rate could not be reduced without plantaflexor recruitment and tetanic stimulation (40ms, lOHz) 
produced only plantaflexion response.
As the epidermis became dehydrated (§6.1.3) contraction response diminished and took an 
increasing proportion of the treatment session (10-15min) for the current to build up to the level for 
effective contraction. Pulse width and ramp rate were therefore reduced at week 16 to minimise 
skin reaction, even though plantaflexion limited intensity to 29mA. Increasing the frequency to 
4Hz (w kl8) produced a semi-fused tibialis anterior contraction. Although intensity was initially 
limited by subject tolerance to 20mA, this subsequently increased, probably resulting in 
plantaflexion recruitment and accounting for the greater foot movement. These parameters also 
reduced the skin reaction, allowing the epidermis to rehydrate and the use of the larger (40x90mm) 
electrodes, which more selectively recruited the tibialis anterior at lower intensities.
Attempts to reduce the pulse width and increase the frequency reduced the tibialis anterior activity, 
such that only a small range of intensity (16-20mA) existed when dorsiflexion occurred before foot 
movement was dominated by plantaflexor recruitment. On occasions, the subject also reported 
plantaflexor spasm and a ‘tight’ feeling in the limb after treatment By week 28, the epidermis had 
became hardened once more. After 9 weeks of treatment with 5.5Hz stimulation, 70ms pulse width, 
8s on, 16s off contraction envelope and session duration of up to 30min, dorsiflexion was minimal 
and contraction force could only be felt with the foot passively held at 90° dorsiflexion. 
Contraction with long trapezoidal pulses soon fatigued. It was therefore concluded that the tibialis 
anterior contraction force was still insufficient to over come the shortened Achilles’ tendon in order 
to produce dorsiflexion. Passive stretching exercise of the Achilles’ tendon for lOmin each day, 
failed to alter the response and steps were taken to produce a brace to hold the foot at 90° 
dorsiflexion during the night, but not completed within this study.
At week 44, a better contraction response was obtained with the subject standing, which allowed 
the electrodes to be placed more centrally over tibialis anterior, without risk of thin tissue over the
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tibia. The patient was also able to tolerate intensities up to 25mA in this position and plantaflexor 
contraction was minimal. Visible contraction of tibialis anterior was obtained from stimulation with 
30ms pulses at 16Hz, although no dorsiflexion was detected. Treatment with these parameters and 
Is on, 4s off contraction cycle continued in this form for the remainder of the study, with minimal 
dorsiflexion and inversion, but taking up to 25min for the contraction to develop, which was 
continued for 15min.
An attempt was made (wk 28) to provide dorsiflexion during gait using ramped long pulse 
stimulation, with the pulse width adjusted to the swing phase and initiated by a hand held switch 
operated by the subject. However dorsiflexion was not sufficient to allow gait pattern to be altered. 
Further investigation awaited greater dorsiflexion and was not repeated within the study period.
SD Curve Measurement
Determination of Strength-Duration curve at smaller pulse widths was precluded by the dominance 
of the plantaflexion movement. The curves illustrate an increase in excitability associated with a 
decrease in Chronaxie (Fig.6.7.1), however analysis is hindered by variation in Rheobase.
PCI measurement
The subject reported a perceived improvement in gait during the treatment period. Physiological 
cost index was measured on 3 occasions during the study without stimulation, though for week 33 
it was measured pre and post a treatment session. The attempt to provide dorsiflexion during gait 
was not practised sufficiently to justify PCI measurement and awaits its greater efficacy. The 
measurements show a considerable improvement in PCI (39%), though predominately due to a 
decrease in heart rate change and not an increase in walking speed and therefore this is probably 
due to the improved blood pressure rather than the stimulation treatment.
W eek 8 W eek 33 W eek 44
Pre trtmt Post trtmt
Resting HR Bt/min 61 67 67 69
Mean HR increase Bt/min 22.7 15.7 16.7 12.7
Mean walking speed m/s 0.74 0.79 0.82 0.68
Mean PCI Bt/m 0.51 0.35 0.34 0.31
Table 6.7.1 Subject LR Physiological Cost Index Measurements
6.7.3 Sensation and Sensory Perception
Sensation of stimulation included sharp pulses, a 'drawing' sensation between the electrodes and a 
'tingling' when the toe flexor muscles were first activated. The subject was generally less tolerant of 
higher frequencies, which produced a 'gripping' sensation, though tolerance increased with
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continued treatment. The subject reported no increase in sensory perception during the study and 
this was only assessed with the monofilaments on one occasion (wk 24), showing a perception of 
the 4.31 filament over most of the foot but worse in some areas of the left.
6.7.4 Skin Response and Condition
Prior to the study, the subject experienced occasional skin aliments including mild dermatitis of the 
hands and usually used moisturising agents daily over the whole body. Intermittently, during the 
course of the study, the skin of both lower limbs developed inflamed pimples, dryness and a thin 
hardened ‘glazed' surface film, but these were exacerbated at the electrode locations. Stimulation 
with long pulses and twitch contractions particularly aggravated the skin, in terms of inflamed 
pimples rather than the uniform eythema of other subjects. Electrode position was rotated to allow 
recovery between sessions and water based Aloe Vera gel was found aid this. Reaction was less 
with shorter pulses and higher frequencies however skin hardening was not avoided. This hardened 
layer as with suntanning (wk 38) diminished tibialis anterior contraction response necessitating 
higher stimulation intensities and delaying the start of contraction by up to 25min, such that session 
length was extended by 15min.
6.7.5 Skin Temperature Measurement
Mean skin temperature in both lower limbs correlate with room temperature (p<0.05) and therefore 
was reduced for the majority of the study during the winter months (Fig.6.7.2). Leg skin 
temperatures were lower on the treatment limb and showed an initial increase in asymmetry, 
though this coincided with inflammation of the contralateral leg. Otherwise, measurements show 
no obvious change in asymmetry during the study, except in the foot where determination of 
segment area was particularly unreliable.
6.7.6 Blood Flow Measurement
As a result of prescribed medication, the subjects' blood pressure declined over the study 
(Fig.6.7.3), but also showed some variation. In week 24 systolic blood pressure was raised above 
the neighbouring measurements; in the preceding week the subject had been diagnosed as de­
hydrated and instructed to drink more liquid. The subject was very active on the morning preceding 
the visit of week 28 and heart rate was raised.
Leg blood flow measurements also show considerable variability (Fig.6.7.4), however this is not 
consistent in both limbs and does not correlate with room environment changes and correlation 
with diastolic pressure is only significant (p<0.05) on the contralatera limb. Initial fluctuation in the 
contralateral limb may be due to the affect of trauma oedema. Mean impedance values show no 
significant correlation to blood flow values, however low values on both limbs in week 4 made
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waveform analysis difficult and accounts for the low blood flow of the contralateral limb and high 
measurement variability of the treated limb. Blood flow of the contralateral limb shows an 
increasing trend up to week 24 and then a marked decline. The treated limb appears to show a 
consistent increase in leg blood flow initially but this is not sustained, however values during the 
period of treatment with twitch contractions (wks 0-18) are greater than those subsequently with 
fused contractions.
Leg blood flow in either limb showed no consistent change immediately after a treatment session 
compared with before. Blood pressure and heart rate during the stimulation session were raised, but 
by no more than routine walking.
6.7.7 Tissue Thickness and Limb Girth
Leg girth measurements (Fig. 6.3.5) show some variability, especially proximally, which probably 
reflect varying degrees of oedema. There is a decreasing trend in the girth of the treatment leg over 
the study, in parallel with that of body weight, however there is a marked decline from week 22, 
not long after the commencement of treatment with tetanic contractions, and increase towards the 
end of the period. Given the small size of tibialis anterior, the effect of treatment on girth is more 
likely to be on limb oedema than muscle bulk. Reliable tissue thickness measurement was not 
possible, because of the difficulties of identifying the tibialis anterior boundary, without a directly 
underlying bone.
6.7.8 Joint Range of Motion
In the subjects' opinion, the ankle on the treated limb has increased in ease of motion. The range of 
motion measurements (Tab.6.7.2), although demonstrating variability, shows consistent change 
only for the contralateral limb. Certainly the decrease in dorsiflexion of the treated limb feared as a 
consequence of plantaflexion is not confirmed and the 'active' value, representing the resting angle 
is unchanged. Inconsistent week 0 values are probably due to operator inexperience.
EXTENSION Plantaflexion) FLEXION (Dorsiflexion)
Week
No.
Left (trtmt) Right 1contrl) Left (trtmt) Right 1contrl)
passive active passive active passive active passive Active
0 30 25 45 90 127
6 32 28 82 104
8 28 26 24 23 74 38 100 94
12 33 37 15 29 80 46 113 103
22 25 32 28 35 78 50 104 95
28 39 24 72 99
38 24 26 25 29 76 98 94
44 25 28 88 45 97 94
Table 6.7.2 Subject LR Ankle Range of Motion (°)
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Figure 6.7.1 Subject LR Strength Duration Curve and Chronaxie Values
Week N o . 0 1 2 3 4 6 8 12 16 18 24 26 38 44
Chronaxie ms 13 13 12 12 S
Treatmt param eters n/c n/c n/c n/c n/c n/c isoM
intensity at max mA 33 39 25 35 40 45 50 29 20 20 20 20 24
overall pulse width ms 300 450 100 80 56 70 60 30
impulse duration twAx ms 10 10 40 40 23 35 30 15
ramp duration tp ms 60 100 2.5 0 0 0 0 0
ramp rate mA/ms 1 0.67 16.7 rect rect rect rect rect
frequency Hz 0.4 0.5 0.5 4 8 5.5 6.6 16
envelope on period sec cont cont cont 4 8 8 4 1
envelope off period sec 10 16 16 8 4
session length min 5 10 15 15 15 20 25 30 15 15 15 15 30 10
current limit mA 80 80 80 80 50 50 50 55 55 40 40 40 40 40
Table 6.7.3 Subject LR Treatment Stimulation Parameters
(n/c -no change, isoM -  isometric, parameter definition see Fig. 3.2.1)
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Figure 6.7.5. Subject LR Leg Girth at locations proximal of lateral malleolus
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7. D i s c u s s i o n  o f  S t u d y  R e s u l t s
7.1 Muscle Excitability and Strength Duration Curve
The study confirmed the findings of Kern, Hofer et al. [1999] and Mokrusch and Neundorfer [1994] 
(§3.4.2) that there is a progressive increase in muscle excitability with continued treatment, in 
terms of a decrease in minimum pulse width needed to cause muscle contraction. For instance, for 
subject LC, before treatment the minimum pulse width required for quadriceps contraction was 
10ms and by the end of the treatment this had decreased to 0.5ms, albeit at a greater intensity. This 
is not merely due to a decrease in apparent skin impedance allowing greater current flow, which on 
the contrary, typically increased as a result of the drying effect of stimulation with the electrodes 
used. Rather the initial treatment with low frequency twitch contractions appears to have had a 
conditioning effect on the muscle fibres, increasing their responsiveness. The few histological 
studies performed following this type of treatment [Mokrusch, Engelhardt at al. 1990, Neumayer, 
Happak at al. 1997] do show improvements in muscle fibre structure (§3.). It is possible its effects 
are both electrical (increasing the fibre membrane excitability) and mechanical (perhaps in 
releasing adhesion between fibres of the muscle and tendons). This was reflected in a decrease in 
Chronaxie during the treatment period and subsequent increase in the follow-up period. The major 
reduction in Chronaxie for subjects LC, LD and LE (from between 20 and 30ms to 13 and 10ms) 
occurred during this initial period of treatment with low frequency twitch contractions with little 
further change with tetanic contractions. This would account for the observations of a previous 
study [Taylor, Ewins at al.,1992] that, although the initial treatment with twitch contractions produced 
no change in tissue property measures, it made possible the later tetanic contractions which did.
The increased excitability is seen in the Strength-Duration (SD) curve (§2.4.4) for those with near 
complete muscle denervation (subjects LC, LD and LE), as a shift of the curve downwards and to 
the left as the threshold intensity is decreased especially at smaller pulses widths. These changes 
can only speculatively be related to fibre changes. Changes in mechanical properties and membrane 
electrical resistance may be expected to effect the response at all pulse widths evenly, whereas 
improvements in the contractile propagation process may effect smaller pulse widths 
proportionately more. However that, the Rheobase values was observed to vary (including 
increases) during the treatment period implies other factors are involved. The intensity was 
measured in terms of current (mA) and the limit of voltage of the unit was not reached until the 
smallest pulse widths. This negates the simple explanation of increased threshold intensity as due 
to increases in skin resistance, which occurred due to hardening of the skin beneath the electrodes. 
However it is possible that this disrupted the current path or added capacitace, necessitating the 
greater current.
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However, Chronaxie did not provide a direct guide to selection of stimulation parameters, largely 
because the threshold of minimum contraction applied only to a portion of the muscle and therefore 
the intensities required to contract the whole muscle at this pulse width were considerably higher. 
Also the SD curve and Chronaxie are determined for twitch contractions and do not indicate the 
muscle response at the higher frequencies required for tetanic contractions. For instance, a twitch 
response down to 3ms was obtained at the start of treatment from subject LC, but tetanic 
contractions could not be sustained over the whole muscle until at least 7 weeks later. It is probable 
that during this period of treatment the necessary changes in muscle structure and metabolism 
occur, with the increase in capillarisation and perfusion observed by others [Brown, Cotter et al. 
1976]. Nethertheless, tetanic contractions were not possible with Chronaxie values of greater than 
10 to 15ms.
For subjects with partial limb denervation (LB and LR) determination of the SD curve was severely 
hindered by co-contraction of the antagonist muscles, which caused limb movement and in 
stretching the muscle of interest and its tendons, could give a false impression of its contraction. 
Hence for subject LR, SD curve analysis was not as effective. However those for LB may reflect 
those of a partially innervated or partially conditioned muscle. It is possible to interpret the 
pronounced 'kink' in the curve (§6.6.2) as the transition between fibres 'conditioned' by voluntary 
control and less responsive ones, especially given that the kink shifted to longer pulses in the 
manner of a re-innervated muscle (Fig.2.4.2). Given the time since injury, it is unlikely that re­
innervation had occurred. It is more likely, (with the apparent innervation of the more distal 
brachioradialis) that the majority of the remaining contractile fibres are innervated but have 
severely deteriorated over years of disuse. This is possibly similar to one case treated by and 
Mokrusch and Neundorfer [1994] (§3.4.1). It would account for the rapid return of voluntary 
control of some fibres and response to 0.3ms pulse widths after conditioning with longer pulses. 
Treatment failed to produce any detectable contraction in the very severely atrophed wrist extensor 
muscles of subject LB, perhaps confirming its denervation, which after 23 years has resulted in 
severe atrophy.
7.2 Contraction Strength
As the muscle excitability increased, so did the strength of contraction for a given pulse width, as 
assessed visually in terms of muscle belly displacement. However, each time the treatment pulse 
width was decreased, the contraction response was reduced initially and then increased 
progressively over subsequent weeks, both in perceived strength and area. For instance, with 
subject LR, muscle contraction was only visible after 4 weeks of treatment as a slight flicker which 
then spread. This may reflect a conditioning of the contractile structures of the fibres as much as an 
increase in their size with the addition of new myofibrils. With isotonic contractions (subjects LC 
and LE ), contraction strength was assessed by means of limb movement. Subjects LB and LR did
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not develop isotonic contraction strength sufficient to overcome the co-contraction of innervated 
antagonist or associated shortened tendons. For subject LB, although the visible bulk of triceps 
recruited during contractions increased, the resting tissue bulk did not, despite 23 weeks of tetanic 
treatment, perhaps due the limited number of still active fibres. With subject LR, 26 weeks of 6Hz 
stimulation was ineffectual in developing sufficient contraction strength for the desired 
dorsiflexion. The 16Hz stimulation possible after 44 weeks, appeared more effective and selective, 
but was also hindered by elevated skin impedance. For subjects LC and LE, quadriceps stimulation 
produced leg movement of up to 14° with the knee at 90°flexion and therefore against minimal 
gravity component but not approaching the full extension achieved in other studies (§3.4.2). This is 
perhaps because isotonic contractions were only performed for a limited period, intensity and fibre 
recruited was limited by the electrodes used or possibility the stimulation pattern used. For instance 
the session length (30min) was longer than most other studies and may led to overuse damage.
Full knee extension contraction was achieved in other studies after 6 months [Mokrusch and 
Neundorfer 1994, Petrovsky, 1991] or 8 months [Kern, 1995] of treatment, though only Kern describes 
an initial period of conditioning treatment with twitch contractions. In this study, tetanic 
contractions were performed by subject LC for 20 weeks and subject LE for 19weeks, of which 7 
and 10 weeks respectively were with isotonic contractions. The period of treatment is therefore 
considerably less and for subject LC was interrupted by illness on several occasions. For subject 
LE, limb movement continued to increase, though not dramatically; for subject LC it declined over 
the last 5 weeks, although this included the periods of illness.
Kern et al. [1999] used large conductive rubber electrodes inside wetted towelling sleeves, with 
which the strength and area of contraction are considerably greater than observed in this study\ 
Perhaps these electrodes permit the use of far greater stimulation intensities (> 150mA) without the 
tissue damage of smaller electrodes^, though at the expense of considerable inconvenience of 
application. The larger size of self adhering electrodes used temporarily with subject LC, indeed 
produced a more distributed contraction and reduced erythema. However, in this study, stimulation 
intensity was restricted to the level of localised dysreflexive sweating, largely due to the 
unconfirmed possibility that the skin bums experienced were due to current concentration in sweat 
pores. These occurred with pulse widths of 100ms or greater, when any charge imbalance between 
the pulses would be greatest. Investigation of this showed a pulse asymmetry of less than 3%, due 
to the progressively diminishing amplitude of the second pulse, an effect apparently associated with 
the electrodes, which retain a charge when isolated (§5.7.2). The electrodes used in this study do 
appear to have introduced problems not reported by others, albeit with greater convenience. 
However smaller electrodes are required for treatment of smaller muscles and further investigation
 ^Presentation and communication at Vienna 6th International FES Workshop Sept 22-25 1998
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of the suitability of size, shape and materials is required, as well as the chemistry occurring at the 
skin interface, for instance Guttmann [1976] suggested salt solution to avoid bums.
The contraction response and effectiveness of the treatment in this study was affected considerably 
by skin impedance, to which the type of electrodes used may or may not contribute. After about 
two weeks of treatment, the contraction did not commence immediately at the start of the session, 
but took several minutes to build up as the current also increased (§6.1.2). The delay was less with 
tetanic contractions and large electrodes except in those with an existing dry skin condition (LE 
and LR). For instance, with subject LR whose epidermis hardened, current increased from 4mA to 
20mA over 15min, with an apparent impedance change from approximately 16kQ to 3.5kQ. This 
change may be a result of the erythema around the electrodes, a charging effect of the electrodes or 
a limitation of the stimulator, though the output voltage was not at its maximum value. No such 
delay was apparent with the equipment used by Kem et al.  ^The delay in start of contraction was 
lengthened to 25min when the duration of contraction was shortened to Is, presumably its effect 
takes longer to accumulate.
The amount of limb movement from isotonic contractions, increased with pulse width and Kem, 
Hofer et al.[1999] recommend the use of 40ms at 20Hz with 2s on, 2s off contraction cycle in sets 
of 6-8 contractions. This 80% pulse duty cycle, raised concern over the possible detrimental effect 
of near continuous current, and so a 50% duty cycle with 20ms at 20Hz or 27ms at 17Hz was 
employed in this study. Kern's stimulation pattern was attempted with subject LC at the end of the 
treatment period, but because of illness only performed for 2 weeks and produced no noticeable 
difference in evaluation measures. However, limb movement was considerably less with 2s 
contraction duration compared with the 8s used previously, when movement and current 
progressively increased during the contraction, despite a rectangular stimulation envelope.
In addition to the pulse width, there was concern during the study as to the most appropriate 
contraction duration and duty cycle. The original intention was to base the treatment pattern on that 
recommended by others who had demonstrated beneficial results. Initially a contraction duration of 
3 or 4s was used, based on that of Kem [1995], but with a rest period of 8s rather than 5s. Later, 
contraction duration was extended to 8s, with 16s rest as this provided a more sustained 
contraction, given the electrode effects noted above and comparable with the 10s on, 30s off used 
by Mokmsch and Neundorfer [1994]. For subject LR, a contraction duration of Is was adopted 
latterly as being more akin to the normal physiological recruitment during gait and therefore less 
likely to induce ovemse damage. However once again this lengthened the delay before start of 
contractions. Given that muscle perfusion in normal adults may be elevated for up to 2min 
following exercise (Fig.3.5.1), it is unlikely that full reperfusion can occur with any of these 
stimulation pattems between contractions, especially given diminished circulation of denervated 
muscle.
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Continuous, 24 hour stimulation of innervated muscle for cardiomyoplasty, can be tolerated and 
damage minimised by use of 2.5Hz [Lexell et al. 1997], however this does not necessarily apply to 
denervated muscle, with its altered metabolism. With subject LE, fatigue of isotonic contraction 
had reduced limb movement to 67% of its initial value after 25mins when the subject usually ended 
the session. Fatigue was similar with subject LC but more pronounced with 2s on, 2s off pattern 
even with a lOmin rest in between, though this could also have been the after effects of influenza. 
Treatment sessions lasted for up to SOminutes, twice a day; the same as employed by Kem in 1995, 
and less than typically employed for innervated muscle. However, others have seen benefit from far 
less treatment time, for instance, 6min treatment per lower limb muscle per day [Mokrusch and 
Neundorfer 1994].
Without the use of an appropriate non-invasive measure, it was not possible to determine whether 
the treatment pattems employed resulted in muscle cellular damage, and further optimisation of 
stimulation parameters necessitates a reliable means. However there was no obvious evidence of 
damage and muscle contractile ability was retained, whereas excess damage is said to lead to its 
complete loss [Herbison, Jaweed et al.l983]. The decrease in thigh girth of subject LC immediately 
proximal to the knee, especially during isometric contractions, is explicable as a toning of the 
muscle tissue and tendons, and that more proximally as due to general body weight loss due to 
infection. Conversely, for subject LE measurements show an increase in thigh girth and tissue 
thickness concurrent with increased body weight. With subject LR, the apparent failure or delay of 
muscle development of tibialis anterior may be attributed to eccentric work damage from co­
contraction of the plantaflexors. However this is the normal manner of working of the muscle 
during the gait cycle from heel strike to prevent 'foot slap' [Soderberg and Knutson 1995] and the lack 
of response appears to be related to skin impedance, but has continued to improve very gradually.
7.3 Evaluation Measures
Each of the treatment evaluation measures performed was subject to considerable variation, some 
of which can be attributed to measurement artefacts and operator clinical inexperience. This degree 
of variation masked any small effect of the treatment that occurred. Only with subject LE, for 
whom treatment continued the longest and most consistently, was there any noticeable change in 
the measures. This suggests the lack of change in other subjects, apart perhaps from LB, is due to 
insufficient treatment period, rather than some overall detrimental treatment effect. Other studies 
only cite the change in evaluation measures after a longer treatment period and therefore 
comparisons are difficult.
7.3.1 Resting Skin Temperature
The measured mean skin temperatures all show a strong correlation with room environment, and it 
is apparent that this is the major cause of change in values which could have been avoided by
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conducting measurements in an environment where temperature and humidity were controlled. 
Contrast of the leg and foot with respect to the background may also be enhanced by using a frozen 
towel behind the limb^, and would improve the reliability of determining the segment area. 
However the environmental changes did highlight the differential deficiencies of vaso-motor 
control of some subjects, resulting in an increase in asymmetry between limbs in lower room 
temperatures. Asymmetry values were typically in excess of those of normals.
There was no consistent treatment effect on skin temperatures observable across all subjects. With 
subjects LE and LR there was a dramatic decrease in mean skin temperatures during the first week 
of treatment despite an increase in room temperature, indicating perhaps an initial negative reaction 
of the treatment, though this may also be due to relative humidity related blood flow changes. For 
subject LC, room temperature also decreased at week 1 therefore masking any such effect, however 
skin temperatures did increase during the initial follow-up period without change in room 
temperature.
Amongst other studies, only that of Taylor (1992) cited a change in resting skin temperature of 
+3°C after 8 weeks of forearm stimulation (§3.4.2). This is corresponds to subject LB, who indeed 
did experience a similar increase in mean skin measurements during the period of treatment with 
long pulse tetanic contractions, both relative to the contralateral, and in absolute values, despite 
decreasing room temperatures. Kem et al. [1995] observed an increase in skin temperature of 1.6°C 
immediately after treatment, which was sustained for up to an hour but only in the thigh. In 
contrast, the increase in skin temperature observed after treatment of subject LE (Tab.6.5.1) also 
occurred distally, but the reversed asymmetry was not observed at other evaluation visits, five 
hours after treatment.
7.3.2 Resting Limb Blood Flow
Again, blood flow measurements exhibit some correlation with environmental conditions, however 
at least some of the variation in values obtained is attributable to many other factors and has been 
observed by others (§3.5.5). Of the two measurements taken of each limb on each occasion, the 
majority show close agreement and no consistent repeat measure effect. However it is apparent that 
subjects holding their breath during the measurement initiates a physiological response, 
contributing to variability in repeat measurements and may result in an underestimate of blood flow 
of the order of 10%. The dZ/dt waveform and repeatability of measurements was more consistent 
with the subject supine rather than recumbent, except for measurement of arm blood flow.
In other studies using impedance plethysmography to determine peripheral blood flow in normals; 
the average of 111 forearm measurements was approximately 155 ml/min (91-282) and the average
 ^Advice from Bums Unit, Salisbury District Hospital
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of 84 lower leg measurements was approximately 235 ml/min (60-639) over all ages [Porter, Swain 
et al. 1985]. No significant difference in blood flow was observed between those below or above 50 
years unless expressed relative to stroke volume, representing a larger proportion as cardiac output 
declined with age. At the start of this study, the approximate arm blood flow for subject LB was 
45ml/min. Although comparison is most appropriate in terms of per unit volume or weight of tissue 
values are expectedly low for the affected arm, but surprising low for the contralateral limb, though 
attributable to measurement artefacts (§6.6.6). For subject LR, leg blood flows, were approximately 
115ml/min throughout the study, which may be reduced from normal by the limited mobility of the 
subject and oedema.
Taylor, Ewins et. al.[1993] also observed considerable variation in impedance plethysmography 
measurement of thigh blood flow in 19 normals (average 324, SD 150 ml/min = 7.1% mean cardiac 
output) but were able to identify a significant difference amongst another 20 with bilateral spastic 
paraplegia following SCI (average 214, SD 153 ml/min = 5.4% cardiac output). In a further group 
of 7 SCI subjects, thigh blood flow was increased (from a mean of 167 ml/min SD 70ml/min = 
5.1% mean cardiac output) to the levels in normals by 3 months of stimulation of the quadriceps 
muscle. The figures in the Taylor study use Lvet from concurrent measurement of cardiac output 
for the beat flow duration (tg) whereas Porter derived it from the dZ/dt waveform, which is 
typically lower. In this study approximate mean values at the start of treatment for the SCI subjects 
are 110 (183) ml/min for subject LE and 95 (128) ml/min for subjects LC , where figures in 
parenthesis are with tB equal to L vet and represent 6.8% and 3.8% respectively of cardiac output 
measured in the follow-up period. The larger blood flow value for subject LE may reflect his 
greater level of innervation, however that it already constitutes a near normal proportion of cardiac 
output may account for the lack of great increase with treatment, with cardiac output being near the 
lowest level specified for normals by Porter [1986] whereas the converse applies to subject LC.
Amidst the variability o f measurement there is some detectable change, which may be attributable 
to the treatment. Thigh blood flow measurement values of subject LC increased in both limbs over 
the treatment period as a whole, by up to 31% (95 to 125ml/min). That flow levels were 
approximately equal in both limbs throughout the study may indicate a non treatment cause. 
However, the subject reported considerable sensation in both limbs during the treatment session 
and Kem (1995) also reported a contralateral limb perfusion increase amongst spastic paraplegics. 
For subject LE, blood flow asymmetry was reversed in favour of the treated limb towards the end 
of the treatment period even though absolute values did not increase greatly from at the start. With 
subject LB, a blood flow increase estimated at 10% occurred during the period of tetanic treatment 
with long pulse stimulation. There was no discernible trend of change in blood flow measurements.
Subject LE also showed a progressive increase in thigh blood flow with treatment of up to 42% at 
15min afterwards, with still increasing trend. Therefore, the effect of twice daily stimulation
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treatment on the averaged daily blood flow is greater than that indicated by the resting value. For 
instance, if blood flow remained elevated at these levels for one hour (as observed for skin 
temperature by Kem, Hofer et al.[1999], it would constitute a 3.5% increase in average flow. It is 
possible that a beneficial effect on skin condition and viability may accme from even short but 
regular periods of elevated blood flow and skin temperature.
The difficulties encountered in interpreting the impedance waveform and surprising results on 
occasions, questions the use of the technique adopted for blood flow measurement in this 
application. Certainly, measurement supine and with concurrent cardiac output measurement is 
recommended to improve consistency. Concurrent measurement with another method of pulsatile 
blood flow, such a doppler ultrasound, may help with interpretation of the waveform and variability 
of values.
7.3.3 Tissue Thickness and Limb Girth
The difficulty and variability of measurement of tissue thickness was largely due to the poor image 
quality of the original ultrasound scanner. However contributing to this, was that measurements 
were taken from images at the time of capture rather than storing them for later processing on a 
single occasion which would allow the tissue interfaces to be identified and changes in thickness 
followed with greater consistency. The method of limb support during measurement requires 
improvement; measurement of the arm were not performed in a consistent position or with the 
subject sufficiently relaxed, and the lower limb was measured with the subject seated on their 
wheelchair cushion, which distorted the proximal thigh, especially for girth measurements. The 
latter may be improved by a supine position. Given the variability of thickness values, concurrent 
measurement of limb girth and body weight were essential for interpreting results, especially for 
contralateral limb changes, although they are also prone to measurement errors and artefacts.
Determination of quadriceps thickness relies upon the correct identification of the intermediate 
tissue interface between the subcutaneous fat and the rectus femoris. Those identified from the 
image have been shown. However, the most consistently identified interface, yields values of the 
ratio of muscle to fat at mid thigh of 1.4 for subject LE and 2.3 for subject LC. Taylor found that 
amongst adult spastic paraplegic SCI subjects, the thigh muscle/fat ratio at mid thigh was 0.9, with 
subcutaneous fat thickness remaining approximately constant at 15.9mm following injury out of a 
total tissue thickness of 30.4mm. Overall tissue thickness was reduced in these denervated subjects 
at 20mm (LE) and 26mm (LC) and this would suggest, that at least for subject LC, the second 
interface identified is more suitable, giving mid thigh ration of 1.0. Muscle/fat ratios amongst 
patients with muscle atrophy due to SMA have been found to reduce from 2.0 to 1.0 [Schmidt and 
Voit 1993].
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Only with subject LE was there an appreciable increase in muscle thickness, which may be due to 
treatment and coincides with longer treatment period. Intermediate interfaces were not consistently 
identified on subject LB, the decrease in tissue thickness of the triceps and arm girth may be due to 
a toning of the tissues and tendons with muscle contractions. Similarly for decreases in limb girth 
occurring adjacent to the knee of subject LC, who reported a greater firmness to the thigh tissue 
and discernible muscle during contractions.
7.3.4 Range of motion
All subjects reported their limbs felt easier to move as a result of treatment. Subject LB in 
particular, experienced an appreciable decrease in resting finger flexion and therefore improved 
range of motion of fingers and wrist of the treated hand. With subjects LE and LR, the concern was 
that co-contraction of the innervated plantaflexors and toe flexors would exacerbate existing tendon 
shortening. Ankle range of motion was unchanged for subject LR but decreased in flexion for 
subject LE by up to 20°, which was not prevented by regular, though not daily standing. However 
the ankle of the treated limb did not appear less easier to move.
7.3.5. Sensory Perception
For most of the treated limbs, sensory perception was too poor to be assessed by the evaluation 
measures. However all subjects reported some sensation of the stimulation and subjects LB and LC 
increased sensory perception in the treated arm and abdomen respectively. The sensation as much 
as the limb movement was considered of benefit by the subjects, and enhanced motivation to 
perform the treatment.
7.4 Clinical Significance of Study
Since the start o f the study, researchers in Vienna [Kem, Hofer et al. 1999] have developed the long 
pulse biphasic technique to demonstrate functional standing for cases of chronic complete lower 
limb flaccid paraplegia and hope to continue towards ambulation. Stimulation, with quite different 
parameters is being employed transcutaneously and subcutaneously to enhance functional 
reinnervation in acute cases of brachial plexus and other peripheral nerve injuries. Both techniques 
appear to provide tangible function benefits, but it remains to be seen, whether these justify their 
adoption as routine clinical treatments.
The focus of this study was on the therapeutic benefits of stimulation to chronically denervated 
muscle, together with the possible functional benefits to cases of partial limb denervation. As 
originally envisaged, further studies with a larger number of subjects are still necessary to establish 
the therapeutic value of direct stimulation o f chronically denervated muscle and its clinical
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treatment viability. However this study has confirmed some of the findings of other studies of its 
potential benefits and highlighted some concerns for these future investigations (§8.2).
In particular the use of nerve accommodation using trapezoidal pulses for partial limb denervation, 
has been shown to increase muscle excitability of denervated muscle. However accommodation 
cannot be achieved at tetanic frequencies because of the limitation of rise time  ^ and therefore it is 
likely that functional stimulation will probably require a combined approach with other techniques 
to avoid or block the recruited nerve fibres. The value of 0.67mA/ms as the maximum rise rate to 
achieve accommodation applied with intensities of up to approximately 40mA, and therefore is of 
the same order of magnitude as that suggested by LeFlohic [1994] (0.2mA/ms = 20% of 100ms) or 
Stephens [1973] (0.3mA/ms = 3Ox Rheobase of lOmA/s) (§2.4.4).
In addition to the intended application of direct LPB stimulation for complete and partial chronic 
denervation, the study also included application to chronic disuse atrophy of innervated muscle and 
therefore highlighting another potential treatment group. It is interesting that if reinnervation 
occurred within the expected 2 years after injury, why it was not apparent earlier. The subject had 
adapted to manage without triceps function and therefore any fibres that were reinnervated did not 
receive loaded exercise and have become disused. It is speculation, as to whether functional use 
could have been restored, had stimulation treatment been applied much earlier, either before or 
after reinnervation, but the evidence cited in this work does suggest this. Certainly it is apparent 
that without the prompting of a treatment programme, the subject lacks the motivation to perform 
daily voluntary exercises with no functional outcome and it is probable that a refinement of the 
EMG based bio-feedback technique would be very suitable for this subject.
 ^Also observed by LeFlohic -  personal communication September 1999
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8. C o n c l u s i o n s  a n d  F u r t h e r  W o r k
8.1 Study Conclusions
The review of existing studies revealed that direct stimulation of complete lower limb denervation 
is being developed successfully towards functional standing. However the therapeutic benefits to 
tissue properties remain to be fully quantified and the application to partial limb denervation yet to 
be fully explored. The preliminary clinical investigations conducted in this study were not 
envisaged to fully test the hypothesis of the therapeutic benefits of long pulse biphasic stimulation 
to chronically denervated muscle, but to confirm the efficacy of the particular technique and the 
equipment developed.
The study has confirmed the findings of others that such stimulation treatment can restore the 
contractile ability of chronically denervated muscle through a progressive increase in muscle 
excitability, allowing a transition from twitch to tetanic isometric and then to isotonic contractions. 
This was demonstrated for three distinct treatment groups, near complete limb denervation (using 
rectangular shaped pulses), partial limb denervation (initially using trapezoidal pulses) and 
innervated muscle subject to long term disuse. However unlike other studies, functional use of this 
contractile ability was not demonstrated, either because of limitation in the technique adopted, or 
more probably, insufficient duration of the treatment period. In particular, difficulties of selectively 
stimulating a denervated muscle amidst surrounding innervated muscle were encountered and this 
limited the development of the muscle towards a functional contraction, even with prolonged 
treatment and as experienced in other studies. Trapezoidal shaped pulses were successful in 
selective recruitment of denervated muscle, but the intensity rise rate required for nerve 
accommodation precludes progression to tetanic frequencies. This highlights the need for a more 
sophisticated stimulation technique or other combinational therapy to allow selective treatment in 
cases of partial denervation.
The study was similarly inconclusive with regard to the therapeutic benefit of the treatment. The 
evaluation measures are suggestive of selective improvements in each of the measures, skin 
temperature, limb blood flow, tissue thickness and joint mobility. It is noteworthy, that the subject 
experiencing greatest benefit, had the longest and least disrupted treatment period, suggesting that 
its limited duration was the primary reason for the lack of significant changes. However, given that 
the changes observed in a previous study at SDH with shorter treatment period were not repeated, 
suggests other influencing factors, such as the length of period of denervation. Also apparent is the 
considerable variability in the evaluation measures, which may have masked any change or trend 
which occurred below this threshold. For the skin temperature and tissue thickness measurements.
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much of the variability can be attributed to measurement artefacts. Whereas for limb blood flow, 
measurement technique artefacts are likely to be a contribution but not the sole cause of its 
variability, which has been shown to be naturally high and therefore highlighting its disadvantage 
as an evaluation measure in this application.
Of the subjects themselves, those with near complete limb denervation, are convinced of the value 
of the treatment. Although the psychological effect of activity in an otherwise long dormant limb 
may be temporary, subjects were obviously more aware and taking greater care of their denervated 
limb than they had done previously. The sensations induced in the limb, the visibility of its 
movement and the act of participating in some exercise, enhanced motivation for attention to and in 
some cases use of the limb, for instance in passive frame standing. These factors can therefore act 
as a prophylaxis, quite apart from any measured improvements to tissue quality. In addition, some 
subjects cited increases in sensory perception and the relief of joint and other aches as definite, 
desirable benefits of the treatment and all wished to continue with it. Only in the case of partial 
denervation when the treatment was directly aimed at a functional outcome (that of restoring 
dorsiflexion), though not achieved, was it perceived not to be worthwhile continuing with the 
present technique alone. However it is probable that the restoration of contractile ability, loading 
and stretching of tendons and joint may prove to be a positive contribution to the eventual 
treatment option.
These investigations were originally intended as a forerunner to further clinical investigations and 
as such, have highlighted a number of limitations to be addressed in regard to the stimulation 
technique, the equipment, the study design and the evaluation measures chosen.
8.2. Suggested Considerations for Future Investigations
8.2.1 Stimulation Technique Considerations
1) All the subjects experienced some skin reaction, such that careful attention to the skin and 
electrodes was required. In particular, for a number of subjects, the skin became dehydrated 
and, in extremes, hardened, which delayed and diminished contraction response. 
Moisturising agents were required to counter this but raised concern over their suitability 
and possible tissue absorption.
2) Larger electrodes, appear to reduce skin reaction and recruit greater muscle area but 
necessitate greater stimulation current to achieve the same perceived contraction strength.
3) Stimulation intensity was restricted to the level of localised dysreflexive sweating and the 
unconfirmed possibility that the skin bums experienced were due to current concentration 
in sweat pores. The large conductive rubber electrodes inside wetted towelling sleeves used
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by Kem, Hofer et al. [1999] permit greater current and strength of contraction at the 
expense of inconvenience of application.
4) Because of the delay in the start of contractions at the start of sessions, longer contraction 
duration and session lengths were used than in other studies and raise the concem over 
possible muscle damage, although none was observed. A rest interval of lOmin within 
sessions and of 1 or 2 days per week may therefore be advisable.
8.2.2 Stimulator Unit Improvements
1) Multiple mode selection to permit concurrent treatment with a number of sets of 
stimulation parameters, for instance in the transition from twitch to tetanic contractions, 
allowing continued conditioning of less responsive fibres and gradual sensory 
accommodation to a change in parameters.
2) Multiple channel output to permit simultaneous stimulation of the same muscle group, with 
superimposed fields to improve selectively, or of multiple muscle groups for therapeutic or 
functional purposes. Possible simultaneous high frequency blocking waveforms.
3) Ramped stimulation envelope to permit a gradual increase in contraction strength during 
isotonic training, avoiding the current jerky movement.
4) Integral indicator of stimulation output current.
5) Pulse width range extension to lOps and 300ms for Strength Duration curve testing.
6) Improvement in Output Power Module efficiency to permit more compact unit for 
functional use.
7) Improvement of User Interface ease of use, display of stimulation output pulse shape and 
automation of pulse selection and intensity recording for Strength Duration curve testing.
8) Incorporate interface with foot switches to control stimulation for gait assistance.
8.2.3 Study Design Improvements
1) Extend treatment period to 12 months preceded by a pre-treatment period of at least 3 
months for collection of at least 4 reliable baseline evaluation measurements. Follow-up 
period should also be at least 3months.
2) Evaluation measurement visits may be less often (probably once a month after the initial 
month) but of longer duration to allow more regular inclusion of all measures and for 
instance, post stimulation treatment measurement of skin temperature and blood flow until 
stabilised to determine effect on peak and average values, rather than just resting.
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3) Evaluation measures should be performed in a temperature and humidity controlled 
environment with sufficient time allowed for acclimatisation with the subject in the supine 
measurement position.
4) Infra red thermography measurement would be improved by use of a frozen towel as 
background to enhance the contrast for very cool limbs.
5) Limb blood flow measurement should be performed with the subject supine. Repeat 
measures should be performed with at least 5 minutes interval between If  Impedance 
Plethesmography is to be used, concurrent measurement of cardiac measurement is 
recommended to guide the choice of beat duration and correlation with another 
measurement technique to account for variability.
6) Tissue thickness measurements should be repeated three times at each occasion. Adequate 
limb support should be provided without causing tissue distortion.
7) Measurement 'raw data' (ultrasound and thermograph images and blood flow waveforms) 
should be stored to permit comparison for consistency of interpretation. Ideally, processing 
should be performed or repeated at one single occasion for final results.
8) Subjects should be advised not to perform treatment on the day.
8.3 Further Work
In addition to continuing the investigation of the therapeutic value of direct stimulation, the 
following are also suggested as in need of investigation.
1) Investigate the therapeutic efficacy of treating multiple muscle groups of each limb.
2) Development of suitable means of assessing muscle damage effects of stimulation to assist 
in the optimisation of stimulation parameters and treatment patterns.
3) Investigation into the optimisation of electrode design, in terms of dimensions and 
materials, including the possibility of current concentration in sweat pores, charging 
effects and chemical interchange with the skin.
4) Investigation of methods of minimising co-contraction of innervated antagonist or adjacent 
muscles, for instance to permit functional stimulation for ‘dropped foot’ compensation.
5) Further experience of the Strength-Duration curve as a diagnostic tool and to guide 
stimulation parameter selection.
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1. study Title /
Investigation of Long Pulse Biphasic electrical stimulation of long term denervated muscle in 
humans to evaluate therapeutic and functional benefits
2. Investigators
This study is being conducted by the University of Surrey Biomedical Engineering Group in 
conjunction with Salisbury District Hospital (SDH) Medical Physics and Biomedical Engineering 
Department (MPBE).
The investigators involved in the study are;
Mr. AH Woodcock, Biomedical Engineering Group, University of Surrey
Dr. DJ Ewins School of Mechanical and Materials Engineering,
Guildford GU2 5XH 
Telephone 01483 259683
Mr. P Taylor Medical Physics and Biomedical Engineering Department,
Salisbury District Hospital, Salisbury, SP2 8BJ 
Telephone 01722 336262 ext. 4060
Medical Consultant to the study is
Mr. A Tromans Duke of Cornwall Spinal Treatment Centre,
Salisbury District Hospital 
Telephone 01722 336262 ext 2431
Physiotherapy and other staff of Salisbury District Hospital will also be involved
3. Research Background
In conditions where the nerve to the muscle (lower motor neurone) is no longer completely 
functional the muscle is said to be denervated, voluntary control of contraction and therefore the 
muscle function is lost or impaired. This may be caused by direct injury of the nerve, 
compression or infection and can occur at the spinal nerve roots, plexi or more peripherally. 
Typically, muscle wasting occurs, especially of the contractile elements, together with changes in 
the muscle fibre membrane, which if prolonged can hinder successful re-innervation. Muscle 
capillary density and blood flow are also reduced, such that if re-innervation does not occur, for 
instance in cases of complete limb denervation, the limb may be more susceptible to poor skin 
condition, infection, prolonged wound healing or sores in addition to poor cosmetic appearance 
and diminished personal esteem of the patient.
These effects may be less pronounced in cases of partial denervation, but re-innervation may still 
be hindered by muscle atrophy and so the greater potential for restoring useful muscle function 
may be lost. However partial function may be restored in such cases surgically by the transfer of 
tendons from an innervated muscle and control either voluntarily or by electrical stimulation.
It is therefore desirable to seek to minimise or at least partially reverse the changes occurring 
following denervation, either to increase the chances of successful re-innervation and restoration 
of muscle function or where this is unlikely, to improve the tissue bulk and perfusion for 
preventative and cosmetic reasons.
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It has been postulated whether such improvements may be achieved by externally initiated 
contraction of the muscle. Indirect electrical stimulation of innervated muscle via its nerve in 
patients with spinal cord injuries has been shown to restore the reduction of muscle bulk (typically 
50%) and limb blood flow (typically 45%) to near normal values over a period of 3 months. 
[Taylor, Ewins et al. 1992]. Contraction of denervated muscle is possible by electrical stimulation 
of the muscle fibres themselves, known as 'direct stimulation', but requires greater intensities and 
pulse widths than indirect stimulation.
Conventional electrical stimulation therapy for denervated muscle consisted of long duration 
(> 150ms) ‘galvanic’ pulses producing twitch type contractions. The frequency of these single 
polarity, monophasic pulses was limited to approximately 1 per second because of fatiguing of the 
muscle and by the potential damage to skin and electrodes because of the lack of charge balance 
[Eichhom, Schubert et al. 1984]. The lack of available equipment for regular unsupervised 
treatment'precluded improvement in the muscle contractile strength and therefore produced little 
therapeutic benefit such that the technique has largely been abandoned as a therapy [Boonstra, 
Van Weerden et al. 1987; Taylor, Ewins et al. 1992].
Use of balanced, alternate polarity, Biphasic pulses with no net charge transfer to the tissue can 
allow pulse widths of approximately 20-30ms and frequencies sufficient to achieve tetanic 
contraction of the muscle. Depending on the period of denervation, it may be necessary to 
commence with twitch contractions from pulse widths of up to 150ms, with a progressive 
reduction and transition to tetanic contractions as the contractile mechanism of the muscle fibres 
is restored, which may take 3-4 months [Kem, et al. 1995]. Treatment with this Long Pulse 
Biphasic (LPB) stimulation for up to 30 minutes each day for 8 months or longer in recent studies 
have demonstrated sustained improvements in muscle contraction force and bulk and limb blood 
flow in lower and upper limb ([Kem 1995],[Mokmsch, Neundorfer 1994],[Taylor, Ewins et al. 
1992],[Petrofsky 1991],[Eichhom, Schubert et al. 1984]^ All were long term, greater than 1 year 
post injury and most were complete lesion cases. However, some state that improvements were 
dependent upon achieving tetanic contractions [Kem, et al. 1995].
Electrical stimulation in some animal studies indicated a detrimental effect on muscle re­
innervation [Brown, Holland et al. 1979], but employed significantly different stimulation 
parameters to those in studies on human muscle. Re-innervation was shown not to be inhibited by 
long pulse stimulation treatment [Mokmsch, Neundorfer 1994] and indeed some current 
unpublished research indicates that it may be enhanced by different stimulation parameters, and 
may therefore also be advocated for acute cases before excess muscle atrophy occurs.
Other studies have concentrated on restoration of the function of denervated muscles, so as to 
maintain standing [Eichhom, Amdt et al. 1987] or foot dorsiflexion [Valencic, Vodovnik et al. 
1986]. In many of these incomplete lesion cases, treatment was hindered by recruitment of 
functioning sensory fibres. Gradually increasing the stimulation intensity using trapezoidal 
shaped pulses, is known to allow accommodation of surrounding nerves [LeFlohic, et al. 1994] 
and may alleviate excess sensation of stimulation and adverse recruitment of neighbouring 
functioning muscles.
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4. Study Objectives and Hypothesis
The objective is to investigate the effects of electrical stimulation of long term (greater than 1 
year) denervated muscle in humans using Long Pulse, Biphasic pulses and surface electrodes in 
respect of:
a) quantitative evaluation of therapeutic benefits (in terms of muscle bulk, limb blood flow, 
skin temperature),
b) optimisation of stimulation parameters including any progressive reduction in pulse width,
c) evaluation of trapezoidal pulse shape and variation of the rate of increase and decrease of 
stimulation intensity for reducing stimulation sensation and recruitment of neighbouring 
muscles in cases of partial denervation (sensory or sensory and motor),
d) eventually to evaluate possible functional benefits (contraction strength, restored muscle 
function, improvements in Activities of daily living).
The hypothesis that therapeutic and functional benefits may accrue from such treatment is based 
on favourable results from previous studies [section 3]. However, it is known from these that the 
response does vary between individuals and benefits are not guaranteed.
5. The treatment
The treatment under evaluation consists of twice per day sessions, of electrical stimulation with 
biphasic pulses of a suitable denervated muscle, using surface electrodes and a battery powered 
stimulator unit at the subjects home. Subjects will commence with five minute sessions, but this 
will be increased during the trial, up to a maximum of 30 minutes and reviewed at each hospital 
visit. The stimulation pulse width is expected to be progressively reduced during the treatment 
period (initially up to 150ms) allowing a transition from the single twitch to fused, tetanic 
contractions, necessary for therapeutic improvements. This is expected to be completed within 3- 
4 months [section 3] and the pulse width and frequency found to produce the most effective 
contraction vrill be used for the remainder of the 6 month treatment period. Stimulation intensity 
will be adjusted by the subject to achieve a reasonable and tolerable strength of muscle 
contraction, though initially and after the transition to tetanic contractions, it will be 
progressively increased from a lower value to avoid overloading of muscles, tendons and joints. 
Rectangular shaped pulses will be used, unless trapezoidal shaped pulses are required to 
minimise stimulation of sensory nerves or neighbouring muscles.
6. Evaluation Measurements
Monitoring and evaluation of the treatment will occur at regular visits by subjects to Salisbury 
District Hospital MPBE Department during the treatment and follow up periods. The 
measurement techniques are all well established, non-invasive and cause minimal discomfort to 
the subject. Standard equipment is to be used [Section 12] which has been checked for 
compliance with the relevant sections of the Medical Equipment Standard (BS5724 Part 2).
To allow quantitative evaluation of the treatment, the following measurements will be made on 
the limb of the muscle undergoing treatment and the contralateral where appropriate to the 
subject’s condition, as a control. These parameters are known to decrease with denervation in 
common with other forms of muscle immobilisation. Measurements a), c) and d) were used to 
evaluate the effect of stimulation training of innervated and denervated muscle of spinal cord 
injured patients and showed significant increases [Taylor, Ewins et al. 1992]. This is of particular
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therapeutic benefit where a complete or near complete limb is impaired. In cases of partial limb 
denervation, these changes may be smaller but any increase in (f) of greater value to the subject;
a) muscle thickness using linear array ultrasound on the selected muscle beneath the 
electrodes and at standard anatomically identifiable locations in-between. Measured prior 
to stimulation at each hospital visit. Limb is to be fully extended passively (if possible) 
and supported away from the muscle being measured. The thickness of surrounding 
muscles and other tissue will also be obtained where possible, to evaluate the selectivity 
of the stimulation, and which may account for changes in the other parameters.
b) limb girth measurement at the same time and locations as muscle thickness using a 
standard measuring tape to the mm.
c) limb blood flow using electrical impedance plethysmography, measured prior to and 
following stimulation treatment at each hospital visit.
d) skin temperature using Infra-red thermography at set angle of projection, measured 
prior to and following stimulation treatment at each hospital visit.
e) muscle innervation/ stimulation sensitivity using Strength-Duration curve 
determination for pulse widths from 0.1 to 300ms prior to stimulation treatment at each 
visit.
f) force generated by muscle contraction (where appropriate) using hand held 
dynamometer on appropriate part of limb, measured prior to and after stimulation 
treatment at each visit.
The following are measured to monitor for fluctuations which may affect baseline comparison 
and for the occurrence of autonomic dysreflexia as a result of treatment, which if severe may 
prevent its continuation;
g) blood pressure using standard automated cuff, at regular intervals throughout each 
hospital visit, including prior to, during and after stimulation treatment.
h) heart rate by same method and at the same times as blood pressure.
I) body weight at the beginning and end of treatment and follow-up periods.
The following assessments will also be performed subjectively, as a means of evaluating the 
treatment and to monitor for any adverse effects which may be alleviated by change of electrode 
type, position or stimulation parameters;
j) limb examination for sores, wounds, oedema, swelling and where appropriate,
range of motion of relevant joints by a suitably qualified therapist including assessment 
for contractures, or abnormalities of movement.
k) skin condition including colour and hydration, from the judgement of investigator and 
comments from subject. Video recording and photographs will be taken of the limb 
providing the subject has given prior consent.
1) skin reaction to the stimulation electrodes.
m)sensory assessment - subjects will be asked to quantify the sensation of a given level of 
stimulation in terms of its nature/duration and intensity (O-lOscale ).
n) nature and strength of contraction by video recording and photographs of the limb 
undergoing stimulation treatment, providing the subject has given prior consent.
o) general observations at hospital visits and daily by the subject, such as, ease and 
motivation for performing the treatment, ease of doing relevant daily living activities, 
limb and body temperature, neurological and autonomic effects (eg: sweating, 
breathlessness, disruption of bladder control).
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7. Potential Risks of Treatment and Participation
The stimulation equipment [section 12] has been checked by SDH MPBE department for 
compliance with the relevant sections of the medical equipment standards (BS5724 Part 2) and 
correct operation will be confirmed by the investigators at each visit to the hospital. Mains 
isolation is ensured by internal batteiy power source, and when under the control of the computer, 
connection is optically isolated.
In common with all forms of electrical stimulation, excessive current through the heart is 
potentially fatal. The risk of this occurrence will be minimised by careful instruction of the 
correct stimulation technique, including strict instruction never to place electrodes across the 
heart or allow stimulator use or application by untrained persons. The subject and/or carer will 
have to demonstrate understanding and competent use of the stimulation equipment, which will 
be monitored at the measurement visits. This will also minimise the risk of excess loading of 
muscle, tendons or joints from incorrectly positioned electrodes or excess intensity of stimulation.
Controversy exists regarding the effect of electrical stimulation on nerve re-growth and therefore 
the potential detrimental effect on muscle re-innervation. Subjects for this study will be at least 1 
year post denervation, after which re-innervation is very unlikely to occur.
Localised erythema (reddening of the skin) at the site of electrodes is normal with electrical 
stimulation and dissipates within 1-2 hours. Greater reaction will be identified at hospital visits or 
by the subject and may be alleviated by electrode position and type, but excess will preclude 
participation. Skin damage can arise from excess intensity or duration of stimulation. The risk of 
this from electrodes peeling from the skin is minimised by using a constant voltage output. The 
risk from incorrect use by the subject, or from an equipment fault, is minimised by monitoring of 
the output and duration of treatment session and automatic shut down of stimulation output with a 
warning to the operator.
The sensation of stimulation can be mildly discomforting at first, but is soon accustomed to, and 
may be alleviated by electrode position or stimulation parameters. Some autonomic response to 
the stimulation is possible which will be monitored for at the hospital visits. Subjects will be 
instructed to look out for any adverse reaction to the treatment, and to contact the investigators for 
advice whenever necessary.
The evaluation measurement techniques are all well established, non-invasive, and without known 
hazard. The measurement visits will last approximately two hours and subjects will be instructed 
to take necessary precautions against pressure related injuries during these and the daily 
stimulation sessions.
Subjects will be warned of the discipline required in performing the daily stimulation treatment 
and attending the hospital for visits. Also not to expect any dramatic benefits from the treatment. 
Subjects are free to withdraw from the study at any time without needing to give a reason.
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8 . Study design
a) Study type
The trial is a one year pilot case study with 5 subjects and no control group, consisting of a 
treatment period and subsequent follow up period without treatment. The study will be mostly 
of an exploratory nature as the exact treatment (stimulation parameters) will vary between 
individuals, dependent on the condition and the duration of denervation, and will be based on 
that of previous studies. Measurements will be taken throughout the trial period to quantify the 
effects of treatment but these will be evaluated on an individual case basis.
b) Trial duration
Providing subject compliance, the treatment period will last for 6 months, as evidence from 
previous studies [Taylor, Ewins et al. 1992] suggests that changes in the evaluation 
measurements will stabilise within this period or at least the trend of any change will be well 
established. The follow-up period without stimulation treatment will also be for 6 months. 
Funding'for the trial cannot support continuation of treatment beyond the trial period, however 
this may be possible if additional funding is available.
c) Sample size
Subject numbers are not intended to permit statistical analysis of results, but rather an indication 
of the effect of the treatment, its clinical feasibility and some optimisation of stimulation 
parameters. If findings are favourable, the study may be expanded to evaluate the effectiveness 
of the treatment over a range of neuro-muscular conditions.
d) Treatment Controls
Subjects with a stable long term condition will be selected and serve as their own controls; with 
all receiving the treatment. The effectiveness of the treatment will be determined by evaluation 
measurements [section 6] taken at regular intervals throughout the trial. Measurements prior to 
treatment will be used as baseline levels for comparison and it is assumed subjects condition 
sufficiently stable not to justify an extended baseline measurement period, especially as contra­
lateral measurements will monitor for fluctuations in baseline levels during the treatment period. 
Measurements during the follow-up period, without treatment will serve to confirm positive 
effects of the treatment.
e) Analysis of Evaluation Measurement Data
The measurements taken at the initial assessment visit are to assist in the selection of subjects 
The baseline value for each parameter will be that obtained at the baseline measurement visit.
The values of the measured parameters and the percentage change from the baseline values will 
be presented with respect to time ( for treatment and follow-up periods) for each subject of the 
treatment limb and contra-lateral. Comparison between subjects may not be appropriate because 
of differences in condition and stimulation parameters, especially in the duration of treatment 
with tetanic contractions, which are thought to be required to produce beneficial effect [section
3]. However with this caveat, the average percentage change for all subjects in each parameter 
may be similarly presented together with the corresponding variance. The data will therefore 
also give an indication of the variability in between subjects.
Comparison with contralateral measurements may assist in the interpretation of results, but may 
be influenced by other factors, especially if the extent of denervation and therefore daily muscle 
activity differs. It is also possible that these may be altered by some autonomic or neurological 
mechanism as a result of the stimulation.
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9. Subject Selection
The trial is to be conducted on 5 subjects, to be selected from previous referrals to Salisbury 
District Hospital MPBE or Spinal Treatment Centre, who have shown evidence of denervated 
muscle. To avoid any potential hindrance to nerve re-growth, these are to be at least one year post 
injury. Subjects will be sought with a denervated muscle that can be selectively stimulated with 
an acceptable level of recruitment of any neighbouring innervated muscle and/or sensory nerve 
fibres and easily accessible for evaluation measurement; a complete lesion of the lower limb and 
stimulation treatment of the quadriceps muscle group being the most suitable. To allow 
intersubject comparison, maximum commonality of condition and stimulated muscle is desirable. 
Subjects should be well adjusted to their medical condition, show comprehension of the trial 
format, treatment and limitations and indicate sufficient commitment for participation. Priority 
will be given to those candidates living closest to Salisbury to minimise travelling inconvenience 
and cost where consistent with the other considerations.
Prior to any participation in the trial, the approval of the subject’s GP/consultant will be obtained. 
The medical history of each subject will also be reviewed by the medical consultant for the trial.
The main reasons for exclusion of candidates are:
a) objection from the subject’s GP/consultant or trial consultant,
b) excess or large variation in heart rate and/or blood pressure or history thereof,
c) heart pacemaker or other implanted device which may be affected by electric fields,
d) other electrical stimulation device or therapy,
e) involvement in other research studies which will affect the results of this trial,
f) pregnancy,
g) local active pressure sores or wounds or less than 1 year post local surgery,
h) tissue oedema or broken skin in the vicinity of the selected muscle,
i) joint contractures, swelling or other skeletal or muscular abnormalities in the limb of interest 
affecting range of motion,
j) expected re-innervation ( injury less than 1 year),
k) age, less than 20 years or greater than 60 years, approximately, unless commitment to trial can
be reasonably given and other medical complications are unlikely to arise,
1) absence of muscle suitable for stimulation and accessible for evaluation measurement
m)intolerance to stimulation (eg. sensation, skin reaction to stimulation electrodes, joint swelling, 
unacceptable autonomic effect such as headaches, or excessive blood pressure)
n) adverse recruitment of neighbouring muscles especially if causing unreasonable movement, 
spasm or pain,
o) unsuitable disposition such as nervous of stimulation treatment, lack of commitment for
duration of trial or excessively optimistic expectations of the benefits from it,
p) unsuitable lifestyle or home environment to ensure regularity of treatment and measurement 
visits,
q) inability of subject or carer to demonstrate competent use of the stimulation equipment or 
comprehension of the required treatment routine.
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10. Outline Plan of Trial
a) Information Sheet
Candidate subjects and their GP/consultant will each receive an information sheet explaining 
the reasons for the trial and the requirements on participating subjects.
b) Initial Assessment Visit
With their GP/consultants approval, candidates will be invited individually to attend without 
obligation, an initial assessment visit at SDH MPBE Department to evaluate their suitability 
for participation in the trial. This will last up to 3 hours and be conducted by a hospital 
Clinical Scientist, the university investigators and a suitably qualified therapist.
Subjects will be requested to refrain from alcohol for 24 hours and from food and drink and 
vigorous exercise for 1 hour prior to the visit and to wear suitable clothing (eg: shorts and 
short sleeved top). A chaperon will be provided for female subjects if necessary. Precautions 
again"St pressure induced tissue damage will be taken and subjects instructed to bring with 
them any custom made equipment.
The visit will commence with an explanation of the format of the trial and stimulation 
treatment with respect to the Consent Checklist to ensure the subject understands the 
requirements of their participation. The subject will be asked to provide written consent if 
willing to participate. In addition to the review by the medical consultant for the trial, an 
external examination [6.j)] will be performed by suitably qualified therapist with regard to 
the exclusion criteria for participation [9.].
To identify a muscle or muscle group suitable for treatment and evaluation measurements, 
the standard electro-therapy technique of Strength-Duration testing [6.e)] will be used to 
explore the extent of denervation of the limb. Optimum stimulation parameters and electrode 
position will be determined for each candidate denervated muscles, with regard to strength of 
contraction, recruitment of neighbouring muscles, sensation or other responses. The most 
appropriate muscle or muscle group, if any, for treatment and assessment will then be 
selected and stimulated with the chosen parameters for a period equivalent to that to be used 
during the initial week of the trial (5minutes). Subject tolerance and compliance to this will 
be assessed including regular blood pressure and heart rate measurements [6.g),h)] and 
extemal-examination [6.j)] with special regard to skin and other possible reactions. Subjects 
will be encouraged to comment on the sensation of stimulation and report any noticeable 
effects.
Evaluation measurements [6.a)-h)] will be performed at the specified times during the visit to 
ensure their feasibility for the subject, allow them to become accustomed to the procedures 
and provide additional confirmation of baseline values.
c) Baseline Measurement Visit
For each of the selected subjects willing to participate in the trial, a second visit to SDH 
MPBE will be arranged at least a week later for baseline values of evaluation measurements 
to be obtained. This will be conducted by a university investigator under the supervision of 
qualified MPBE staff and last up to 3 hours.
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The format of the visit will be similar to the initial assessment with a check for contra­
indications to stimulation including blood pressure and heart rate measurements and an 
external examination. A period of stimulation treatment equivalent to that to be used during 
the initial week of the trial (Sminutes) will be performed after confirming the previously 
identified electrode positions on the selected muscle as optimum for the chosen stimulation 
parameters. Evaluation measurements [6a)-i)] and assessments [6k)-o)] will be performed at 
the specified times and after the stimulation, an external examination to check for skin or 
other reaction. Subjects will be encouraged to comment on the sensation of stimulation and 
report any noticeable effects.
Positioning of electrodes, connection to the stimulator and adjustment of stimulation intensity 
to achieve the required level of contraction will be demonstrated to and practised by the 
subject and/or carer. Full instruction in the use of the equipment will be given with reference 
to the User Instruction Manual; including all controls and indicator lamps and that the unit 
should be switched off and the researcher contacted in the case of failure, whether indicated 
or not. Warning will also be given of the potential risk from misuse of the unit and the 
necessity of keeping it out of the reach of children. Connection of the stimulator unit to the 
battery re-charging unit will also be demonstrated.
The required daily stimulation treatment routine will be discussed with the subject including 
timetabling and environment, to ensure they can realistically undertake participation. The 
format of subsequent regular measurement visits will be explained and dates provisionally 
agreed. The subject will then take home a stimulator unit programmed with their treatment 
parameters, battery charger and leads, supplies of electrodes, an User Instruction Manual for 
the equipment and treatment Observation Sheet.
d) Stimulation Treatment
At home, subjects will be required to perform the stimulation treatment of the selected 
muscle twice a day as demonstrated at the hospital visit. These sessions should be of the 
duration and times agreed with each subject at the previous measurement visit and any 
variation from this should be recorded on the Observation Sheet. They will also be 
encouraged to note down any observations regarding the stimulation, such as the comparative 
level of sensation, ease of obtaining a contraction and therapeutic or functional effects arising 
from the treatment, such as limb sensation, temperature, skin condition or colour, or ease of 
doing daily living tasks. Subjects will be instructed to examine themselves for swelling, skin 
reaction and be for aware for autonomic responses and, that in the case of any adverse 
reaction, to cease treatment and contact the investigators immediately or seek other medical 
assistance.
e) Measurement Visits
Each subject will be required to re-visit MPBE department at Salisbury for repeat 
measurements of those taken during the baseline measurement visit. These will occur at one 
week intervals for the first month, at two week intervals for the second and third months and 
at 4 week intervals thereafter. The total number of visits to MPBE Salisbury by each patient 
will therefore be 13 over 6 months and 19 over 12 months. The higher frequency of visits may 
be maintained if measurements indicate a continued rapid change. Visits will last about 2 
hours and be conducted by one of the university investigators under the supervision of
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qualified MPBE staff. Ideally they will all be arranged at the same time of day for each 
individual subject.
Subject stimulation technique, parameters, electrodes position, treatment session duration and 
skin or other reaction will be reviewed at each occasion and the stimulator re-programmed 
accordingly. As the subject becomes more accustomed to the stimulation, the duration of the 
daily treatment session may be increased up to a maximum of 30 minutes with subject 
tolerance of this confirmed during the visit. If tetanic contractions become possible, the 
session duration may be decreased and then progressively increased again to allow the subject 
to become accustomed to this form of contraction.
The treatment may have to be ceased if adverse reaction to the stimulation is observed, such 
as excessive heart rate or blood pressure. Adverse skin reaction may be avoided by changing 
the type of electrodes or stimulation parameters, but if persistent this may also preclude 
continuation of the treatment.
11. Subject records
Measurement data, video recordings and photographs of subjects will be kept confidential, 
referenced only by a subject identification code the details of which will be kept separately from 
the records. This and other subject information will be accessible only to the investigators. It 
may be made available to the subject’s GP/consultant on request, but will be anonymous if 
presented in publicly in reports, journal articles or conference proceedings. Additional written 
consent will be obtained from subjects to allow video recordings and photographs to be taken 
and if these are permitted to be presented publicly. Where the anonymity of the subject cannot 
be preserved in such material then these will be stored separately from other records.
12. Equipment for Trial
a) Stimulation Equipment
1) LPSTIMIO Long Pulse Stimulator Unit manufactured at University of Surrey to BS5724 Part 
2 guidelines
• self contained, portable unit ( 150x170x55mm), powered by an internal battery,
• single channel bi-phasic stimulation output in accordance with stored set of parameters;
• stimulation intensity 0-100mA, 0-1 GOV,
• pulse width 1-500 ms ( both positive and negative impulses)
• pulse rise time 0.5 - 250ms (linearly increasing)
• inter-pulse interval 30ms- 12s
• variable pulse repetition pattern
• maximum treatment time limit of 30 minutes
• internal monitoring inhibits output in case of excess output, electrodes not connected, 
low battery level or detected circuit failure
•  operator controls for ON/OFF, stimulation intensit>^ and mode selection
• indication o f  ON state, stimulation output pulse , output inh ib ited , battery level low
• external connection to stimulation electrodes or battery re-charging unit (mutually 
exclusive), Personal computer, and Control Signals
2) Re-charging unit - mains powered for re-charging stimulator unit batteiy in situ.
3) Stimulation Electrodes - standard surface stimulation electrodes
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4) Opto-isolator interface unit for connection of Stimulator unit to PC
5) Personal Computer (PC) with Lab VIEW user interface programme to allow
• control of stimulation parameters ‘on-line’ during stimulation
• downloading of parameters into stimulator unit for independent operation
• Strength-Duration measurement, controlling pulse width and monitoring intensity
b) Evaluation Measurement Equipment [section 6]
a) Muscle thickness
Dynamic Imaging System XLF Linear Array 3.5 MHz Ultrasound scanner, producing a 
cross-sectional image of the underlying tissues which may be printed. Measurement 
through non-absorptive gel pad to prevent tissue deformation. Non-allergenic, water based 
gel used on skin to provide good ultrasound signal transmission into tissue.
b) Muscle girth measured with standard flexible measuring tape to nearest mm.
c) Limb Blood flow
Minnesota Electrical Impedance Cardiograph [Porter, Swain et al. 1985; Porter, Swain 
1986] and 2 pairs of circumferential stainless steel electrodes, mounted 4 cm apart on 
webbing straps which are placed at either end of the body segment of interest. The 
equipment passes a lOOkHz, 4mA signal between the two outer electrodes. The rate of 
change of electrical impedance measured between the inner electrodes is proportional to 
the pulsatile blood flow, from which actual blood flow can be calculated.
d) Skin Temperature
Thermovision 780 SW Scanner System - Infra-red video camera and PC based image 
display of temperature of objects within field of view, following calibration against an 
object of known temperature,
e) Muscle sensitivity/innervation
Strength-Duration testing is a standard electro-therapy technique in which the muscle of 
interest is stimulated with single pulses of widths; 0.1, 0.3, 1.0, 3.0, 10, 30 ,100 and 
300ms, whilst the corresponding intensity required for each to obtain a minimum 
contraction response is recorded. The stimulation pulses and intensity measurement will 
be achieved using the LPSTlMiO Stimulator unit. ^
f) force generated
Hand held Dynamometer held against the limb of interest at a suitable position
g) skin condition & nature of contraction
standard portable video camera, tripod, VHS recorder, photographic camera
m) body weight - standard scales or sling harness scales as appropriate
n,o) heart rate and blood pressure,- standard portable, combined automated monitor
13. Resources
a) University will manufacture, test and maintain stimulation equipment
b) SDH will supply measurement equipment and any associated consumables
c) Travelling costs o f subjects will be met by the Inspire Foundation, who have provided £1500.
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Electrical stimulation is now used quite extensively for the toning of muscles to enhance 
cosmetic appearance and strength. It can also be used to restore muscle function, such as 
raising the foot during walking, grasping of the hand, control of breathing and internal organs. 
This treatment involves stimulation of the nerve controlling the muscle with an electric field 
from electrodes applied to the skin surface or implanted near the nerve and is used by people 
who have damage to their brain or spinal cord (typically T12 and above).
In conditions where the nerve to the muscle is no longer functional the muscle is said to be 
denervated. Typically muscle wasting occurs and there is a reduction in blood flow. Recent 
studies have shown that these effects can be at least partially restored by electrical stimulation 
of the muscle fibres themselves, known as 'direct stimulation'. However, this requires greater 
intensities and pulse widths than stimulation via the nerve and careful application of the 
stimulation current to ensure there is no skin damage
The purpose of this study is to quantify the effects of using Long Pulse Diphasic (LPB) 
electrical stimulation on the tissue quality of long term denervated muscle. We will also 
evaluate the effectiveness of variation of stimulation pulse shape at minimising the sensation 
of stimulation and later, investigate the possibility of producing functional muscle use. The 
initial trial will be conducted on 5 volunteer subjects over 12 months, progressing with 
additional volunteers if results appear beneficial. Volunteers must have lower motor neurone 
nerve damage due to peripheral nerve lesion, low level spinal cord lesion or a brachial plexus 
lesion and be at least 1 year post injury.
If you agree to participate in this study, you will be asked to attend an initial assessment visit at 
Salisbury to evaluate your response to electrical stimulation and to reveal any adverse 
muscular action, pain or skin reaction. Given satisfactory responses and your willingness 
(together with that of your GP or Consultant) to continue with the trial, a second visit to the 
hospital will be arranged at which you will be supplied with electrodes and a portable battery 
powered stimulator unit. You will be required to apply the electrodes to the skin and perform 
the stimulation on yourself twice a day, initially for periods of five minutes at a time and 
increasing to up to 30 minutes according to your tolerance. The strength of muscle contraction 
is determined by the intensity of the stimulation which will be under your control. You will 
receive full instruction in how to use the equipment, to position the electrodes and to identify 
the required level of muscle contraction. We will also discuss how best to arrange the 
stimulation time into your daily routine. You will also be supplied with a battery re-charging 
unit and be shown how to use this as necessary' between treatment sessions.
In order to evaluate the e ffec tiv en ess o f  the treatm ent, you w ill be asked to m ake regular v isits  
to  Salisbury H ospital lasting about 2 hours, in itially  at 1-2 w eek  intervals, and extending to 4  
w eek s as the trial continues. N on -in vasive  m easurem ents w ill be taken o f  m uscle  depth (usin g  
ultrasound), lim b blood flo w  (by electrical im pedance plethysm ography), skin temperature (by  
Infra-red therm ography), heart rate and b lood  pressure and contraction force i f  appropriate.
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Prior to these visits, you will be requested not to drink alcohol for 24 hours beforehand or take 
food, drink or vigorous exercise for 1 hour beforehand, as these will affect the measurements. 
With your permission, stimulation of the muscle undergoing treatment will be recorded on 
video or photographed and these will be kept confidentially. The stimulation parameters 
programmed into your stimulator may also be changed at these occasions as the muscle 
strength develops. You will be asked to use the stimulator for 6 months and then to stop the 
stimulation treatment but continue to visit the hospital for measurements at monthly intervals 
for up to a further 6 months.
Provided the operating instructions are adhered to, there is minimal risk from the equipment 
which automatically protects against excessive output intensit>'. The measurements to be taken 
hre all non-invasive and are well established techniques. The sensation of stimulation can be 
somewhat discomforting at first but one soon becomes accustomed to it. Some temporary 
reddening of the skin usually occurs beneath the electrodes. Excessive discomfort or skin 
reaction, if not alleviated by different electrodes or stimulation parameters, may preclude 
participation in the trial. This will be monitored regularly at the hospital visits.
You are free to decline to participate in the trial or withdraw from it at any time without 
needing to give a reason and without penalty or affecting future medical treatment. Equally the 
organisers reserve the right to decline or withdraw the treatment if it proves unsuitable, but this 
will usually be explained. Participants will be asked to inform the researchers of any activity or 
other medical treatment which may affect the results of the trial and this will be discussed at 
the initial visit. All personal information and correspondence associated with the trial will be 
held in strict confidence, available only to your GP or Consultant but not publicly. Results and 
measurement data of the trial will only be presented anonymously and video or photographs 
only with your permission.
The initial assessment visit will provide opportunity for discussion and explanation of the trial 
without obligation. For ease of access to muscles, please bring or wear shorts and short 
sleeved top (for example Tee shirt or Crop Top), also any special cushions or such like you use 
for pressure relief. Please feel free to bring a friend, family member or carer if you wish to. A 
chaperon may be provided if required. No payment can be made for participation in the trial, 
but your travelling expenses can be reimbursed. If you would like any further information in 
the meantime please contact either;
Paul Taylor
Salisbury District Hospital, Medical Physics and Biomedical Engineering Department
Tel: 01722 336262 ext 4065
Dr David Ewins or Alan Woodcock 
University of Surrey, Biomedical Engineering Group, Guildford GU2 5XH 
Tel: 01483 259683
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1. Subject Assessment Visit /
Objectives: 1) assess suitability of subject for participation in trial including,
2) identification of suitable denervated muscle or muscle group for stimulation 
treatment
Location: Salisbury District Hospital (SDH)
Medical Physics and Biomedical Engineering (MPBE) Department,
Duration: up to 3 hours 
Conducted bv: a qualified Medical Physicist,
university investigators, 
qualified therapist as required, 
subject chaperon provided if necessary 
Environment: comfortable temperature(~25°C) and humidity for examination 
Subject position: supine or seated with the limb extended,
but will depend upon the individuals condition 
Precautions: subject should;
not consume alcohol during the 24 hours before visit 
not consume food or drink or take vigorous exercise for 1 hour before visit 
bring/wear shorts and short sleeved top (eg; tee shirt or crop top) 
bring any cushions or other custom devices for pressure relief
Procedure: (refer to Subject Assessment Form)
a) Consent check list - review of the trial, stimulation technique, medical exclusion criteria
b) Consent form if subject willing to proceed with participation,
c) heart rate & blood pressure measurement at approximately 15 minute intervals thereafter 
including prior to, during and after stimulation
d) limb examination for skin condition, sores, wounds, oedema and where appropriate,
range of motion measurement of relevant joints by suitably qualified therapist including 
assessment for contractures, swelling and abnormalities of movement.
e) skin temperature measurement at rest using Infra-red thermography
f) limb blood flow measurement at rest using electrical impedance plethysmography
g) demonstration of experience of stimulation on subject muscle known to be innervated, 
preferably on contralateral limb with 300ps pulses and
sensory assessment subjects will be asked to quantify the sensation of a given level of 
stimulation intensity in terms of its nature /duration and severity (scale of 1-10)
h) extent of denervation of the limb is to be explored from the response of muscles to 
stimulation with pulse widths between lOOps (to which only innervated muscle responds) 
and 300ms.
Having identified candidate denervated muscles for treatment (those only responding to 
longer pulses width, an iterative process may be required to establish the following (i) & (j)
Page 1 of 6
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i) Optimum electrode position will be determined for the candidate denervated muscles 
when stimulating with pulse widths of 300ms, to maximise contraction response and 
minimise recruitment of neighbouring innervated muscles, pain or skin reaction. The latter 
may be alleviated by an alternative electrode type. Positioning may have to altered if 
different parameters are to be use for treatment (especially for tetanic contraction) and once 
established, will be recorded with respect to anatomical landmarks for future reference
j) Optimum stimulation parameters, by determining for each candidate muscle the 
minimum pulse width possible to achieve a reasonable contraction and the frequency and 
intensity tolerable to the subject. This exploration will be performed with extreme caution 
at avoid damage to muscle, tendons or joints, especially if tetanic contractions are possible 
though these may not be advisable for initial treatment. If recruitment of neighbouring 
innervated muscles, pain or skin reaction remain excessive with reasonable stirhulation 
intensity, then the effectiveness of alleviating with progressively longer rise and fall times 
to the stimulation pulses (trapezoidal shaped) will be evaluated
k) selection of the most suitable muscle or muscle group for stimulation treatment and 
evaluation measurement for each subject will be made
I) muscle thickness measured using linear array ultrasound scanner on the selected muscle 
beneath the stimulation electrodes and at anatomically identifiable locations in-between on 
treatment limb and contralateral.
m)limb girth measured at these same locations on the selected muscle and at positions of 
electrical impedance electrodes on treatment limb and contralateral using standard 
measuring tape.
n) force generated by stimulation of selected muscle with the optimum parameters, (if tetanic 
contraction obtained) using hand held dynamometer suitably positioned against the limb.
o) period of stimulation (5 minutes) of the selected muscle with the corresponding 
parameters will be performed to evaluate patient tolerance of the treatment. Fatigue of any 
contraction obtained will be assessed and the stimulation repetition envelope may be 
adjusted accordingly.
nature of contraction will be recorded on video tape, if the subject has provided consent.
p) skin reaction to the stimulation electrodes will be monitored during these tests and if 
excessive may be alleviated by change of electrode type, position or stimulation parameters. 
However any alteration will require repetition of SD curve measurement and re­
optimisation of the parameters.
q) sensory assessment subjects will be asked to quantify the sensation of stimulation of the 
selected muscle with a given level of intensity, in terms of its nature /duration and severity 
(scale of 1-10) and beginning and end of the stimulation period.
r) review interview to summarise the findings to subject and assess patient compliance to 
treatment including subjects own observations. Where suitable for the trial, to discuss 
suitable times for the stimulation and measurement visits in the subjects daily routine and 
any prohibitive activities or medication. Confirm participation if known and arrange date 
for baseline visit.
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2. Baseline Measurement Visit
Objectives: 1) obtain baseline values of evaluation measurements
2) confirm stimulation parameters and electrode positions for subject
3) instruct and demonstrate use of stimulation equipment and issue to subject
4) discuss arrangements for daily stimulation treatment and observing response 
Location: Salisbuiy District Hospital (SDH)
Medical Physics and Biomedical Engineering (MPBE) Department,
Duration; up to 3 hours 
Conducted bv: a qualified Medical Physicist,
universit)' investigators, 
qualified therapist as required, 
subject chaperon provided if necessary 
Environment: comfortable temperature(~25°C) and humidity for examination 
Subject position: supine or seated with the limb extended, dependent on subjects condition 
Precautions: subject should;
• not consume alcohol during the 24 hours before visit
• not consume food or drink or take vigorous exercise for 1 hour before visit
• bring/wear shorts and short sleeved top (eg; tee shirt or crop top)
• bring any cushions or other custom devices for pressure relief
• not have food or fluid intake until at least after item (f)
Procedure: (refer to Evaluation Measurement Form)
a) body weight measurement using standard scales or sling balance as appropriate
b) heart rate & blood pressure measurement at approximately 15 minute intervals thereafter 
including prior to, during and after stimulation
c) limb examination for skin condition, sores, wounds, oedema and where appropriate,
range of motion measurement of relevant joints by suitably qualified therapist including 
assessment for contractures, swelling and abnormalities of movement.
d) skin colour may be recorded on video or with photographs for comparative evaluation if 
the subject has provided prior consent
e) skin temperature measurement at rest using Infra-red thermography on treatment limb and 
contra-lateral or other limb
f) limb blood flow measurement at rest using electrical impedance plethysmography on 
treatment limb and contra-lateral or other limb
g) muscle thickness measured using linear array ultrasound scanner at the previously 
identified locations on the selected muscle on treatment limb and contralateral.
h) limb girth using standard measuring tape, at these same locations on the selected muscle 
and at positions of electrical impedance electrodes on treatment limb and contralateral.
i) sensory assessment sensory assessment subjects will be asked to quantify the sensation of 
stimulation on an inneivated muscle (eg: on contralateral) with 0.3ms pulses and a given 
level of intensity, in terms of its nature /duration and severit)' (scale of 1-10).
j) electrode position identified previously will be confirmed as optimum in respect of 
maximum contraction response and minimum recruitment of neighbouring innervated 
muscles and sensation for the stimulation parameters previously identified as optimum.
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k) Strength-Duration curve measurement of the selected denervated muscle to provide an 
indication of the sensitivity of the muscle fibre membrane. The muscle is stimulated with 
single pulses of widths of 6.1,0.3,1.0, 3.0,10,30,100 and 300ms, whilst the corresponding 
intensity required for each to obtain a minimum contraction response is measured using the 
stimulator itself under the control of the computer.
I) stimulation parameters for treatment will be altered if SD measurement indicates altered 
sensitivity (minimum pulse width).
m)force generated by stimulation of selected muscle with the optimum parameters, (if tetanic 
contraction obtained) using hand held dynamometer suitably positioned against the limb.
n) period of stimulation (Sminutes) of the selected muscle, using the parameters identified as 
optimum: Fatigue of any contraction obtained will be assessed and the stimulation 
repetition envelope may be adjusted accordingly.
nature of contraction will be recorded on video tape, if the subject has provided consent.
o) skin reaction to the stimulation electrodes will be monitored during these tests and if 
excessive may be alleviated by change of electrode type, position or stimulation parameters. 
However any alteration will require repetition of SD curve measurement and re­
optimisation of the parameters.
p) sensory assessment subjects will be asked to quantify the sensation of stimulation of the 
selected muscle with a given level of intensit)', in terms of its nature /duration and severity 
(scale of 1-10) at the beginning and end of the stimulation period.
At the end of the period, stimulation will be ceased and electrodes removed to allow
q) skin temperature as per (e). Measurements will then be repeated at approximately 10 
minute intervals during r) to v) until stable value reached, with care to ensure the same 
angle of projection
r) limb blood flow measurement as per (f),
s) observation review of the effects of stimulation treatment including comments by subject 
with regard to neurological and autonomic effects (eg: sweating, bladder control)
t) demonstration of stimulation technique and equipment. Positioning of electrodes, 
connection to the stimulator and adjustment of stimulation intensity to achieve the required 
level of contraction will be demonstrated to and practised by the subject. Full instruction in 
the procedures and precautions of using the equipment will be given with reference to the 
User Instruction Manual.. Connection of the stimulator unit to the battery re-charging unit 
will also be demonstrated. The subject or carer will have to demonstrate understanding and 
competent use of the equipment before it is issued to them. Subjects will also be instructed 
to examine their skin a few hours after the visit and before and after each treatment session 
for adverse reaction and to contact one of the research team should any occur.
u) review of daily stimulation routine, session duration . The suitability of the timetabling 
and of the environment for the treatment will be discussed, to ensure they can realistically 
undertake participation. The programme of evaluation measurement visits will be outlined 
and dates provisionally agreed.
v) issue of equipment to subject -a stimulator unit programmed with their optimum treatment 
parameters, supplies of electrodes and leads, battery charger and leads, a User Instruction 
Manual for the equipment and copies of the Subject Obseivation Sheet.
Appendix D Evaluation Measurement Procedure D-5
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
D E N E R V A T E D  M U SC L E  STIM U LA TIO N  TRIAL  
Evaluation Measurement Procedure
3. Evaluation Measurement Visits
Objectives: 1) monitor for adverse effects of treatment
2) obtain values of evaluation measurements
3) review optimum stimulation parameters and electrode positions for subject
4) confirm competent stimulation technique and use of equipment by subject
5) review Subject Observation Sheet and the effects of the treatment noticed 
Location: Salisbury District Hospital (SDH)
Medical Physics and Biomedical Engineering (MPBE) Department,
Frenuencv of Visits: 1 week intervals for the 1st month,
2 week intervals for the 2nd and 3rd months,
4 week intervals thereafter, unless measurements indicate a continued 
rapid change necessitating maintaining the high frequency of visits or 
 ^ transition to tetanic contractions occurs.
Time of Dav - Ideally at the same time of day for each individual subject.
Duration: approximately 2 hours 
Conducted by: a qualified Medical Physicist,
university investigators, 
qualified therapist as required, 
subject chaperon provided if necessaiy 
Environment: comfortable temperature(~25°C) and humidity for examination 
Subject position: supine or seated with the limb extended,
but will depend upon the individuals condition 
Precautions: subject should;
• not consume alcohol during the 24 hours before visit
• not consume food or drink or take vigorous exercise for 1 hour before visit
• not perform the stimulation treatment session on the day of the visit
• bring their stimulator, electrodes and any broken equipment with them
• bring/wear shorts and short sleeved top (eg; tee shirt or crop top)
• bring any cushions or other custom devices for pressure relief
• not have food or fluid intake until at least after item (f)
Procedure: (refer to Evaluation M easurem ent Form)
After a review of the daily treatment with the subject, the procedure will be as per 2(a)-(v), 
with the amendments as described below
a) body weight will only be measured at baseline measurement visit and end on treatment 
period if this is difficult
1) Adjustment of stimulation param eters
Denervated muscle is expected to become more sensitive to stimulation and respond to 
progressively smaller pulse widths during the initial months of treatment and will be 
indicated by the Strength-Duration test. As this occurs, the stimulator unit will be re­
programmed with smaller pulse width and where appropriate, increased frequency. 
Eventually this may permit tetanic contractions to be achieved and to which the subject may 
have to become accustomed, with a gradual increase in contraction strength (stimulation 
intensity) over a period of a few days/weeks according to their tolerance. If not already 
employed, it may also be necessary to introduce trapezoidal shaped stimulation pulses to
5
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alleviate pain or recruitment of neighbouring innervated muscles. The effectiveness of 
variation in the rate of increase/decrease in intensity of each pulse at achieving this can also 
be investigated. As tetanic contractions become possible, the frequency of measurement 
visits may be increased again to monitor for the greater tissue changes expected and to 
ensure the subjects technique provides sufficient contraction strength without causing 
excessive recruitment of neighbouring muscles, abnormal limb motion or joint loading.
n) period of stimulation will be of the duration being used by the subject during the preceding 
week unless altered by the investigators;
Adjustment of treatment session duration
As the subject becomes more accustomed to the stimulation, the duration of the daily treatment 
session (and the limit programmed into the unit) may be increased up to a maximum of 30 
minutes. This will be reviewed at each visit in conjunction with the stimulation parameters and 
subject tolerance to any change evaluated during the period of stimulation of the visit. If 
tetanic contractions become possible, the session duration may be decreased and then 
progressively increased again to allow the subject to become accustomed to this form of 
contraction.
0 & s) Monitoring for adverse reaction
The treatment may have to be ceased if adverse reaction to the stimulation is observed, such as 
excessive heart rate or blood pressure. Adverse skin reaction may be avoided by changing the 
type of electrodes or stimulation parameters, but if persistent this may also preclude 
continuation of the treatment.
p) sensory assessment
If a subject develops sensation from the stimulation after previously having none, then 
quantifiable measurement of sensation may be introduced, such as Von Fray hairs.
t) Subject stimulation technique
The patient will be asked to apply the electrodes and adjust the level of contraction, so that 
their technique can be monitored and corresponding stimulation intensity will be recorded for 
reference. Initially this will be conducted with the subjects current stimulation parameters and 
will be repeated if the parameters are altered to accommodate changes in the muscle 
sensitivity, see (3b).
v) issue stimulation equipment
Subjects will be issued with replacements for any items of equipment found to be faulty or 
broken.
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STORESEPARATEl^YÎTom Subject Personal Details
Subject Week No C onductedl^........................................................................... Date
code Time...
Finish.
Subject Observations from treatment (page 2 for examination details)
Completed treatment routine Y es/N o Ob.Sht Y es/N o Usage AN5/6(mins)................ No.sessions (AN7).
Skin reaction - excess Yes/No....
Skin condition/warmth....................
Sensation............... ......................... .
Contraction/fatigue..........................
Other m.recruittnent  .............
Headaches/dizziness/breathlessness.,
Change in ADL/mobility..................
Other/general...................................
Replacement Equipment: Stimulator Unit , re-programmed .Electrodes , Leads .Charger   Ob.Sht.
details............................................................................................................................................... .....................................
Expenses £....................  Receipt No.......................
Medical condition/medication change Yes/No GP aware Yes/No
Non-presription medication/lotions,
Bodv weight........................Kg .......................................................................................................
Precautions for measurement Pressure relieving device Yes / N o ..............................................
Last eating/drinking...........................................................................................................................................  time.
Alcohol in last 24hrs..........................................................................................................    time.
Last stimulation session Last exercise...................................
Change in exercise pattern Yes /  No  ..................................................................................................................
Change in diet pattern Yes /  No.........................................................................................................................................................
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Examination Treatment Limb...................... Contralateral. ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
skin temperature 
(including from 
thermography)
skin condition/ 
feel to touch 
(dry/clamy)
subject sensation
rashes/sores
wounds/surgery
tissue oedema
joint swelling
joint movement 
/contractures
muscle bulk
muscle spasm/ 
voluntary control
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Skin temperature seated / reclined / lying.................................................... for.............mins.
File Name........................................... Thermal range............................................... °C
time room tmp. ReI.H
“C %
TreattnentLimb | Contralateral
ext area pxls min nax mean SD ext area pxls min nax mean SD diff
Photograph No.............. Flash Yes /  no time Bid Pres. HR
/
File Name.,
time room tmp. Rel.H
Zo IQ/s cal.............. “C %
Treatment Limb Contralateral
Mt d/cm Zo/n HR LVet SV/ BF ext  d/cm Zo/fl HR LVet SV BF difTr.
Muscle thickness seated / reclined / lying. time Bid Pres.
/
HR
Treatment Limb Contralateral
location muscle thickness limb firth location muscle thickness
-
Skin Sensitivity Two Point Discrimination Yes/No Other,
Limb Blood Flow seated / reclined / lying.................................. at rest for.............mins
File Name ............................... Zo Ifi/s cal...........................................
time room tmp. Rel.H
°C %
Treatment Limb Contalateral
ext d/cm Zo/n HR LVet SV/ BF ext d/cm Zo/n HR LVet SV BF diffr.
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Refreshments provided Yes. / N o .............................................................................................
Subject Stimulation Treatment Demonstration - parameters as programmed for treatment
Intensity : Threshold mA .Treatment  mA,
Contraction nature...................................................................................................................
time Bid Pres. HR
/
Comments.
Strength duration Curve (stimulation intensity required for minimum discernable contraction) state contraction location
monoohaslc 100/1/1 Treatment limb intensity (mAW Contralateral limb..... . . . . . . . . . . .... Intensity (mA)A/
pulse
width(ms)
parmeters
AN4/AN5 thr contr thr contr
0.3 1 /1
' 0.5 1/91
1.0 1/240
3.0 9 /91
10 20/144
30 60/144
60 120/144
100 200/144
200 237/244
Review of parameters & electrode position unit used. electrodes used.
stimulation parameters lo /V o /IN  Zo muscle contraction other musclerecruitment sensation
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stimulation parameters lo /V o /IN  Zo muscle contraction other musclerecruitment sensation
Force generated.fNl..............measured.at............
Stimulation for a period o f .................... minutes
Contraction nature.............
Inten mA
fatigue............
Other muscles
time Bid Pres. HR
/
•Video. Yes/no
Skin reaction,
Photographs No.
Sensation.
Other,
KEEP INFORMA TION CONFIDENTIAL
time Bid Pres. HR
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Appendix E Evaluation Measurement Form E-6
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Evaluation Measurement Form
Treatment Limb 1 Contralateral
ext area pxls min nax mean S D / ext area pxls min nax mean SD diff
/
Photograph No................  Flash Yes / no
Limb Blood Flow seated / reclined /  lying.. at rest for mins
time room tmp. Rel.H
°C %
Treatment Limb Contalateral
ext d/cm Zo/£2 HR LVet SV/ BF ext d/cm Zo/n HR LVet SV BF diffr.
Stimulation parameters - change Yes/No Intensity............. mA
AN 1-3/.........../ .........../........... /  pulse ramp............... ms at  mA
AN4*5/........../.........../  pulse width............................... ms
AN6*7/........../.........../ frequency/ipi Hz  ms
AN8 / .........../  inter-impulse inteval.............................  ms
Envelope on/off Bank2 AN2/3 /............/ ............ / sec
Session length am..............min, pm....................min
Stimulator Programming TXD STIM parameters
TXD [P] STIM enter parameters TRANSFER 
TXD [P] Fault levels
Electrode position - change Yes/No
Switch OFF unit 
Switch ON unit
RXD STIM - fill out table opposite 
RXD Fault levels - fill out table 
TXD STATS
RXD STATS - check cleared
Observation sht:............
Nex visit date................................
Comments
ANl AN2 AN3 AN4 msr.50% 
□
Max Intensity
AN5 AN6 AN7 AN8 | |
ANl AN2 AN3 AN4
□  □ □ □  .  M
□  □
AN5 AN6 AN7
b2 b3
□  □
TXD Fault levels
ANl AN2 AN3 AN4
□ □ □ □
AN5 AN6 AN7 AN8
□ □ □ □
time Bid Pres. HR
/
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Appendix F Subject Observation Sheet F-1
University of Surrey Biomedical Engineering Group 
in conjunction with
SALISBURY Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
HtAlTH CARE DENERVATED MUSCLE STIMULATION TRIAL
Daily Observation Sheet
Use the stimulator each day at the times and for the period agreed. Fill out this sheet at each session 
Any serious adverse effects, STOP THE STIMULATION, contact the research team or seek medical advice.
Week In case of EMERGENCY, contact your GP or emergency services,
No...............................................  try to inform the research team
Subiect
code
DATE TIME SESSION
LENGTH
OBSERVATIONS
Please bring this observation sheet with you to your next hospital visit.
C ontact the research  team  a t any tim e 
Alan Woodcock, Dr David Ewins (01483) 259683, Paul Taylor (01722) 336262 ext 4065
Appendix G Skin Temperature Asym m etry of Limb Segments G-1
Thermographic Assessment: Significance Levels 
Limb segment asymmetry in normals, supplied by SDH MPBE
Lower Limbs Mean
Temp
Differen
ce(°)
Standard
Deviation
Mid anterior thigh 0.23 0.19
Mid posterior thigh 0.17 0.16
Mid patella 0.28 0.22
Mid tibia 0.26 0.17
Calf 0.23 0.18
Dorsum 0.35 0.25
Plantar 0.35 0.25
Upper Limbs and Back:- Females
Forearm 0.98 0.49
Elbow 0.82 0.43
Upper arm 0.78 0.47
Shoulder 0.74 0.5
Neck 0.38 0.19
Upper Thoracic 0.24 0.16
Lower Thoracic 0.32 0.19
Upper Limbs and Back:- Males
Forearm 0.72 0.38
Elbow 0.70 0.38
Upper arm 0.58 0.34
Shoulder 0.64 0.36
Neck 0.30 0.18
Upper Thoracic 0.24 0.15
Lower thoracic 0.20 0.16
Appendix H Post Treatment Period Questionnaire H-1
University of Surrey Biomedical Engineering Group 
flT  SALISBURY in conjunction with
HEALTH CARE District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIALKmnusT
Subject Questionnaire -post treatment
Subiect
code
Week no
Today’s 
Date ...
Date stopped 
treatment
Week no
This questionnaire is to help us evaluate the effectiveness of the trial.
Please answer the questions honestly, do not try to be ‘kind’ to the researchers in your reply.
The information will remain confidential. Your response will not prejudice your future treatment 
in any way and there will also be opportunity for discussion as required.
• Please answer all the questions; write ‘N/A’ (Not Applicable) or ‘none’ rather than leave a blank
• For questions with a choice of reply please tick the desired response, (eg; Yes I I No I I )
• For other questions with a box, please enter a number according to the specified scale.
• Use the spaces provided for details as requested and any additional comments of suggestions,
(if necessary, continue on the reverse side of the page, including the question number)
1 ) Before you started the trial, what were your expectations of the benefits of the treatment ?
2) Were you sorry to have to stop the treatment ? Y e s Q  No Q
3) Do you feel the duration of the trial was : too short | | long enough too long | |
Please explain your answer....................................................... ..............................................
4) On the whole, do you feel the treatment was of benefit to you ? ■Yes □  No □
5) What was the single most significant outcome (good or bad) of your participation in the trial ?
quest_la.doc KEEP INFORMA TION CONFIDENTIAL Page 1 o f 10
Appendix H _________________________Post Treatment Period Questionnaire H-2
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
6) How convenient did you find performing the treatment ?
Please use this scale to rate the following aspects of use and then specify the detail or comments;
veiy convenient convenient | 4 | acceptable ( 3 | inconvenient 2 very inconvenient | I |
a) positioning o f the limb CZI.
b) positioning o f the electrodes [%].
c) care o f electrodes (washing etc) [% ].
d) skin care at electrode positions I I.
e) duration o f treatment session [%].
f) time o f day o f  sessions [%]
g) the controls o f the stimulator I I..
h) adjustment o f stimulation level [H I ..
i) connections o f the stimulator [ H ..
j) recharging the stimulator I !..
k) in general / overall H I .
other comments...............
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Appendix H _________________________Post Treatment Period Questionnaire H-3
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department
DENERVATED MUSCLE STIMULATION TRIAL 
Subject Questionnaire -post treatment
7) Is the current treatment procedure convenient enough for you
to continue with it on a long term basis if necessary ? yes I I No I I
IfNo, how would the procedure have to be modified to enable you to do so ?
8) Which type and size of electrodes did you Pals Blue Gel | | Grev Pals Flex | |
find most effective or prefer to use ? 5x5 cm square Q  3 3 x 5.4 cm | |
4x9  cm rectanglrj | 7.5 cm round H I
8 X 14 cm oval | |
9) How often did you wash the electrodes ? ............................................................
10) How often did you wash the skin in the area o f treatment ?.................................................
1 1 )  Did you use any creams or ointment on your skin in the area of treatment ? Yes H I  No I I 
If  Yes, please specify what and when used.....................................................
12) Typically, how long did it take you to get set up prior to the treatment session ? ...............................
13) Typically, how long did it take you to remove the equipment after the session ? ...............................
15) Did you have any reliability problems using the stimulation equipment at home ? Y e sH I  No I I
IfYes. please specify;.................................................... ........... .
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Appendix H _________________________Post Treatment Period Questionnaire_____________________________________________ H-4
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
15) Did you use the stimulator at locations other than your own home ? Yes I I No I I
IfYes, please specify where and if you experienced any additional problems in using it there;
16) Do you have any suggestions for improvement of the stimulation equipment ?
17) How adequate was the information provided to you about the treatment and participation in the trial ? 
Please use this scale to rate the following aspects of the explanation given to you,
very good 5 good H I  adequate H I  less than adequate [Y ] poor [T ]
and make additional comments or suggestions for improvements in the space provided
a) the purpose of trial I I ............................ .................................................
b) the format of the trial I I ................................................................................................
d) the treatment procedure I I ................................................................................................
e) use of the stimulation equipment I I ................................................................................................
f) stimulator instruction manual I I  ...............................................................................................
18) What additional information or explanation would you like to have had before or during the trial ?
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Appendix H ________________________ Post Treatment Period Questionnaire H-5
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
19) During a typical treatment session, whilst using the stimulator what effects did you experience ? 
Please use this scale to rate the following aspects and then specify the details of the effect,
severe H I  moderate [~3~| slight | 2 | none noticeablej 1 |very severe
If the effect varied from one session to the next, please use the scale to describe the largest and 
smallest effects and how often these occurred. Similarly, specify if the effect varied over the course 
of the trial, perhaps as the stimulation parameters were altered. Please also indicate how long any 
effect continued after the treatment and comment on whether you thought the effect was of benefit.
a) skin reaction at the electrode sites I I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   ; . . .
b) temperature of the treated limb I I
c) sensation of the stimulation (eg: pins & needles, burning feeling, etc) I I
d) sensitivity of the treated limb (egitouch sensitivity, numbness, etc) I I
e) sensation/sensitivity of other areas
f) contraction of other muscles □
KEEP INFORMATION CONFIDENTIAL Pages
Appendix H   Post Treatment Period Questionnaire H-6
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
19) Remember this question refers to effets during a treatment session.whilst using the stimulator,
g) muscle tightness H I .-................. .................................................................
h) muscle spasms I I.
i) swelling of joints or tissue | | ,
j) ease of motion of joints | |
k) bladder/bowel function
1) headaches
m) nosebleeds
n) body temperature or sweating
O
□
□
o) other effects, please specify I I
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Appendix H  Post Treatment.Period Questionnaire H-7
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
20) Comparing vour general condition (without stimulation).before starting the trial and at the end, 
has this been affected by participating in the trial ?
Please use this scale to rate the following aspects and then specify the details and any comments; 
much improved[~5~| some improvement | 4 | no change made worse much worse | 1 |
a) skin conditi on at the electrode sites I 1..........................................................................................
b) skin condition of the treated limb I I
c) cosmetic appearance of the limb □
d) temperature of the treated limb □
e) body temperature or sweating □
f) sensations in the treated limb □
g) sensitivity of the treated limb □
h) sensation/sensitivity in other areas□
i) any voluntary muscle control I 1 ................................................................................... .........
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Appendix H _________________________Post Treatment Period Questionnaire_______________________________________________ H-8
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department.
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatment
20) Remember, this question refers to any effect on your general condition (without stimulation), 
comparing before and after the trial
j) muscle spasms -severity I I .........................................................................................................
k) muscle spasms -frequency] | .................................................................. ......................................
1) muscle tone or tightness I I .........................................................................................................
m) swelling of tissue .........................................................................................................
n) swelling of joints I I ..........................................................................................................
p) ease o f motion o f joints I I .........................................................................................................
q) ease o f movement of limb I I .........................................................................................................
r) mobility EZl................................................................................. ...... ...... .............
s) bladder function I I ................................................................ .........................................
u) bowel function j j ..............................................................................................................................................................
v) nose bleeds EZl...................................................... .....................................................
w) headaches I I .........................................................................................................
x) energy levels or tiredness I I ..........................................................................................................
y) appetite, eating patterns I I .........................................................................................................
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Appendix H ________________________ Post Treatment Period Questionnaire H-9
University of Surrey Biomedical Engineering Group 
in conjunction with
Salisbury District Hospital Medical Physics and Biomedical Engineering Department
DENERVATED MUSCLE STIMULATION TRIAL
Subject Questionnaire -post treatmpnr
20) z) sleep patterns ( 1...........................................
aa) other effects on your general condition ?, (eg: changes to the opposite, untreated limb)
21^ In what manner and how often do you use/exercise the limb in addition to the stimulation treatment ? 
(specify if formal physio or other therapy)...........................................
2 2 )  Does the stimulation treatment help with this use/exercise ? Yes [%] No I I
If Yes, please specify how;.........................................................
23) Would you like to continue to use the stimulator
as a routine treatment on a long term basis? Y e s O  No EH
24) If Yes, what benefits would you expect to receive from the treatment ?
KEEP INFORMA TION CONFIDENTIAL Page 9
Appendix: K PC User Interface D isplay Screen Parameters K-1
The PCUI consists of a series o f nine screens, (example Fig. 5.6.1), each selected by means o f the 
Mode Select menu and performing one o f die functions o f the interface, with parameters o f each 
screen as follows. Pulse parameters as defined in Figure 3.4.1.
RXD-STIM
RXBANKA
AN1
AN2
AN3
AN4
AN5
AN6
AN7
AN8
MSR>50% 
Max Intensity
TXBANKB
AN1
AN2
AN3
AN4
AN5
AN6
Displays the current stimulation parameters
pulse step size no. of increments at each DAC update } determines
MSB of ramp delay } value entered in 16 bit delay loop } stimulation pulse
LSB of ramp delay } within pulse DAC update loop } ramp rate
MSB of max pulse time } 16 bit value determining the duration of
LSB of max pulse time (150=500ps) } pulse at maximum amplitude t^ AX
IRQ time } determines Interrupt Service Request Interval
{256-AN6]*256*Period ; (81=50ms, 116=40ms), 156=30ms)
IPi count [muitiples of IRQ] }determines frequency of stimulation pulses
Inter-Inter pulse IntervaMOOpS } determines interval between opposite polarity
} impulses o f the biphasic stimulation pulses 
yellow indicates pulse width (PW) greater than IPI
the intensity value at which PW greater than IPI
AN7
AN8
bo
b1
Interrupts per second 
ON Time (seconds)
OFF Time (seconds)
Session Time (minutes) 
Current Pot Value [not used in 
Stimulation Power [1:2:4]
Max 
Half 
Quarter 
Max. current before Fail Mode
I l f
biphasic/mono
green
red
envelope
green
red
number of ISQ’s per sec,determined by BKA-AN6 
} stimulation envelope ON and OFF durations 
} in seconds
Duration limit o f each stimulation session 
TXD]
Scaling of stimulation intensity control sensitivity 
scaling by 1 
scaling by 0.5 
scaling by 0.25 
value o f stimulation current when fail warning 
occurs and current reduced to zero
stimulation pulse type: 
biphasic 
monophasic 
stimulation envelope status 
envelope enable
disabled -  continuous pulse train
b2 external stimulation triggered by external mput
b3 capacitor not used
RXD'Monitor Displays the monitored parameters (output current, voltage and Vp)
RXBANKA measured values represented digitally (0 -  255) with scaling as indicated
(see Fig.5.5.4 for definition measurement point o f stimulation pulse)
AN1 BAT_A Battery voltage before pulse } digital value 200 = ~11V)
AN2 BAT G Battery voltage at end o f pulse } 188= 10.5V
AN3 CUR A Output current before pulse } digital value approximately
AN4 CUR B Output current at end o f ramp } equal to lo (mA) up to 100mA
AN5 OVT_C Output voltage at end of 1®^ pulse } digital value approx. equal to
AN6 OVT_G Output voltage at end o f 2"  ^pulse } twice Vo (V) up to lOOV
AN7 CUR.C Output current at end of 1®^ pulse } digital value scaling as B , C
AN8 CUR G Output current at end o f 2“^  pulse }
Appendix K PC User Interface D isplay Screen Param eters K-2
RXD-Fault levels
RXBANKA
AN1
AN2
AN3
AN4
AN5
AN6
AN7
AN8
Displays the current monitored parameters warning thresholds
warning occurs when threshold values (0-255) exceeded according to Tab.5,5.1
Intermittent Battery Warning 
Continuous Battery Warning 
Warning ON time (IRQ’s) 
Warning OFF time (IRQ’s) 
Max Current at Pulse B start 
C:G Current Band
Max Intensity (rate test) 
Intensity Rate (rate test)
} warning thresholds with digital value 
} scaling as per monitor 
} values set the audible wamign duty cycle 
} (typical values 1:40)
} max permitted lo (mA) between pulses 
}max permitted difference in lo between 
} end of pulses measured at C and G 
} max intensity value before warning occures 
} max change in intensity allowed per IRQ 
} before warning occurs
RXD STATS Displays the current session and cumulative usage statistics
RXBANKA
AN1 LSB Session Use [seconds] } Duration of stimulator use during this session
AN2 MSB Session use [seconds] } in seconds
AN3 Session Use [minutes] } in minutes
AN4 Not used [0]
AN5 LSB Use [minutes] } Duration o f stimualor use since count last zeroed
AN6 MSB Use [minutes] } in minutes
AN7 LSB Use [count] [Number of times stimulator switched on since
AN8 MSB Use [count] } count last zeroed
TXDfn-STIM Enters stimulation parameters for temporary use, until switch off
Parameters as RXD STIM
TXD[P]-STIM Enters stimulation parameters for permanent storage 
Parameters as RXD STIM
TXD[T]-Fault levels Enters monitored param eter thresholds for temporary use
Parameters as RXD Fault levels
TXD[P]-Fault levels Enters monitored param eter thresholds for permanent storage 
Parameters as RXD Fault levels
TXD STATS Clears the current session and cumulative usage statistics
Parameters as RXD STATS
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Appendix M  Stim ulator Failure Mode & Effects Analysis _____________________________________ M-1
S t i m u l a t o r  F a i l u r e  M o d e  a n d  E f f e c t  A n a l y s i s
Following is an analysis o f the single fault failure modes o f the stimulator unit with respect to the 
effect on the output to the patient and any hazard thereby arising. The relevant circuit fault 
monitor, its action and the resultant output state are specified. The unit is thereby shown to be 
rendered safe to the user in all single fault conditions. Dual fault failures are not included because 
of their lower probably o f occurrence. An associated audio and visual warning also occurs upon 
detection of a fault (section 3.2.3) but these are not included in this analysis.
Components numbers referred to are those of the output Power Module 
Abbreviations ;
av.Iprimary average primary current during fault condition without monitor action * 
value depends upon the choseb stimulation pattern 
fault dum the period for which the fault has an effect on the stimulator output:
on -the output is only effected during the stimulation pulse
cont -the fault condition output is continuous 
mon, M monitor
VsT mon sawtooth waveform monitor
VccM monitor o f Vcc supply by MAX1232 -activated at Vcc=4.5v
VeM monitor o f Ve supply -activated at Ve=7v (PWDN)
VpM continuous monitoring of Vp (ANALOGUE PWR)
wdog Watchdog monitor in Microcontroller module
Vo output voltage
lo output current
Ip transformer primary current
Isec transformer secondary current
Vst Sawtooth waveform voltage
VcoMP PWM comparator output voltage
Iclamp current through output clamp path (U6)
MCM Microcontroller Module
0PM Output Power Module
pC Microcontroller device (16C73) part o f MCM
DAC Digital to Analogue converter in MCM
FET Field Effect Transistor (T3 switching primary current)
E/D Enable/Disable signal from MCM to 0PM
0/P CLMP Output Clamp signal from MCM to 0PM
o/c open circuit (ooQ connection)
s/c short circuit (OQ connection)
o/p output (usually the stimulation output to patient)
i/p input
incr. increase
deer. decrease
norm/nrm normal
rect.spulse rectangular subpulse shape to primary current waveform
intermit intermittent
swtchg switching ..referring to switching of primary current by FET
conectr connector
s.probe oscilloscope probe connection
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Appendix N  M O SF E T Thermal Calculations N-1
From IRF530 data sheet following method o f Clemente, (1993)
(Hexfet, power MOSFET Designers Manual Vol.3 pl37 - International Rectifier,
Maximum Junction temperature T jmax = 175 °C  
Roscon) =  0 .1 6 0  (max) @ V g s = 1 0 V ,  Id = 8.4A
— 0.430 @ Tj = 175 °C figure 4 of data sheet
Thermal Resistance Re (°CAV)
J -  device junction, C=device case, S=heatsink, A=ambient
RejA -Rejc + Rees + ResA = (T jmax - T a) / Id^ R:DS(on)
I dmax =  V (T jmax -  T a)  /  R qja. R]DS(on)
With no heatsink fitted:
ReJAMAX - = 62°C/W
With 21°CAV heatsink fitted:
RejA =1.7 + 0 . 5  + 21 =23.2°C/W
Idmax =  V(175-45)/ 62.0.43 =  2 .2 A
Idmax =  V (175-45)/ 23.2.0.43 = 3 .6A
W yiV E R SIT Y  C /  S U R R E Y  LIBRARY
